<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003148.pub3" GROUP_ID="CF" ID="627000080715093457" MERGED_FROM="" MODIFIED="2014-06-17 10:07:24 +0100" MODIFIED_BY="Tracey Remmington" REVIEW_NO="0041" REVMAN_SUB_VERSION="5.2.11 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2014-06-17 09:38:22 +0100" MODIFIED_BY="Tracey Remmington">
<TITLE MODIFIED="2013-12-18 16:14:18 +0000" MODIFIED_BY="[Empty name]">Psychological interventions for individuals with cystic fibrosis and their families</TITLE>
<CONTACT>
<PERSON ID="12578105910407464875110902155833" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Lutz</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Goldbeck</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Lutz.Goldbeck@uniklinik-ulm.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dptm. Child and Adolescent Psychiatry/Psychotherapy</DEPARTMENT>
<ORGANISATION>University Clinic Ulm</ORGANISATION>
<ADDRESS_1>Steinhoevelstr. 5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ulm</CITY>
<ZIP>D-89075</ZIP>
<REGION>Baden-Württemberg</REGION>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+49 731 50061661</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2>+49 731 50061662</FAX_2>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2014-06-17 09:38:22 +0100" MODIFIED_BY="Tracey Remmington">
<PERSON ID="12578105910407464875110902155833" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Lutz</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Goldbeck</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Lutz.Goldbeck@uniklinik-ulm.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dptm. Child and Adolescent Psychiatry/Psychotherapy</DEPARTMENT>
<ORGANISATION>University Clinic Ulm</ORGANISATION>
<ADDRESS_1>Steinhoevelstr. 5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ulm</CITY>
<ZIP>D-89075</ZIP>
<REGION>Baden-Württemberg</REGION>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+49 731 50061661</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2>+49 731 50061662</FAX_2>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="93652181619767542838120309142353" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Astrid</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Fidika</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Astrid.Fidika@uniklinik-ulm.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dptm. Child and Adolescent Psychiatry/Psychotherapy</DEPARTMENT>
<ORGANISATION>University Clinic Ulm</ORGANISATION>
<ADDRESS_1>Steinhoevelstr. 5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ulm</CITY>
<ZIP>D-89075</ZIP>
<REGION>Baden-Württemberg</REGION>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="52215018126776319482120309142616" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Marion</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Herle</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>Marion.Herle@uniklinik-ulm.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dptm. Child and Adolescent Psychiatry/Psychotherapy</DEPARTMENT>
<ORGANISATION>University Clinic Ulm</ORGANISATION>
<ADDRESS_1>Steinhoevelstr. 5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ulm</CITY>
<ZIP>D-89075</ZIP>
<REGION>Baden-Württemberg</REGION>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="001EC6F882E26AA20035135A986E16B7" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Alexandra</FIRST_NAME>
<MIDDLE_INITIALS>L</MIDDLE_INITIALS>
<LAST_NAME>Quittner</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Psychology</POSITION>
<EMAIL_1>aquittner@miami.edu</EMAIL_1>
<EMAIL_2/>
<URL>http://www.psy.miami.edu/faculty/aquittner/home.html</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Psychology</DEPARTMENT>
<ORGANISATION>University of Miami</ORGANISATION>
<ADDRESS_1>5665 Ponce de Leon Blvd.</ADDRESS_1>
<ADDRESS_2>Coral Gables</ADDRESS_2>
<CITY>Miami</CITY>
<ZIP>FL 33146-2070</ZIP>
<REGION>Florida</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 305 284 8439</PHONE_1>
<PHONE_2>+1 305 992 2411</PHONE_2>
<FAX_1>+1 305 284 4795</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2014-06-11 09:53:02 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="11" MONTH="6" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="12" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="11" MONTH="6" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2003"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-06-11 09:56:11 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-06-11 09:56:11 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="6" YEAR="2014"/>
<DESCRIPTION>
<P>Searches carried out identified 28 new relevant reports. Ten reports related to seven newly identified studies (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>) were included in this review. One previous classified as ongoing is now included (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>).</P>
<P>Nine of the new relevant reports were not eligible for inclusion. Three studies (<LINK REF="STD-Quittner-2011" TYPE="STUDY">Quittner 2011</LINK>; <LINK REF="STD-Quittner-2012" TYPE="STUDY">Quittner 2012</LINK>, <LINK REF="STD-Riekert-2012" TYPE="STUDY">Riekert 2012</LINK>) were recorded as ongoing and six studies are awaiting classification/information from authors.</P>
<P>Due to a new Cochrane Review on 'Self-management education for cystic fibrosis' (<LINK REF="REF-Savage-2011" TYPE="REFERENCE">Savage 2011</LINK>) all five previously included studies with an purely educational approach were excluded (<LINK REF="STD-Cheuvront-1998" TYPE="STUDY">Cheuvront 1998</LINK>; <LINK REF="STD-Trapp-1998" TYPE="STUDY">Trapp 1998</LINK>; <LINK REF="STD-Stapleton-2001" TYPE="STUDY">Stapleton 2001</LINK>; <LINK REF="STD-Davis-2002" TYPE="STUDY">Davis 2002</LINK>; <LINK REF="STD-Downs-2006" TYPE="STUDY">Downs 2006</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-06-11 09:55:29 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="6" YEAR="2014"/>
<DESCRIPTION>
<P>Leading author changed (new: Lutz Goldbeck) and new co-authors joined the team (Astrid Fidika and Marion Herle).</P>
<P>The title has been changed from 'Psychological interventions from people with cystic fibrosis and their families'.</P>
<P>The definition of psychological intervention was changed to be more precise and the classification of types of interventions, as well as specification of types of outcomes has been changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-05-14 15:12:43 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-05-14 15:12:43 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-08-12 14:53:33 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="29" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-08-12 14:53:33 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="29" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Twenty new reports were found. Eleven reports related to five new studies (Chernoff 2002; Davis 2002; Downs 2006; Powers 2005; Stapleton 2001) which were included in this review and three reports related to studies already included.</P>
<P>A single report of one study was excluded and four reports related to three studies which were recorded as ongoing. It was unclear whether one further report represented a new study or simply an additional report of an existing study and so awaits classification.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2009-08-12 14:53:33 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="29" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>The title has been changed from 'Psychological interventions for cystic fibrosis'.<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="21" MONTH="3" YEAR="2008"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Royal Liverpool Children's NHS Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>National Institutes of Health</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-06-11 22:06:58 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2014-06-11 21:52:00 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-06-11 21:51:01 +0100" MODIFIED_BY="[Empty name]">Psychological treatments to help individuals with cystic fibrosis and their caregivers manage the disease</TITLE>
<SUMMARY_BODY MODIFIED="2014-06-11 21:52:00 +0100" MODIFIED_BY="[Empty name]">
<P>Cystic fibrosis is a genetic disorder that damages many of the body's organs and can shorten a person's life span. The disease is progressive, stressful to manage, and needs complex and time-consuming treatments, leaving patients and caregivers stressed due to the challenges of the treatment. Thus, individuals with cystic fibrosis and their family members often need help to cope better and to deal with their thoughts and feelings. They also need assistance in managing the demands of the prescribed treatment schedules. In addition, infection control guidelines recommend the isolation of people with cystic fibrosis from others with the same disease, leading to a lack of peer support and potential social isolation.</P>
<P>We looked for studies of psychological treatments in individuals of all ages with cystic fibrosis and their families which aimed to reduce anxiety and depression, to improve adjustment, quality of life, and even medical outcomes, as well as knowledge, skills, and decisions regarding care. The review includes 16 studies with a total of 556 participants. Even though there many different psychological interventions, only a few have been evaluated for individuals with CF and their families. Due to the lack of high quality studies, it is not possible to currently show which psychological treatments are most helpful to those with cystic fibrosis and their caregivers. Five out of the 16 studies we found evaluated behavioural interventions to improve dietary intake. We found that in children aged 4 to 12 years receiving a nutritional intervention plus behavioural management training, consumed about 276 per day more than children just receiving the nutritional intervention. We also found that a structured decision-making tool for adults considering lung transplantation improved their knowledge, assisted in setting realistic expectations, and reduced indecision.</P>
<P>In summary, there is some evidence that behavioural interventions targeting specific illness-related symptoms and behaviours can work. More studies on psychological interventions with more people are urgently needed. There are several ongoing randomised controlled studies aimed at improving adherence to prescribed treatments, but final results are not yet available. We recommend multicentre studies to provide evidence for which interventions are most effective for the key issues faced by people with cystic fibrosis and their caregivers.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-06-11 21:49:44 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-09-27 13:26:58 +0100" MODIFIED_BY="Nikki Jahnke">
<P>With increasing survival estimates for individuals with cystic fibrosis, long-term management has become an important focus. Psychological interventions are largely concerned with adherence to treatment, emotional and social adaptation and health-related quality of life. We are unaware of any relevant systematic reviews.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-06-11 09:57:03 +0100" MODIFIED_BY="[Empty name]">
<P>To determine whether psychological interventions for people with cystic fibrosis provide significant psychosocial and physical benefits in addition to standard medical care.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-06-11 21:48:47 +0100" MODIFIED_BY="[Empty name]">
<P>Studies were identified from two Cochrane trials registers (Cystic Fibrosis and Genetic Disorders Group; Depression, Anxiety and Neurosis Group), Ovid MEDLINE and PsychINFO; unpublished trials were located through professional networks and Listserves.<BR/>
<BR/>Most recent search of the Cystic Fibrosis and Genetic Disorders Group's register: 19 December 2013.</P>
<P>Most recent search of the Depression, Anxiety and Neurosis Group's register: 12 November 2013.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-06-11 21:48:57 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled studies of a broad range of psychological interventions evaluating subjective and objective health outcomes, such as quality of life or pulmonary function, in individuals of all ages with cystic fibrosis and their immediate family. We were interested in psychological interventions, including psychological methods within the scope of psychotherapeutic or psychosomatic mechanism of action (e.g. cognitive behavioural, cognitive, family systems or systemic, psycho-dynamic, or other, e.g. supportive, relaxation, or biofeedback), which were aimed at improving psychological and psychosocial outcomes (e.g. quality of life, levels of stress or distress, psychopathology, etc.), adaptation to disease management and physiological outcomes.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-06-11 21:49:11 +0100" MODIFIED_BY="[Empty name]">
<P>Three authors were involved in selecting the eligible studies and two of these authors assessed their risk of bias.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-06-11 10:07:09 +0100" MODIFIED_BY="[Empty name]">
<P>The review includes 16 studies (eight new studies included in this update) representing data from 556 participants. Studies are diverse in their design and their methods. They cover interventions with generic approaches, as well as interventions developed specifically to target disease-specific symptoms and problems in people with cystic fibrosis. These include cognitive behavioural interventions to improve adherence to nutrition or psychosocial adjustment, cognitive interventions to improve adherence or those associated with decision making in lung transplantation, a community-based support intervention and other interventions, such as self-hypnosis, respiratory muscle biofeedback, music therapy, dance and movement therapy, and a tele-medicine intervention to support patients awaiting transplantation.</P>
<P>A substantial proportion of outcomes relate to adherence, changes in physical status or other specific treatment concerns during the chronic phase of the disease.</P>
<P>There is some evidence that behavioural interventions targeting nutrition and growth in children (4 to 12 years) with cystic fibrosis are effective in the short term. Evidence was found that providing a structured decision-making tool for patients considering lung transplantation improves patients' knowledge of and expectations about the transplant, and reduces decisional conflict in the short term. One study about training in biofeedback-assisted breathing demonstrated some evidence that it improved some lung function measurements. Currently there is insufficient evidence for interventions aimed at other aspects of the disease process.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-06-11 21:49:44 +0100" MODIFIED_BY="[Empty name]">
<P>Currently, insufficient evidence exists on psychological interventions or approaches to support people with cystic fibrosis and their caregivers, although some of the studies were promising. Due to the heterogeneity between studies, more of each type of intervention are needed to support preliminary evidence. Multicentre studies, with consequent funding implications, are needed to increase the sample size of these studies and enhance the statistical power and precision to detect important findings. In addition, multicentre studies could improve the generalisation of results by minimizing centre or therapist effects. Psychological interventions should be targeted to illness-specific symptoms or behaviours to demonstrate efficacy.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-06-11 22:06:58 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2014-06-11 10:57:43 +0100" MODIFIED_BY="[Empty name]">
<P>Cystic fibrosis (CF) is the most common life-limiting, hereditary disease among those of European descent; between four and five per cent of these people carry the recessive gene and 1 per 2500 live births are affected worldwide (<LINK REF="REF-Bobadilla-2002" TYPE="REFERENCE">Bobadilla 2002</LINK>). The incidence of CF is rare in native African, Asian and Oriental people (<LINK REF="REF-Tsui-1990" TYPE="REFERENCE">Tsui 1990</LINK>). The disease is manifested by generalised dysfunction of the exocrine glands, which produce excessively viscous mucus secretions. The pancreas and lungs are the main organs affected and prognosis is largely determined by the extent of the pulmonary damage. The treatment regimen for CF is complex and time-consuming, and is primarily aimed at slowing or preventing the secondary effects of the disease. Primary components of the current daily regimen include the following.</P>
<OL>
<LI>Airway clearance or chest physiotherapy and postural drainage using a variety of devices (acapella, flutter, chest wall oscillation)</LI>
<LI>Nebulised medications - bronchodilators, antibiotics, mucous thinning agents</LI>
<LI>Antibiotics &#8211; oral, nebulised, or intravenous</LI>
<LI>Replacement of pancreatic enzymes</LI>
<LI>Increased calorie intake through foods or nutritional supplementation - orally, nasogastrically or through a gastrostomy tube</LI>
<LI>Gene correctors for specific mutations of the CF gene</LI>
</OL>
<P>Significant increases in life span have been achieved due mainly to the availability of specialist multidisciplinary CF centres, early diagnosis via newborn screening, and treatment breakthroughs. In the USA in 1990, the mean and median ages at diagnosis were 2.9 years and 7 months, respectively (<LINK REF="REF-FitzSimmons-1993" TYPE="REFERENCE">FitzSimmons 1993</LINK>). The median survival age in the USA doubled between 1969 and 1990, from 14 to 28 years (<LINK REF="REF-FitzSimmons-1993" TYPE="REFERENCE">FitzSimmons 1993</LINK>) and those children born in the UK in 2000 have a predicted median age of survival of greater than 50 years (<LINK REF="REF-Dodge-2007" TYPE="REFERENCE">Dodge 2007</LINK>). Data from the CF Foundation Patient Registry show that in 2010, more than 47.5 per cent of all people with CF in the USA are 18 years or older.<B> </B>The median predicted age of survival in 2010 was 38.3 years, and the<B> </B>median age at diagnosis was five months (<LINK REF="REF-US-Patient-Registry-Annual-Data-Report-2010" TYPE="REFERENCE">US Patient Registry Annual Data Report 2010</LINK>).</P>
<P>Thus, CF is no longer solely a childhood disease, and as a consequence, long-term management issues have become more relevant, with increasing emphasis placed upon adherence to the medical regimen and the transition to adulthood while living with a chronic, life-threatening condition. In addition to the profound, emotional impact of a disease that is life-shortening, a major challenge for families is to balance the demands of daily CF care with the developmental needs of the affected individual and other family members (<LINK REF="REF-Quittner-1992a" TYPE="REFERENCE">Quittner 1992a</LINK>; <LINK REF="REF-Quittner-1992b" TYPE="REFERENCE">Quittner 1992b</LINK>; <LINK REF="REF-Quittner-1998" TYPE="REFERENCE">Quittner 1998</LINK>). The ultimate goal is to attend to the health needs of the individual without sacrificing overall quality of life of that person or their family. Thus, the major areas for concern from a psychosocial perspective include emotional and social adjustment, adherence to treatment, and health-related quality of life. These challenges must be placed within the context of the individual's age, from infancy through adolescence to adulthood, and within the context of the disease process, from initial diagnosis to death.</P>
<P>Although there have been descriptive overviews of psychosocial research in the area (<LINK REF="REF-Stark-1995" TYPE="REFERENCE">Stark 1995</LINK>; <LINK REF="REF-Miller-1999" TYPE="REFERENCE">Miller 1999</LINK>; <LINK REF="REF-Bluebond_x002d_Langner-2001" TYPE="REFERENCE">Bluebond-Langner 2001</LINK>) there have been no systematic reviews of intervention studies for those affected by CF until the first version of the current review was published in 2003 (<LINK REF="REF-Glasscoe-2003" TYPE="REFERENCE">Glasscoe 2003</LINK>). A meta-analysis of behavioural and emotional problems and self-concept in children aged 3 to 19 years with a variety of chronic medical conditions showed that these children had an increased risk of overall adjustment problems (<LINK REF="REF-Lavigne-1992" TYPE="REFERENCE">Lavigne 1992</LINK>). Those with CF fell into a group of moderate impact, with a pooled effect size of &#8706; = 0.5 in studies comparing those with CF to normative data (n = 9) and &#8706; = 0.44 in studies making comparisons to controls (n = 7) (<LINK REF="REF-Cohen-1992" TYPE="REFERENCE">Cohen 1992</LINK>). The most prevalent psychiatric diagnoses reported by Thompson in a 7 to 14 year age group with CF were anxiety (37%) and oppositional disorder (23%) (<LINK REF="STD-Thompson-1990" TYPE="STUDY">Thompson 1990</LINK>), while Pearson reported anxiety (22%) and depression (42%) as most prevalent in a 16 to 40 year age group with CF (<LINK REF="REF-Pearson-1991" TYPE="REFERENCE">Pearson 1991</LINK>). Targeted interventions aimed at addressing these symptoms of distress are a major focus for psychological interventions, utilizing a diverse range of theoretical perspectives for example with the paediatric population (<LINK REF="REF-Beale-2006" TYPE="REFERENCE">Beale 2006</LINK>). Although these older, cross-sectional studies do not document the development of psychological dysfunction over time, they generally demonstrate that a majority of those affected with CF adapt well, which is partially in line with more current data. Depression is one of the major mental health problems worldwide with prevalence rates estimated between 6.9% in Europe (<LINK REF="REF-Wittchen-2011" TYPE="REFERENCE">Wittchen 2011</LINK>) and 8.6% in the USA (<LINK REF="REF-Kessler-2012" TYPE="REFERENCE">Kessler 2012</LINK>). In the context of chronic conditions depression is of high relevance, because it is known as a risk factor for poor adherence to treatment (<LINK REF="REF-DiMatteo-2000" TYPE="REFERENCE">DiMatteo 2000</LINK>). Quittner reviewed studies examining rates of depression in patients with CF and reported higher rates of depression compared to healthy population (<LINK REF="REF-Quittner-2008" TYPE="REFERENCE">Quittner 2008</LINK>). Within a large epidemiological study (TIDES study) data from a representative sample of German patients with CF (N = 670, age range 12 to 64 years) showed that about one in 10 patients reported high levels of depressive symptoms, but elevated depression was not more common than in community samples, except for those with severe disease (<LINK REF="REF-Goldbeck-2011b" TYPE="REFERENCE">Goldbeck 2011b</LINK>). In summary, epidemiological studies examining symptoms of depression in CF were not conclusive in the question whether they occur more frequently in individuals with CF compared to the general population. Nevertheless, the Goldbeck study revealed that elevated anxiety scores were documented in about one in five patients and that they were more prevalent in adult German patients with CF compared to a community sample (<LINK REF="REF-Goldbeck-2011b" TYPE="REFERENCE">Goldbeck 2011b</LINK>).</P>
<P>Regarding parent caregivers, a multicentre study within the TIDES study showed that anxious and depressive symptoms are more common in German parents of minors with CF (N = 650) than in a community sample of adults matched by age and gender (<LINK REF="REF-Besier-2011a" TYPE="REFERENCE">Besier 2011a</LINK>). More than one-third (37.2%) of parents showed elevated levels of anxious symptoms, compared to 18.9% of a population sample and significantly more parents reported elevated levels of depressive symptoms (28% versus 21%). Only a minority of affected caregivers (13.6%) received any form of specialist treatment for their mental health problems (<LINK REF="REF-Besier-2011b" TYPE="REFERENCE">Besier 2011b</LINK>). A study conducted in the USA also found elevated levels of symptoms of depression in children (29%), in mothers (35%), and in fathers (23%), whereupon adherence to airway clearance was lowest for children with symptoms of depression and a less secure child-parent relationship (<LINK REF="REF-Smith-2010" TYPE="REFERENCE">Smith 2010</LINK>).</P>
<P>Adherence to the prescribed treatment regimen is one of the most challenging aspects of managing CF and parents often feel critically responsible for ensuring that these treatments are performed on a daily basis. Studies identifying rates of non-adherence in chronic paediatric conditions report that it affects about 50% to 75% of the children and adolescents (<LINK REF="REF-Rapoff-2010" TYPE="REFERENCE">Rapoff 2010</LINK>) and about 50% of adult patients (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>). For CF, reported rates vary widely, depending on different types of treatment and attempts to measure adherence. For example rates of approximately 45% (<LINK REF="STD-Quittner-2000" TYPE="STUDY">Quittner 2000</LINK>) and 64% to 74% (<LINK REF="REF-Modi-2006" TYPE="REFERENCE">Modi 2006</LINK>) for adherence to airway clearance in children with CF were reported. Moreover, rates for enzyme medication were reported as ranging from 27% to 46% (<LINK REF="REF-Modi-2006" TYPE="REFERENCE">Modi 2006</LINK>). Abbott described amounts of adherence reported in the CF literature and pointed out, that it is higher for simple treatment-related behaviours than for behaviours of more complexity (<LINK REF="REF-Abbott-2009" TYPE="REFERENCE">Abbott 2009</LINK>). Adherence to the major pulmonary medications, including inhaled mucolytics, inhaled antibiotics, and azithromycin, is for instance generally 50% or less (<LINK REF="REF-Modi-2010" TYPE="REFERENCE">Modi 2010</LINK>; <LINK REF="REF-Eakin-2011" TYPE="REFERENCE">Eakin 2011</LINK>). Dietary management is also necessary to prevent pulmonary decline. Although nutritional status improves, for example data from the 2011 German CF Registry showed that about 26% the of children and adolescents still have a BMI scoring below the 15<SUP>th</SUP> percentile and approximately 23.5% of adults have a BMI lower than 19 kg/m<SUP>2</SUP> (<LINK REF="REF-Stern-2012" TYPE="REFERENCE">Stern 2012</LINK>). Hence, a substantial proportion of patients need to improve their nutritional status. Overall, there is evidence that poor adherence reduces the effectiveness of treatment, might be responsible for disease progression and ultimately might reduce survival in chronic conditions in general (<LINK REF="REF-DiMatteo-2002" TYPE="REFERENCE">DiMatteo 2002</LINK>).</P>
<P>As psychological interventions have to be adapted to the developmental level of the patients, the broad age range of individuals with CF (from infancy to later adulthood) and the corresponding developmental tasks, a variety of intervention methods and aims are required in order to cope with the disease. Furthermore, psychological interventions should be designed according to the stage of the disease, ranging from the normal health status of infants diagnosed by newborn screening to the severe disease of patients awaiting a lung transplantation and those in the terminal stage of CF needing palliative interventions. Interventions aimed at reducing stress and improving coping may improve both psychological outcomes and disease management, including adherence to prescribed treatments and thus hopefully improving medical outcomes (<LINK REF="REF-Bartholomew-1991" TYPE="REFERENCE">Bartholomew 1991</LINK>; <LINK REF="REF-Smith-2010" TYPE="REFERENCE">Smith 2010</LINK>). Thus, the potential of psychological interventions goes beyond a mere improvement of mental health or psychosocial functioning, once the interactions of health-related behaviour and medical outcomes are considered. Therefore, a range of psychological interventions may be needed according to the broad scope of CF-related challenges. The scope of this review is therefore not limited to a certain type of problem, intervention, or category of outcome. Rather, the literature research is oriented towards a broad range of options for psychological interventions, with a focus on sound methodological studies.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-06-11 10:58:56 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>To describe the extent and quality of existing research on the efficacy of psychological interventions for individuals with CF and their families.</LI>
<LI>To establish whether the effects of psychological interventions, in addition to standard multidisciplinary care, provide significant benefits for the psychological and physical well-being of individuals with CF and their families.</LI>
<LI>To compare the effectiveness of different psychological interventions within major target areas, such as newborn screening, adherence to nutrition, airway clearance, and other medications, decision making in lung transplant, coping and adapting to treatment regimen, transitioning toward independence and adult care, and maintaining or improving health-related quality of life.</LI>
<LI>If psychological interventions were shown to be effective in these areas, then we planned to explore whether these effects varied depending on demographic characteristics of the family, socioeconomic status, age of the individual, or stage of the disease.</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2014-06-11 21:53:16 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2014-06-11 21:52:33 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-06-11 21:52:33 +0100" MODIFIED_BY="[Empty name]">
<P>All randomised controlled studies, published and unpublished.</P>
<P>We also considered quasi-randomised controlled studies, such as those using alternation and controlled studies, if a reasonable assumption could be made that the baseline was similar in both groups.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-06-11 11:01:10 +0100" MODIFIED_BY="[Empty name]">
<P>Children, adolescents and adults diagnosed with CF - individuals of all ages, from any ethnic group, and during all stages of the disease process will be included.</P>
<P>Parents or caregivers of a child or an adult with CF.</P>
<P>Siblings of a child or an adult with CF.</P>
<P>Nuclear family of a child or an adult with CF in which these individuals were identified collectively as a family unit.  </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-06-11 11:07:34 +0100" MODIFIED_BY="[Empty name]">
<P>A precise definition of psychological interventions is often missing in reviews on psychological interventions for patients with chronic illnesses (e.g. cancer (<LINK REF="REF-Hodges-2011" TYPE="REFERENCE">Hodges 2011</LINK>)). The following definition was used to identify possible interventions for the current review (modelled after the definition used by Pai for paediatric oncology (<LINK REF="REF-Pai-2006" TYPE="REFERENCE">Pai 2006</LINK>).</P>
<P>An intervention was defined as a psychological intervention and eligible for the review if it fulfilled the following:</P>
<OL>
<LI>included psychological methods within the scope of psychotherapeutic or psychosomatic mechanism of action (e.g. cognitive behavioural, cognitive, family systems or systemic, psycho-dynamic, or other like supportive, relaxation, biofeedback) and were provided in structured interactions between a participant and a facilitator;</LI>
<LI>was facilitated by psychologists, psychotherapists, and therapists in training or other trained professionals supervised by a clinical psychologist or therapist;</LI>
<LI>targeted areas for treatment set out in the aims and objectives for this review. The main targets for psychological interventions are: genetic screening for CF, adherence to treatments (e.g. nutrition, airway clearance, or other medication), coping or adapting to prescribed treatments, decision making in lung transplantation, and transitions towards independence and adult care;</LI>
<LI>was aimed at improving psychological or psychosocial outcomes (e.g. quality of life, levels of stress or distress, psychopathology etc.), adaptation to disease management or physiological outcomes (or both);</LI>
<LI>was compared to either no psychological intervention (apart from standard multidisciplinary care providing psychological support) or to an alternative psychological intervention;</LI>
<LI>was conducted in an individually-oriented, family-oriented or group setting.</LI>
</OL>
<P>The following broad categories were used to classify the different types of interventions.</P>
<P>1. Cognitive behavioral</P>
<P>2. Cognitive</P>
<P>3. Family systems or systemic</P>
<P>4. Psychodynamic</P>
<P>5. Other interventions</P>
<P>Within the five categories, subcategories will be used to classify the included studies. Those subcategories arise from the predetermined target areas for psychological interventions highlighted in the objectives. The main targets with implications for psychological interventions are: genetic screening for CF; adherence to treatment; nutrition; airway clearance; decision making in lung transplantation; and transition toward independence and adult care.</P>
<P>A review on interventions aimed exclusively at supporting adherence to treatment for CF is currently underway. Therefore, non-psychological interventions to promote adherence are not included in this review. Interventions only containing educational methods or educational approaches aimed at improving self-management were excluded in the current update because a separate Cochrane Review on &#8216;Self-management education for cystic fibrosis&#8217; was published in 2011 (<LINK REF="REF-Savage-2011" TYPE="REFERENCE">Savage 2011</LINK>).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-06-11 11:20:40 +0100" MODIFIED_BY="[Empty name]">
<P>The following outcome measures were of interest for the review. Due to the range of interventions and potential outcomes we classified them into broad categories according to their clinical relevance. We accepted any measure with adequate psychometric properties demonstrating reliability and validity in relation to psychological, social outcomes, or quality of life outcomes or a combination of these. All outcome data that were reported at a single time point post-intervention (or follow up) or were calculated as change scores were included.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary Outcomes</HEADING>
<OL>
<LI>Well-being and functioning</LI>
<OL>
<LI>Measures assessing health-related quality of life or psychopathology or distress and focusing on the affected child, adolescent or adult or their family or both.</LI>
<LI>Assessment of psychopathology or distress (any standardized interview that identifies a psychiatric disorder with 'The Diagnostic and Statistical Manual of Mental Disorders' (DSM) or an 'International Classification of Diseases' (ICD) category in an affected child or adult with CF or any self-report measure of emotional difficulties, such as anxiety or depression, or behavioural difficulties).</LI>
</OL>
<LI>Pulmonary function</LI>
<OL>
<LI>Objective measures of lung function (in infants younger than six years of age: chest radiograph scores and in older children, adolescents and adults: forced vital capacity (FVC), forced expiratory volume at one second (FEV<SUB>1</SUB>), residual volume/total lung capacity (RV/TLC), 25% to 75% of forced expiratory flow (FEF<SUB>25-75%</SUB>) (as % predicted)).</LI>
</OL>
<LI>Weight and height or body mass index (BMI)</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary Outcomes</HEADING>
<OL>
<LI>Adherence to treatment</LI>
<OL>
<LI>Measures of adherence (child, adolescent, adult or parent) to the treatment regimen including: pill counts; electronic monitors; calorie and dietary intake; self-report forms; semi-structured interviews; and diary reports.</LI>
</OL>
<LI>Social functioning</LI>
<OL>
<LI>Measures of how well the child, adolescent or adult is able to participate in developmentally appropriate social activities, to access social support systems, and to develop appropriate peer relationships and social skills.</LI>
<LI>Measures of academic performance deficits or achievements or employment in a child, adolescent or adult with CF.</LI>
</OL>
<LI>Cognitive psychological outcomes</LI>
<OL>
<LI>Measures of the coping strategies.</LI>
<LI>Measures of decision-making strategies or conflicts.</LI>
<LI>Measures of self-esteem, social competence, perceptions of their own appearance or body image, locus of control, self-efficacy or sense of coherence.</LI>
</OL>
<LI>Relational or family adjustment</LI>
<OL>
<LI>Measures of the relationship between the parents of the affected child, adolescent or adult or with their partner, of family functioning or communication and interaction patterns.</LI>
</OL>
<LI>Utilization and costs of health-care services</LI>
<OL>
<LI>Measures estimating the financial cost of the intervention in relation to its efficacy for the individual with CF or their family (or both) or costs for the health care services and utilization.</LI>
<LI>Number of hospital admissions, excluding the visits in CF centres for routine assessment.</LI>
<LI>Number of days hospitalised, excluding the visits in CF centres for routine assessment.</LI>
</OL>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-06-11 21:52:52 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2014-06-11 21:52:52 +0100" MODIFIED_BY="[Empty name]">
<P>Search strategies developed by the Cochrane Depression, Anxiety and Neurosis Group and the Cochrane Cystic Fibrosis and Genetic Disorders Group were undertaken. Relevant studies were identified from the Cystic Fibrosis Trials Register using the terms: motivation OR behaviour OR mental health in CF OR genetic counselling.</P>
<P>The Cystic Fibrosis Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (updated each new issue), quarterly searches of MEDLINE, a search of Embase to 1995 and the prospective handsearching of two journal - <I>Pediatric Pulmonology </I>and<I> </I>the<I> Journal of Cystic Fibrosis</I>. Unpublished work was identified by searching the abstract books of three major cystic fibrosis conferences: the International Cystic Fibrosis Conference; the European Cystic Fibrosis Conference and the North American Cystic Fibrosis Conference. For full details of all searching activities for the register, please see the relevant sections of the <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/CF/frame.html">Cystic Fibrosis andGenetic Disorders Group Module</A>.</P>
<P>For the current update of the review, searches were updated in June 2012 (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) and were carried out for all years in the Cochrane Central Register of Controlled Trials (CENTRAL), OVID MEDLINE, OVID Embase, and OVID PsycINFO.</P>
<P>Date of the most recent search of the Cystic Fibrosis and Genetic Disorders Group's Cystic Fibrosis Trials Register: 19 December 2013.<BR/>Date of the most recent search of the Depression, Anxiety and Neurosis Group: 12 November 2013.<BR/>
</P>
<P>In addition, the Clinical Trial Registry (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>) was used to identify possible ongoing studies using the following term: 'cystic fibrosis'.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-06-11 11:25:44 +0100" MODIFIED_BY="[Empty name]">
<P>Efforts were made to locate unpublished findings through personal contacts with researchers active in this field and professional networks including listserves.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-06-11 21:53:16 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2014-06-11 21:53:04 +0100" MODIFIED_BY="[Empty name]">
<P>Three authors (LG, AF, MH), working independently in groups of two, selected the studies relevant for inclusion in the current update of the review. The authors LG and AF checked one third of the studies, AF and MH checked a further third and LG and MH checked the remaining studies. The authors used a study eligibility form devised for the selection process. If two authors could not reach a consensus, then they asked one of the other authors to decide. In the case of studies published by one of the authors, a co-author assessed this for eligibility.</P>
<P>For previous versions of the review, two authors (CG and AQ) independently selected the studies that were relevant for inclusion in the review using a study eligibility form devised for this purpose.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-06-11 11:34:01 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors (AF and MH) independently extracted data using a data extraction form. If they could not reach a consensus, then they asked one of the remaining authors to decide.</P>
<P>For previous versions of the review two authors (CG and AQ) independently extracted the data to be analysed using a data extraction form.</P>
</DATA_EXTRACTION>
<EFFECT_MEASURES MODIFIED="2014-06-11 11:34:46 +0100" MODIFIED_BY="[Empty name]">
<P>For binary outcomes with sufficient data, the authors calculated a pooled estimate of the treatment effect for each outcome. A comparison was made between the odds of an outcome occurring in the group receiving the treatment of interest versus the control group (odds ratio (OR) and 95% confidence interval (CI)).</P>
<P>For continuous outcomes, the authors calculated a pooled estimate of the treatment effect with a mean difference (MD) with 95% CIs.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-06-11 21:53:16 +0100" MODIFIED_BY="[Empty name]">
<P>In the event that groups are cluster-randomised, the authors will use the inverse variance method and report results as a fixed MD (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>). Furthermore, the authors will explore whether the study reported appropriate analyses, taking the cluster design into account. If this is not the case they will perform correct analyses, as recommended in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>).</P>
<P>In the event that a study compared more than one intervention, the authors will compare the primary active treatment to usual care (or at least biased control condition).</P>
<P>Deeks recommends for cross-over studies to first of all prove whether the cross-over design is appropriate for the intervention and outcomes, which need to be reversible (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>). Secondly, to take into consideration the possibility of substantial carry-over or period effects. Different options are available for the incorporation of cross-over study data into meta-analyses different options are available ranging from conservative methods to just analysing data from the first period. The selection of an appropriate method will be based on the characteristics of the study and the reported data.</P>
</UNIT_OF_ANALYSIS>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-06-11 11:37:33 +0100" MODIFIED_BY="[Empty name]">
<P>When appropriate, the authors pooled results and they used the I<SUP>2</SUP> statistic to judge whether the results of different studies were inconsistent. The authors assumed the following overlapping percentage intervals of the I<SUP>2</SUP> statistic for quantifying heterogeneity (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>): 0% to 40% (might not be important); 30% to 60% (may represent moderate heterogeneity); 50% to 90% (may represent substantial heterogeneity); and 75% to 100% (considerable heterogeneity). Additionally, the authors conducted a visual inspection of the forest plot and chi<SUP>2</SUP> test.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-06-11 11:37:58 +0100" MODIFIED_BY="[Empty name]">
<P>We have analysed data using a random-effects model.</P>
<P>The authors investigated the pooling of results when the interventions were:</P>
<UL>
<LI>of the same type of interventions defined in the methods section 'Types of interventions';</LI>
<LI>were comparable in the psychological methods used, the setting, the addressed outcomes and participants;</LI>
<LI>being compared to an equal control condition.</LI>
</UL>
<P>The authors extracted data at post-treatment and when available, including short- and long-term follow-up data.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-06-11 11:40:40 +0100" MODIFIED_BY="[Empty name]">
<P>If the authors identify heterogeneity of pooled results, they will use subgroup analyses to explore the possible sources of heterogeneity.</P>
<P>They plan to group studies into conceptually similar interventions and, if sufficient data are available, they will perform subgroup analyses with respect to the following list.</P>
<OL>
<LI>Socioeconomic level of the individual and family (education level, income level, occupation)</LI>
<LI>Age of the affected individual with CF (infants, toddlers, and preschool children under five years of age, school-aged children ages 5 to 12 years, adolescents ages 13 to 18 years, adults 19 years+)</LI>
<LI>Stage of the disease process (pre-diagnosis stage, diagnosis phase through the the first year post-diagnosis, chronic phase - intervening years between the diagnosis and terminal phase, terminal phase - when the affected child or adult's condition was such that active treatment had ceased and only palliative measures were being offered)</LI>
</OL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-05-07 09:37:06 +0100" MODIFIED_BY="[Empty name]">
<P>In future, if sufficient data are available, the authors will undertake a sensitivity analysis comparing the findings of studies with a high risk of bias to results when these studies are excluded. Due to the small number of studies currently included and the different types, interventions and outcome measures, a sensitivity analysis was not feasible.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-06-11 22:06:58 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-06-11 21:54:31 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2014-06-11 21:54:05 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Results of the search of previous versions of the review</HEADING>
<P>Originally, a total of 70 RCTs (99 reports) were reviewed; 28 studies (50 reports) were relevant. In a previous version of the review, 13 RCTs (25 reports) were included (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Cheuvront-1998" TYPE="STUDY">Cheuvront 1998</LINK>; <LINK REF="STD-Trapp-1998" TYPE="STUDY">Trapp 1998</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stapleton-2001" TYPE="STUDY">Stapleton 2001</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Davis-2002" TYPE="STUDY">Davis 2002</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Downs-2006" TYPE="STUDY">Downs 2006</LINK>) and five studies were classified as ongoing (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Quittner-2000" TYPE="STUDY">Quittner 2000</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Watson-2004" TYPE="STUDY">Watson 2004</LINK>; <LINK REF="STD-Watson-2006" TYPE="STUDY">Watson 2006</LINK>). Two of the ongoing studies were concerned with adherence (<LINK REF="STD-Quittner-2000" TYPE="STUDY">Quittner 2000</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>). Ten studies were classified as 'awaiting information from authors' (<LINK REF="STD-Williams-1987" TYPE="STUDY">Williams 1987</LINK>; <LINK REF="STD-Klig-1989" TYPE="STUDY">Klig 1989</LINK>; <LINK REF="STD-Davis-1990" TYPE="STUDY">Davis 1990</LINK>; <LINK REF="STD-Petzel-1991" TYPE="STUDY">Petzel 1991</LINK>; <LINK REF="STD-Mischler-1998" TYPE="STUDY">Mischler 1998</LINK>; <LINK REF="STD-Stark-1998" TYPE="STUDY">Stark 1998</LINK>; <LINK REF="STD-Cannon-1999" TYPE="STUDY">Cannon 1999</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Bryon-2000" TYPE="STUDY">Bryon 2000</LINK>; <LINK REF="STD-Powers-2003a" TYPE="STUDY">Powers 2003a</LINK>). A total of 42 studies (49 reports) were not eligible for inclusion in the review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Results of the new search for the current update</HEADING>
<P>For the current update of the review a total of 1705 titles and abstracts (1365 without duplicates) were identified. A total of 33 new studies (55 reports) were identified for reviewing as potentially relevant for inclusion. Three of these are still ongoing (<LINK REF="STD-Quittner-2011" TYPE="STUDY">Quittner 2011</LINK>; <LINK REF="STD-Quittner-2012" TYPE="STUDY">Quittner 2012</LINK>; <LINK REF="STD-Riekert-2012" TYPE="STUDY">Riekert 2012</LINK>). We are awaiting further information from authors for 12 studies (14 reports) (<LINK REF="STD-Wainwright-2009" TYPE="STUDY">Wainwright 2009</LINK>; <LINK REF="STD-Huang-2010" TYPE="STUDY">Huang 2010</LINK>; <LINK REF="STD-Jessup-2010" TYPE="STUDY">Jessup 2010</LINK>; <LINK REF="STD-Patel-2010" TYPE="STUDY">Patel 2010</LINK>; <LINK REF="STD-Cummings-2011" TYPE="STUDY">Cummings 2011</LINK>; <LINK REF="STD-Hatziagorou-2011" TYPE="STUDY">Hatziagorou 2011</LINK>;<LINK REF="STD-Ruddy-2011" TYPE="STUDY">Ruddy 2011</LINK>; <LINK REF="STD-Irons-2012" TYPE="STUDY">Irons 2012</LINK>; <LINK REF="STD-Hass-2012" TYPE="STUDY">Hass 2012</LINK>; <LINK REF="STD-Goldbeck-2013" TYPE="STUDY">Goldbeck 2013</LINK>; <LINK REF="STD-Powers-2013" TYPE="STUDY">Powers 2013</LINK>; <LINK REF="STD-Widman-2013" TYPE="STUDY">Widman 2013</LINK>). Eleven studies were not eligible for inclusion (<LINK REF="STD-Dodd-2001" TYPE="STUDY">Dodd 2001</LINK>; <LINK REF="STD-Stark-2002" TYPE="STUDY">Stark 2002</LINK>; <LINK REF="STD-Rodrigue-2005" TYPE="STUDY">Rodrigue 2005</LINK>; <LINK REF="STD-Ralston-2008" TYPE="STUDY">Ralston 2008</LINK>; <LINK REF="STD-Bingham-2010" TYPE="STUDY">Bingham 2010</LINK>; <LINK REF="STD-Pop-Jordanova-2010" TYPE="STUDY">Pop Jordanova 2010</LINK>; <LINK REF="STD-Castellani-2011" TYPE="STUDY">Castellani 2011</LINK>; <LINK REF="STD-Georgiopoulos-2011" TYPE="STUDY">Georgiopoulos 2011</LINK>; <LINK REF="STD-Goldbeck-2011a" TYPE="STUDY">Goldbeck 2011a</LINK>; <LINK REF="STD-Rault-2012" TYPE="STUDY">Rault 2012</LINK>; <LINK REF="STD-Rozenfeld-2012" TYPE="STUDY">Rozenfeld 2012</LINK>). Seven newly identified studies (15 reports) are included in the current update of the review (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>). Details of the number of reports yielded by the new search are shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>. Where necessary, we contacted authors of the included studies for additional data to allow quantitative analysis. We have not been able to locate contact details on any of the authors concerning one study (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>). For three studies only narrative reporting of results were possible (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005;</LINK> <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>).</P>
<P>Four of the 12 newly identified studies awaiting classification were published as abstracts (<LINK REF="STD-Wainwright-2009" TYPE="STUDY">Wainwright 2009</LINK>; <LINK REF="STD-Jessup-2010" TYPE="STUDY">Jessup 2010</LINK>; <LINK REF="STD-Patel-2010" TYPE="STUDY">Patel 2010</LINK>; <LINK REF="STD-Hatziagorou-2011" TYPE="STUDY">Hatziagorou 2011</LINK>) and one journal article did not include any quantitative data (<LINK REF="STD-Cummings-2011" TYPE="STUDY">Cummings 2011</LINK>). The remaining seven studies were identified in the latest search in December 2013 and are still awaiting classification for inclusion (<LINK REF="STD-Huang-2010" TYPE="STUDY">Huang 2010</LINK>; <LINK REF="STD-Ruddy-2011" TYPE="STUDY">Ruddy 2011</LINK>; <LINK REF="STD-Hass-2012" TYPE="STUDY">Hass 2012</LINK>; <LINK REF="STD-Irons-2012" TYPE="STUDY">Irons 2012</LINK>; <LINK REF="STD-Goldbeck-2013" TYPE="STUDY">Goldbeck 2013</LINK>; <LINK REF="STD-Powers-2013" TYPE="STUDY">Powers 2013</LINK>; <LINK REF="STD-Widman-2013" TYPE="STUDY">Widman 2013</LINK>). Information available to date on the studies is presented in the '<LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>' tables.</P>
<P>One of the previous studies assessed as ongoing is now awaiting information from authors (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>) and one is now included in the review (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>). Additionally, two previously ongoing studies were not eligible for the review due to an educational approach of the intervention (<LINK REF="STD-Watson-2004" TYPE="STUDY">Watson 2004</LINK>; <LINK REF="STD-Watson-2006" TYPE="STUDY">Watson 2006</LINK>).</P>
<P>Report characteristics of all previous and new relevant studies are listed in an additional table (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
</SUBSECTION>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-06-11 21:54:10 +0100" MODIFIED_BY="[Empty name]">
<P>Sixteen RCTs and one CCT (a total of 33 reports), representing data from 556 participants, had sufficient data for inclusion in the analyses of this review (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>Twelve of the included studies were conducted in the USA, one in Australia (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>), one in Australia and Canada (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>), and two in the UK (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>). One study was ongoing at the time of the original review and has not yet been published in full (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>). Summary details of these studies are given in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' section.</P>
<P>Participants were children in one study (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>), children and their caregivers in seven of the studies (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>), children and adolescents in one study (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>), adolescents and their families in one study (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>) and only adults in two of the included studies (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>). In four further studies, patients with a broad age range were enrolled (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>).</P>
<P>Due to the wide scope of this review, included studies were diverse in their design and methods. Those that were relevant for inclusion sometimes involved differing combinations of interventions for various aspects of the psychological management of CF. On occasion individual studies compared two or more types of intervention with each other.</P>
<P>All the included studies can be considered within the different methods the interventions contained as stated in the section '<LINK TAG="CRIT_INTERVENTIONS" TYPE="SECTION">Types of interventions</LINK>'. Further distinction within these groupings arises from the predetermined target areas for psychological interventions highlighted in the '<LINK TAG="OBJECTIVES" TYPE="SECTION">Objectives</LINK>' section (newborn screening, adherence to treatment, transplantation, adapting to treatment regimen, and maintaining or improving health-related quality of life, and transitioning toward independence and adult care).</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Cognitive behavioral</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.1 Cognitive behavioral interventions to improve adherence</HEADING>
<P>There are five studies in this group (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>). These involved educational or cognitive behavioural interventions, or both, with a stronger cognitive component in the three Stark studies (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>). The outcomes measured were mostly physical, i.e. dietary input specifically linked to nutrition status, and oriented towards adherence.</P>
<P>The Stark study compared the effectiveness of a group behavioural intervention in primary school age children and their parents in improving dietary input with a wait list control (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>). The earlier study by Powers examined the effectiveness of two nutritional interventions with children younger than three years of age and their parents (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>). Behavioural management training and nutrition education for parents were compared to nutrition education alone. The primary outcome indicator was number of calories consumed per day. The more recent Powers study is more focused and systematic in its design and assessment of individualised nutritional counselling compared to behavioural parent training, with children under five years of age (<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>). Another study by Stark compared the effectiveness of two group approaches to promoting dietary input in school-age children and their parents (<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>). One intervention involved nutrition education and the other involved behavioural management training for parents. The primary outcome for all of these studies was the number of calories consumed per day. The latest study by Stark also compared the effectiveness of two approaches (nutrition education versus behavioural plus nutrition education) for children ages from four to twelve years and their parents, with the aim of improving caloric intake and weight (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Cognitive behavioral interventions to improve psychosocial adjustment</HEADING>
<P>This subcategory includes one study that assessed the effectiveness of an intervention consisting of an individually tailored intervention during a home visit and a structured group session (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>). The intervention was based on teaching problem solving and training social skills. The children aged eight to twelve years were educated and supported with the following specific problems: finding out about the CF-diagnosis, explaining CF-related differences, dealing with teasing about CF, and keeping up with peers during physical activity. The control group received treatment as usual. Outcomes were assessed to measure differences between groups on psychosocial adjustment, functional health and physiological health status.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Cognitive</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Cognitive interventions to improve adherence</HEADING>
<P>Both studies in this group utilized a cognitive approach to improve adherence or health care utilization (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>). One study provided a written self-disclosure intervention compared to standard care and was designed to improve health-care utilization in adolescents or adults with CF (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>). Participants were asked to write three times over a 20-minute period (once in the CF clinic, twice at home) without being concerned with spelling or syntax. The first topic related to the most distressing experience of their life with possible connections between the topic to their relationships with others (e.g. family, friends etc.) and to their past, present, or future. For the following two writing sessions, participants could change from one topic to another. The second study assessed the effectiveness of motivational interviewing provided via telephone over a three-month period (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>). It is a non-confrontational, patient-centred counselling style for enhancing behaviour change by helping patients explore and resolve ambivalence. Comparisons of the intervention to usual treatment were made on the primary outcome of adherence to aerosolised antibiotics; lung function was also measured pre- and post-intervention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Cognitive interventions associated with decision making in lung transplantation</HEADING>
<P>There is one study in this category (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>). In addition to usual counselling, patients with advanced CF were provided with an evidence-based decision aid as they considered referral for lung transplantation. Comparisons were made with usual care. Patients received a paper version of the decision aid and could also access it online using the provided password. The aim was to improve patient knowledge about options when considering lung transplantation and facilitate more realistic expectations about transplantation to decrease decisional conflict.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Family systems or systemic</HEADING>
<P>The study included in this category assessed its effectiveness as a psychosocial intervention for parenting a child with a chronic illness (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>). It was designed to mobilise community-based support linking new parent or child dyads (or both) with experienced parent or professional dyads. Each experienced dyad consisted of a trained network mother and a 'child life specialist'. This experienced pair initiated home visits, telephone calls and special family events aimed at enhancing adaptation and reducing stress. The generic program was targeted to children with diabetes, sickle cell, CF or moderate to severe asthma. However, the emotional outcomes reported by caregivers were reported separately, enabling the specific effect for CF to be estimated.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Psychodynamic</HEADING>
<P>No studies were eligible for this category.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Other interventions</HEADING>
<P>Six studies are included within this category (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>).The CCT by Belsky assessed the effects of self-hypnosis on psychological and physiological functioning in children aged from 7 to 18 years with CF (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>). Children were taught a hypnotic technique within a two-week period. Outcomes were physiological and psychological indicators. The Delk study was an RCT to assess the effectiveness of a respiratory muscle biofeedback technique used with adolescent and adult participants (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>). It was specifically targeted at enhancing the efficacy of breathing during physiotherapy using electromyographic trapezius muscle feedback in comparison to promoting relaxation, not specifically associated with physiotherapy. The primary outcome was pulmonary function. The Hernandez-Reif RCT that assessed the effectiveness of massage therapy compared to bedtime reading, as an adjunct to physiotherapy when delivered to primary school-aged children by parents (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>). The primary outcome was pulmonary function. The Grasso RCT assessed the effectiveness of music therapy in enhancing the experience of physiotherapy in mothers and infants under two years of age, diagnosed with CF (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>). The primary outcomes were ratings of emotional (child and parent enjoyment) and cognitive (parents' perception of the time it took to perform physiotherapy) variables. The Goodill RCT assessed the effectiveness of dance and movement therapy in adult hospitalised patients compared to controls (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>). Mood state, adherence, self-care expectations and body image were targeted for improvement. The remaining RCT by Wilkinson evaluated the feasibility of a video link to support patients on the transplantation list and their families (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>). On a weekly basis tele-medicine sessions were used to discuss relevant issues between the consultant and the patient. Outcomes were quality of life, symptoms of anxiety and depression, and healthcare utilisation.</P>
<P>A summary of the categories of outcome measures reported in studies included in this review can be viewed in 'Additional tables' (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Subgroups</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Age group of the individual with CF</HEADING>
<P>Three studies involved infants (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>). Seven studies involved school-aged children (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>, <LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>, <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>); two study involved adolescents and adults (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>); and the remaining four studies involved adults only (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>, <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Socioeconomic status (SES)</HEADING>
<P>Eight of the included studies conducted an assessment of SES for the purposes of establishing equivalent group characteristics at baseline (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>). No attempt was made to stratify samples on the basis of SES groupings.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Stage of CF condition</HEADING>
<P>Three studies were conducted during or soon after the diagnosis of CF (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>). Two studies were conducted within a period when patients were considered for lung transplantation (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>), but no study was conducted explicitly with those individuals affected with CF during the terminal stage of their disease state (palliative care). In the remaining 14 studies, stage of disease severity was not specified, although most occurred during the chronic management period.</P>
<P>Details of the subgroup membership of studies in this review can be viewed in 'Additional tables' (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>). No subgroup analyses were conducted due to insufficient data.<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-06-11 21:54:31 +0100" MODIFIED_BY="[Empty name]">
<P>Fifty-nine studies with 66 reports were excluded. The reasons for exclusion for each individual study are listed in the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' section.</P>
<P>Five previously included studies on educational interventions (<LINK REF="STD-Cheuvront-1998" TYPE="STUDY">Cheuvront 1998</LINK>; <LINK REF="STD-Trapp-1998" TYPE="STUDY">Trapp 1998</LINK>; <LINK REF="STD-Stapleton-2001" TYPE="STUDY">Stapleton 2001</LINK>; <LINK REF="STD-Davis-2002" TYPE="STUDY">Davis 2002</LINK>; <LINK REF="STD-Downs-2006" TYPE="STUDY">Downs 2006</LINK>) have now been excluded following the publication of a separate review in 2011 (<LINK REF="REF-Savage-2011" TYPE="REFERENCE">Savage 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Studies awaiting assessment</HEADING>
<P>A total of 22 studies are now awaiting information from authors (<LINK REF="STD-Williams-1987" TYPE="STUDY">Williams 1987</LINK>; <LINK REF="STD-Klig-1989" TYPE="STUDY">Klig 1989</LINK>; <LINK REF="STD-Davis-1990" TYPE="STUDY">Davis 1990</LINK>; <LINK REF="STD-Petzel-1991" TYPE="STUDY">Petzel 1991</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Mischler-1998" TYPE="STUDY">Mischler 1998</LINK>; <LINK REF="STD-Stark-1998" TYPE="STUDY">Stark 1998</LINK>; <LINK REF="STD-Cannon-1999" TYPE="STUDY">Cannon 1999</LINK>; <LINK REF="STD-Bryon-2000" TYPE="STUDY">Bryon 2000</LINK>; <LINK REF="STD-Powers-2003a" TYPE="STUDY">Powers 2003a</LINK>; <LINK REF="STD-Wainwright-2009" TYPE="STUDY">Wainwright 2009</LINK>; <LINK REF="STD-Huang-2010" TYPE="STUDY">Huang 2010</LINK>; <LINK REF="STD-Jessup-2010" TYPE="STUDY">Jessup 2010</LINK>; <LINK REF="STD-Patel-2010" TYPE="STUDY">Patel 2010</LINK>; <LINK REF="STD-Cummings-2011" TYPE="STUDY">Cummings 2011</LINK>; <LINK REF="STD-Hatziagorou-2011" TYPE="STUDY">Hatziagorou 2011</LINK>; <LINK REF="STD-Ruddy-2011" TYPE="STUDY">Ruddy 2011</LINK>; <LINK REF="STD-Hass-2012" TYPE="STUDY">Hass 2012</LINK>; <LINK REF="STD-Irons-2012" TYPE="STUDY">Irons 2012</LINK>; <LINK REF="STD-Goldbeck-2013" TYPE="STUDY">Goldbeck 2013</LINK>; <LINK REF="STD-Powers-2013" TYPE="STUDY">Powers 2013</LINK>; <LINK REF="STD-Widman-2013" TYPE="STUDY">Widman 2013</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>To date, four studies are listed as ongoing (<LINK REF="STD-Quittner-2000" TYPE="STUDY">Quittner 2000</LINK>; <LINK REF="STD-Quittner-2011" TYPE="STUDY">Quittner 2011</LINK>; <LINK REF="STD-Quittner-2012" TYPE="STUDY">Quittner 2012</LINK>; <LINK REF="STD-Riekert-2012" TYPE="STUDY">Riekert 2012</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-06-11 21:54:53 +0100" MODIFIED_BY="[Empty name]">
<P>For judging the risk of bias for the studies being included in this update the evaluation criteria proposed by Higgins in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(version 5.1) (<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>) were used.</P>
<P>Details for every study and reasons for judgement are described within the risk of bias tables in the section &#8216;<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>&#8217;. Only one of the included studies was judged as adequately meeting all criteria (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
<P>It should be mentioned that most of the included studies were small in their sample size, which might have influenced the ability of randomisation to deliver equivalence at baseline.</P>
<SUBSECTION>
<HEADING LEVEL="4">Allocation (selection bias)</HEADING>
<P>Sequence generation was judged to be low risk in eight of the studies (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>), was unclear for seven studies (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>) and was judged as high for one study (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>Allocation concealment was judged to be low in six of the studies (<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>), to be high in one study (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>) and unclear in the other nine studies (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding (performance bias and detection bias)</HEADING>
<P>Blinding participants and providers of psychological interventions is quite difficult. To keep them unaware of the received or provided treatment is almost impossible. Details on blinding especially regarding the blinding of outcome assessors were judged as high risk in five studies (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>), low risk in six studies (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>) and unclear in five studies (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008;</LINK> <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Incomplete outcome data (attrition bias)</HEADING>
<P>Judgments of possible biases due to the nature, amount or handling incomplete outcome data were assessed as the following: low risk for nine studies (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>), high risk for three studies (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>) and unclear risk for four studies (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Selective reporting (reporting bias)</HEADING>
<P>Assessment of selective outcome reporting revealed the following results for the studies: low risk for four studies (<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>), high risk for four studies (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>; <LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>) and unclear risk for the other eight studies (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>; <LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>; <LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>; <LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>, <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
</SUBSECTION>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-06-11 22:06:58 +0100" MODIFIED_BY="[Empty name]">
<P>The studies included in this review were so diverse in their methodologies that the objective of pooling results became impossible. A large number of different outcome measures were used and are described below for clarity and readability. Of the outcomes defined in '<LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>', only those reported in one or more of the included primary studies are described below. If an outcome was not described, it is not reported in any of the target groups. Within psychological interventions adverse events or harms are not usually an issue and none of the included studies reported any such information. There were insufficient data to conduct subgroup analyses with respect to age, stage of condition or SES within any data comparisons.</P>
<P>
<I>Please note</I>: the comparison groups and outcome groups refer to the graphs located in <LINK TAG="DATA_COLLECTION" TYPE="SECTION">Data collection and analysis</LINK>. We report only those outcomes which have relevant data included in the primary reports.</P>
<P>A brief overview of all main findings can be seen in the summary of findings tables. The findings were classified in accordance to the types of interventions. Main findings for cognitive behavioural interventions can be found in the <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>, for cognitive interventions in the <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>, and for other interventions in <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK> and <LINK REF="SOF-04" TYPE="SOF">Summary of findings table 4</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">1. Cognitive behavioral</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1.1 Cognitive behavioral interventions to improve adherence</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 1 - Behavioural group treatment versus wait list control</HEADING>
<P>One study with eight participants is included (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>
<U>: Pulmonary function</U>
<BR/>Subcategory 1.1.1: FEV<SUB>1</SUB>% predicted (absolute values)<BR/>Subcategory 1.1.2: FVC% predicted (absolute values)<BR/>Subcategory 1.1.3: FEF<SUB>25-75%</SUB> predicted (absolute values)<U>
<BR/>
</U>This behavioural intervention group did not show any demonstrable effect on pulmonary function as measured by three independent indicators: FEV<SUB>1 </SUB>% predicted, MD -11.70 (95% CI -40.35 to 16.95); FVC % predicted, MD -6.00 (95% CI -31.16 to 19.16); and FEF<SUB>25-75</SUB>% predicted, MD -32.90 (95% CI -98.93 to 33.13).</P>
<P>
<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>
<U>: Anthropometric measures</U>
<I> </I>
<BR/>Subcategory 1.2.1: Weight (z score)<BR/>Subcategory 1.2.2: Height (z score)<BR/>A significant effect demonstrated that a group behavioural intervention increased children's weight when scores were converted to z scores, MD 1.02 (95% CI 0.04 to 2.00) (P = 0.04). However, no significant group differences were observed in height z scores, MD 0.00 (95% CI -1.46 to 1.46).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">SECONDARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>
<U>: Adherence</U>
<BR/>Subcategory 1.3.1: Activity level - resting energy expenditure (% predicted)<BR/>Subcategory 1.3.2: Activity level - resting energy expenditure (Kcal/24 hours)<BR/>We were unable to find any evidence that a behavioural group intervention had any effect on resting energy expenditure either in terms of % predicted, MD 9.87 (95% CI -11.58 to 31.32) or Kcal/24 hours, MD 148.00 (95% CI -182.61 to 478.61).</P>
<P>Subcategory 1.3.3: Activity level - activity points<BR/>There was no significant effect on the activity points, MD -1.00 (95% CI -9.75 to 7.75).</P>
<P>Subcategory 1.3.4: Change in Kcalorie intake<BR/>The data for this outcome were reported in the source paper as calories and were converted to Kcalories in order to reduce the scale and thus contain the confidence intervals on the graph.<BR/>For change in Kcalorie intake there was a significant effect in favour of the group behavioural intervention, MD 0.93 (95% CI 0.31 to 1.55) (P = 0.003).</P>
<P>
<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>
<U>: Nutrition status (additional outcome)</U>

<BR/>
Subcategory 1.4.1: % Body fat<BR/>No significant group differences were observed in % body fat, MD -0.65 (95% CI -4.41 to 3.11).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 2 - Nutritional intervention plus behavioural management training (BEH) versus nutritional intervention alone (NUT)</HEADING>
<P>Three studies are included: one with eight participants (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>); one with seven participants (<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>); and one with 67 participants (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>). The interventions involved educational and cognitive behavioural components. The three studies utilised the same design and intervention, allowing the data to be pooled.</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>
<U>: Anthropometric change scores</U>
<BR/>
</P>
<P>Subcategory 2.1.1: Change in weight (kg)<BR/>When data from two studies were combined, no significant differences were found for change in weight, MD 0.11 (95% CI -0.84 to 1.07) (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>). The result should be interpreted carefully due to the fact that the two included studies reported converse effects and the I<SUP>2</SUP> statistic coefficient for pooling the two studies is relatively high (I<SUP>2</SUP> = 73%).<BR/>
<BR/>Subcategory 2.1.2: Change in height (cm)<BR/>Data reported by Powers showed no significant differences for change in height, MD -2.03 (95% CI -4.87 to 0.81) between the two groups post-intervention (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>).</P>
<P>Subcategory 2.1.3: Change in weight (kg) two-year follow-up and 2.1.4: Change in height (cm) two-year follow up<BR/>Data reported by Stark showed no significant differences at two-year follow-up for change in weight, MD 0.52 (95% CI -1.34 to 2.38) and change in height, MD -0.20 (95% -1.45 to 1.05) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).<BR/>
<BR/>Subcategories 2.1.5: BMIz change post-intervention and 2.1.6: BMIz change two-year follow up<BR/>Data reported by Stark on BMIz change scores did not show a significant difference between the two compared groups, MD 0.20 (95% CI -0.02 to 0.42), but did show a difference with borderline statistical significance (P = 0.05) at two-year follow up, MD 0.35 (95% CI 0.00 to 0.70) in favour with the behavioural management intervention (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).<BR/>
<BR/>Subcategory 2.1.7: HAZ change two-year follow up<BR/>Again, this outcome was only reported by Stark, the HAZ change scores (height for age z-scores) at two-year follow up did not reveal a significant difference between the groups, MD -0.01 (95% CI -0.17 to 0.15) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
<P>
<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>
<U> % Anthropometric</U>
</P>
<P>Subcategories 2.2.1 and 2.2.2: % Ideal body weight and 2.2.3 and 2.2.4: Weight % for age<BR/>The final two anthropometric measures, only reported by Powers, showed a significant effect size in favour of the intervention (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>). Although these data showed that the behavioural intervention succeeded in achieving substantial increases at follow up in % ideal body weight, MD 49.49 (95% CI 23.39 to 75.59) (P = 0.00002) and weight % for age, MD 24.70 (95% CI 12.77 to 36.63) (P &lt; 0.0001), the values at baseline for both these measures were also significantly different in the same direction, MD 50.40 (95% CI 5.28 to 95.52) (P = 0.03); MD 25.30 (95% CI 2.70 to 47.90) (P = 0.03)).</P>
<P>
<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>
<U>: Anthropometric</U>
</P>
<P>Subcategory 2.3.1: Weight (kg) post intervention<BR/>Subcategory 2.3.2: Weight (kg) two-year follow up<BR/>Subcategory 2.3.3: Height (cm) two-year follow up<BR/>Subcategory 2.3.4: HAZ two-year follow up<BR/>Subcategory 2.3.5: BMIz post intervention<BR/>Subcategory 2.3.6: BMIz two-year follow up<BR/>One study reported on this outcome and found no differences between the two groups in either of the assessed measures at post intervention or at two-year follow up: weight post intervention, MD -0.28 (95% CI -3.84 to 3.28); weight two-year follow up, MD -1.00 (95% CI -6.26 to 4.26); height two-year follow up, MD -2.80 (95% CI -10.88 to 5.28); HAZ two-year follow up, MD -0.15 (95% CI -0.54 to 0.24); BMIz post intervention, MD -0.08 (95% CI -0.54 to 0.38); BMIz two-year follow up, MD 0.15 (95% CI -0.26 to 0.56) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
<P>
<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>
<U>: Pulmonary function</U>
</P>
<P>Subcategories 2.4.1: FEV<SUB>1</SUB> two-year follow up and 2.4.2: FEV<SUB>1</SUB> change two-year follow up<BR/>One study measured pulmonary function at two-year follow up via FEV<SUB>1</SUB>, no significant differences could be observed in the FEV<SUB>1</SUB> score, MD 0.00 (95% CI -13.03 to 13.03) or in the FEV<SUB>1</SUB> change score, MD 5.16 (95% CI -8.49 to 18.81) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">SECONDARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>
<U>: Adherence (nutrition) </U>
</P>
<P>Subcategory 2.5.1: % RDA (Kcal/day)<I>
<BR/>
</I>One study showed no significant difference between the comparison groups for % RDA (Kcal/day), MD 8.52 (95% CI -18.95 to 35.99) (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>).</P>
<P>Subcategory 2.5.2: Total calories consumed per day<BR/>Three studies reported on this outcome (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>). They showed a significant difference (P = 0.010) in the total number of calories consumed per day, MD 275.85 (95% CI 66.65 to 485.05) favouring behavioural management training as compared to nutrition education alone.</P>
<P>Subcategory 2.5.3: Change in calorie intake<BR/>Data from the three studies showed a significant difference between the comparison groups for change in calorie intake, MD 364.06 (95% CI 191.99 to 536.13) (P &lt; 0.0001) (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>; <LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
<P>Subcategory 2.5.4: Two-year follow up caloric intake<BR/>One study showed no significant differences at two-year follow up in caloric intake, MD 112.00 (95% CI -216.56 to 440.56) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).<BR/>
<BR/>Subcategory 2.5.5: Two-year follow up change in caloric intake<BR/>Similiarly, Stark reported no significant differences between the groups could be shown in change in caloric intake scores after the two-year follow up period, MD 188.00 (95% CI -75.57 to 451.57) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).<BR/>
<BR/>Subcategory 2.5.6: Estimated energy requirements (% EER)<BR/>Stark showed a significant difference favouring the behavioural intervention in % EER, MD 21.00 (95% CI 7.76 to 34.24) (P = 0.002) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).<BR/>
<BR/>Subcategory 2.5.7: Change in % EER<BR/>Stark showed a significant difference favouring the behavioural intervention was also found in change in % EER, MD 21.00 (95% CI 9.22 to 32.78) (P = 0.0005) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).<BR/>
<BR/>Subcategory 2.5.8: Two-year follow up % EER<BR/>In % EER at two-year follow up, Stark showed no significant difference between the two groups, MD 9.00 (95% CI -5.09 to 23.09) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).<BR/>
<BR/>Subcategory 2.5.9: two-year follow-up change in % EER<BR/>Stark showed no significant difference between the groups in change in %EER at two-year follow up, MD 9.00 (95% CI -4.73 to 22.73) (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
<P>
<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>
<U>: Relational - Parent-child interaction</U>
<BR/>Subcategory 2.1.1: Nursing Satellite Assessment Training Feeding Scale (NCAST) - carer or infant total score (<LINK REF="REF-Sumner-1994" TYPE="REFERENCE">Sumner 1994</LINK>)<BR/>This is an observational measure administered during a family meal. It has 76-items that assess a set of empirically derived and objectively observed behaviours that characterise carer-child communication and interaction during feeding. This measure is a reliable and valid observation tool with internal consistency (Chronbach alpha) ranging from 0.73 to 0.86. From the only study reporting this outcome, we were unable to find evidence that behavioural management training improves parent-child communication and interaction during feeding as assessed by the NCAST total score, MD 4.60 (95% CI -0.40 to 9.60) (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>).<BR/>
</P>
<P>
<LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>
<U>: Nutritional status</U>
</P>
<P>Subcategory 2.7.1: % Body fat<BR/>Powers showed no statistical difference was evidenced between the groups in % body fat, MD 0.20 (95% CI -9.43 to 9.83) (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 3 - Behavioral and nutritional intervention (BEH) versus standard care control (CTL)</HEADING>
<P>One study with 10 participants was included (<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>).</P>
<P>
<I>SECONDARY OUTCOMES</I>
</P>
<P>
<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>
<U>: Total energy intake per day (kcal)</U>
<BR/>There was a substantially larger intake of calories per day in the children in the intervention group post-treatment, MD 979.10 (95% CI 266.17 to 1692.03) (P = 0.007) compared with the control group (<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>). The design of the study did not permit this comparison to be repeated at follow up, although calorie intake remained stable from post-treatment to three- and 12-month follow up. This represents a clinically significant finding that should be replicated with a larger study.</P>
<P>
<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>
<U>: % Fat intake</U>
<BR/>The finding for fat intake was in the predicted direction although not significant statistically, MD 10.40 (95% CI -0.51 to 21.31) (<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.2 Cognitive behavioral interventions to improve psychosocial adjustment</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 4 - Educational problem-solving and social skills interventions versus usual care</HEADING>
<P>One study with 116 participants was included for this comparison (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>
<U>: Pulmonary function (FEV<SUB>1</SUB>)</U>
</P>
<P>Subcategories 4.1.1: Three months; 4.1.2: six months; and 4.1.3: Nine months<BR/>There were no statistically significant differences in pulmonary function (FEV<SUB>1</SUB>) between the two groups at any time point: three months, MD 2.02 (95% CI -4.78 to 8.82); six months, MD 3.35 (95% CI -3.28 to 9.98); nine months, MD -2.44 (95% CI -9.04 to 4.16) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>:<U> Height in cm</U>
</P>
<P>Subcategories 4.2.1: Three months; 4.2.2: Six months; and 4.2.3: Nine months<BR/>No statistically significant differences in height in cm between the intervention and usual care could be found at: three months, MD 1.00 (95% CI -2.23 to 4.23); at six months, MD 1.83 (95% CI -3.03 to 6.69); and at nine months, MD -0.54 (95% CI -3.92 to 2.84) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>
<U>: Weight in kg</U>
</P>
<P>Subcategories 4.3.1: Three months; 4.3.2: Six months; and 4.3.3: Nine months<BR/>The outcome weight in kg did not statistically significant differ at any of the three points in time between the two groups: three months, MD 0.17 (95% CI -1.98 to 2.32); six months, MD 0.27 (95% CI -2.09 to 2.63); nine months, MD -0.53 (95% CI -3.03 to 1.97) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<I>SECONDARY OUTCOMES</I>
</P>
<P>
<LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>
<U>: Perceived illness experience</U>
</P>
<P>Subcategories 4.4.1: Three months; 4.4.2: Six months; and 4.4.3: Nine months<BR/>This outcome was measured with 'The perceived Illness Experience Scale' (<LINK REF="REF-Eiser-1995" TYPE="REFERENCE">Eiser 1995</LINK>). Regarding the perceived illness experience (impact of chronic illness) by the participating children, no statistically significant differences between the intervention and usual care group were found at: three months, MD -4.31 (95% CI -12.69 to 4.07); six months, MD -1.09 (95% CI -9.03 to 6.85); nine months, MD - 6.60 (95% CI -13.98 to 0.78)) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>
<U>: Children's loneliness </U>
</P>
<P>Subcategories 4.5.1: Three months; 4.5.2: Six months; and 4.5.3: Nine months<BR/>Children's loneliness was measured with the 'Children's Loneliness Scale' (<LINK REF="REF-Asher-1984" TYPE="REFERENCE">Asher 1984</LINK>). No statistically significant differences between the groups at any point in time were observed at: three months, MD -0.76 (95% CI -4.26 to 2.74); six months, MD 0.39 (95% CI -2.78 to 3.56); nine months, MD -2.17 (95% CI -5.73 to 1.39) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK>
<U>: Social support peers</U>
</P>
<P>Subcategory 4.6.1: three months, sub-category 4.6.2: six months, and sub-category 4.6.3: nine months<BR/>This outcome is measured with the subscale 'Peers' of the 'Social Support Scale for Children' (<LINK REF="REF-Harter-1986" TYPE="REFERENCE">Harter 1986</LINK>). No statistically significant differences were found between the two groups at: three months MD 0.75 (95% CI -0.59 to 2.09); at six months MD -0.05 (95% CI -1.13 to 1.03); and at nine months, MD -0.09 (95% CI -1.13 to 0.95) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK>
<U>: Social support classmates</U>
</P>
<P>Subcategories 4.7.1: Three months; 4.7.2: Six months; and 4.7.3: Nine months<BR/>This outcome is measured with the subscale 'Classmates' of the 'Social Support Scale for Children' (<LINK REF="REF-Harter-1986" TYPE="REFERENCE">Harter 1986</LINK>). No statistically significant differences were found between the two groups at: three months, MD 0.06 (95% CI -1.59 to 1.71); at six months, MD 0.35 (95% CI -1.11 to 1.81); and at nine months, MD 1.33 (95% CI -0.20 to 2.86) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.08" TYPE="ANALYSIS">Analysis 4.8</LINK>
<U>: Self-competence &#8211;</U> <U>subscale 'Global self-worth'</U>
</P>
<P>Subcategory 4.8.1: three months, sub-category 4.8.2: six months, and sub-category 4.8.3: nine months<BR/>This outcome is measured with the subscale 'Global self-worth' of the 'Self-perception Profile for Children' (<LINK REF="REF-Harter-1985" TYPE="REFERENCE">Harter 1985</LINK>). No statistically significant differences were observed at any point in time: three months, MD 0.36 (95% CI -0.84 to 1.56); six months, MD 0.31 (95% CI -0.81 to 1.43); nine months, MD 0.63 (95% CI -0.54 to 1.80) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.09" TYPE="ANALYSIS">Analysis 4.9</LINK>
<U>: Self-competence - subscale 'scholastic competence'</U>
</P>
<P>Subcategories 4.9.1: Three months; 4.9.2: Six months; and 4.9.3: Nine months<BR/>This outcome is measured with the subscale 'Scholastic competence' of the 'Self-perception Profile for Children' (<LINK REF="REF-Harter-1985" TYPE="REFERENCE">Harter 1985</LINK>). This measure did not show any statistically significant effect between the groups at any point in time: three months, MD 0.28 (95% CI -1.38 to 1.94); six months, MD 0.55 (95% CI -0.93 to 2.03); nine months, MD 0.76 (95% CI -0.65 to 2.17) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.10" TYPE="ANALYSIS">Analysis 4.10</LINK>
<U>: Self-competence &#8211; subscale 'Social acceptance'</U>
</P>
<P>Subcategories 4.10.1: Three months; 8.10.2: Six months; and 8.10.3: Nine months<BR/>This outcome is measured with the subscale 'Social acceptance' of the 'Self-perception Profile for Children' (<LINK REF="REF-Harter-1985" TYPE="REFERENCE">Harter 1985</LINK>). No statistically significant difference was found at: three months, MD -0.38 (95% CI -1.85 to 1.09); six months, MD 0.24 (95% CI -1.09 to 1.57); or nine months, MD 0.52 (95% CI -0.84 to 1.88) between the intervention and usual care group (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.11" TYPE="ANALYSIS">Analysis 4.11</LINK>
<U>: Self-competence &#8211; subscale 'Athletic competence'</U>
</P>
<P>Subcategories 4.11.1: Three months, 4.11.2: Six months; and 4.11.3: Nine months<BR/>This outcome is measured with the subscale 'Athletic competence' of the 'Self-perception Profile for Children' (<LINK REF="REF-Harter-1985" TYPE="REFERENCE">Harter 1985</LINK>). No statistically significant differences between the groups at any point in time were observed: three months, MD 0.59 (95% CI -0.90 to 2.08); six months, MD 0.33 (95% CI -1.09 to 1.75); nine months, MD 0.12 (95% CI -1.38 to 1.62) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.12" TYPE="ANALYSIS">Analysis 4.12</LINK>
<U>: Self-competence &#8211; subscale 'physical appearance'</U>
</P>
<P>Subcategories 4.12.1: Three months; 4.12.2: Six months; and 4.12.3: Nine months<BR/>This outcome is measured with the subscale 'Physical appearance' of the 'Self-perception Profile for Children' (<LINK REF="REF-Harter-1985" TYPE="REFERENCE">Harter 1985</LINK>). No statistically significant differences were found between the two groups at: three months, MD 0.38 (95% CI -0.94 to 1.70); at six months, MD 0.45 (95% CI -0.82 to 1.72); and at nine months, MD 0.75 (95% CI -0.49 to 1.99) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.13" TYPE="ANALYSIS">Analysis 4.13</LINK>
<U>: Self-competence &#8211; subscale &#8216;behavioural conduct&#8217;</U>
</P>
<P>Subcategories 4.13.1: Three months; 4.13.2: Six months; and 4.13.3: Nine months<BR/>This outcome is measured with the subscale 'Behavioural conduct' of the 'Self-perception Profile for Children' (<LINK REF="REF-Harter-1985" TYPE="REFERENCE">Harter 1985</LINK>). No statistically significant differences between the groups at any point in time were observed: three months, MD 0.62 (95% CI -0.89 to 2.13); six months, MD 0.14 (95% CI -1.35 to 1.63); nine months, MD 0.16 (95% CI -1.24 to 1.56) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
<P>
<LINK REF="CMP-004.14" TYPE="ANALYSIS">Analysis 4.14</LINK>
<U>: Functional health status</U>
</P>
<P>Subcategory 4.14.1: three months; sub-category 4.14.2: six months, and sub-category 4.14.3: nine months<BR/>This outcome was measured with 'The Functional Disability Inventory' (<LINK REF="REF-Walker-1991" TYPE="REFERENCE">Walker 1991</LINK>). Functional health status was not significantly different at all three points in time between the intervention and usual care group: three months, MD -0.05 (95% CI -1.86 to 1.76); six months, MD 0.17 (95% CI -1.43 to 1.77); nine months, MD 0.73 (95% CI -0.80 to 2.26) (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Cognitive</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">2.1 Cognitive interventions to improve adherence</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 5 - Written self-disclosure intervention versus standard care</HEADING>
<P>One study with 39 participants was included (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
<P>
<I>PRIMARY OUTCOMES</I>
</P>
<P>
<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>
<U>: Subjective health status- PHQ</U>
</P>
<P>Subcategory 5.1.1: Depression scale three-month follow up<BR/>Subcategory 5.1.2: Anxiety scale three-month follow up<BR/>Subcategory 5.1.3: Somatic complaints three-month follow up<BR/>Subcategory 5.1.4: Stressful life events three-month follow up<BR/>Subjective health status was measured with the &#8216;Patient Health Questionnaire (PHQ; <LINK REF="REF-Spitzer-1994" TYPE="REFERENCE">Spitzer 1994</LINK>). On the subscales 'Anxiety', MD -0.80 (95% CI -2.28 to 0.68), 'Depression', MD -1.50 (95% CI -4.11 to 1.11), and 'Stressful life events', MD 0.50 (95% CI -2.95 to 3.95), the two groups did not differ significantly at three-months follow up. The subscale 'Somatic complaints' showed a statistically significant difference at the three-month follow up (P = 0.0007) in favour of the written self-disclosure intervention, MD -3.10 (95% CI -5.36 to -0.84) (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
<P>
<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>
<U>: Subjective health status &#8211;SF-12</U>
</P>
<P>Subcategory 5.5.1: Physical health status three-month follow up<BR/>Subcategory 5.5.2: Mental health status three-month follow up<BR/>The subjective health status of the participating adolescents and adults with CF measured with the SF-12 (<LINK REF="REF-Ware-1993" TYPE="REFERENCE">Ware 1993</LINK>). At the three-month follow up, the two groups did not differ statistically on the 'Physical health' subscale, MD 0.50 (95% CI -5.90 to 6.90) or on the 'Mental health' subscale, MD 4.20 (95% CI -1.01 to 9.41) (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
<P>
<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>
<U>: FEV<SUB>1</SUB> three-months follow up</U>
<BR/>FEV<SUB>1</SUB> as a physiological disease severity measure did not show a statistically significant difference between the intervention and standard medical care group, MD -1.90 (95% CI -14.93 to 11.13) (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
<P>
<LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>
<U>: BMI three months follow up</U>
<BR/>At the three-month follow up, BMI as a physiological disease severity measure did not differ between the two groups, MD 0.30 (95% CI -1.35 to 1.95) (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">SECONDARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-005.05" TYPE="ANALYSIS">Analysis 5.5</LINK>
<U>: Health care utilization</U>
</P>
<P>Subcategory 5.5.1: Outpatient utilization three-month follow up<BR/>Subcategory 5.5.2: Inpatient utilization three-month follow up<BR/>The data for health care utilization was retrieved from patient chart review. The number of outpatient visits and inpatient hospitalisation days were determined for the three months prior to and after enrolment in the study. There were no significantly different differences regarding outpatient visits, MD -0.80 (95% CI -1.93 to 0.33) and the inpatient hospitalisation days, MD -2.80 (95% CI -8.03 to 2.43) at three-month follow up, although the authors reported a significant reduction of the number of days patients spent in hospital due to the intervention (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>). This indicated the importance of reporting change scores.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 6 - Motivational Interviewing via telephone (three-month period) versus treatment as usual</HEADING>
<P>One study with 35 participants was included (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>
<U>: Quality of Life</U>
</P>
<P>Subcategory 6.1.1: Physical functioning<BR/>Subcategory 6.1.2: Social functioning<BR/>Subcategory 6.1.3: Treatment issues<BR/>Subcategory 6.1.4: Chest symptoms<BR/>Subcategory 6.1.5: Emotional functioning<BR/>Subcategory 6.1.6: Concerns for the future<BR/>Subcategory 6.1.7: Interpersonal relationships<BR/>Subcategory 6.1.8: Body image<BR/>Subcategory 6.1.9: Career concerns<BR/>This group of outcomes includes different domains of CF-specific quality of life. These data were collected using the CFQOL[A1]  (<LINK REF="STD-Gee-2000" TYPE="STUDY">Gee 2000</LINK>). We could only find a significant effect (P = 0.03) of the 'Motivational Interviewing' intervention on the domain &#8216;Body image&#8217;, MD 15.17 (95% CI 1.85 to 28.49). On the domain 'Emotional functioning', no significant effect (P = 0.07) of the intervention was observed, MD 7.88 (95% CI -0.53 to 16.29). Further, no significant group differences were found in: 'Physical functioning', MD 1.75 (95% CI -6.64 to 10.14); 'Social functioning', MD 6.78 (95% CI -3.55 to 17.11);  'Treatment issues', MD -3.09 (95% CI -20.10 to 13.92); 'Chest symptoms', MD 4.39 (95% CI -5.91 to 14.69); 'Concerns for the future', MD -1.30 (95% CI -18.06 to 15.46); 'Interpersonal relationships', MD 1.92 (95% CI -10.76 to 14.60); or 'Career concerns', MD 4.63 (95% CI -12.81 to 22.07) (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>).</P>
<P>
<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>
<U>: Psychological distress</U>
</P>
<P>Subcategory 6.2.1: STAI-Short Form<BR/>Subcategory 6.2.2: HADS anxiety<BR/>Subcategory 6.2.3: HADS depression<BR/>Post intervention, there were no significant effects of the 'Motivational Interviewing' intervention on symptoms of anxiety measured with STAI -Short Form, MD -5.50 (95% CI -12.05 to 1.05), symptoms of anxiety measured with HADS, MD -0.65 (95% CI -2.76 to 1.46), or symptoms of depression measured with HADS, MD 0.07 (95% CI -1.64 to 1.78) (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>).</P>
<P>
<LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>:<U> Lung function</U>
</P>
<P>Subcategory 6.3.1: FEV<SUB>1</SUB>
<BR/>Subcategory 6.3.2: FVC<BR/>We were unable to find any evidence that a 'Motivational Interviewing' intervention via telephone had any effect on the lung function post-intervention in either: FEV<SUB>1</SUB>, MD 1.88 (95% CI -11.44 to 15.20); or in FVC, MD -2.07 (95% CI -14.49 to 10.35) (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>).</P>
<P>
<I>SECONDARY OUTCOME</I>
</P>
<P>
<LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>:<U> % Adherence behaviour</U>
</P>
<P>There were no significant group differences observed in rate of adherence post-intervention, MD 4.32 (95% CI -26.77 to 35.41) (<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.2 Cognitive interventions associated with transplantation</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 7 - Decision aid for patients considering lung transplantation versus usual care</HEADING>
<P>One study with 149 participants was included (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">SECONDARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>
<U>: Participants&#8217; knowledge</U>
</P>
<P>Subcategory 7.1.1: Three-week follow up<BR/>Subcategory 7.1.2: Change in knowledge (week three to baseline)<BR/>We were able to find evidence that a decision aid for patients considering lung transplantation improves patients&#8217; knowledge: three-week follow-up score, MD 0.98 (95% CI 0.66 to 1.31 (P &lt; 0.00001); and change in knowledge, MD 0.94 (95% CI 0.53 to 1.35) (P &lt; 0.0001) (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>
<LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>
<U>: Patients' expectations</U>
</P>
<P>Subcategory 7.2.1: Three-week follow up<BR/>Subcategory 7.2.2: Change in expectation score (week three to baseline)<BR/>Realistic expectations scores were used to measure patients&#8217; perceptions of the level of risk for surgery and probabilities of survival. Significant differences between the two groups were found for scores at the three-week follow up, MD 0.73 (95% CI 0.51 to 0.95) (P &lt; 0.00001) and change scores, MD 0.66 (95% CI 0.37 to 0.95) (P &lt; 0.0001) in favour of the decision aid intervention (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>
<LINK REF="CMP-007.03" TYPE="ANALYSIS">Analysis 7.3</LINK>
<U>: Decisional conflict</U>
</P>
<P>Subcategory 7.3.1: Total score three-week follow up<BR/>Subcategory 7.3.2: Subscale - certainty three-week follow up<BR/>Subcategory 7.3.3: Subscale - informed three-week follow up<BR/>Subcategory 7.3.4: Subscale - values three-week follow up<BR/>Subcategory 7.3.5: Subscale - support three-week follow up<BR/>Subcategory 7.3.6: Subscale - satisfaction with decision three-week follow up<BR/>Subcategory 7.3.7: Change in total score (week three to baseline)<BR/>This outcome was measured with the 'Decisional Conflict Scale' (<LINK REF="REF-O_x0027_Connor-1995" TYPE="REFERENCE">O'Connor 1995</LINK>). The scale includes five subscales and one total score. Scores range from 0 (low decisional conflict) to 100 (high decisional conflict). A minimal clinically important difference was established: patients scoring of 25 or less tend to make decisions.</P>
<P>Significant differences between both groups in favour of the decision aid intervention were found for the total score at three-week follow up, MD -8.80 (95% CI -13.70 to -3.90) (P = 0.0004); the subscale 'certainty', MD -10.00 (95% CI -18.63 to -1.37) (P = 0.02); the subscale 'informed', MD -12.70 (95% CI -17.77 to -7.63) (P &lt; 0.00001); the subscale 'values', MD -6.90 (95% CI -13.12 to -0.68) (P = 0.03); the subscale 'support', MD -7.60 (95% CI -12.15 to -2.75) (P = 0.002) and the subscale 'satisfaction with decision', MD -7.50 (95% CI -13.42 to -1.58) (P = 0.01). In contrast, no significant differences were observed in the change in the total score from baseline to three-week follow up, MD 3.30 (95% CI -2.28 to 8.88) (P = 0.25). All means across these scales, at the three-week follow up, fell under the MID cut-off of 25 points indicating absence of relevant decisional conflict, except the subscale 'certainty' (Decision aid group (mean (SD)): 26.4 (25.9); usual care group: 36.4 (27.8)) (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>
<LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>
<U>: Patient's stated choice three-week follow up</U>
</P>
<P>Subcategory 7.4.1: Referral for transplantation<BR/>Subcategory 7.4.2: Declined referral for transplantation<BR/>Subcategory 7.4.3: Unsure<BR/>For all subcategories no significant differences in the rate of patients were found: for 'Referral for transplantation', OR 0.85 (95% CI 0.43 to 1.72); for 'Declined referral for transplantation', OR 1.69 (95% CI 0.61 to 4.71); and for 'Unsure', OR 0.88 (95% CI 0.39 to 2.00) (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>
<LINK REF="CMP-007.05" TYPE="ANALYSIS">Analysis 7.5</LINK>
<U>: Durability of patient decision (12-month follow up)</U>
</P>
<P>The outcome also considered whether patients chose the same option as reported at three-week follow up or not. No significant difference between groups was found on durability of the patients&#8217; decisions observed at 12-month follow up, OR 2.47 (95% CI 0.94 to 6.52) (P = 0.06) (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>
<LINK REF="CMP-007.06" TYPE="ANALYSIS">Analysis 7.6</LINK>
<U>: Preparation for decision-making three-week follow up</U>
</P>
<P>This outcome was measured with a questionnaire asking whether patients felt prepared to make a decision by using the provided information. The two groups differed significantly at the three-week follow up, providing evidence that the participants in the decision aid group felt better prepared to make a decision, MD 11.30 (95% CI 2.95 to 19.65) (P = 0.009) (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>
<LINK REF="CMP-007.08" TYPE="ANALYSIS">Analysis 7.8</LINK>:<U> Values congruence</U>
</P>
<P>The choices of patients were consistent with their values across both groups (decision aid versus usual care) (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>, p.765). Patients choosing a referral for lung transplantation rated living longer as very important, OR 1.80 (CI 95% 1.02 to 3.18) (P = 0.04); avoiding hassle, stress, and worry of lung transplantation less important, OR 0.77 (95% CI 0.60 to 0.99) (P = 0.047), in comparison to those declining lung transplantation (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
<P>
<LINK REF="CMP-007.08" TYPE="ANALYSIS">Analysis 7.8</LINK>
<U>: Acceptability</U>
</P>
<P>Subcategory 7.8.1: Received the right amount of information<BR/>Subcategory 7.8.2: Materials were helpful in helping to arrive at a decision<BR/>Subcategory 7.8.3: Definitely or probably recommend the materials<BR/>Both groups received material with information on lung transplantation. Regarding acceptability of this information, a significant higher number of participants reported that they received the right amount of information, OR 4.47 (95% CI 2.22 to 9.02) (P = 0.008) and would definitely or probably recommend the materials they received, OR 4.93 (95% CI 1.04 to 23.32) (P = 0.04) in the decision aid than comparison group. In contrast to the authors, we did not find a significant difference between groups in whether the material was perceived as helpful in arriving at a decision, OR 1.72 (95% CI 0.89 to 3.33) between the two groups (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. Family systems or Systemic</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 8 - Community-based support program versus contact telephone number</HEADING>
<P>One study with 13 participants was included (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>
<U>:<B> </B>Psychiatric Symptom Index - Anxiety subscale - mothers</U>
</P>
<P>Subcategory 8.1.1: Mother's anxiety - 12 months post-baseline<BR/>This is an 11-item anxiety subscale which returns a standardised score with a possible range of 0 to 100 (<LINK REF="REF-Ilfeld-1976" TYPE="REFERENCE">Ilfeld 1976</LINK>). Although the reported effects for the whole group of carers of children with a chronic illness in the source article showed reduced anxiety following the intervention, when comparisons were made for the subgroup of carers with a child with CF, no significant difference was found between groups, MD -3.60 (95% CI -18.14 to 10.94) at 12-month post-baseline. This subgroup was small and unlikely to demonstrate a clear effect, however it served to illustrate the pattern of the data within the group (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. Psychodynamic</HEADING>
<P>No comparisons to report.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5. Other interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 9 - Biofeedback assisted breathing re-training (BRT) versus biofeedback assisted relaxation training (RLXT)</HEADING>
<P>One study with 26 participants was included (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOME</HEADING>
<P>
<LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>
<U>: Pulmonary function (the study author's primary outcome indicator)</U>
<BR/>Subcategory 9.1.1: FEV<SUB>1</SUB> (litres per second) (absolute values)<BR/>Subcategory 9.1.2: FVC (litres) (absolute values)<BR/>Subcategory 9.1.3: FEF<SUB>25-75%</SUB> (litres per second) (absolute values)<BR/>Two of three measures of lung function were better in the intervention than control group post-study (at four weeks). These were FEV<SUB>1</SUB>, MD 0.54 (95% CI 0.15 to 0.93) (P = 0.007) and FEF<SUB>25-75%</SUB>, MD 0.67 (95% CI 0.10 to 1.24) (P = 0.02). The FVC measure was not significantly different between the groups at this time point, MD 0.87 (95% CI -0.09 to 1.83). This set of findings shows that biofeedback-assisted breathing re-training is associated with improvement in some measures of spirometric lung function in adolescents with CF. These findings have clinical significance for the combined effects of physiotherapy and biofeedback (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 10 - Massage therapy versus bedtime reading control</HEADING>
<P>One study with 20 participants was included (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>
<U>: Well-being</U>
<BR/>Three measures were utilised; one was aimed at the parents' emotional state (subcategory 10.1.1) and the remaining two assessed the child's emotional state (sub-categories 10.1.2 and 10.1.3).<BR/>
</P>
<P>Subcategory 10.1.1: State Trait Anxiety Inventory for parent (STAI) (<LINK REF="REF-Spielberger-1970" TYPE="REFERENCE">Spielberger 1970</LINK>)<BR/>This inventory measures anxiety of adults as an emotional state, i.e. the anxiety that a person experiences under certain conditions, and personality trait, i.e. a relatively enduring personality characteristic that reflects the individual's propensity to respond with anxiety to a broad range of conditions. The measure has 20 items and has acceptable concurrent validity and internal consistency. This emotional outcome measure showed a significant effect 30 days after completing the intervention in favour of massage for the parent, MD -9.10 (95% CI -17.84 to -0.36) (P = 0.04) in reducing anxiety (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>).</P>
<P>
<BR/>Subcategory 10.1.2: State Trait Anxiety Inventory for children (STAIC) (<LINK REF="REF-Spielberger-1973" TYPE="REFERENCE">Spielberger 1973</LINK>)<BR/>This is an adaptation of the adult STAI that has already been described above (Outcome 3.1.1) for children of school age and adolescents who are below average reading level. The scale has 20 items with acceptable internal validity. This emotional outcome measure showed a significant effect 30 days after completing the intervention in favour of massage for the child, MD -8.20 (95% CI -12.36 to -4.04) (P = 0.0001) in reducing anxiety (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>).<BR/>
<BR/>Subcategory 10.1.3: Profile of Mood States (POMS)<I> </I>(<LINK REF="REF-McNair-1971" TYPE="REFERENCE">McNair 1971</LINK>) (child only)<BR/>This measure is a modification for children of the original POMS designed for adults; items that focused on depressed symptoms were simplified based on the POMS manual. Only the depression subscale was utilised, which comprised 19 adjectives describing how the child felt right now, rated on a 5-point rating scale. The measure has good face validity for measuring depressed mood in children. Significant improvements in this outcome measure were found at post-day 30 in favour of massage for overall mood state, MD -5.50 (95% CI -8.81 to -2.19) (P = 0.001) (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>).</P>
<P>In summary, these three emotional outcome measures showed significant effects in favour of: massage for the child and the parent with respect to anxiety and mood state in children, suggesting that massage reduced anxiety levels in both the parent and the child and reduced the child's depressive symptoms. Although the sample was small, the consistency of these results indicate a clinically important result, with implications for managing affective states.</P>
<P>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>
<U>: Pulmonary function </U>
<BR/>
</P>
<P>Subcategory 10.2.1: Peak air flow (PEFR) at day 1<BR/>Subcategory 10.2.2: Peak air flow (PEFR) at day 30.<BR/>At day 1 the two groups did not differ statistically on their pulmonary function, MD 16.50 (95% CI -64.04 to 97.04). We did not find that massage therapy affected pulmonary function at day 30, MD 53.90 (95% CI -43.27 to 151.07) (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 11 - Music therapy versus familiar music and no audiotape control</HEADING>
<P>One study with 20 participants was included (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>
<U>: Enjoyment (the study author's primary outcome indicator)</U>
<BR/>Subcategories 11.1.1 and 11.1.2: Enjoyment - parent &amp; child<BR/>This outcome utilised an ad hoc seven point bi-polar rating scale measuring enjoyment of the routine. These outcome measures are highly subjective and their validity has not been tested. Parents ranked their own enjoyment and their perception of their child's enjoyment of chest physiotherapy (CPT) in the comparison groups (music therapy versus familiar music tape and no audiotape) on these scales. Significant effects were found in favour of music therapy for enjoyment during CPT by both child, MD 2.05 (95% CI 0.51 to 3.59) (P = 0.009) and parent, MD 1.20 (95% CI 0.22 to 2.18) (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>).</P>
<P>
<LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>
<U>: Cognitive (the study author's primary outcome indicator)</U>
<BR/>Subcategory 11.2.1: Parent perception of time<BR/>This measured the parents' perception of how long they felt it took to complete the CPT in minutes. The score was compared to the actual time the parent recorded on a diary chart. The MD had wide CIs, so we did not find any evidence of an effect here, MD -4.70 (95% CI -16.93 to 7.53) (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 12 - Self-hypnosis versus control</HEADING>
<P>One study with twelve participants was included (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>We were not able to perform quantitative analysis based on the data the authors provided in their report and were not able to contact the authors to provide detailed data. Therefore we report the results the authors described.</P>
<SUBSECTION>
<HEADING LEVEL="6">
<I>PRIMARY OUTCOMES</I>
</HEADING>
<P>
<LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>
<U>: Anxiety</U>
</P>
<P>The authors reported the following results: No group differences were observed (U = 15, P &gt; 0.05) for 'State Anxiety'. A significant difference between experimental and control group was found for 'Trait Anxiety' (U = 1.5, P &lt; 0.004) with change scores reflecting decreases in 'Trait Anxiety' for the experimental group and increases for the control group (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>
<LINK REF="CMP-012.02" TYPE="ANALYSIS">Analysis 12.2</LINK>
<U>: Impact on 'Family Scale'</U>
</P>
<P>The authors reported that there were no group differences observed (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>
<LINK REF="CMP-012.03" TYPE="ANALYSIS">Analysis 12.3</LINK>
<U>: 'Child Behavior Checklist'</U>
</P>
<P>The authors reported that there were no group differences observed (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>
<LINK REF="CMP-012.04" TYPE="ANALYSIS">Analysis 12.4</LINK>
<U>: Average peak flow expiratory flow rate</U>
</P>
<P>The authors reported the following result: The mean PEFR score showed an increase of approximately 76 points from pre- to post-test in the experimental group, whereas it dropped approximately 12 points in the control group. This difference proved to be significant (U = 0, P &lt; 0.001). The difference between the two groups was also significant at the four-month follow up (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>
<LINK REF="CMP-012.05" TYPE="ANALYSIS">Analysis 12.5</LINK>
<U>: Height and weight</U>
</P>
<P>No group differences were observed by the authors (U = 125, P &gt; 0.05) at four month follow up (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">SECONDARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-012.06" TYPE="ANALYSIS">Analysis 12.6</LINK>
<U>: Rating of the parents' assessment of the child's illness</U>
</P>
<P>No group differences were observed (U = 15, P &gt; 0.05) (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>
<LINK REF="CMP-012.07" TYPE="ANALYSIS">Analysis 12.7</LINK>
<U>: 'Locus of Control'</U>
</P>
<P>Significant differences were found by the authors in change of 'Locus of Control' (U = 0, P = 0.001) between the experimental and the control groups: scores of the experimental group decreased, which indicates more internality (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>
<LINK REF="CMP-012.08" TYPE="ANALYSIS">Analysis 12.8</LINK>
<U>: 'Health Locus of Control'</U>
</P>
<P>Significant differences were found in change of Children&#8217;s Health Locus of Control (U = 0, P = 0.001) between the experimental and control groups. The scores of the experimental group increased, which means that children&#8217;s internal expectancies related to health improved more in the experimental group (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
<P>
<LINK REF="CMP-012.09" TYPE="ANALYSIS">Analysis 12.9</LINK>
<U>: Self-concept</U>
</P>
<P>Self-concept scores improved significantly more in the experimental group than control groups (U = 1.5, P = 0.003) (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 13 - Home telemedicine for patients awaiting transplantation versus usual care</HEADING>
<P>One study with seven participants was included here (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>).</P>
<P>We were not able to perform quantitative analysis based on the data the authors provided in their report and did not receive a response on our query for detailed data. However, we describe the provided results of the report.</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-013.01" TYPE="ANALYSIS">Analysis 13.1</LINK>
<U>: Quality of life</U>
</P>
<P>The quality of life was measured with the 'Cystic Fibrosis Quality of Life Questionnaire' (<LINK REF="STD-Gee-2000" TYPE="STUDY">Gee 2000</LINK>). The authors reported that the intervention group showed a significant improvement in the subjects&#8217; perception of body image (P = 0.002) (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>).</P>
<P>
<LINK REF="CMP-013.02" TYPE="ANALYSIS">Analysis 13.2</LINK>
<U>: Anxiety</U>
</P>
<P>The authors reported: "There was no significant change in anxiety before and after link-up for the telemedicine group or before and after clinic attendance for either group. There was no difference in the change of anxiety from pre to post link-up for the telemedicine group or for the control group in pre and post clinic attendance" (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, p.184).</P>
<P>
<LINK REF="CMP-013.03" TYPE="ANALYSIS">Analysis 13.3</LINK>
<U>: Depression</U>
</P>
<P>The authors reported: "At the end of the study there was a higher reporting of depression, which was associated with a higher reporting of anxiety, in both groups" (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, p.184).</P>
<P>
<I>SECONDARY OUTCOME</I>
</P>
<P>
<LINK REF="CMP-013.04" TYPE="ANALYSIS">Analysis 13.4</LINK>
<U>: Coping of carers</U>
</P>
<P>Regarding the coping of the participating carers no significant differences between the two groups were found by the authors (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>).</P>
<P>
<LINK REF="CMP-013.05" TYPE="ANALYSIS">Analysis 13.5</LINK>
<U>: health care utilization</U>
</P>
<P>The authors reported that the two groups did not show any significant differences on the following outcomes: number of visits; general practitioner; courses of IV antibiotics; length of hospital inpatient stay; or visits either to hospital or GP (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Comparision 14 - Dance/Movement therapy for adults versus control</HEADING>
<P>One study with 14 participants was included here (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>).</P>
<P>We were not able to perform quantitative analysis based on the data the authors provided in their report and we did not receive detailed data from the authors. Therefore, we report the results the author described in the published paper (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">PRIMARY OUTCOMES</HEADING>
<P>
<LINK REF="CMP-014.01" TYPE="ANALYSIS">Analysis 14.1</LINK>
<U>: Mood state</U>
</P>
<P>The mood state was measured with 'The Profile of Mood States' (POMS) (<LINK REF="REF-McNair-1992" TYPE="REFERENCE">McNair 1992</LINK>).The author described that the repeated measures ANOVA revealed a statistically significant effect of time group, and gender on the subscale 'confusion-bewilderment' (F (2,20) = 5.99, P = 0.007, eta2 = 0.231). Men participating in the treatment group showed the strongest effect regarding changes in the mood state of participants (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>).</P>
<P>
<I>SECONDARY OUTCOMES</I>
</P>
<P>
<LINK REF="CMP-014.02" TYPE="ANALYSIS">Analysis 14.2</LINK>
<U>: Adherence to exercise and nutrition regimen</U>
</P>
<P>The author reported the following results: No significant differences on exercise or nutrition post-intervention or one-month follow up (one month later). However, significant differences were found at follow up between groups on adherence to nutrition regimens (Chi2 (1, N = 23) = 4.485, P = 0.03), with lower levels of adherence in the control group (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>).</P>
<P>
<LINK REF="CMP-014.03" TYPE="ANALYSIS">Analysis 14.3</LINK>
<U>: Body image</U>
</P>
<P>The author stated that no group differences were observed (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-06-11 21:58:55 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-06-11 21:48:28 +0100" MODIFIED_BY="[Empty name]">
<P>Psychological interventions for patients with CF are heterogenous in many respects, including their target populations (caregivers, young children, adults), focus of the intervention (e.g., adherence, nutrition, depression and anxiety, improved health-related quality of life), age and stage of disease, and outcome measures. This makes it extremely difficult to compare and evaluate the efficacy of these interventions using meta-analytic techniques. In addition, the range of psychosocial challenges faced by this population, which include high treatment burden, poor adherence, risk for depression and anxiety, transition to adult care, and ultimately, declining health, increases the difficulty of accumulating intervention data in a particular area. A recent consensus conference, organized by the European Cystic Fibrosis Society, published a prioritised list of the key issues that should be addressed in research in the next decade (<LINK REF="REF-Bradley-2012" TYPE="REFERENCE">Bradley 2012</LINK>), along with reviews and recommendations of the best outcome measures in allied health professionals and nursing research. This included next to adherence, physical activity, nutritional interventions as well as interventions for newborns. Developing and seeking funding for psychological intervention studies in high priority areas would be one way to build the evidence base that is needed.</P>
<P>In terms of the complex psychological issues in coping with CF and its treatment regimen, only limited data on interventions is available. The retrieved primary studies used interventions with generic approaches utilized in the context of patients with CF, e.g. providing motivational interviewing to adult patients via telephone, behavioral group interventions for children and caregivers with nutritional problems, or interventions providing a decision aid for patients considering lung transplantation.</P>
<P>Given the heterogeneity of the interventions and outcome measure, it is not currently possible to identify an overall effect of psychological interventions for patients with CF and their caregivers. For approximately half of the retrieved studies, some positive evidence fort he intervention was found. Most of the successful interventions were disease-specific.</P>
<P>Interventions with the most evidence were those that combined educational and behavioral techniques to improve dietary intake and nutritional status. The combined intervention was compared to nutrition education alone. By pooling the results of three studies, it was shown that these behavioral interventions were effective in increasing calorie intake in underweight children with CF in the short-term (<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>; <LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>). Additionally, one of the three studies showed that this intervention was also effective in increasing the proportion of estimated energy requirements of these children over a short period of time. Longer studies are needed to see if these effects are maintained over time or if 'booster sessions' are needed.</P>
<P>Promising interventions were reported in single studies. A combination of an educational session plus a decision-making aid (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>) improved patients' knowledge of and expectations about the transplant, with decisional conflict reduce in the short-term</P>
<P>Furthermore, on the basis of three single studies, we found some evidence to suggest that biofeedback, massage and music therapy might be a helpful adjunct during physical therapy. Biofeedback-assisted breathing re-training (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>) compared to biofeedback assisted relaxation training over the course of eight sessions was superior in enhancing lung function, especially FEV<SUB>1</SUB>. Massage therapy compared to bedtime reading (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>) was superior to reducing symptoms of anxiety in parents and children, and symptoms of depression in children.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-06-11 15:49:38 +0100" MODIFIED_BY="[Empty name]">
<P>In relation to the broad area of psychosocial challenges in CF, only a few studies with rigorous research designs were identified for this review. A number of clinically relevant psychological issues have not yet been studied. Of note, few interventions have been developed or evaluated to address parental responses to newborn screening, transitions to adult care, or palliative care. In addition, areas of high clinical relevance across stages of the disease, such as adherence, depression and anxiety, and health-related quality of life are underrepresented or currently absent from the literature.</P>
<P>For example, despite published national data indicating that caregivers and other members of the family are at high risk for psychological symptoms due to the illness (<LINK REF="REF-Besier-2011a" TYPE="REFERENCE">Besier 2011a</LINK>; <LINK REF="REF-Besier-2011b" TYPE="REFERENCE">Besier 2011b</LINK>), no studies addressing these issues were available and eligible for inclusion. Moreover, no studies investigating the application of evidence-based psychotherapy approaches to prevent or reduce comorbid psychological distress were found. In sum, although recent evidence has demonstrated that there are significant psychological needs to be met for both caregivers and patients, the evidence on psychological interventions applied to this population is highly incomplete.</P>
<P>Interventions were delivered in a variety of modes, including individual, group, face-to-face, and telephone or Internet-based communication. Given recent infection control guidelines (<LINK REF="REF-Kerem-2005" TYPE="REFERENCE">Kerem 2005</LINK>; <LINK REF="REF-Miroballi-2012" TYPE="REFERENCE">Miroballi 2012</LINK>), group-based psychological interventions for patients are not recommended. More research is needed on the efficacy and effectiveness of psychological interventions delivered via the Internet using Skype or other video-conferencing software.</P>
<P>Importantly, patients and family members face a number of barriers in attempting to access psychological interventions, including:</P>
<OL>
<LI>distance to the centre;</LI>
<LI>insurance coverage and cost;</LI>
<LI>availability of a psychologist or trained mental health provider on the CF team or in hospital; and</LI>
<LI>availability of a trained provider in the patient&#8217;s local community.</LI>
</OL>
<P>Applicability of group interventions into the individual outpatient treatment setting requires availability of a number of eligible families at the same time.</P>
<P>Another critical issue is the availability of trained mental health providers on CF specialty teams. Data from the iCARE study suggest that CF team members need additional training in counselling, but can quickly be trained to deliver a structured, behavioral intervention with brief phone supervision. If we are hoping to integrate highly structured, manualised psychological interventions into CF care, we will have to address the need for mental health training and expertise within CF teams. Currently, there are only a few comprehensive, patient-centred CF Centers that routinely collect and display data on the psychosocial functioning of its CF cohort (e.g. Sophia Children&#8217;s Hospital, ErasmusMC, Netherlands; CF Center,<I> </I>Medical University Innsbruck, Austria). Implementation of evidence-based psychological treatments will require carefully trained, specialized providers to implement disease-specific, evidence-based treatments. It is possible that these interventions, aimed at improving adherence for example, may provide costs savings in the long-run by reducing pulmonary exacerbations and therefore, inpatient hospitalisation costs.</P>
<P>Furthermore, the improvements of therapy and care in CF lead to the assumption that there is a contemporary era of care effect in the included studies. Hence, the validity of newer studies is estimated to be higher for today&#8217;s individuals with CF.</P>
<P>
<I>Footnote:</I> It is important to note that this review did not include data on primarily educational interventions because they were included in a separate review (<LINK REF="REF-Savage-2011" TYPE="REFERENCE">Savage 2011</LINK>). However, since many psychosocial interventions combine education with other strategies (e.g., problem-solving, MI) it is somewhat artificial to draw the line between purely educational versus psychological interventions.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-06-11 21:58:55 +0100" MODIFIED_BY="[Empty name]">
<P>The evidence presented in this review, which is based on data from only a few very heterogenous studies (16), involving a total of 556 participants, is limited by the quality of the available research. One major challenge in conducting high quality research in CF, which is a rare disease, is having large enough samples. In this review, more than half of the included studies had small sample sizes given their aims and only a few studies conducted a formal power calculation to ensure that they had the necessary sample to detect statistically significant differences. Due to the small number of studies and limited number of participants we were not able to explore whether the effect varied by type of intervention, socioeconomic status, age of the individual, or stage of the disease. Given that CF is a rare disease, larger samples with more diverse patients will require implementation and analysis of multicentre studies. This increases the complexity of obtaining funding and maintaining standardization of procedures and methods, but is likely a critical step in evaluating the efficacy of psychological interventions. Several multi-site studies are currently in process (e.g. <LINK REF="STD-Quittner-2011" TYPE="STUDY">Quittner 2011</LINK>; <LINK REF="STD-Quittner-2012" TYPE="STUDY">Quittner 2012</LINK>) and will likely report their results in the next two years.</P>
<P>The assessment of risk of bias indicated that the quality of many of the earlier intervention studies, in terms of study design and methods, fell far short of typical requirements. Several important studies were excluded from previous versions of the review, because participants were not randomised (e.g. <LINK REF="STD-Bartholomew-1997" TYPE="STUDY">Bartholomew 1997</LINK>; <LINK REF="STD-Hains-1997" TYPE="STUDY">Hains 1997</LINK>; <LINK REF="STD-Johnson-2001" TYPE="STUDY">Johnson 2001</LINK>).</P>
<P>We would also like to acknowledge that the quality of RCTs is improving and that most of the newly included studies paid more rigorous attention to the design, methods and reporting standards for RCTs than those in the past. Missing information on important details of the study design and procedures was associated with unclear risk of bias. Although most authors reported some information about the randomisation procedure, few provided enough detailed information to determine whether allocation concealment occurred. Although it is generally not feasible to blind therapists to the type of psychological intervention being delivered or participants from whether they are in the treatment or control arm of the study, it is always possible to blind assessors; however, this aspect of blinding was only reported in a few studies. It was also more difficult to detect significant differences between groups because data on changes in the outcome variables were not provided. Additionally, three studies of interest did not provide enough quantitative data to perform analysis. Another weakness in reporting is that some of the studies did not describe whether they pre-specified a primary outcome. Psychological interventions often have several endpoints, making it critical to specify which outcome variable is the primary and which are considered secondary. Another common limitation is inadequate correction for multiple tests in the analytic phase. Most of the retrieved studies, especially the newer ones, provided sufficient information about the intervention (duration, qualification of therapists etc.) or the treatment manuals were available online (e.g. <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>; <LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>). However, just four of the studies reported some actions or methods to ensure treatment fidelity (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>; <LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; <LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>; <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>).</P>
<P>Quality indicators should have been grouped for the purposes of a sensitivity analysis. However, we could not distinguish between levels of quality (e.g., good, fair, poor) due to the fact that most studies were single studies Replications by independent groups are missing for the majority of positive findings. Currently, the body of evidence is of insufficient quality and quantity to draw any firm conclusions.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-06-11 21:55:24 +0100" MODIFIED_BY="[Empty name]">
<P>We are confident to have identified all relevant studies guided by the objectives of this review. The selection of studies, the assessment of risk of bias, and data extraction were conducted independently by two authors. Potentially disagreements were discussed within the working group. A potential conflict of interest should be mentioned. The authors LG and AQ are investigators of some of the considered interventions studies for this review. Unfortunately, for three of the included studies, we were only able to describe the results because of insufficient quantitative data. However, most of the authors we contacted were extremely helpful and provided a great deal of data and information. There are several ongoing studies that should be ready to publish their results fairly soon (<LINK REF="STD-Quittner-2000" TYPE="STUDY">Quittner 2000</LINK>; <LINK REF="STD-Quittner-2011" TYPE="STUDY">Quittner 2011</LINK>; <LINK REF="STD-Quittner-2012" TYPE="STUDY">Quittner 2012</LINK>; <LINK REF="STD-Riekert-2012" TYPE="STUDY">Riekert 2012</LINK>).</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-06-11 15:52:56 +0100" MODIFIED_BY="[Empty name]">
<P>The findings and respectively the drawn evidence for psychological interventions for patients with CF and their families are in line with other reviews focusing research on psychological interventions for chronically ill children, adolescents, and adults. In common with other Cochrane Reviews, e.g. on psychological interventions for children or adults with asthma (<LINK REF="REF-Yorke-2005" TYPE="REFERENCE">Yorke 2005</LINK>; <LINK REF="REF-Yorke-2006" TYPE="REFERENCE">Yorke 2006</LINK>) the evidence base is still lacking in quantity and quality.</P>
<P>In terms of other chronic illnesses, such as cancer in children and adolescents, more sufficient data of studies on psychological interventions are available to draw conclusions on the evidence in this particular illness. Two reviews highlight the support for the evidence of psychological interventions for caregivers and siblings in some of the relevant outcomes (<LINK REF="REF-Pai-2006" TYPE="REFERENCE">Pai 2006</LINK>; <LINK REF="REF-Prchal-2009" TYPE="REFERENCE">Prchal 2009</LINK>). In a more recent systematic review (<LINK REF="REF-Sansom_x002d_Daly-2012" TYPE="REFERENCE">Sansom-Daly 2012</LINK>), the most positive results were found for skills-based, multiple-session interventions for young adults with chronic illnesses; this is comparable to the results we found for the behavioral interventions for young children with feeding problems.</P>
<P>In general, most authors of reviews, regardless systematically or not, state that there is a need for greater rigor in designing, performing and reporting intervention studies for patients with a chronic illness and their families more rigorously (e.g. <LINK REF="REF-Plante-2001" TYPE="REFERENCE">Plante 2001</LINK>; <LINK REF="REF-Beale-2006" TYPE="REFERENCE">Beale 2006</LINK>; <LINK REF="REF-Seitz-2009" TYPE="REFERENCE">Seitz 2009</LINK>; <LINK REF="REF-Sansom_x002d_Daly-2012" TYPE="REFERENCE">Sansom-Daly 2012</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-06-11 22:02:40 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-05-07 10:46:02 +0100" MODIFIED_BY="[Empty name]">
<P>The studies of CF-specific interventions developed especially for patients with CF, such as interventions for those considering lung transplantation or behavioral interventions for children with feeding problems are supported by the evidence to date. Providing an additional decision aid to patients considering lung transplantation was associated with improvements patient's knowledge and realistic expectations and enabled the patient to reduce decisional conflict. The structured decision aid used in this trial is available via the Internet (in English and French language). After failure of nutrition counselling alone to improve calorie intake, behavioral interventions aiming at improving intake should be considered, in the short-term, as an alternative to tube-feeding with its medical and psychosocial side effects (e.g. <LINK REF="REF-Oliver-2004" TYPE="REFERENCE">Oliver 2004</LINK>; <LINK REF="REF-Van-Biervliet-2004" TYPE="REFERENCE">Van Biervliet 2004</LINK>; <LINK REF="REF-Hazel-2006" TYPE="REFERENCE">Hazel 2006</LINK>). Multi-component, behavioural interventions have shown the greatest promise in improving adherence, one of the greatest challenges faced by both patients and care teams. Current RCTs testing these strategies in CF are currently underway and should report results within the next year or two. Other interventions, such as biofeedback combined with physiotherapy are promising, although there are too few studies at this point to provide clear evidence. Therefore, we cannot currently recommend these interventions for implementation in clinical practice. Importantly, to utilize these interventions, psychologists or other members of the multidisciplinary team must be trained in their implementation. Health care providers with these skills are often not available in CF centres and thus, it may also be necessary to increase the behavioural expertise of providers or develop clinical pathways to referrals outside the CF centre.</P>
<P>Additionally, practitioners and clinical researchers should also be aware of other systematic reviews that have demonstrated that psychological interventions are beneficial. These include behavioural strategies to cope with procedural pain and distress (e.g., anxiety about needles, pic line insertions). These studies are not focused exclusively on patients with CF and thus, were not the focus of the current review (<LINK REF="REF-Uman-2013" TYPE="REFERENCE">Uman 2013</LINK>).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-06-11 22:02:40 +0100" MODIFIED_BY="[Empty name]">
<P>To summarise our findings: high quality efficacy and effectiveness studies of psychological interventions for CF are becoming more common, but there is an urgent need for studies with larger samples, more diverse characteristics (e.g., inclusion of minorities), replication of promising results, and better reporting of the methodological aspects of these studies. We are encouraged to report that some of the studies in this review utilized this approach and more are in the pipeline. We must also acknowledge that conducting large-scale, multicentre studies requires large funding sources, complex coordination of procedures and methods across sites, and complex multi-level modelling of both predictors and primary and secondary outcomes. To move this effort forward may require leadership from the various national CF associations in Europe and the US, and collaborative efforts by clinical researchers testing psychological interventions. The International TIDES study on comorbid depression and anxiety in patients with CF and their caregivers (<I>see</I> <A HREF="https://vpn.uniklinik-ulm.de/https/0/webmail.klinik.uni-ulm.de/owa/redir.aspx?C=6564702fd87845b18ba09333596446f5&amp;URL=http%3a%2f%2fwww.tides-cf.org%2f">http://www.tides-cf.org/</A>) with multiple funding in nine different countries, coordinated by one international study centre, involving multiple researchers and clinicians across the nine countries and finally in a joint effort collecting data of more than 6000 patients (<LINK REF="REF-Quittner-2012b" TYPE="REFERENCE">Quittner 2012b</LINK>) could serve as a model for effective international research collaboration and could be applied in international intervention studies with a need of larger samples.</P>
<P>A number of technological advances may also be helpful in overcoming the challenges of this rare disease, for example having online access for a decision aid for patients considering lung transplantation (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>). The development of patient registries by individual countries (UK, Germany, US), as well as ECFS, represents an enormous technological advance that improves our ability to collect demographic and health outcome data on a large scale.  The implementation of electronic medical records (EMR), which may be accessed with patient permission, may also facilitate data collection in key areas, such as adherence. In addition, development of electronic monitoring devices that measure ingestion of medications and pulmonary function, may also improve the accuracy of data collection and enable data collection on a much larger scale. </P>
<P>Our review also highlighted some important and common pitfalls of intervention research. Selection of a primary outcome is critical and if several outcomes are tested, attention should be paid to statistical adjustments for multiple tests to reduce the frequency of Type I errors. It is also important in the design phase to select reliable, well-validated measures that are consistent with the targeted outcome (i.e. adherence behavior, decisional conflict etc.) and are thus, able to demonstrate the efficacy of the psychological intervention.It should also be noted that the likelihood of finding evidence is higher for studies which target specific aspects of the treatment regimen (e.g. behavioural nutrition interventions) and pre-specified outcomes, rather than conducting non-specific interventions using more generic approaches and general outcomes.</P>
<P>We identified areas of need that have not been targeted to date in clinical research of psychological interventions. Key among these are:  interventions addressing at improving adherence, for patients at the end stage of the disease, interventions aimed at the psychological consequences of newborn screening/diagnosis, supportive interventions for  caregivers, families, and siblings of patients with CF, and psychotherapy interventions for co-morbid mental disorders. To deliver interventions to patients/caregivers more conveniently, researchers and clinicians should take advantage of new technologies, such as the Internet, in designing their studies. If effective, Internet-based interventions could improve access to a larger, more diverse group of patients and potentially reduce common barriers (e.g., distance to centre, need to miss school or work). Thus, psychological interventions could become more accessible, potentially less costly, and more convenient for patients.  </P>
<P>In terms of reporting, there is room for improvement in implementing the standards in reporting methods that are set out in the CONSORT statement (<LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>) and it's extension for non-pharmacological interventions (<LINK REF="REF-Boutron-2008" TYPE="REFERENCE">Boutron 2008</LINK>), including the reporting of change scores.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-06-11 15:54:06 +0100" MODIFIED_BY="[Empty name]">
<P>We appreciate the support and guidance of the Cochrane Cystic Fibrosis and Gentic Disorders Group. We would like to thank the Neurosis, Anxiety and Depression Group from the Cochrane Collaboration for their help with the search strategy for psychological interventions.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2012-10-24 10:01:17 +0100" MODIFIED_BY="[Empty name]">
<P>None known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-10-24 10:01:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Lutz Goldbeck (LG) is taking principal responsibility for updating the review. He screened titles, abstracts, and reviewed papers against inclusion criteria. He drafted the updated review. He was appraising quality of papers and interpreted results of data analysis.</P>
<P>Astrid Fidika (AF) is co-author for the review. She was screening titles, abstracts and, retrieved papers against the inclusion criteria. She extracted data from included papers, appraised quality of papers, took the leading role in contacting authors of papers for additional information. She investigated data analysis and interpretation, data management for the review, and entered data into RevMan. She provided advice on conducting the update of the systematic review and was involved in drafting the update.</P>
<P>Marion Herle (MH) is co-author for the review. She was screening titles, abstracts and, retrieved papers against the inclusion criteria. She extracted data from included papers and appraised quality of papers. She also cross-checked data entry of results for each outcome to Revman.</P>
<P>Alexandra L. Quittner (AQ) provided general advice on the review and interpretation of results for the current update. She has contributed a broad overview to the process of updating this review. She has supported CG for the original review and previous updates, and fine-tuned the strategy for reviewing intervention studies within this vast and complex area. She also initiated the debate surrounding evidence-based interventions with the international psychosocial interest group, which enhanced the discussion of the findings.</P>
<P>Claire A. Glasscoe (CG) was guarantor for the previous updates and the original review. She drafted the review  and drew on the expertise of others to refine it.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-09-27 11:08:23 +0100" MODIFIED_BY="[Empty name]">
<P>The Definition of psychological intervention was been changed to a more precisely definition of psychological intervention and classification types of intervention has been changed.</P>
<P>Due to a new Cochrane Review on 'Self-management education for cystic fibrosis', studies with a purely educational approach are not longer included for this review (<LINK REF="REF-Savage-2011" TYPE="REFERENCE">Savage 2011</LINK>).</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2012-08-07 16:08:25 +0100" MODIFIED_BY="Nikki Jahnke"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-06-17 09:43:14 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2014-06-17 09:43:14 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2014-05-07 11:24:52 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Belsky-1994" MODIFIED="2012-08-22 15:54:02 +0100" MODIFIED_BY="[Empty name]" NAME="Belsky 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-08-22 15:54:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Belsky J, Khanna P</AU>
<TI>The effects of self-hypnosis for children with cystic fibrosis: a pilot study</TI>
<SO>American Journal of Clinical Hypnosis</SO>
<YR>1994</YR>
<VL>36</VL>
<NO>4</NO>
<PG>282-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chernoff-2002" NAME="Chernoff 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chernoff RG, Ireys HT, DeVet KA, Kim Y</AU>
<TI>A randomized, controlled trial of a community-based support program for families of children with chronic illness: Pediatric outcomes</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>2002</YR>
<VL>156</VL>
<NO>6</NO>
<PG>533-539</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ireys HT, Chernoff R, DeVet KA, Kim Y</AU>
<TI>Maternal outcomes of a randomized controlled trial of a community-based support program for families of children with chronic illnesses</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>2001</YR>
<VL>155</VL>
<NO>7</NO>
<PG>771-777</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Christian-2006" MODIFIED="2013-12-19 13:30:20 +0000" MODIFIED_BY="[Empty name]" NAME="Christian 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-12-19 13:30:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian B, D'Auria J, Belyea M</AU>
<TI>Loneliness in school age children with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2003</YR>
<VL>Suppl 25</VL>
<PG>366</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002391"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-19 13:29:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian B</AU>
<TI>Functional disability and quality of life of school-age children with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>38 Suppl 27</VL>
<PG>356</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002744"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-19 13:25:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian B</AU>
<TI>The impact of chronic illness on quality of life in children with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2006</YR>
<VL>41 Suppl 29</VL>
<PG>398</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003069"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-19 13:26:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian B</AU>
<TI>The interface between physical activity, growth, and pulmonary function with the psychosocial impact of cystic fibrosis in children [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2005</YR>
<VL>40 Suppl 28</VL>
<PG>370</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002985"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-27 12:14:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Christian BJ &amp; D'Auria JP</AU>
<TI>Building life skills for children with cystic fibrosis: Effectiveness of an intervention</TI>
<SO>Nursing Research</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>5</NO>
<PG>300-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-23 23:44:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian BJ, D'Auria JP, Belyea MJ, Retsch-Bogart GZ</AU>
<TI>Psychosocial status of school-age children with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1999</YR>
<VL>Suppl 19</VL>
<PG>329</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delk-1994" NAME="Delk 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Delk KK, Gevirtz R, Hicks DA, Carden F, Rucker R</AU>
<TI>The effects of biofeedback assisted breathing retraining on lung functions in patients with cystic fibrosis</TI>
<SO>Chest</SO>
<YR>1994</YR>
<VL>105</VL>
<NO>1</NO>
<PG>23-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodill-2005" MODIFIED="2012-08-22 15:54:22 +0100" MODIFIED_BY="[Empty name]" NAME="Goodill 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-08-22 15:54:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodill SW</AU>
<TI>Dance/movement therapy for adults with cystic fibrosis: pilot data on mood and adherence</TI>
<SO>Alternative Therapies in Health &amp; Medicine</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>1</NO>
<PG>76-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grasso-2000" NAME="Grasso 2000" YEAR="2000">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Grasso MC, Button BM, Allison DJ, Sawyer SM</AU>
<TI>Benefits of music therapy as an adjunct to chest physiotherapy in infants and toddles with cystic fibrosis</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2000</YR>
<VL>29</VL>
<NO>5</NO>
<PG>371-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grasso MC, Button BM, Sawyer SM, Allison DJ</AU>
<TI>Music: Meeting the challenge of adherence to chest physiotherapy for infants and toddlers with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1998</YR>
<VL>Suppl 17</VL>
<PG>397</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hernandez_x002d_Reif-1999" NAME="Hernandez-Reif 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hernandez-Reif M, Field T, Krasnegor J, Martinez E, Schwartzman M, Mavunda K</AU>
<TI>Children with cystic fibrosis benefit from massage therapy</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>2</NO>
<PG>175-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Powers-2003" MODIFIED="2013-11-25 09:56:04 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Powers 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Byars KC, Mitchell MJ, Schindler T, Patton SR, Zeller MH</AU>
<TI>A randomized pilot study of behavioral treatment to increase calorie intake in toddlers with cystic fibrosis</TI>
<SO>Child Health Care</SO>
<YR>2003</YR>
<VL>32</VL>
<PG>297-311</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-05-01 14:56:29 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Powers SW, Byars KC, Mitchell MJ, Schindler T, Patton SR, Zeller MH</AU>
<TI>Nutritional benefits of two early intervention programs for toddlers with cystic fibrosis: A randomized pilot study</TI>
<SO>personal communication</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-11-25 09:56:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Schindler T, Schwarber L, Deeks CM, Byars KC, Arthur S, et al</AU>
<TI>Behavioral treatment to improve nutrition in toddlers with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1999</YR>
<VL>Suppl 19</VL>
<PG>329</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powers-2005" MODIFIED="2014-04-03 12:14:47 +0100" MODIFIED_BY="[Empty name]" NAME="Powers 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Jones JS, Ferguson KS, Heidemann M, Henry R, Piazza-Waggoner C, et al</AU>
<TI>Behavioural treatment for toddlers and pre-schoolers with cystic fibrosis produces recommended energy intake and normal rates of growth [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>27</NO>
<PG>361</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Jones JS, Ferguson KS, Henry R, Heidemann M, Patton SR, et al</AU>
<TI>Overcoming barriers to evidence-based nutrition treatment for preschoolers such as distance from cystic fibrosis center and multiple food allergies [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>27</NO>
<PG>341</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Jones JS, Ferguson KS, Piazza-Waggoner C, Daines C, Acton JD</AU>
<TI>Randomized clinical trial of behavioral and nutrition treatment to improve energy intake and growth in toddlers and preschoolers with cystic fibrosis</TI>
<SO>Pediatrics</SO>
<YR>2005</YR>
<VL>116</VL>
<NO>6</NO>
<PG>1442-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-03 12:14:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Piazza-Waggoner C, Jones J, Daines C, Acton J</AU>
<TI>Impact of behavioral and nutrition treatment for toddlers and preschoolers with CF on energy intake and growth maintains for 12 and 18 months [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2005</YR>
<VL>40</VL>
<NO>Suppl 28</NO>
<PG>372</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-05-01 14:57:16 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW</AU>
<TI>Nutrition in early childhood: focus on parent interaction [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2003</YR>
<VL>Suppl 25</VL>
<PG>138</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Quinn-2004" MODIFIED="2012-08-08 17:31:21 +0100" MODIFIED_BY="[Empty name]" NAME="Quinn 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-08-08 17:31:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Quinn J, Latchford G, Duff A, Conner M, Pollard K, Morrison L, Conway S, Marsden R</AU>
<TI>Measuring, predicting and improving adherence to inhalation therapy in patients with CF: Randomised controlled study of motivational interviewing [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>S27</NO>
<PG>360</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stark-1996" NAME="Stark 1996" YEAR="1996">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stark LJ, Mulvihill MM, Powers SW, Jelalian E, Keating K, Creveling S, et al</AU>
<TI>Behavioral intervention to improve calorie intake of children with cystic fibrosis: Treatment versus wait list control</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1996</YR>
<VL>22</VL>
<NO>3</NO>
<PG>240-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Stark-2003" MODIFIED="2014-04-03 12:14:53 +0100" MODIFIED_BY="[Empty name]" NAME="Stark 2003" YEAR="">
<REFERENCE MODIFIED="2014-04-03 12:14:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stark LJ, Opipari LC, Spieth LE, Jelalian E, Quittner AL, Higgins L, et al</AU>
<TI>Contribution of behavior therapy to dietary treatment in cystic fibrosis: A randomized controlled study within 2-year follow-up</TI>
<SO>Behavior Therapy</SO>
<YR>2003</YR>
<VL>34</VL>
<NO>2</NO>
<PG>237-258</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Stark LJ</AU>
<TI>Contribution of behavior therapy to nutrition adherence in cystic fibrosis: A two-year randomized controlled study</TI>
<SO>Personal communication</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stark-2009" MODIFIED="2014-04-03 12:15:01 +0100" MODIFIED_BY="[Empty name]" NAME="Stark 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-07-13 14:38:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Janicke DM, Mitchell MJ, Quittner AL, Piazza-Waggoner C, Stark LJ</AU>
<TI>The impact of behavioral intervention on family interactions at mealtime in pediatric cystic fibrosis</TI>
<SO>Children's Health Care</SO>
<YR>2008</YR>
<VL>37</VL>
<NO>1</NO>
<PG>49-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-13 14:40:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stark LJ, Opipari-Arrigan L, Quittner AL, Bean J, Powers SW</AU>
<TI>The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46</VL>
<NO>1</NO>
<PG>31-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-03 12:15:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stark LJ, Quittner AL, Powers SW, Opipari Arrigan L, Bean JA, Duggan C, et al</AU>
<TI>A randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis</TI>
<SO>Archives of Pediatrics &amp; Adolescent Medicine</SO>
<YR>2009</YR>
<VL>163</VL>
<NO>10</NO>
<PG>915-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-2003" MODIFIED="2013-10-23 23:17:21 +0100" MODIFIED_BY="[Empty name]" NAME="Taylor 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-10-23 23:17:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Taylor LA, Wallander JL, Anderson D, Beasley P, Brown RT</AU>
<TI>Improving health care utilization, improving chronic disease utilization, health status, and adjustment in adolescents and young adults with cystic fibrosis: A preliminary report</TI>
<SO>Journal of Clinical Psychology in Medical Settings</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>1</NO>
<PG>9-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vandemheen-2009" MODIFIED="2014-05-07 11:24:52 +0100" MODIFIED_BY="[Empty name]" NAME="Vandemheen 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-07 11:24:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vandemheen K, Stacey D, Hennessey R, Gooyers T, Salgado J, Freitag A, et al</AU>
<TI>Translating research into practice: implementing a decision aid for adult cystic fibrosis patients [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46 (Suppl 34)</VL>
<PG>427</PG>
<IDENTIFIERS MODIFIED="2014-05-07 11:24:52 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 11:24:52 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011188"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-03 12:14:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vandemheen KL, O'Connor A, Bell SC, Freitag A, Bye P, Jeanneret A, et al</AU>
<TI>Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2009</YR>
<VL>180</VL>
<NO>8</NO>
<PG>761-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilkinson-2008" MODIFIED="2014-04-03 12:14:16 +0100" MODIFIED_BY="[Empty name]" NAME="Wilkinson 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-04-03 12:14:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wilkinson OM, Duncan-Skingle F, Pryor JA, Hodson ME</AU>
<TI>A feasibility study of home telemedicine for patients with cystic fibrosis awaiting transplantation</TI>
<SO>Journal of Telemedicine and Telecare</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>4</NO>
<PG>182-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-05-07 11:33:58 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Barbero-1996" NAME="Barbero 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barbero GJ</AU>
<TI>The science and humanity of cystic fibrosis</TI>
<SO>Current Problems in Pediatrics</SO>
<YR>1996</YR>
<VL>26</VL>
<NO>10</NO>
<PG>345-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bartholomew-1997" MODIFIED="2014-04-03 12:15:08 +0100" MODIFIED_BY="[Empty name]" NAME="Bartholomew 1997" YEAR="1997">
<REFERENCE MODIFIED="2014-04-03 12:15:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bartholomew LK, Czyzewski DI, Parcel GS, Swank PR, Sockrider MM, Mariotto MJ, et al</AU>
<TI>Self-management of cystic fibrosis: Short-term outcomes of the Cystic Fibrosis Family Education Program</TI>
<SO>Health Education and Behavior</SO>
<YR>1997</YR>
<VL>24</VL>
<NO>5</NO>
<PG>652-666</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bingham-2010" MODIFIED="2012-07-04 16:53:16 +0100" MODIFIED_BY="[Empty name]" NAME="Bingham 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-04 16:53:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bingham PM, Bates JH, Thompson Figueroa J, Lahiri T</AU>
<TI>A breath biofeedback computer game for children with cystic fibrosis</TI>
<SO>Clinical Pediatrics</SO>
<YR>2010</YR>
<VL>49</VL>
<NO>4</NO>
<PG>337-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brady-1991" MODIFIED="2013-09-27 13:06:52 +0100" MODIFIED_BY="[Empty name]" NAME="Brady 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-09-27 13:06:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brady MS, Rickard K, Yu PL, Eigen H</AU>
<TI>Effectiveness and safety of small versus large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1991</YR>
<VL>10</VL>
<NO>2</NO>
<PG>79-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brandt-1996" NAME="Brandt 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brandt NJ, Schwartz M, Skovby F, Clausen H</AU>
<TI>A follow-up study of carriers of cystic fibrosis</TI>
<SO>Ugeskrift for laeger</SO>
<YR>1996</YR>
<VL>158</VL>
<NO>33</NO>
<PG>4623-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-1994" NAME="Brown 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown RK, Kelly FJ</AU>
<TI>Evidence of increased oxidative damage in patients with cystic fibrosis</TI>
<SO>Pediatric Research</SO>
<YR>1994</YR>
<VL>36</VL>
<NO>4</NO>
<PG>487-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Castellani-2011" MODIFIED="2013-09-27 13:26:09 +0100" MODIFIED_BY="[Empty name]" NAME="Castellani 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-09-27 13:26:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Castellani C, Perobelli S, Bianchi V, Seia M, Melotti P, Zanolla L, et al</AU>
<TI>An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests</TI>
<SO>American Journal of Medical Genetics. Part A</SO>
<YR>2011</YR>
<VL>155A</VL>
<NO>4</NO>
<PG>778-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheuvront-1998" MODIFIED="2012-08-07 15:52:24 +0100" MODIFIED_BY="[Empty name]" NAME="Cheuvront 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-08-07 15:52:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cheuvront B, Sorenson JR, Callanan NP, Stearns SC, DeVellis BM</AU>
<TI>Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives</TI>
<SO>American Journal of Medical Genetics</SO>
<YR>1998</YR>
<VL>75</VL>
<NO>5</NO>
<PG>461-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-07 15:52:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorenson JR, Cheuvront B, Bruning A, Talton S, DeVellis BM, Kock G, et al</AU>
<TI>Proband and parent assistance in identifying relatives for cystic fibrosis carrier testing</TI>
<SO>American Journal of Medical Genetics</SO>
<YR>1996</YR>
<VL>63</VL>
<NO>3</NO>
<PG>419-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-07 15:52:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorenson JR, Cheuvront B, DeVellis BM, Callanan N, Silverman L, Kock G, et al</AU>
<TI>Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients</TI>
<SO>American Journal of Medical Genetics</SO>
<YR>1997</YR>
<VL>70</VL>
<NO>2</NO>
<PG>121-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clayton-1995" NAME="Clayton 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, Campbell PW, Phillips JA</AU>
<TI>Teaching about cystic fibrosis carrier screening by using written and video information</TI>
<SO>American Journal of Human Genetics</SO>
<YR>1995</YR>
<VL>57</VL>
<NO>1</NO>
<PG>171-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davis-2002" MODIFIED="2013-12-19 13:38:06 +0000" MODIFIED_BY="[Empty name]" NAME="Davis 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-12-19 13:38:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Davis MA, Quittner AL, Stack CM, Yang MC</AU>
<TI>Controlled evaluation of the STARBRIGHT CD-ROM program for children and adolescents with Cystic Fibrosis</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>4</NO>
<PG>259-67</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002613"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-19 13:35:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davis MA, Quittner AL, Stack CM</AU>
<TI>Controlled evaluation of the STARBRIGHT Explorer Series CD-Rom program for children and adolescents with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2002</YR>
<VL>Suppl 24</VL>
<PG>351</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002209"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-07 15:50:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Quittner AL, Drotar D</AU>
<TI>Controlled trial of family interventions for cystic fibrosis</TI>
<SO>NIH Research Grant, Oct 1997 to Aug 2003</SO>
<YR>1997</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-07 15:50:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wade SL</AU>
<TI>Commentary: Computer-based interventions in pediatric psychology</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>4</NO>
<PG>269-272</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dodd-1997" MODIFIED="2014-04-03 12:15:14 +0100" MODIFIED_BY="[Empty name]" NAME="Dodd 1997" YEAR="1997">
<REFERENCE MODIFIED="2014-04-03 12:15:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dodd ME, Abbott J, Haworth CS, Moorcroft AJ, Webb AK</AU>
<TI>Validity of a visual numerical general quality of life scale and chest scale in adults with cystic fibrosis [abstract]</TI>
<SO>Thorax</SO>
<YR>1997</YR>
<VL>52 Suppl 6</VL>
<PG>A45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dodd-2001" MODIFIED="2013-10-23 23:44:11 +0100" MODIFIED_BY="[Empty name]" NAME="Dodd 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-10-23 23:44:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dodd J, Barry S, Moran A, Gallagher C</AU>
<TI>The effect of verbal motivation on exercise  performance in patients with cystic fibrosis [abstract]</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2001</YR>
<VL>163 (5 Suppl)</VL>
<PG>A624</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Donaldson-1995" MODIFIED="2014-04-03 12:15:21 +0100" MODIFIED_BY="[Empty name]" NAME="Donaldson 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Donaldson C, Shackley P, Abdalla M, Miedzybrodzka Z</AU>
<TI>Willingness to pay for antenatal carrier screening for cystic fibrosis</TI>
<SO>Health Economics</SO>
<YR>1995</YR>
<VL>4</VL>
<NO>6</NO>
<PG>439-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marteau TM, Michie S, Miedzybrodzka ZH, Allanson A</AU>
<TI>Incorrect recall of residual risk three years after carrier screening for cystic fibrosis: A comparison of two-step and couple screening</TI>
<SO>American Journal of Obstetrics &amp; Gynecology</SO>
<YR>1999</YR>
<VL>181</VL>
<NO>12</NO>
<PG>165-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Miedzybrodzka ZH, Haites N, Hall M, Templeton A, Marteau T, Dean J, et al</AU>
<TI>Two approaches to ante-natal carrier screening for cystic fibrosis [abstract]</TI>
<SO>Proceedings of the 11th International Cystic Fibrosis Congress</SO>
<YR>1992</YR>
<PG>TP20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miedzybrodzka ZH, Hall MH, Mollison J, Templeton A, Russell IT, Dean JC, et al</AU>
<TI>Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise versus couple screening</TI>
<SO>British Medical Journal</SO>
<YR>1995</YR>
<VL>310</VL>
<NO>6976</NO>
<PG>353-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-03 12:15:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miedzybrodzka ZH, Marteau TM</AU>
<TI>Recall of residual risk three years after carrier screening for CF: a comparison of two-step and couple screening [abstract]</TI>
<SO>Journal of Medical Genetics</SO>
<YR>1999</YR>
<VL>36 Suppl 1</VL>
<PG>570</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wald NJ, Brock DJH, Haddow EJ, Doherty RA</AU>
<TI>Antenatal screening for cystic fibrosis [letter]</TI>
<SO>British Medical Journal</SO>
<YR>1995</YR>
<VL>310</VL>
<NO>6988</NO>
<PG>1199</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Downs-2006" MODIFIED="2014-04-03 12:15:27 +0100" MODIFIED_BY="[Empty name]" NAME="Downs 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-04-03 12:15:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Downs JA, Roberts CM, Blackmore AM, Le Souëf PN, Jenkins SC</AU>
<TI>Benefits of an education programme on the self-management of aerosol and airway treatments for children with cystic fibrosis</TI>
<SO>Chronic Respiratory Disease</SO>
<YR>2006</YR>
<VL>3</VL>
<PG>19-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eng-1997" NAME="Eng 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eng CM, Schechter C, Robinowitz J, Fulop G, Burgert T, Levy B, et al</AU>
<TI>Prenatal genetic carrier testing using triple disease screening</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1997</YR>
<VL>278</VL>
<NO>15</NO>
<PG>1268-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Falkman-1977" NAME="Falkman 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Falkman C</AU>
<TI>Cystic fibrosis - A psychological study of 52 children and their families</TI>
<SO>Acta Paediatrica Scandinavia</SO>
<YR>1977</YR>
<VL>Suppl 269</VL>
<PG>7-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gee-2000" NAME="Gee 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gee L, Abbott J, Conway SP, Etherington C, Webb AK</AU>
<TI>Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis</TI>
<SO>Thorax</SO>
<YR>2000</YR>
<VL>55</VL>
<NO>11</NO>
<PG>946-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Georgiopoulos-2011" MODIFIED="2012-07-04 16:49:31 +0100" MODIFIED_BY="[Empty name]" NAME="Georgiopoulos 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-07-04 16:49:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Georgiopoulos AM, Hua LL</AU>
<TI>The diagnosis and treatment of attention deficit-hyperactivity disorder in children and adolescents with cystic fibrosis: A retrospective study</TI>
<SO>Psychosomatics: Journal of Consultation Liaison Psychiatry</SO>
<YR>2011</YR>
<VL>52</VL>
<NO>2</NO>
<PG>160-166</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goa-1997" NAME="Goa 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goa KL, Lamb H</AU>
<TI>Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis</TI>
<SO>Pharmacoeconomics</SO>
<YR>1997</YR>
<VL>12</VL>
<NO>3</NO>
<PG>409-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldbeck-2001" NAME="Goldbeck 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldbeck L, Babka C</AU>
<TI>Development and evaluation of a multi-family psychoeducational program for cystic fibrosis</TI>
<SO>Patient Education and Counselling</SO>
<YR>2001</YR>
<VL>44</VL>
<NO>2</NO>
<PG>187-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldbeck-2011a" MODIFIED="2012-08-09 08:46:43 +0100" MODIFIED_BY="[Empty name]" NAME="Goldbeck 2011a" YEAR="2011">
<REFERENCE MODIFIED="2012-07-04 16:58:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldbeck L, Holling I, Schlack R, West C, Besier T</AU>
<TI>The impact of an inpatient family-oriented rehabilitation program on parent-reported psychological symptoms of chronically ill children</TI>
<SO>Klinische Padiatrie</SO>
<YR>2011</YR>
<VL>223</VL>
<NO>2</NO>
<PG>79-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonciartz-1988" NAME="Gonciartz 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonciartz Z, Besser P, Lelek E, Gundermann KJ, Johannes KJ</AU>
<TI>Randomised placebo-controlled double blind trial on 'essential' phospholipids in the treatment of fatty liver associated with diabetes</TI>
<SO>Medicine &amp; Chirurgie Digestives</SO>
<YR>1988</YR>
<VL>17</VL>
<PG>61-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Green-1995" NAME="Green 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Green JM</AU>
<TI>Obstetricians' views on prenatal diagnosis and termination of pregnancy: 1980 compared with 1993</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1995</YR>
<VL>102</VL>
<NO>3</NO>
<PG>228-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gremse-1998" NAME="Gremse 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gremse DA, Lytle JM, Sacks AI, Balistreri WF</AU>
<TI>Characterization of failure to imbibe in infants</TI>
<SO>Clinical Pediatrics</SO>
<YR>1998</YR>
<VL>37</VL>
<NO>5</NO>
<PG>305-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grody-1997" NAME="Grody 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grody WW, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Fang CY, Cantor RM, et al</AU>
<TI>PCR based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population</TI>
<SO>American Journal of Human Genetics</SO>
<YR>1997</YR>
<VL>60</VL>
<NO>4</NO>
<PG>935-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gulmans-1999" NAME="Gulmans 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gulmans VA, de Meer K, Brackel HJL, Faber JAJ, Berger R, Helders PJM</AU>
<TI>Outpatient Exercise training in Children with Cystic Fibrosis: Physiological Effects, Perceived Competence, and Acceptability</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1999</YR>
<VL>28</VL>
<NO>1</NO>
<PG>39-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haddow-1999" NAME="Haddow 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haddow JE, Bradley LA, Palomaki GE, Doherty RA</AU>
<TI>Issues for implementing prenatal screening for cystic fibrosis: results of a working conference</TI>
<SO>Journal of Medical Screening</SO>
<YR>1999</YR>
<VL>6</VL>
<NO>2</NO>
<PG>60-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hains-1997" NAME="Hains 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hains AA, Davies WH, Behrens D, Biller JA</AU>
<TI>Cognitive behavioral interventions for adolescents with cystic fibrosis</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>1997</YR>
<VL>22</VL>
<NO>5</NO>
<PG>669-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hains--2001" NAME="Hains  2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Hains AA, Davies WH, Behrens D, Freeman ME, Biller JA</AU>
<TI>Effectiveness of a cognitive behavioral intervention for adults with cystic fibrosis</TI>
<SO>Journal of Clinical Psychology in Medical Settings</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hodson-1997" NAME="Hodson 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hodson ME</AU>
<TI>Psychosocial aspects for the management of adults with cystic fibrosis</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1997</YR>
<VL>Suppl 16</VL>
<PG>113-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jelalian-1998" NAME="Jelalian 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jelalian E, Stark LJ, Reynolds L, Seifer R</AU>
<TI>Nutrition intervention for weight gain in cystic fibrosis: A meta-analysis</TI>
<SO>Journal of Pediatrics</SO>
<YR>1998</YR>
<VL>132</VL>
<NO>3 Pt 1</NO>
<PG>486-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-2001" NAME="Johnson 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson KB, Ravert RD, Everton A</AU>
<TI>Hopkins Teen Central: Assessment of an internet-based support system for children with cystic fibrosis</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>2</NO>
<PG>E24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kollberg-1982" NAME="Kollberg 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kollberg H</AU>
<TI>Sociomedical conditions for Swedish patients with cystic fibrosis. A review of the past twelve years</TI>
<SO>International Journal of Rehabilitation Research</SO>
<YR>1982</YR>
<VL>5</VL>
<NO>3</NO>
<PG>345-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krauth-1999" NAME="Krauth 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krauth C, Busse R, Smaczny C, Ullrich G, Wagner TO, Weber J, et al</AU>
<TI>Cost comparison of hospital and ambulatory I.V. therapy in adult cystic fibrosis patients: Results of a controlled prospective study</TI>
<SO>Medizinische Klinik</SO>
<YR>1999</YR>
<VL>94</VL>
<NO>10</NO>
<PG>541-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Le-Heuzey-1997" NAME="Le Heuzey 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Le Heuzey MF, Mouren-Simeoni MC, Navarro J</AU>
<TI>Psychological adjustment of children and adolescents with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1997</YR>
<VL>Suppl 16</VL>
<PG>259</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leonard-1995" NAME="Leonard 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leonard KP, Bartholomew LK, Swank PR, Parcel GS</AU>
<TI>A comparison of two approaches to education about carrier testing for cystic fibrosis</TI>
<SO>Journal of Genetic Counselling</SO>
<YR>1995</YR>
<VL>4</VL>
<NO>2</NO>
<PG>97-113</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindstr_x00f6_m-1994" NAME="Lindström 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Entered by TR: Lindstr&amp;#246;m B. The essence of existence. On the quality of life of children in the Nordic countries. G&amp;#246;teborg, Sweden: Thesis, NHV- Report, The Nordic School of Public Health, 1994:3.&lt;/p&gt;" PRIMARY="NO" TYPE="OTHER">
<AU>Lindström B</AU>
<TI>The essence of existence. On the quality of life of children in the Nordic countries</TI>
<SO>Thesis - NHV - Report, The Nordic School of Public Health, Göteborg, Sweden</SO>
<YR>1994</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loader-1996" NAME="Loader 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH, et al</AU>
<TI>Cystic fibrosis carrier population screening in the primary care setting</TI>
<SO>American Journal of Human Genetics</SO>
<YR>1996</YR>
<VL>59</VL>
<NO>1</NO>
<PG>234-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magnussen-1992" NAME="Magnussen 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magnussen H, Scheidt Mackes M</AU>
<TI>The effect of flupertine on respiratory drive in healthy probands and patients with various lung diseases</TI>
<SO>Pneumologie</SO>
<YR>1992</YR>
<VL>46</VL>
<PG>580-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Phillipson-2000" NAME="Phillipson 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Phillipson GT, Petrucco OM, Matthews CD</AU>
<TI>Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection</TI>
<SO>Human Reproduction</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>2</NO>
<PG>431-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pollitt-1997" NAME="Pollitt 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV, et al</AU>
<TI>Neonatal screening for inborn errors of metabolism: cost, yield and outcome</TI>
<SO>Health Technology Assessment</SO>
<YR>1997</YR>
<VL>1</VL>
<NO>7:i-iv</NO>
<PG>1-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pop-Jordanova-2010" MODIFIED="2012-07-04 16:56:12 +0100" MODIFIED_BY="[Empty name]" NAME="Pop Jordanova 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-04 16:55:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pop Jordanova N, Gucev Z.</AU>
<TI>Game-based peripheral biofeedback for stress assessment in children</TI>
<SO>Pediatrics International</SO>
<YR>2010</YR>
<VL>52</VL>
<NO>3</NO>
<PG>428-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ralston-2008" MODIFIED="2012-07-25 15:47:44 +0100" MODIFIED_BY="[Empty name]" NAME="Ralston 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-07-25 15:47:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ralston S, Roohi M</AU>
<TI>A randomized, controlled trial of smoking cessation counseling provided during child hospitalization for respiratory illness</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2008</YR>
<VL>43</VL>
<NO>6</NO>
<PG>561-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramstr_x00f6_m-2000" NAME="Ramström 2000" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramström H, Erwander I, Mared L, Kornfält R, Seiving B</AU>
<TI>Pharmaceutical intervention in the care of cystic fibrosis patients</TI>
<SO>Journal of Clinical Pharmaceutical Therapy</SO>
<YR>2000</YR>
<VL>25</VL>
<NO>6</NO>
<PG>427-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rault-2012" MODIFIED="2014-05-07 11:20:54 +0100" MODIFIED_BY="[Empty name]" NAME="Rault 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-07 11:20:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>David V, Rault G, Pougheon-Bertrand D, Dorenlot E</AU>
<TI>Therapeutic patient education and quality improvement program: What synergy?</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2013</YR>
<VL>12 (Suppl 1)</VL>
<PG>S136</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 11:19:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rault G, Pougheon-Bertrand D, David V, Minguet G, Lombrail P</AU>
<TI>CF quality improvement program: A pilot phase to implement the us QIP approach in France [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>401-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rodrigue-2005" MODIFIED="2014-04-03 12:25:42 +0100" MODIFIED_BY="[Empty name]" NAME="Rodrigue 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-04-03 12:25:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rodrigue JR, Baz MA, Widows MR, Ehlers SL</AU>
<TI>A randomized evaluation of quality-of-life therapy with patients awaiting lung transplantation</TI>
<SO>American Journal of Transplantation</SO>
<YR>2005</YR>
<VL>5</VL>
<NO>10</NO>
<PG>2425-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rozenfeld-2012" MODIFIED="2014-05-07 11:33:58 +0100" MODIFIED_BY="[Empty name]" NAME="Rozenfeld 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-07 11:33:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rozenfeld S, Mantin H, Mussaffi H, Taizi T, Landau E, Kadosh D, et al</AU>
<TI>Effect of Snoezlen on pain perception and anxiety in CF infants during sputum suction [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 (Suppl 35)</VL>
<PG>441</PG>
<IDENTIFIERS MODIFIED="2014-05-07 11:33:57 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 11:33:57 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000042"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stapleton-2001" MODIFIED="2012-08-07 15:51:48 +0100" MODIFIED_BY="[Empty name]" NAME="Stapleton 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-08-07 15:51:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stapleton D, Tunnicliffe L, McGuiness D, Sheriff J, Sly P</AU>
<TI>Development of a nutrition and behaviour intervention program: Go and Grow with CF</TI>
<SO>Australian Journal of Nutrition and Diet</SO>
<YR>1998</YR>
<VL>55</VL>
<PG>130-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-07 15:51:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stapleton DR, Gurrin LC, Zubrick SR, Silburn SR, Sherriff JL, Sly PD</AU>
<TI>What do children with cystic fibrosis and their parents know about nutrition and pancreatic enzymes?</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>2000</YR>
<VL>100</VL>
<NO>12</NO>
<PG>1494-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-07 15:51:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stapleton DR, Gurrin LC, Zubrick SR, Silburn SR, Sly PD</AU>
<TI>The effect of 'Go and Grow with CF' on nutrition and pancreatic enzyme knowledge of children with cystic fibrosis</TI>
<SO>Australian Journal of Nutrition and Dietetics</SO>
<YR>2001</YR>
<VL>58</VL>
<NO>3</NO>
<PG>164-168</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stark-2002" MODIFIED="2014-04-03 12:15:40 +0100" MODIFIED_BY="[Empty name]" NAME="Stark 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-04-03 12:15:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stark LJ, Mackner LM, Kessler JH, Opipari LiC, Quittner AL</AU>
<TI>Preliminary findings for calcium intake in children with cystic fibrosis following behavioral intervention for caloric intake</TI>
<SO>Children's Health Care</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>2</NO>
<PG>107-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thompson-1990" NAME="Thompson 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thompson RJ, Hodges K, Hamlett KW</AU>
<TI>A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and nonreferred children</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>1990</YR>
<VL>15</VL>
<NO>6</NO>
<PG>745-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thornton-1995" NAME="Thornton 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thornton JG, Hewison J, Lilford RJ, Vail A</AU>
<TI>A randomised trial of three methods of giving information about prenatal testing</TI>
<SO>British Medical Journal</SO>
<YR>1995</YR>
<VL>311</VL>
<NO>7013</NO>
<PG>1127-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Trapp-1998" MODIFIED="2012-08-07 15:51:57 +0100" MODIFIED_BY="[Empty name]" NAME="Trapp 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-08-07 15:51:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Trapp M, Barton S, Morgan H, Lockyer L</AU>
<TI>Self-administration of drugs for cystic fibrosis</TI>
<SO>Professional Nurse</SO>
<YR>1998</YR>
<VL>14</VL>
<NO>3</NO>
<PG>199-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tullis-1995" NAME="Tullis 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tullis DE, Guyatt GH</AU>
<TI>Quality of life in cystic fibrosis</TI>
<SO>Pharmacoeconomics</SO>
<YR>1995</YR>
<VL>8</VL>
<NO>1</NO>
<PG>23-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villari-1994" NAME="Villari 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villari B, Hess OM, Piscione F, Vassalli G, Weber KT, Chiariello M</AU>
<TI>Heart function in chronic pressure overload caused by aortic stenosis: The role of collagen tissue</TI>
<SO>Cardiologia</SO>
<YR>1994</YR>
<VL>39</VL>
<NO>6</NO>
<PG>411-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ward-1999" NAME="Ward 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ward SA, Tomezsko JL, Holsclaw DS, Paolone AM</AU>
<TI>Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>69</VL>
<NO>5</NO>
<PG>913-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watson-2004" MODIFIED="2014-04-03 12:15:47 +0100" MODIFIED_BY="[Empty name]" NAME="Watson 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-04-03 12:15:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Watson H, Truby H, Haworth CS, Bilton D</AU>
<TI>Pilot study to evaluate a home-based behavioural nutrition programme for adults</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2004</YR>
<VL>3 Suppl 1</VL>
<PG>S75</PG>
<EN>3</EN>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watson-2006" MODIFIED="2014-04-03 12:15:52 +0100" MODIFIED_BY="[Empty name]" NAME="Watson 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-04-03 12:15:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Watson H, Bilton D, Truby H</AU>
<TI>A randomised controlled trial of a behavioural nutrition education programme "Eat Well with CF" for adults with CF</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2006</YR>
<VL>5 Suppl 1</VL>
<PG>S73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Welkenhuysen-1996" NAME="Welkenhuysen 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Welkenhuysen M, Evers-Kiebooms G, Decruyenaere M, Van-den-Berghe H, Bande-Knops J, Van-Gerven V</AU>
<TI>Adolescents' attitudes towards carrier testing for cystic fibrosis and its relative stability over time</TI>
<SO>European Journal of Human Genetics</SO>
<YR>1996</YR>
<VL>4</VL>
<NO>1</NO>
<PG>52-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-1997" NAME="Williams 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams PD, Hanson S, Karlin R, Liebergen A, Olson J, Barnard MU, et al</AU>
<TI>Outcomes of a nursing intervention for siblings of chronically ill children: A pilot study</TI>
<SO>Journal of Social Pediatric Nursing</SO>
<YR>1997</YR>
<VL>2</VL>
<NO>3</NO>
<PG>127-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolter-1997" NAME="Wolter 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wolter JM, Bowler SD, McCormack JG, Nolan PJ</AU>
<TI>Home versus hospital therapy including intravenous antibiotics in cystic fibrosis [abstract]</TI>
<SO>Proceedings of the Annual Scientific Meeting of the 11th Thoracic Society of Australia and New Zealand (TSANZ)</SO>
<YR>1994</YR>
<PG>148</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wolter JM, Bowler SD, Nolan PJ, McCormack JG</AU>
<TI>Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects</TI>
<SO>European Respiratory Journal</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>4</NO>
<PG>896-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolter JM, Bowler SD, Nolan PJ, McCormack JG</AU>
<TI>Intravenous home therapy - a randomised trial in adult cystic fibrosis patients [abstract]</TI>
<SO>Australian and New Zealand Journal of Medicine</SO>
<YR>1995</YR>
<VL>25</VL>
<PG>567</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-06-10 11:40:05 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bryon-2000" NAME="Bryon 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bryon M, Burton J, Tostevin M, Madge S</AU>
<TI>A home visit programme to improve health status and psychosocial functioning of families with a child with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2000</YR>
<VL>Suppl 20</VL>
<PG>336</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cannon-1999" NAME="Cannon 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cannon C, Benitez J, Scarbary J, Taylor K, Guill M</AU>
<TI>In-home videoconferencing for cystic fibrosis patient education [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1999</YR>
<VL>Suppl 19</VL>
<PG>333</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cummings-2011" MODIFIED="2014-04-03 12:16:05 +0100" MODIFIED_BY="[Empty name]" NAME="Cummings 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-04-03 12:16:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cummings E, Hauser J, Cameron-Tucker H, Fitzpatrick P, Jessup M, Walters EH, et al</AU>
<TI>Enhancing self-efficacy for self-management in people with cystic fibrosis</TI>
<SO>Studies in Health Technology and Informatics</SO>
<YR>2011</YR>
<VL>169</VL>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-03 12:16:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jessup MM, Hauser J, Cameron-Tucker H, Cummings E, Turner P, Blizzard L, Reid D</AU>
<TI>Facilitating self-management in adolescents and adults with cystic fibrosis: a pilot study [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46 Suppl 34</VL>
<PG>405</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davis-1990" MODIFIED="2013-12-19 13:34:38 +0000" MODIFIED_BY="[Empty name]" NAME="Davis 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davis P, Davis S, Mather F, Waring W</AU>
<TI>A randomized trial of home intravenous antibiotic therapy (HIVAT) in cystic fibrosis (CF): Short-term psychological effects [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1990</YR>
<VL>Suppl 5</VL>
<PG>281-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davis S, Mather F, Tankersly P, Waring W</AU>
<TI>A randomized trial of home intravenous antibiotic therapy (HIVAT) in cystic fibrosis (CF): Short-term safety and efficacy [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1990</YR>
<VL>Suppl 5</VL>
<PG>245</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldbeck-2013" MODIFIED="2014-06-10 11:14:04 +0100" MODIFIED_BY="[Empty name]" NAME="Goldbeck 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-06-10 11:14:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldbeck L, Hebestreit H, Junge S, Sens B, Smaczny C, Frank M, et al</AU>
<TI>Vemse-CF - A prospective controlled care-research study investigating the effects of a comprehensive psychosocial intervention [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>430</PG>
<IDENTIFIERS MODIFIED="2014-05-07 11:45:58 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 11:45:58 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000138"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hass-2012" MODIFIED="2014-05-07 11:49:09 +0100" MODIFIED_BY="[Empty name]" NAME="Hass 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-07 11:49:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01729585</AU>
<TI>The effects of massage therapy on QOL in youth/young adults with cystic fibrosis</TI>
<SO>http://clinicaltrials.gov/show/NCT01729585NCT01729585</SO>
<YR>(accessed 01 Apil 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hatziagorou-2011" MODIFIED="2014-04-03 12:16:12 +0100" MODIFIED_BY="[Empty name]" NAME="Hatziagorou 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-04-03 12:16:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hatziagorou E, Chourdakis M, Chrisochoou E, Avramido V, Tsanakas J</AU>
<TI>Nutritional education improves energy intake and weight gain in children with cystic fibrosis [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2011</YR>
<VL>10 Suppl1</VL>
<PG>S73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2010" MODIFIED="2014-05-07 11:48:56 +0100" MODIFIED_BY="[Empty name]" NAME="Huang 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-05-07 11:48:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01253733</AU>
<TI>TAHLC - texting to promote adolescent health liaisons and chronic disease management.</TI>
<SO>http://clinicaltrials.gov/show/NCT01253733</SO>
<YR>(accessed 01 April 2014)</YR>
<IDENTIFIERS MODIFIED="2014-05-07 11:48:30 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 11:48:30 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011528"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Irons-2012" MODIFIED="2014-05-07 11:51:01 +0100" MODIFIED_BY="[Empty name]" NAME="Irons 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-07 11:50:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Irons JY, Kenny DT, McElrea M, Chang AB</AU>
<TI>Singing therapy for young people with cystic fibrosis : a randomized controlled pilot study</TI>
<SO>Music and Medicine</SO>
<YR>2012</YR>
<VL>4</VL>
<NO>3</NO>
<PG>136-45</PG>
<IDENTIFIERS MODIFIED="2014-05-07 11:50:20 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 11:50:20 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000007892"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jessup-2010" MODIFIED="2014-04-03 12:16:17 +0100" MODIFIED_BY="[Empty name]" NAME="Jessup 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-04-03 12:16:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jessup MM, Cameron-Tucker H, Cummings E, Hauser J, Joseph L, Saddington H, et al</AU>
<TI>'Someone to talk to': Adolescent and adult CF patients' feedback on their experience of a mentoring and IT intervention [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2010</YR>
<VL>9 Suppl 1</VL>
<PG>S107</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kalnins-1996" MODIFIED="2013-12-19 11:40:08 +0000" MODIFIED_BY="[Empty name]" NAME="Kalnins 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-12-19 11:40:08 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Christine Baldwin [01/02/2000][13/03/2003][]; Claire A Glasscoe [01/02/2001][08/12/2003][]; Rosalind Smyth [01/02/1997][27/03/2003][]; Vanessa Jane Poustie [][27/03/2003][]; Eileen Savage [11/03/2010][][]&lt;/p&gt;" NOTES_MODIFIED="2013-12-19 11:40:08 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kalnins D, Durie P</AU>
<TI>Oral supplements versus normal food intake in children and adults [abstract]</TI>
<SO>Israel Journal of Medical Sciences</SO>
<YR>1996</YR>
<VL>32 Suppl</VL>
<PG>SD120-1</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000001421"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-19 11:38:44 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Christine Baldwin [01/02/2000][11/12/2003][]; Claire A Glasscoe [01/02/2001][05/12/2003][]; Rosalind Smyth [01/03/1997][27/03/2003][]; Vanessa Jane Poustie [][27/03/2003][]; Eileen Savage [11/03/2010][][]&lt;/p&gt;" NOTES_MODIFIED="2013-12-19 11:38:44 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kalnins D, Durie PR, Corey M, Ellis L, Pencharz P, Tullis E</AU>
<TI>Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF? [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1996</YR>
<VL>381</VL>
<NO>Suppl 13</NO>
<PG>314-5</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000001420"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klig-1989" NAME="Klig 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klig S, Denning C, Jacoby J, Xia F, Gaerlan P, Bisberg D, et al</AU>
<TI>Biopsychosocial examination of two methods of pulmonary therapy [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1989</YR>
<VL>Suppl 4</VL>
<PG>145</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mischler-1998" MODIFIED="2014-04-03 12:16:25 +0100" MODIFIED_BY="[Empty name]" NAME="Mischler 1998" YEAR="1998">
<REFERENCE MODIFIED="2014-04-03 12:16:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, et al</AU>
<TI>Nutritional benefits of neonatal screening for cystic fibrosis</TI>
<SO>New England Journal of Medicine</SO>
<YR>1997</YR>
<VL>337</VL>
<NO>14</NO>
<PG>963-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farrell PM, Mischler EH</AU>
<TI>Newborn screening for cystic fibrosis</TI>
<SO>Advances in Pediatrics</SO>
<YR>1992</YR>
<VL>39</VL>
<PG>36-69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fost N, Farrell PM</AU>
<TI>A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: A unique ethical dilemma</TI>
<SO>Clinical Research</SO>
<YR>1989</YR>
<VL>37</VL>
<PG>495-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Mischler EH, Wilford BS, Fost N, Laxona A, Reiser C, Sauer CM, et al</AU>
<TI>Cystic fibrosis newborn screening: Impact on reproductive behavior and implications for genetic counseling</TI>
<SO>Pediatrics</SO>
<YR>1998</YR>
<VL>102</VL>
<NO>1 Pt 1</NO>
<PG>44-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patel-2010" MODIFIED="2014-06-10 11:10:56 +0100" MODIFIED_BY="[Empty name]" NAME="Patel 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-06-10 11:10:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patel L, Glasscoe C, Dixon C, Dyer K, Southern KW</AU>
<TI>Does administering a parent reported outcome measure during the annual review process improve the self efficacy of the carer of a child with CF? [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2010</YR>
<VL>45 Suppl 33</VL>
<PG>441</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petzel-1991" NAME="Petzel 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petzel SV, Finkelstein J, Budd J, Ellis LBM</AU>
<TI>Adherence in cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1991</YR>
<VL>Suppl 6</VL>
<PG>308</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powers-2003a" MODIFIED="2014-04-03 12:16:36 +0100" MODIFIED_BY="[Empty name]" NAME="Powers 2003a" YEAR="2003">
<REFERENCE MODIFIED="2014-04-03 12:16:36 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;17th Annual North American Cystic Fibrosis Conference, Anaheim, California&lt;/p&gt;" NOTES_MODIFIED="2014-04-03 12:16:36 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Powers SW</AU>
<TI>Nutrition in early childhood: Focus on parent interaction</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2003</YR>
<VL>Suppl 25</VL>
<PG>138-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="5"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powers-2013" MODIFIED="2014-06-10 11:40:05 +0100" MODIFIED_BY="[Empty name]" NAME="Powers 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-06-10 11:37:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chamberlin LA, Sullivan S, Stark L, Powers SW</AU>
<TI>Adjusting recruitment strategies and intervention format to meet enrollment goals in a multicenter trial of a behavioural treatment [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>438</PG>
<IDENTIFIERS MODIFIED="2014-05-07 11:52:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 11:52:39 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000140"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-10 11:40:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Stark L, Chamberlin L, Sullivan S, Filigno S, Rausch J</AU>
<TI>A multi-site, randomized, controlled clinical trial of behavioral and nutrition treatment for preschoolers with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>402</PG>
<IDENTIFIERS MODIFIED="2014-05-07 11:54:16 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 11:54:16 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000143"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ruddy-2011" MODIFIED="2014-05-07 12:20:27 +0100" MODIFIED_BY="[Empty name]" NAME="Ruddy 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-07 11:55:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01325766</AU>
<TI>Study of yoga as a therapy for cystic fibrosis (CF) patients</TI>
<SO>http://clinicaltrials.gov/show/NCT01325766</SO>
<YR>(accessed 01 April 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stark-1998" NAME="Stark 1998" YEAR="Suppl">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stark LJ, Quittner AL, Opipari LC, Jones E, Powers SW, Higgins L, et al</AU>
<TI>The contribution of behavior therapy to enhancing adherence in school-age children with CF: The example of diet [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1998</YR>
<VL>Suppl 17</VL>
<PG>110-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wainwright-2009" MODIFIED="2014-04-03 12:16:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wainwright 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-04-03 12:16:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wainwright C, Saddington H, Busch J, Blizzard L, Cameron-Tucker H, Cheney J, et al</AU>
<TI>Improving self efficacy in adolescents and young adults with cystic fibrosis [abstract]</TI>
<SO>Journal of Cystic Fibrosis </SO>
<YR>2009</YR>
<VL>8 Suppl 2</VL>
<PG>S93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Widman-2013" MODIFIED="2014-05-07 11:57:30 +0100" MODIFIED_BY="[Empty name]" NAME="Widman 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-07 11:57:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01957072</AU>
<TI>Pilot study of behavioural intervention for nutrition in cystic fibrosis</TI>
<SO>http://clinicaltrials.gov/show/NCT01957072</SO>
<YR>(accessed 01 April 2014)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-1987" NAME="Williams 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Williams J, Handy DA, Booth IW, Weller PH</AU>
<TI>Intensive dietary counselling with adolescents with cystic fibrosis: What are the effects? [abstract]</TI>
<SO>Proceedings of the 10th International Cystic Fibrosis Congress; 1998 March 5-10; Sydney</SO>
<YR>1988</YR>
<PG>165</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Williams J, Handy DA, Weller PH, Booth IW</AU>
<TI>Intensive dietary counselling In adolescents with cystic fibrosis</TI>
<SO>Gut</SO>
<YR>1987</YR>
<VL>28</VL>
<PG>A1352</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2014-06-17 09:43:14 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Quittner-2000" MODIFIED="2014-05-07 11:59:38 +0100" MODIFIED_BY="[Empty name]" NAME="Quittner 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-05-07 11:59:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>DeLambo KE, Ievers-Landis CE, Drotar D, Quittner AL</AU>
<TI>Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>5</NO>
<PG>343-53</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-31 13:46:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="BOOK_SECTION">
<AU>Quittner AL, Drotar D, Ievers-Landis C, Slocum N, Seidner D, Jacobsen J</AU>
<TI>Adherence to medical treatments in adolescents with cystic fibrosis: The development and evaluation of family-based interventions</TI>
<SO>Promoting adherence to medical treatment in childhood chronic illness: Concepts, methods, and interventions</SO>
<YR>2000</YR>
<PG>383-407</PG>
<EN>First</EN>
<ED>Drotar D</ED>
<PB>Lawrence Earlbaum Associates</PB>
<CY>Mahjah NJ</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-31 13:46:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Drotar D, Ievers-Landis C</AU>
<TI>Intervention to increase adolescent adherence to treatment: preliminary comparisons of family therapy and cystic fibrosis family education [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1998</YR>
<VL>Suppl 17</VL>
<PG>113-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-31 13:46:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Quittner AL, Drotar D, Ivers-Landis C, Slocum N, Buu A</AU>
<TI>Measuring adherence to treatment in adolescents with cystic fibrosis: Pros and cons of electronic monitoring [abstract]</TI>
<SO>Conference proceedings of the 8th Florida Conference on Child Health Psychology; 2001 April; Florida</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-31 13:46:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Quittner AL, Johnson SB, Modi A</AU>
<TI>Controlled evaluation of a clinic-based intervention to promote adherence in children with cystic fibrosis</TI>
<SO>Personal communication</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Quittner-2011" MODIFIED="2014-06-17 09:43:14 +0100" MODIFIED_BY="[Empty name]" NAME="Quittner 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-06-17 09:43:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alpern AN, McLean KA, Marciel KK, Zhang J, Riekert KA, Quittner AL</AU>
<TI>Effects of clinical supervision on treatment fidelity in icare [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47</VL>
<NO>S35</NO>
<PG>433-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-17 09:42:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barker D, Quittner AL, Riekert KA</AU>
<TI>Relating patterns of social support from friends and family to health-related quality of life [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>433</PG>
<IDENTIFIERS MODIFIED="2014-06-17 09:42:45 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-06-17 09:42:45 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000139"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-17 09:41:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blackwell LS, Romero SL, Marciel KK, Romero CV, Quittner AL</AU>
<TI>Pain in adolescents and young adults with CF: location, severity and predictors [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>430</PG>
<IDENTIFIERS MODIFIED="2014-06-17 09:41:23 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-06-17 09:41:23 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000041"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-17 09:42:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McLean KA, Quittner AL, Alpern AN, Marciel KK, Riekert KA</AU>
<TI>Healthcare provider acceptability of problem-solving in the I change adherence and raise expectations (iCARE) study [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>437</PG>
<IDENTIFIERS MODIFIED="2014-06-17 09:42:16 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-06-17 09:42:16 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000126"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 12:13:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Quittner A, Kimberg C, Marciel K, Zhang J, Riekert K</AU>
<TI>Randomized, Controlled trial of a behavioral adherence intervention for adolescents with cystic fibrosis: I change adherence and raise expectations (iCARE) [abstract]</TI>
<SO>Chest</SO>
<YR>2011</YR>
<VL>140</VL>
<NO>4 Suppl</NO>
<PG>908a</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-17 09:43:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Alpern AN, McLean KA, Marciel KK, Zhang J, Riekert KA.</AU>
<TI>Clinical supervision improves treatment fidelity to an adherence intervention [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2012</YR>
<VL>11</VL>
<NO>Suppl 1</NO>
<PG>S9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-17 09:41:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Riekert KA</AU>
<TI>I Change adherence and raise expectations: the iCARE study</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>136</PG>
<IDENTIFIERS MODIFIED="2014-06-17 09:41:48 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-06-17 09:41:48 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000125"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-07-31 14:17:37 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-07-31 14:17:37 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01232478"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Quittner-2012" MODIFIED="2014-06-10 11:11:19 +0100" MODIFIED_BY="[Empty name]" NAME="Quittner 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-07 12:09:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blackwell LS, Romero SL, Romero CV, McLean KA, Dawkins K, Hoag J, et al</AU>
<TI>CFfone: a social networking site for adolescents and young adults with CF [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>430</PG>
<IDENTIFIERS MODIFIED="2014-05-07 12:08:58 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 12:08:58 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011184"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-03 12:16:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marciel KK, Saiman L, Quittell LM, Dawkins K, Quittner AL</AU>
<TI>Cell Phone Intervention to Improve Adherence: CysticFibrosis Care Team, Patient, and Parent Perspectives</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2010</YR>
<VL>45</VL>
<NO>2</NO>
<PG>157-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-03 12:17:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Romero SL, Blackwell LS, Marciel KK, Romero CV, Dawkins K, et al</AU>
<TI>Effect of CFfone on knowledge of disease management, psychological well-being, and health-related quality of life in adolescents and young adults with CF [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2012</YR>
<VL>11 Suppl 1</VL>
<PG>S137</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-07 12:10:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Romero SL, Blackwell LS, McLean KA, Monzon AD, Dawkins K</AU>
<TI>Efficacy of an online social networking site: CFFONE results</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>135</PG>
<IDENTIFIERS MODIFIED="2014-05-07 12:10:46 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 12:10:46 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000144"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-10 11:11:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Romero SL, Blackwell LS, Romero CV, Marciel KK, Dawkins K, et al</AU>
<TI>Preliminary results on the efficacy of an online social network for adolescents with CF: age and disease severity group comparisons [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>388</PG>
<IDENTIFIERS MODIFIED="2014-05-07 12:12:03 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 12:12:03 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011541"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-07-31 10:26:04 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-07-31 10:26:04 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01183286"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Riekert-2012" MODIFIED="2014-05-07 12:06:11 +0100" MODIFIED_BY="[Empty name]" NAME="Riekert 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-07 12:06:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riekert KA, Borrelli B, Bilderback AV, green A, Eakin MN</AU>
<TI>Building adherence to live and navigate my CF experience: the balance study</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 (Suppl 36)</VL>
<PG>133</PG>
<IDENTIFIERS MODIFIED="2014-05-07 12:06:11 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-05-07 12:06:11 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000142"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-07-20 14:33:02 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-07-20 14:32:56 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01013896"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-06-10 10:45:23 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-06-10 10:45:23 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abbott-2009" MODIFIED="2014-04-03 12:17:09 +0100" MODIFIED_BY="[Empty name]" NAME="Abbott 2009" TYPE="JOURNAL_ARTICLE">
<AU>Abbott J, Havermans T, Harta A</AU>
<TI>Adherence to the medical regimen: clinical implications of new findings</TI>
<SO>Current Opinion in Pulmonary Medicine</SO>
<YR>2009</YR>
<VL>15</VL>
<NO>9</NO>
<PG>597-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Asher-1984" MODIFIED="2013-10-29 11:04:28 +0000" MODIFIED_BY="[Empty name]" NAME="Asher 1984" TYPE="JOURNAL_ARTICLE">
<AU>Asher SR, Hymel S, Renshaw PD</AU>
<TI>Loneliness in children</TI>
<SO>Child Development</SO>
<YR>1984</YR>
<VL>55</VL>
<NO>4</NO>
<PG>1456-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bartholomew-1991" NAME="Bartholomew 1991" TYPE="JOURNAL_ARTICLE">
<AU>Bartholomew LK, Parcel GS, Seilheimer DK, Czyzewski D, Spinelli SH, Congdon B</AU>
<TI>Development of a health education program to promote the self-management of cystic fibrosis.</TI>
<SO>Health Education Quarterly</SO>
<YR>1991</YR>
<VL>18</VL>
<NO>4</NO>
<PG>429-443</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beale-2006" MODIFIED="2008-05-09 09:51:17 +0100" MODIFIED_BY="[Empty name]" NAME="Beale 2006" TYPE="JOURNAL_ARTICLE">
<AU>Beale IL</AU>
<TI>Scholarly literature review: Efficacy of psychological interventions for pediatric chronic illnesses</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>5</NO>
<PG>437-451</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Besier-2011a" MODIFIED="2014-05-07 12:04:15 +0100" MODIFIED_BY="[Empty name]" NAME="Besier 2011a" TYPE="JOURNAL_ARTICLE">
<AU>Besier T, Born A, Henrich G, Hinz A, Quittner AL, Goldbeck L, et al</AU>
<TI>Anxiety, depression, and life satisfaction in parents caring for children with cystic fibrosis</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46</VL>
<NO>7</NO>
<PG>672-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Besier-2011b" MODIFIED="2014-05-07 12:04:24 +0100" MODIFIED_BY="[Empty name]" NAME="Besier 2011b" TYPE="JOURNAL_ARTICLE">
<AU>Besier T, Goldbeck L</AU>
<TI>Anxiety and depression in adolescents with CF and their caregivers</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2011</YR>
<VL>10</VL>
<NO>6</NO>
<PG>435-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bluebond_x002d_Langner-2001" MODIFIED="2013-09-27 10:26:44 +0100" MODIFIED_BY="[Empty name]" NAME="Bluebond-Langner 2001" TYPE="BOOK">
<AU>Bluebond-Langner M, Lask B, Angst DB</AU>
<SO>Psychosocial Aspects of Cystic Fibrosis</SO>
<YR>2001</YR>
<ED>Bluebond-Langner M, Lask B, Angst DB</ED>
<PB>Arnold</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bobadilla-2002" NAME="Bobadilla 2002" TYPE="JOURNAL_ARTICLE">
<AU>Bobadilla JL, Macek Jr M, Fine JP, Farrell PM</AU>
<TI>Cystic Fibrosis: A worldwide analysis of CFTR mutations - correlation with incidence data and application to screening</TI>
<SO>Human Mutation</SO>
<YR>2002</YR>
<VL>19</VL>
<PG>575-606</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boutron-2008" MODIFIED="2013-09-27 10:28:20 +0100" MODIFIED_BY="[Empty name]" NAME="Boutron 2008" TYPE="JOURNAL_ARTICLE">
<AU>Boutron I, Moher D, Altman DG, Schulz K, Ravaud P; the CONSORT Group</AU>
<TI>Extending the CONSORT Statement to randomized trials of nonpharmacologic treatment: explanation and elaboration</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2008</YR>
<VL>148</VL>
<NO>4</NO>
<PG>295-309</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bradley-2012" MODIFIED="2013-01-04 14:50:22 +0000" MODIFIED_BY="[Empty name]" NAME="Bradley 2012" TYPE="JOURNAL_ARTICLE">
<AU>Bradley JM, Madge S, Morton AM, Quittner AL, Elborn JS; Allied Health and Nursing Professions Working Group, European Cystic Fibrosis Society</AU>
<TI>Cystic fibrosis research in allied health and nursing professions</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2012</YR>
<VL>11</VL>
<NO>5</NO>
<PG>387-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1992" MODIFIED="2008-05-09 09:51:17 +0100" MODIFIED_BY="[Empty name]" NAME="Cohen 1992" TYPE="JOURNAL_ARTICLE">
<AU>Cohen J</AU>
<TI>Quantitative Methods in Psychology: A Power Primer</TI>
<SO>Psychological Bulletin</SO>
<YR>1992</YR>
<VL>112</VL>
<NO>1</NO>
<PG>155-159</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2013-09-27 10:29:07 +0100" MODIFIED_BY="[Empty name]" NAME="Deeks 2011" TYPE="BOOK_SECTION">
<AU>Deeks J, Higgins J, Altman D</AU>
<TI>Chapter 9 Analysing data and undertaking meta-analysis</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</SO>
<YR>2011</YR>
<ED>Higgins JPT, Green S</ED>
<PB>The CochraneCollaboration, 2011. Available from www.cochrane-handbook.org</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DiMatteo-2000" MODIFIED="2014-02-27 13:01:04 +0000" MODIFIED_BY="[Empty name]" NAME="DiMatteo 2000" TYPE="JOURNAL_ARTICLE">
<AU>DiMatteo M, Lepper H, Croghan TW</AU>
<TI>Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence</TI>
<SO>Arch Intern Med</SO>
<YR>2000</YR>
<VL>160</VL>
<NO>14</NO>
<PG>2101-2107</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DiMatteo-2002" MODIFIED="2014-05-07 12:03:14 +0100" MODIFIED_BY="[Empty name]" NAME="DiMatteo 2002" TYPE="JOURNAL_ARTICLE">
<AU>DiMatteo M, Giordani P, Lepper H, Croghan TW</AU>
<TI>Patient adherence and medical treatment outcomes: a meta-analysis</TI>
<SO>Medical Care</SO>
<YR>2002</YR>
<VL>40</VL>
<NO>9</NO>
<PG>794-811</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dodge-2007" NAME="Dodge 2007" TYPE="JOURNAL_ARTICLE">
<AU>Dodge JA, Lewis PA, Stanton M, Wilsher J</AU>
<TI>Cystic fibrosis mortality and survival in the UK: 1947-2003</TI>
<SO>European Respiratory Journal</SO>
<YR>2007</YR>
<VL>29</VL>
<PG>522-526</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eakin-2011" MODIFIED="2014-04-03 12:17:41 +0100" MODIFIED_BY="[Empty name]" NAME="Eakin 2011" TYPE="JOURNAL_ARTICLE">
<AU>Eakin MN, Bilderback A, Boyle MP, Mogayzel PJ, Riekert KA</AU>
<TI>Longitudinal association between medication adherence and lung health in people with cystic fibrosis</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2011</YR>
<VL>10</VL>
<PG>258-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eiser-1995" MODIFIED="2013-10-29 11:02:45 +0000" MODIFIED_BY="[Empty name]" NAME="Eiser 1995" TYPE="JOURNAL_ARTICLE">
<AU>Eiser C, Havermans T, Craft A, Kernahan J</AU>
<TI>Development of a measure to assess the perceived illness experience after treatment for cancer</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1995</YR>
<VL>72</VL>
<NO>4</NO>
<PG>302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FitzSimmons-1993" NAME="FitzSimmons 1993" TYPE="JOURNAL_ARTICLE">
<AU>FitzSimmons SC</AU>
<TI>The changing epidemiology of cystic fibrosis</TI>
<SO>Journal of Pediatrics</SO>
<YR>1993</YR>
<VL>122</VL>
<NO>1</NO>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goldbeck-2011b" MODIFIED="2012-08-09 08:46:19 +0100" MODIFIED_BY="[Empty name]" NAME="Goldbeck 2011b" TYPE="JOURNAL_ARTICLE">
<AU>Goldbeck L, Besier T, Hinz A, Singer S, Quittner AL; TIDES Group</AU>
<TI>Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis</TI>
<SO>Chest</SO>
<YR>2010</YR>
<VL>138</VL>
<NO>4</NO>
<PG>929-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harter-1985" MODIFIED="2013-10-25 09:35:00 +0100" MODIFIED_BY="[Empty name]" NAME="Harter 1985" TYPE="BOOK">
<AU>Harter S</AU>
<SO>Manual: Self-perception profile for children</SO>
<YR>1985</YR>
<PB>CO: University of Denver</PB>
<CY>Denver</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harter-1986" MODIFIED="2013-10-25 09:34:46 +0100" MODIFIED_BY="[Empty name]" NAME="Harter 1986" TYPE="BOOK">
<AU>Harter S</AU>
<SO>Manual: Social support scale for children</SO>
<YR>1986</YR>
<PB>CO: University of Denver</PB>
<CY>Denver</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hazel-2006" MODIFIED="2014-04-03 12:17:47 +0100" MODIFIED_BY="[Empty name]" NAME="Hazel 2006" TYPE="JOURNAL_ARTICLE">
<AU>Hazel R</AU>
<TI>The psychosocial impact on parents of tube feeding their child</TI>
<SO>Paediatric Nursing</SO>
<YR>2006</YR>
<VL>18</VL>
<NO>4</NO>
<PG>19-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011b" MODIFIED="2012-08-10 12:13:32 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011b" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Altman DG</AU>
<TI>Chapter 8: Assessing risk of bias in included studies</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</SO>
<YR>2011</YR>
<ED>Higgins JPT, Green S</ED>
<PB>The CochraneCollaboration, 2011. Available from www.cochrane-handbook.org.</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hodges-2011" MODIFIED="2014-04-03 12:17:51 +0100" MODIFIED_BY="[Empty name]" NAME="Hodges 2011" TYPE="JOURNAL_ARTICLE">
<AU>Hodges LJ, Walker J, Kleiboer AM, Ramirez AJ, Richardson A, Velikova G, et al</AU>
<TI>What is a psychological intervention? A metareview and practical proposal</TI>
<SO>Psychooncology</SO>
<YR>2011</YR>
<VL>20</VL>
<NO>5</NO>
<PG>470-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ilfeld-1976" NAME="Ilfeld 1976" TYPE="JOURNAL_ARTICLE">
<AU>Ilfeld F</AU>
<TI>Further validation of a psychiatric symptom index in a normal population</TI>
<SO>Psychological Reports</SO>
<YR>1976</YR>
<VL>39</VL>
<PG>1215-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kerem-2005" MODIFIED="2014-04-03 12:18:41 +0100" MODIFIED_BY="[Empty name]" NAME="Kerem 2005" TYPE="JOURNAL_ARTICLE">
<AU>Kerem E, Conway S, Elborn S, Heijerman H</AU>
<TI>Standards of care for patients with cystic fibrosis: a European consensus</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2005</YR>
<VL>41</VL>
<PG>7-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kessler-2012" MODIFIED="2014-04-03 12:18:33 +0100" MODIFIED_BY="[Empty name]" NAME="Kessler 2012" TYPE="JOURNAL_ARTICLE">
<AU>Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU</AU>
<TI>Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States</TI>
<SO>International Journal of Methods in Psychiatric Research</SO>
<YR>2012</YR>
<VL>21</VL>
<NO>3</NO>
<PG>169-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lavigne-1992" MODIFIED="2008-05-09 09:51:17 +0100" MODIFIED_BY="[Empty name]" NAME="Lavigne 1992" TYPE="JOURNAL_ARTICLE">
<AU>Lavigne JV, Faier-Routman J</AU>
<TI>Psychological adjustment to pediatric physical disorders: A meta-analytic review</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>1992</YR>
<VL>17</VL>
<NO>2</NO>
<PG>133-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McNair-1971" NAME="McNair 1971" TYPE="BOOK">
<AU>McNair DM, Lorr M, Droppleman LF</AU>
<SO>POMS Profile of Mood States</SO>
<YR>1971</YR>
<PB>Educational and Industrial Testing Service</PB>
<CY>San Diego</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McNair-1992" MODIFIED="2013-10-25 09:18:05 +0100" MODIFIED_BY="[Empty name]" NAME="McNair 1992" TYPE="BOOK">
<AU>McNair D M, Lorr M, Droppleman LF</AU>
<SO>Revised manual for the Profile of Mood States</SO>
<YR>1992</YR>
<PB>CA: Educational and Industrial Testing Services</PB>
<CY>San Diego</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miller-1999" MODIFIED="2008-05-09 09:51:16 +0100" MODIFIED_BY="[Empty name]" NAME="Miller 1999" TYPE="BOOK_SECTION">
<AU>Miller DL, Jelalian E, Stark LJ</AU>
<TI>Cystic Fibrosis</TI>
<SO>Handbook of Pediatric and Adolescent Health Psychology</SO>
<YR>1999</YR>
<EN>First</EN>
<ED>Goreczny AJ, Hersen M</ED>
<PB>Allyn and Bacon</PB>
<CY>Boston</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miroballi-2012" MODIFIED="2014-04-03 12:18:49 +0100" MODIFIED_BY="[Empty name]" NAME="Miroballi 2012" TYPE="JOURNAL_ARTICLE">
<AU>Miroballi Y, Garber E, Jia H, Zhou JJ, Alba L, Quittell LM, et al</AU>
<TI>Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47</VL>
<NO>2</NO>
<PG>144-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Modi-2006" MODIFIED="2014-04-03 12:18:58 +0100" MODIFIED_BY="[Empty name]" NAME="Modi 2006" TYPE="JOURNAL_ARTICLE">
<AU>Modi AC, Lim CS, Yu N, Geller D, Wagner MH, Quittner AL</AU>
<TI>A multi-method assessment of treatment adherence for children with cystic fibrosis</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2006</YR>
<VL>5</VL>
<PG>177-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Modi-2010" MODIFIED="2014-04-03 12:19:03 +0100" MODIFIED_BY="[Empty name]" NAME="Modi 2010" TYPE="JOURNAL_ARTICLE">
<AU>Modi AC, Cassedy AE, Quittner AL, Accurso F, Sontag M, Koenig JM, et al</AU>
<TI>Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2010</YR>
<VL>35</VL>
<PG>1028-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<PG>1191-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Connor-1995" MODIFIED="2013-09-27 11:15:42 +0100" MODIFIED_BY="[Empty name]" NAME="O'Connor 1995" TYPE="JOURNAL_ARTICLE">
<AU>O'Connor AM</AU>
<TI>Validation of a decisional conflict scale</TI>
<SO>Medical Decision Making</SO>
<YR>1995</YR>
<VL>15</VL>
<NO>1</NO>
<PG>25-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oliver-2004" MODIFIED="2014-04-03 12:19:10 +0100" MODIFIED_BY="[Empty name]" NAME="Oliver 2004" TYPE="JOURNAL_ARTICLE">
<AU>Oliver MR, Heine RG, Ng CH, Volders E, Olinsky A</AU>
<TI>Factors affecting clinical outcome in gastrostomy-fed children with cystic fibrosis</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>37</VL>
<PG>324-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pai-2006" MODIFIED="2014-04-03 12:19:17 +0100" MODIFIED_BY="[Empty name]" NAME="Pai 2006" TYPE="JOURNAL_ARTICLE">
<AU>Pai AL, Drotar D, Zebracki K, Moore M, Youngstrom E</AU>
<TI>A meta-analysis of the effects of psychological interventions in pediatric oncology on outcomes of psychological distress and adjustment</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>9</NO>
<PG>978-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pearson-1991" MODIFIED="2008-05-09 09:51:17 +0100" MODIFIED_BY="[Empty name]" NAME="Pearson 1991" TYPE="JOURNAL_ARTICLE">
<AU>Pearson DA, Pumariega AJ, Seilheimer DK</AU>
<TI>The development of psychiatric symptomatology in patients with cystic fibrosis</TI>
<SO>Journal of the American Academy of Child &amp; Adolescent Psychiatry</SO>
<YR>1991</YR>
<VL>30</VL>
<NO>2</NO>
<PG>290-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Plante-2001" MODIFIED="2014-04-03 12:19:38 +0100" MODIFIED_BY="[Empty name]" NAME="Plante 2001" TYPE="JOURNAL_ARTICLE">
<AU>Plante WA, Lobato D, Engel R</AU>
<TI>Review of group interventions for pediatric chronic conditions</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2001</YR>
<VL>26</VL>
<NO>7</NO>
<PG>435-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Prchal-2009" MODIFIED="2013-11-25 09:46:33 +0000" MODIFIED_BY="[Empty name]" NAME="Prchal 2009" TYPE="JOURNAL_ARTICLE">
<AU>Prchal A, Landolt MA</AU>
<TI>Psychological interventions with siblings of pediatric cancer patients: a systematic review</TI>
<SO>Psychooncology</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>12</NO>
<PG>1241-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Quittner-1992a" NAME="Quittner 1992a" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, DiGirolamo AM, Michel M, Eigen H</AU>
<TI>Parental Response to Cystic Fibrosis: A Contextual Analysis of the Diagnosis Phase</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>1992</YR>
<VL>17</VL>
<NO>6</NO>
<PG>683-704</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Quittner-1992b" NAME="Quittner 1992b" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Opipari LC, Regoli MJ, Jacobsen J, Eigen H</AU>
<TI>The impact of caregiving and role strain on family life: Comparisons between mothers of children with cystic fibrosis and matched controls</TI>
<SO>Rehabilitation Psychology</SO>
<YR>1992</YR>
<VL>37</VL>
<NO>4</NO>
<PG>275-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Quittner-1998" NAME="Quittner 1998" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Espelage DL, Opipari LC, Carter B, Eid N, Eigen H</AU>
<TI>Role strain in couples with and without a child with a chronic illness: Associations with marital satisfaction, intimacy, and daily mood</TI>
<SO>Health Psychology</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>2</NO>
<PG>112-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Quittner-2008" MODIFIED="2014-04-03 12:19:46 +0100" MODIFIED_BY="[Empty name]" NAME="Quittner 2008" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I</AU>
<TI>Prevalence and impact of depression in cystic fibrosis</TI>
<SO>Current Opinion in Pulmonary Medicine</SO>
<YR>2008</YR>
<VL>14</VL>
<PG>582-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Quittner-2012b" MODIFIED="2014-05-07 12:02:33 +0100" MODIFIED_BY="[Empty name]" NAME="Quittner 2012b" TYPE="OTHER">
<AU>Quittner AL</AU>
<TI>Setting Up a Multi-National Trial: Lessons Learned in the TIDES study.<I> </I>Paper presented at the European Cystic Fibrosis Society Conference, Dublin, Irl</TI>
<SO>http://www.ecfs.eu/files/webfm/webfiles/File/AHP_Nursing%20Research/Dublin%20Presentations/TIDES%20Lessons%20Learned%206-7-12.pdf</SO>
<YR>(accessed 05 December 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rapoff-2010" MODIFIED="2014-04-03 12:19:51 +0100" MODIFIED_BY="[Empty name]" NAME="Rapoff 2010" TYPE="BOOK">
<AU>Rapoff M</AU>
<SO>Adherence to Pediatric Medical Regimens</SO>
<YR>2010</YR>
<EN>2nd ed. Issues in Clinical Child Psychology</EN>
<PB>Springer Science+Business Media</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sansom_x002d_Daly-2012" MODIFIED="2014-04-03 12:20:46 +0100" MODIFIED_BY="[Empty name]" NAME="Sansom-Daly 2012" TYPE="JOURNAL_ARTICLE">
<AU>Sansom-Daly UM, Peate M, Wakefield CE, Bryant RA, Cohn RJ</AU>
<TI>A systematic review of psychological interventions for adolescents and young adults living with chronic illness</TI>
<SO>Health Psychology</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>3</NO>
<PG>380-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Savage-2011" MODIFIED="2013-09-27 10:34:39 +0100" MODIFIED_BY="[Empty name]" NAME="Savage 2011" TYPE="COCHRANE_REVIEW">
<AU>Savage E, Beirne PV, Ni Chroinin M, Duff A, Fitzgerald T, Farrell D</AU>
<TI>Self-management education for cystic fibrosis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2013-09-27 10:34:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-09-27 10:34:39 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD007641.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Seitz-2009" MODIFIED="2012-11-09 14:14:33 +0000" MODIFIED_BY="[Empty name]" NAME="Seitz 2009" TYPE="JOURNAL_ARTICLE">
<AU>Seitz DC, Besier T, Goldbeck L</AU>
<TI>Psychosocial interventions for adolescent cancer patients: a systematic review of the literature</TI>
<SO>Psychooncology</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>7</NO>
<PG>683-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-2010" MODIFIED="2014-04-03 12:20:55 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 2010" TYPE="JOURNAL_ARTICLE">
<AU>Smith BA, Modi AC, Quittner AL, Wood BL</AU>
<TI>Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2010</YR>
<VL>45</VL>
<PG>756-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spielberger-1970" NAME="Spielberger 1970" TYPE="BOOK">
<AU>Spielberger CD, Gorsuch RC, Lushene RE</AU>
<SO>The State Trait Anxiety Inventory</SO>
<YR>1970</YR>
<PB>Consulting Psychological Press</PB>
<CY>Palo Alto, CA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spielberger-1973" NAME="Spielberger 1973" TYPE="BOOK">
<AU>Spielberger CD</AU>
<SO>State Trait Anxiety Inventory for Children</SO>
<YR>1973</YR>
<PB>Consulting Psychological Press</PB>
<CY>Palo Alto, CA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spitzer-1994" MODIFIED="2013-10-23 23:25:12 +0100" MODIFIED_BY="[Empty name]" NAME="Spitzer 1994" TYPE="JOURNAL_ARTICLE">
<AU>Spitzer R, Williams J, Kroenke D, Linzer M, deGruy F, Hahn S, et al</AU>
<TI>Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study</TI>
<SO>JAMA</SO>
<YR>1994</YR>
<VL>272</VL>
<NO>22</NO>
<PG>1749-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stark-1995" MODIFIED="2008-05-09 09:51:16 +0100" MODIFIED_BY="[Empty name]" NAME="Stark 1995" TYPE="BOOK_SECTION">
<AU>Stark LJ, Jelalian E, Miller DL</AU>
<TI>Cystic Fibrosis</TI>
<SO>Handbook of Pediatric Psychology</SO>
<YR>1995</YR>
<EN>2nd</EN>
<ED>Roberts MC</ED>
<PB>Guildford Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stern-2012" MODIFIED="2014-05-07 12:01:38 +0100" MODIFIED_BY="[Empty name]" NAME="Stern 2012" TYPE="BOOK">
<AU>Sens B, Stern M</AU>
<SO>Qualitaetssicherung Mukoviszidose  - Ueberblick ueber den Gesundheitszustand der Patienten 2011</SO>
<YR>2012</YR>
<PB>Hippocampus Verlag</PB>
<CY>Bad Honnef</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sumner-1994" NAME="Sumner 1994" TYPE="BOOK">
<AU>Sumner G, Spietz A</AU>
<SO>Caregiver/parent-child interaction teaching manual</SO>
<YR>1994</YR>
<PB>NCAST Publications</PB>
<CY>Seattle, WA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tsui-1990" NAME="Tsui 1990" TYPE="JOURNAL_ARTICLE">
<AU>Tsui LC</AU>
<TI>Population Analysis of the Major Mutation in Cystic Fibrosis</TI>
<SO>Human Genetics</SO>
<YR>1990</YR>
<VL>85</VL>
<NO>4</NO>
<PG>391-445</PG>
<ED>Romeo C &amp; Devoto M</ED>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Uman-2013" MODIFIED="2013-10-23 23:32:06 +0100" MODIFIED_BY="[Empty name]" NAME="Uman 2013" TYPE="COCHRANE_REVIEW">
<AU>Uman LS, Birnie KA, Noel M, Parker JA, Chambers CT, McGrath PJ, Kisely SR</AU>
<TI>Psychological interventions for needle-related procedural pain and distress in children and adolescents</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2013-10-23 23:31:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-23 23:31:24 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005179.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-US-Patient-Registry-Annual-Data-Report-2010" MODIFIED="2013-10-23 23:32:58 +0100" MODIFIED_BY="[Empty name]" NAME="US Patient Registry Annual Data Report 2010" TYPE="OTHER">
<TI>US Patient Registry Anual Data Report 2010</TI>
<SO>http://www.cff.org/UploadedFiles/LivingWithCF/CareCenterNetwork/PatientRegistry/2010-Patient-Registry-Report.pdf (accessed 06 August 2012)</SO>
<MD>http://www.cff.org/UploadedFiles/LivingWithCF/CareCenterNetwork/PatientRegistry/2010-Patient-Registry-Report.pdf</MD>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Biervliet-2004" MODIFIED="2013-10-29 11:00:45 +0000" MODIFIED_BY="[Empty name]" NAME="Van Biervliet 2004" TYPE="JOURNAL_ARTICLE">
<AU>Van Biervliet S, De Waele K, Van Winckel M, Robberecht E</AU>
<TI>Percutaneous endoscopic gastrostomy in cystic fibrosis: patient acceptance and effect of overnight tube feeding on nutritional status</TI>
<SO>Acta Gastroenterol Belg</SO>
<YR>2004</YR>
<VL>67</VL>
<NO>3</NO>
<PG>241-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walker-1991" MODIFIED="2013-10-29 11:00:24 +0000" MODIFIED_BY="[Empty name]" NAME="Walker 1991" TYPE="JOURNAL_ARTICLE">
<AU>Walker LS, Greene JW</AU>
<TI>The functional disability inventory: Measuring a neglected dimension of child health status</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>1991</YR>
<VL>16</VL>
<NO>1</NO>
<PG>39-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ware-1993" MODIFIED="2013-09-27 11:30:59 +0100" MODIFIED_BY="[Empty name]" NAME="Ware 1993" TYPE="OTHER">
<AU>Ware J, Snow K, Kosinski M, Gandek B</AU>
<TI>SF-36 Health Survey: Manual and interpretation guide</TI>
<SO>The Health Institute, New England Medical Center</SO>
<YR>1993</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2003" MODIFIED="2014-04-03 12:21:23 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2003" TYPE="BOOK">
<AU>World Health Organisation</AU>
<TI>Adherence to long term therapies: evidence for action</TI>
<SO>Adherence to long term therapies: evidence for action</SO>
<YR>2003</YR>
<PB>WHO</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wittchen-2011" MODIFIED="2014-04-03 12:21:17 +0100" MODIFIED_BY="[Empty name]" NAME="Wittchen 2011" TYPE="JOURNAL_ARTICLE">
<AU>Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Joensson B, et al</AU>
<TI>The size and burden of mental disorders and other disorders of the brain in Europe 2010</TI>
<SO>European Neuropsychopharmacology</SO>
<YR>2011</YR>
<VL>21</VL>
<NO>9</NO>
<PG>655-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yorke-2005" MODIFIED="2013-10-23 23:36:30 +0100" MODIFIED_BY="[Empty name]" NAME="Yorke 2005" TYPE="COCHRANE_REVIEW">
<AU>Yorke J, Fleming SL, Shuldham C</AU>
<TI>Psychological interventions for children with asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-10-23 23:36:30 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-23 23:36:30 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003272.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yorke-2006" MODIFIED="2013-10-23 23:40:39 +0100" MODIFIED_BY="[Empty name]" NAME="Yorke 2006" TYPE="COCHRANE_REVIEW">
<AU>Yorke J, Fleming SL, Shuldham C</AU>
<TI>Psychological interventions for adults with asthma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-10-23 23:40:23 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-23 23:40:23 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002982.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-09-27 10:26:10 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Glasscoe-2003" MODIFIED="2013-09-27 10:26:10 +0100" MODIFIED_BY="[Empty name]" NAME="Glasscoe 2003" TYPE="COCHRANE_REVIEW">
<AU>Glasscoe CA, Quittner AL</AU>
<TI>Psychological interventions for cystic fibrosis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-09-27 10:26:10 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-09-27 10:26:10 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003148.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-12-19 14:11:52 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Aitken-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Aitken 2011" TYPE="JOURNAL_ARTICLE">
<AU>Aitken ML, Caldwell E, Wilhelm E, Goss CH</AU>
<TI>Early intervention in pulmonary exacerbation [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46 Suppl 34</VL>
<PG>332, Abstract no: 331</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000135"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Andrade-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Andrade 2013" TYPE="JOURNAL_ARTICLE">
<AU>Andrade T, Guitton B, Monteiro E, Deolindo V</AU>
<TI>Education for physiotherapeutic caregivers of patients with cystic fibrosis [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2013</YR>
<VL>12 Suppl 1</VL>
<PG>S106, Abstract no: 225</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011529"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Barker-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Barker 2013" TYPE="JOURNAL_ARTICLE">
<AU>Barker D, Quittner AL, Riekert KA</AU>
<TI>Relating patterns of social support from friends and family to health-related quality of life [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>433, Abstract no: 615</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000139"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blackwell-2012" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Blackwell 2012" TYPE="JOURNAL_ARTICLE">
<AU>Blackwell LS, Romero SL, Romero CV, McLean KA, Dawkins K, Hoag J, et al</AU>
<TI>CFfone: a social networking site for adolescents and young adults with CF [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>430, Abstract no: 562</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011184"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blackwell-2012a" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Blackwell 2012a" TYPE="JOURNAL_ARTICLE">
<AU>Blackwell LS, Romero SL, Marciel KK, Romero CV, Quittner AL</AU>
<TI>Pain in adolescents and young adults with CF: location, severity and predictors [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>430, Abstract no: 561</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000041"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chamberlin-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Chamberlin 2013" TYPE="JOURNAL_ARTICLE">
<AU>Chamberlin LA, Sullivan S, Stark L, Powers SW</AU>
<TI>Adjusting recruitment strategies and intervention format to meet enrollment goals in a multicenter trial of a behavioural treatment [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>438, Abstract no: 630</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000140"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chan-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Chan 2013" TYPE="JOURNAL_ARTICLE">
<AU>Chan S, Tullis E, Cortes D</AU>
<TI>The added value of a pharmacist in identifying drug-related needs of cystic fibrosis patients in a large adult clinic [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>400, Abstract no: 528</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000141"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cottrell-1994" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Cottrell 1994" TYPE="UNPUBLISHED">
<AU>Cottrell CK</AU>
<TI>The effects of self-management training in children/adolescents with cystic fibrosis</TI>
<SO>Unpublished Doctoral Dissertation, Ohio University, Ohio, US</SO>
<YR>1994</YR>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000007848"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cottrell-1996" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Cottrell 1996" TYPE="JOURNAL_ARTICLE">
<AU>Cottrell CK, Young GA, Creer TL, Holroyd KA, Kotses H</AU>
<TI>The development and evaluation of a self-management program for cystic fibrosis</TI>
<SO>Pediatric Asthma, Allergy &amp; Immunology</SO>
<YR>1996</YR>
<VL>10</VL>
<NO>3</NO>
<PG>109-18</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000007844"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Driscoll-2009" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Driscoll 2009" TYPE="JOURNAL_ARTICLE">
<AU>Driscoll KA, Killian M, Johnson SB, Silverstein JH, Deeb LC</AU>
<TI>Predictors of study completion and withdrawal in a randomized clinical trial of a pediatric diabetes adherence intervention</TI>
<SO>Contemporary Clinical Trials</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>3</NO>
<PG>212-20</PG>
<CY>United States</CY>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011198"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Driscoll-2010" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Driscoll 2010" TYPE="JOURNAL_ARTICLE">
<AU>Driscoll KA, Johnson SB, Barker D, Quittner AL, Deeb LC, Geller DE, et al</AU>
<TI>Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosis</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2010</YR>
<VL>35</VL>
<NO>8</NO>
<PG>814-22</PG>
<CY>United States</CY>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011199"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Driscoll-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Driscoll 2011" TYPE="JOURNAL_ARTICLE">
<AU>Driscoll KA, Johnson SB, Tang Y, Yang F, Deeb LC, Silverstein JH</AU>
<TI>Does blood glucose monitoring increase prior to clinic visits in children with type 1 diabetes?</TI>
<SO>Diabetes Care</SO>
<YR>2011</YR>
<VL>34</VL>
<NO>10</NO>
<PG>2170-3</PG>
<CY>United States</CY>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011200"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fischer-2003" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Fischer 2003" TYPE="JOURNAL_ARTICLE">
<AU>Fischer R, Naehrig S, Schelling JS, Horn M, Huber RM</AU>
<TI>Telemonitoring in adult cystic fibrosis patients [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2003</YR>
<VL>Suppl 25</VL>
<PG>371</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002398"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Geller-2010" MODIFIED="2013-12-19 14:11:52 +0000" MODIFIED_BY="[Empty name]" NAME="Geller 2010" TYPE="JOURNAL_ARTICLE">
<AU>Geller DE, Flume PA, Brockhaus F, Zhang J, Angyalosi G, He E, et al</AU>
<TI>Treatment convenience and satisfaction of tobramycin inhalation powder (TIP) versus TOBI in cystic fibrosis (CF) patients [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2010</YR>
<VL>9 Suppl 1</VL>
<PG>S22, Abstract no: 82</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003511"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Geller-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Geller 2011" TYPE="JOURNAL_ARTICLE">
<AU>Geller DE, Flume PA, Konstan M, Angyalosi G, Higgins M</AU>
<TI>Microbiological and clinical response to tobramycin inhalation powder (TIP&#8482;) in cystic fibrosis patients with chronic Pseudomonas aeruginosa (Pa) infection [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2011</YR>
<VL>10 Suppl 1</VL>
<PG>S21, Abstract no: 82</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010633"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Goldbeck-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Goldbeck 2013" TYPE="JOURNAL_ARTICLE">
<AU>Goldbeck L, Hebestreit H, Junge S, Sens B, Smaczny C, Frank M, et al</AU>
<TI>Vemse-CF - A prospective controlled care-research study investigating the effects of a comprehensive psychosocial intervention [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>430, Abstract no: 608</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000138"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Irons-2012" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Irons 2012" TYPE="JOURNAL_ARTICLE">
<AU>Irons JY, Kenny DT, McElrea M, Chang AB</AU>
<TI>Singing therapy for young people with cystic fibrosis : a randomized controlled pilot study</TI>
<SO>Music and Medicine</SO>
<YR>2012</YR>
<VL>4</VL>
<NO>3</NO>
<PG>136-45</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000007892"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Konstan-2010" MODIFIED="2013-12-19 14:11:18 +0000" MODIFIED_BY="[Empty name]" NAME="Konstan 2010" TYPE="JOURNAL_ARTICLE">
<AU>Konstan M, Flume PA, Brockhaus F, Angyalosi G, He, E, et al</AU>
<TI>Safety and efficacy of tobramycin inhalation powder (TIP) in treating CF patients infected with Pseudomonas aeruginosa (Pa) [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2010</YR>
<VL>9 Suppl 1</VL>
<PG>S22, Abstract no: 82</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003510"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Konstan-2010a" MODIFIED="2013-12-19 14:11:21 +0000" MODIFIED_BY="[Empty name]" NAME="Konstan 2010a" TYPE="JOURNAL_ARTICLE">
<AU>Konstan MW, Flume PA, Brockhaus F, Angyalosi G, He E, Zhang J, et al</AU>
<TI>Tobramycin inhalation powder (TIP) versus tobramycin inhalation solution (TOBI®): the EAGER trial [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2010</YR>
<VL>45 Suppl 33</VL>
<PG>303, Abstract no: 235</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010710"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Konstan-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Konstan 2011" TYPE="JOURNAL_ARTICLE">
<AU>Konstan MW, Flume PA, Kappler M, Chiron R, Higgins M, Brockhaus F, et al</AU>
<TI>Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2011</YR>
<VL>10</VL>
<NO>1</NO>
<PG>54-61</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000005985"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lagoe-2005" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Lagoe 2005" TYPE="JOURNAL_ARTICLE">
<AU>Lagoe E, Labella S, Arnold G, Rowley PT</AU>
<TI>Cystic fibrosis newborn screening: a pilot study to maximize carrier screening</TI>
<SO>Genetic Testing</SO>
<YR>2005</YR>
<VL>9</VL>
<NO>3</NO>
<PG>255-60</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000002797"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Marostica-2012" MODIFIED="2013-12-19 14:11:23 +0000" MODIFIED_BY="[Empty name]" NAME="Marostica 2012" TYPE="JOURNAL_ARTICLE">
<AU>Marostica PJ, Hommerding P, Makarewicz G, Baptista R, Donadio MV</AU>
<TI>Efficacy of an educational intervention of physical activity for children and adolescents with cystic fibrosis [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2012</YR>
<VL>11 Suppl 1</VL>
<PG>S36, Abstract no: WS16.6</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010720"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McColley-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="McColley 2011" TYPE="JOURNAL_ARTICLE">
<AU>McColley S, Rietschel E, Brockhaus F, Angyalosi G, Higgins M</AU>
<TI>Safety of inhaled tobramycin in patients with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46 Suppl 34</VL>
<PG>344, Abstract no: 365</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010634"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McCoy-2008" MODIFIED="2013-12-19 14:11:26 +0000" MODIFIED_BY="[Empty name]" NAME="McCoy 2008" TYPE="JOURNAL_ARTICLE">
<AU>McCoy KS, Retsch-Bogart GZ, Gibson R, Oermann C, Braff MH, Montgomery AB</AU>
<TI>Relevance of established susceptibility breakpoints to clinical efficacy of inhaled antibiotic therapies in cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2008</YR>
<VL>43 Suppl 31</VL>
<PG>351</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003289"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McCoy-2009" MODIFIED="2013-12-19 14:11:29 +0000" MODIFIED_BY="[Empty name]" NAME="McCoy 2009" TYPE="JOURNAL_ARTICLE">
<AU>McCoy KS, Retsch-Boagrt GZ, Gibson RL, Oermann CM, McKevitt M, Montgomery AB</AU>
<TI>Efficacy of Aztreonam Lysine for inhalation (AZLI) in patients with cystic fibrosis and drug resistant P. aeruginosa (DRPA) [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2009</YR>
<VL>8 Suppl 2</VL>
<PG>S28</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003449"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McCoy-2010" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="McCoy 2010" TYPE="JOURNAL_ARTICLE">
<AU>McCoy K, Retsch-Bogart G, Gibson RL, Oermann C, Braff M, Montgomery AB</AU>
<TI>Investigation of susceptibility breakpoints for inhaled antibiotic therapies in cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2010</YR>
<VL>45 Suppl 33</VL>
<PG>341, Abstract no: 340</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010623"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McLean-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="McLean 2013" TYPE="JOURNAL_ARTICLE">
<AU>McLean KA, Quittner AL, Alpern AN, Marciel KK, Riekert KA</AU>
<TI>Healthcare provider acceptability of problem-solving in the I change adherence and raise expectations (iCARE) study [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>437, Abstract no: 626</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000126"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-NCT01253733-2009" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="NCT01253733 2009" TYPE="JOURNAL_ARTICLE">
<AU>NCT01253733</AU>
<TI>TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management</TI>
<SO>Http://clinicaltrials.gov/show/NCT01253733</SO>
<YR>2009</YR>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011528"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Parkins-2008" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Parkins 2008" TYPE="JOURNAL_ARTICLE">
<AU>Parkins VM, Parkins MD, Peets AD, Montgomery M, Brager NP// Rabin HR</AU>
<TI>Effect of an educational intervention designed to promote cystic fibrosis knowledge in specialty residents [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2008</YR>
<VL>43 Suppl 31</VL>
<PG>462, Abstract no: 713</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011179"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Plosker-2010" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Plosker 2010" TYPE="JOURNAL_ARTICLE">
<AU>Plosker GL</AU>
<TI>Aztreonam lysine for inhalation solution: in cystic fibrosis</TI>
<SO>Drugs</SO>
<YR>2010</YR>
<VL>70</VL>
<NO>14</NO>
<PG>1843-55</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010622"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Powers-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Powers 2013" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Stark L, Chamberlin L, Sullivan S, Filigno S, Rausch J</AU>
<TI>A multi-site, randomized, controlled clinical trial of behavioral and nutrition treatment for preschoolers with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>Suppl 36</VL>
<PG>402, Abstract no: 532</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000143"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Quitnner-2009" MODIFIED="2013-12-19 14:11:33 +0000" MODIFIED_BY="[Empty name]" NAME="Quitnner 2009" TYPE="JOURNAL_ARTICLE">
<AU>Quitnner AL, Retsch-Bogart GZ, McCoy KS, Oermann CM, Gibson R, Lewis S, et al</AU>
<TI>Effect of a 28-day course of aztreonam for inhalation solution (AZLI) on responses to individual CFQ-R respiratory symptoms score questions among patients with CF [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2009</YR>
<VL>44 Suppl 32</VL>
<PG>305, Abstract no: 266</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003457"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Quitnner-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Quitnner 2011" TYPE="JOURNAL_ARTICLE">
<AU>Quitnner AL, Henig NR, Lewis S, Derchak PA, McCoy KS, Oermann CM, et al</AU>
<TI>Effects of chronic intermittant aztreonam for inhalation solution (AZLI) on health-related quality of life (HRQOL) in persons with cystic fibrosis (CF) and P. aeruginosa [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46 Suppl 34</VL>
<PG>299, Abstract no: 240</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011261"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Quitnner-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Quitnner 2013" TYPE="JOURNAL_ARTICLE">
<AU>Quitnner AL, Riekert KA</AU>
<TI>I Change adherence and raise expectations: the iCARE study</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>136, Symposium summary no: S7.3</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000125"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Quittner-2012" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Quittner 2012" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Romero SL, Blackwell LS, Romero CV, Marciel KK, Dawkins K, et al</AU>
<TI>Preliminary results on the efficacy of an online social network for adolescents with CF: age and disease severity group comparisons [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>388, Abstract no: 450</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011541"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Quittner-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Quittner 2013" TYPE="JOURNAL_ARTICLE">
<AU>Quittner AL, Romero SL, Blackwell LS, McLean KA, Monzon AD, Dawkins K</AU>
<TI>Efficacy of an online social networking site: CFFONE results</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>135, Summary no: S7.2</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000144"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Regnault-2011" MODIFIED="2013-12-19 14:11:36 +0000" MODIFIED_BY="[Empty name]" NAME="Regnault 2011" TYPE="JOURNAL_ARTICLE">
<AU>Regnault A, Balp MM, Kulich K, Esteve L, Viala-Danten M</AU>
<TI>Association of treatment satisfaction and compliance of cystic fibrosis (CF) patients using inhaled tobramycin treatment in the EAGER study [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2011</YR>
<VL>10 Suppl 1</VL>
<PG>S82, Abstract no:323</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010711"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Regnault-2012" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Regnault 2012" TYPE="JOURNAL_ARTICLE">
<AU>Regnault A, Balp MM, Kulich K, Viala-Danten M</AU>
<TI>Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2012</YR>
<VL>11</VL>
<NO>6</NO>
<PG>494-501</PG>
<CY>Netherlands</CY>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011297"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Retsch_x002d_Bogart-2007" MODIFIED="2013-12-19 14:11:40 +0000" MODIFIED_BY="[Empty name]" NAME="Retsch-Bogart 2007" TYPE="JOURNAL_ARTICLE">
<AU>Retsch-Bogart GZ, Montgomery B, Gibson R, McCoy K, Oermann CM, Cooper P</AU>
<TI>Phase 3 trial (AIR-CF 1) measuring improvement in respiratory symptoms in patients with cystic fibrosis (CF) following treatment with aztreonam lysine for inhalation [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2007</YR>
<VL>42 Suppl 30</VL>
<PG>310</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003182"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Retsch_x002d_Bogart-2008" MODIFIED="2013-12-19 14:11:45 +0000" MODIFIED_BY="[Empty name]" NAME="Retsch-Bogart 2008" TYPE="JOURNAL_ARTICLE">
<AU>Retsch-Bogart GZ, McCoy KS, Gibson RL, Oermann CM</AU>
<TI>Sustained improvement in pulmonary function following a 28-day course of 75mg azli tid therapy [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2008</YR>
<VL>43 Suppl 31</VL>
<PG>320</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003286"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Retsch_x002d_Bogart-2008a" MODIFIED="2013-12-19 14:11:49 +0000" MODIFIED_BY="[Empty name]" NAME="Retsch-Bogart 2008a" TYPE="JOURNAL_ARTICLE">
<AU>Retsch-Bogart GZ, McCoy KS, Gibson RL, Oermann C, Montgomery AB</AU>
<TI>Source of improvements in lung function in patients with cystic fibrosis (CF) following treatment with aztreonam lysine for inhalation (AZLI) [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2008</YR>
<VL>43 Suppl 31</VL>
<PG>320</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000003445"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Retsch_x002d_Bogart-2009" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Retsch-Bogart 2009" TYPE="JOURNAL_ARTICLE">
<AU>Retsch-Bogart GZ, Quittner AL, Gibson RL, Oermann CM, McCoy KS, Montgomery AB, et al</AU>
<TI>Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis</TI>
<SO>Chest</SO>
<YR>2009</YR>
<VL>135</VL>
<NO>5</NO>
<PG>1223-32</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000010621"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Riekert-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Riekert 2013" TYPE="JOURNAL_ARTICLE">
<AU>Riekert KA, Borrelli B, Bilderback AV, green A, Eakin MN</AU>
<TI>Building adherence to live and navigate my CF experience: the balance study</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2013</YR>
<VL>48 Suppl 36</VL>
<PG>133, Summary no: S7.1</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000142"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Romero-2010" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Romero 2010" TYPE="JOURNAL_ARTICLE">
<AU>Romero SL, Blackwell LS, Armenteros E, Quittner AL</AU>
<TI>Patient and parent-reported conflict: age and gender differences and associations with disease severity [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2010</YR>
<VL>45 Suppl 33</VL>
<PG>446, Abstract no: 623</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011545"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rozenfeld-2012" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Rozenfeld 2012" TYPE="JOURNAL_ARTICLE">
<AU>Rozenfeld S, Mantin H, Mussaffi H, Taizi T, Landau E, Kadosh D, et al</AU>
<TI>Effect of Snoezlen on pain perception and anxiety in CF infants during sputum suction [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2012</YR>
<VL>47 Suppl 35</VL>
<PG>441, Abstract no: 595</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000042"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sands-2013" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Sands 2013" TYPE="JOURNAL_ARTICLE">
<AU>Sands D, Sapiejka E, Mazurek H, Gaszczyk G</AU>
<TI>Use of an electronic monitoring system to generate objective information on patients' adherence to taking treatments of a novel tobramycin solution (VANTOBRA) [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2013</YR>
<VL>12 Suppl 1</VL>
<PG>S66, Abstract no: 70</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011292"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sands-2013a" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Sands 2013a" TYPE="JOURNAL_ARTICLE">
<AU>Sands D, Sapiejka E, Mazurek H, Gaszczyk G</AU>
<TI>A randomised comparison of VANTOBRA and TOBI in cystic fibrosis patients with chronic pseudomonas aeruginosa infection for pharmacokinetic and therapeutic equivalence [abstract]</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2013</YR>
<VL>12 Suppl 1</VL>
<PG>S66, Abstract no: 69</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011293"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Vandemheen-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Vandemheen 2011" TYPE="JOURNAL_ARTICLE">
<AU>Vandemheen K, Stacey D, Hennessey R, Gooyers T, Salgado J, Freitag A, et al</AU>
<TI>Translating research into practice: implementing a decision aid for adult cystic fibrosis patients [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46 Suppl 34</VL>
<PG>427, Abstract no: 588</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011188"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wainwright-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="Wainwright 2011" TYPE="JOURNAL_ARTICLE">
<AU>Wainwright CE, Quittner AL, Geller DE, Nakamura C, Wooldridge JL, Gibson RL, et al</AU>
<TI>Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2011</YR>
<VL>10</VL>
<NO>4</NO>
<PG>234-42</PG>
<CY>Netherlands</CY>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500100000011273"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-West-2011" MODIFIED="2013-12-19 11:37:35 +0000" MODIFIED_BY="[Empty name]" NAME="West 2011" TYPE="JOURNAL_ARTICLE">
<AU>West NE, Goss CH, Lechtzin N</AU>
<TI>Design and planning of the early intervention in cystic fibrosis exacerbation randomized trial [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2011</YR>
<VL>46 Suppl 34</VL>
<PG>345, Abstract no: 368</PG>
<IDENTIFIERS MODIFIED="2013-12-19 11:37:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER OTHERTYPE="CRS-ID" TYPE="OTHER" VALUE="5500125000000136"/>
</IDENTIFIERS>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-06-16 08:53:29 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-06-11 22:44:32 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-06-11 22:08:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Belsky-1994">
<CHAR_METHODS MODIFIED="2014-06-11 15:55:25 +0100" MODIFIED_BY="[Empty name]">
<P>CCT.</P>
<P>Pilot study that assessed the effects of self-hypnosis on psychological and physiological functioning of children ages 7 to 18 years with CF.</P>
<P>Hypothesis: hypnosis is associated with enhanced performance on clinical rating criteria and with improved scores in self-concept and other psychological tests.</P>
<P>The study used a pre- and post-test design with control group and repeated measures.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 15:55:31 +0100" MODIFIED_BY="[Empty name]">
<P>12 children with CF ages 7 - 18 years attending a local CF clinic.</P>
<P>Population of interest: 30 (met eligibility).</P>
<P>Number included: 12.</P>
<P>Control group: 5 girls and 2 boys.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-07 12:40:22 +0000" MODIFIED_BY="[Empty name]">
<P>The parents and children in the experimental group had three appointments within a 2-week period during which time the children were taught a hypnotic technique.</P>
<P>The hypnotic induction is described in detail in the article.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:08:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>CF illness ratings</B>: Shwachman- Kulzcycki system standard form has been completed by the physician at baseline, which is based on 100 maximum points measuring four categories: general activity, physical examination, nutrition, and radiographic findings. Other illness variables included each patient's average PEFR, height, weight, and number of hospital admissions during 2 years prior to the study.</P>
<P>
<B>Parents' measures</B>: 'Impact on Family Scale' (measures family functioning); 'Child Behavior Checklist' (parents' perception of behavioral problems and competencies); rating of the parents' assessment of the child's illness; parents also provided a record of school days missed by their child for 3 years before the pretest.</P>
<P>
<B>Children's measures</B>: LOC was assessed with the Nowicki Strickland (1973) LOC for Children and with the Children's HLOC (Parcel &amp; Mayer, 1978) which is a 20-item area specific measure of expectancies regarding locus of control and prediction of health-related behavior. Self-concept was assessed with the Piers Harris Children's Self-Concept Scale (1964). Anxiety was assessed with the STAIC (Spielberger 1973).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-22 15:54:02 +0100" MODIFIED_BY="[Empty name]">
<P>None of the authors could be contacted for questions on provided data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:09:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chernoff-2002">
<CHAR_METHODS MODIFIED="2008-05-01 13:56:03 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Parallel RCT.<BR/>Comparing the effect for carers of children with a chronic illness of a comprehensive community-based support programme with having a contact telephone number for an experienced mother of a child with a similar illness.<BR/>For children it was hypothesised that those in the experimental group would have better mental health at the end of the intervention than controls. For the mothers it was hypothesised that those in the intervention group would report fewer psychological symptoms than control mothers.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-03 12:09:07 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest N = 193.<BR/>Sample agreeing to participate N = 161 children with a chronic illness and their mothers. Children with diabetes, sickle cell, CF or moderate to severe asthma were included.<BR/>For CF subgroup: n = 7 assigned to the intervention group and n = 6 controls.<BR/>Included children aged 7 - 11 years living within 80 km radius of Baltimore, with no learning disability, with a mother as a primary carer, on the telephone, speaking English, and diagnosed &gt; 6 months ago.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:08:29 +0100" MODIFIED_BY="[Empty name]">
<P>1. Community-based support programme over 15 months - trained network mother + child life specialist pairing.<BR/>a. 7 home visits<BR/>b. twice-weekly telephone calls<BR/>c. 3 special family events<BR/>2. Control group are given a contact number for an experienced mother.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:09:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Children</B>
<BR/>a. personal adjustment and role skills<BR/>b. depression<BR/>c. anxiety<BR/>d. self-perception<BR/>
<B>Mothers</B>
<BR/>a. anxiety<BR/>b. depression<BR/>c. stressful life events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 15:57:42 +0100" MODIFIED_BY="[Empty name]">
<P>POI: anxiety subscale - 11 items self-report from 'Psychiatric Symptom Index'.<BR/>The groups were equivalent at baseline although these data not reported for individual disease subgroups.<BR/>Network mothers were trained and supervised and a manual was produced.</P>
<P>Treatment fidelity: the authors reported that weekly meetings took place to ensure that intervention was provided as planned (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>, p.534/35).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:11:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christian-2006">
<CHAR_METHODS MODIFIED="2014-06-11 15:58:05 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>2-group, experimental, repeated-measures design (baseline, 3, 6, and 9 months intervals) with randomly assigned participants to intervention and usual care group.</P>
<P>Hypothesis: children with CF who receive the intervention will improve significantly on 3 parameters (psychosocial adjustment, functional health status, physiologic health) over the time compared to children who received usual care.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 15:58:58 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest: N = 128.</P>
<P>Number of randomised participants: N = 116.</P>
<P>Control group 'usual care': N = 58.</P>
<P>Intervention group 'educational problem-solving and social skills intervention': N = 58.</P>
<P>Included children with CF aged 8 - 12 years receiving care from one of four CF centres in North Carolina (USA).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:11:20 +0100" MODIFIED_BY="[Empty name]">
<P>Educational problem-solving and social skills intervention (N = 58) versus usual care (N = 58).</P>
<P>Children in the problem-solving group received individual, tailored intervention during one home visit and a structured group session (conducted approximately 2 weeks after individual home visit).</P>
<P>Intervention was designed to support children (8 - 12years) with the following specific problems:</P>
<P>1. finding out about the CF diagnosis;</P>
<P>2. explaining CF-related differences;</P>
<P>3. dealing with teasing about CF;</P>
<P>4. keeping up with peers during physical activity.</P>
<P>The intervention contains 4 modules. In every module there was a focus on one of the 4 mentioned areas of problems (1-4). The intervention team received detailed information about the intervention protocol and was trained and supervised conducting the intervention.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:00:26 +0100" MODIFIED_BY="[Empty name]">
<P>5 questionnaires which are developed for children were read aloud by research assistant to the children. The following questionnaires were used to the assess different constructs:</P>
<P>Psychosocial adjustment was assessed by:</P>
<P>- Perceived Illness Experience Scale (35 items);</P>
<P>- Children's Loneliness Scale (16 items);</P>
<P>- Social Support Scale for Children (16 items);</P>
<P>- Self-Perception Profile for Children (30 items).</P>
<P>Functional Health Status was assessed by:</P>
<P>- Functional Disability Inventory (15 items).</P>
<P>Physiolgical Health Status:</P>
<P>- Pulmonary function (FEV<SUB>1</SUB>).</P>
<P>- Height and weight.</P>
<P>- BMI.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:12:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Delk-1994">
<CHAR_METHODS MODIFIED="2008-05-01 12:51:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Parallel RCT.<BR/>Comparing the effects of therapy that it is targeted with aim of facilitating physiotherapy and when it is aimed at increasing relaxation.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-01 14:05:54 +0100" MODIFIED_BY="Nikki Jahnke">
<P>N = 26.<BR/>Aged 10 - 41 years.<BR/>Groups matched by age and severity of disease using Shwachman-Kulczycki scoring system prior to randomisation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:00:57 +0100" MODIFIED_BY="[Empty name]">
<P>1. Biofeedback assisted breathing re-training (N = 13).<BR/>2. Biofeedback assisted relaxation training (N = 13).<BR/>8 sessions over 4 weeks.<BR/>Delivered by psychology and biofeedback students under supervision.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:12:10 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Lung function</B>:<BR/>1. FVC;<BR/>2. FEV<SUB>1</SUB>;<BR/>3. FEF <SUB>25-75%</SUB>.<BR/>
<B>Evaluation at</B>:<BR/>1. 3 pre-study assessments, 18 months prior to study commencement;<BR/>2. baseline;<BR/>3. post-study;<BR/>4. follow up.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:01:08 +0100" MODIFIED_BY="[Empty name]">
<P>POI: Pulmonary function.<BR/>The groups were equivalent at baseline on age, severity of disease, height, weight, and pre-treatment lung functions.<BR/>Both groups believed they were being given an intervention so effective blinding of participants - no information about blinding of trainers and pulmonary function technicians.<BR/>Not clear how sample was selected or from what population they were drawn.<BR/>Analysed as ITT apart from one missing matched pair in FEV<SUB>1</SUB> outcome measure.<BR/>Limited follow-up data.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 21:55:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goodill-2005">
<CHAR_METHODS MODIFIED="2014-06-11 21:55:50 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>Compared brief dance/movement therapy for adult CF patients during an exacerbation of CF symptomatology to standard care.</P>
<P>In the study it was explored whether treatment group participants would show more positive mood state, better adherence with self-care expectations, and a healthier and/or more positive body image.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-22 15:54:22 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were 17 years or older and hospitalised for CF treatment. All were Caucasian except one, who was African-American.</P>
<P>Pre-test and post-test data were collected for 42 participants, follow-up data for 24 participants (14 in the treatment group and 10 in the control group).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-22 15:54:22 +0100" MODIFIED_BY="[Empty name]">
<P>The intervention consisted of 3 individual or small group DMT sessions over a 7- to l0-day time period. DMT, a creative arts psychotherapy, utilizes guided movement activity with creative and non-verbal communication processes for increasing self-awareness, enhancing expressive competence, and integrating cognitive, physical, social, and emotional functioning.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:02:50 +0100" MODIFIED_BY="[Empty name]">
<P>Mood state was measured with 'The Profile of Mood States' (POMS): scores for 'Total Mood Disturbance' and 6 subscales: 'Tension'; 'Depression'; 'Fatigue'; 'Confusion'; 'Anger'; and 'Vigor'.</P>
<P>Body image was assessed with human figure drawings created by the participants and rated by trained raters (levels of acceptable agreement r = .85).</P>
<P>Adherence: an adherence questionnaire developed for this study posed two simple questions regarding adherence with physician instructions for exercise and nutrition regimens: "How much did you do of what was instructed for exercise? for nutrition?" Response options were, "l did almost everything" (or "about half" or "little or nothing") of "what I was expected to do.&#8221;</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-22 15:54:22 +0100" MODIFIED_BY="[Empty name]">
<P>Contacted the leading author for detailed data on the outcome measures.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 16:03:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grasso-2000">
<CHAR_METHODS MODIFIED="2014-06-11 16:03:36 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel RCT.<BR/>Comparing the effects of music therapy in enhancing the experience of physiotherapy with no effective intervention.<BR/>Random allocation to 2 groups. Groups matched for spread of ages, frequency of CPT and number of rural families.<BR/>Control group experienced 2 consecutive conditions - control and placebo control with repeated measures.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:03:43 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest N = 26.<BR/>Five refused. Recruitment rate 87.5%.<BR/>Sample comprised N = 21.<BR/>N = 1 withdrew from intervention group.<BR/>Caregivers of one or more children with CF - parent most responsible for CPT.<BR/>Children aged 6 to 24 months with diagnosis at least two months prior to start of study.<BR/>Exclusions - children admitted to hospital with a chest infection.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:03:55 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group (N = 10):<BR/>1. Music Therapy Tape (TT) with 5 minute explanation and instruction to use as often as they liked plus diary chart (N = 10).<BR/>Control group (N = 10):<BR/>2. No audiotape (NT control).<BR/>3. Familiar music tape (FT placebo control) plus diary chart .<BR/>The study lasted for 12 weeks with the control group experiencing 2 conditions each for a period of 6 weeks in the order of 2. then 3.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-01 14:13:13 +0100" MODIFIED_BY="Nikki Jahnke">
<P>1. Enjoyment - child &amp; parent.<BR/>2. Perception of time.<BR/>Evaluation at baseline, 6 weeks and 12 weeks.<BR/>Ad hoc test measure.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-03 12:09:45 +0100" MODIFIED_BY="[Empty name]">
<P>POI: enjoyment in child and parent and perception of time in parent.<BR/>Equivalence at baseline for:<BR/>1. age;<BR/>2. sex;<BR/>3. stage of condition.<BR/>Analysed as ITT apart from one dropout.<BR/>Participants not informed about whether they were in treatment group.</P>
<P>Treatment fidelity/compliance: The authors reported that the 'participants were asked to complete a diary chart to monitor frequency of tape use' (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>, p.373).<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 21:55:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hernandez_x002d_Reif-1999">
<CHAR_METHODS MODIFIED="2014-06-11 21:55:59 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel RCT.<BR/>Control group offered intervention on completion of study.<BR/>Comparing the effect of massage in enhancing pulmonary function.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-01 14:14:15 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Population of interest N = 24, aged 5 - 18 years.<BR/>1 refused and 3 dropped out.<BR/>Total sample n = 20 parent/child dyads.<BR/>Children aged 5 - 12 years.<BR/>Intervention group: 9 mothers, 1 father &amp; 10 children.<BR/>Control group: 10 mothers &amp; 10 children.<BR/>Mean baseline scores on NIH clinical score:<BR/>intervention group 82.2; control group 82.0.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:04:25 +0100" MODIFIED_BY="[Empty name]">
<P>1. Massage therapy (N = 10).<BR/>2. Bedtime reading control (N = 10).<BR/>Every evening for 30 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-01 14:18:13 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Parents: anxiety (STAI).<BR/>Children: anxiety (STAIC); mood (POMS); peak flow (PEFR).<BR/>Assessment at baseline (Day 1) &amp; Day 30.<BR/>Assessment: pre- and post-Day 1; pre- and post-Day 30.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:04:36 +0100" MODIFIED_BY="[Empty name]">
<P>POI: peak flow.<BR/>Fewer than 15% refused or dropped out.<BR/>Equivalence at baseline for:<BR/>1. sex of parent;<BR/>2. age of child;<BR/>3. SES;<BR/>4. severity.<BR/>No blinding of participants or therapists and blinding of assessors unclear.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:13:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Powers-2003">
<CHAR_METHODS MODIFIED="2008-05-01 14:19:07 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Parallel RCT.<BR/>Examine the effectiveness of 2 nutritional interventions.<BR/>Hypotheses:<BR/>1. children participating in both groups will increase their calorie intake;<BR/>2. children participating in both groups will show significant increases in weight.<BR/>Sequence of randomisation - number drawn from a box.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:13:46 +0100" MODIFIED_BY="[Empty name]">
<P>N = 12.<BR/>Less than 3 years old.<BR/>Confirmed diagnosis of CF with pancreatic insufficiency.<BR/>No other disease or condition known to affect growth.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:04:54 +0100" MODIFIED_BY="[Empty name]">
<P>1. Nutrition intervention with strategies for enhancing calorie intake - behavioral management training for parents designed to encourage children to eat food consistent with CF dietary recommendations (N = 7).<BR/>2. Nutrition intervention only (N = 5).<BR/>Both groups received 8 sessions (45 to 60 minutes) over 1 year:<BR/>Sessions 1 to 4 (3 months) intensive education;<BR/>Sessions 5 to 8 (9 months) review of education material.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-01 14:20:16 +0100" MODIFIED_BY="Nikki Jahnke">
<P>1. Average number of calories consumed per day.<BR/>2. Weight (kg).<BR/>Assessments at baseline and follow up 1 year later.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-09-27 11:04:01 +0100" MODIFIED_BY="Nikki Jahnke">
<P>POI: daily calorie intake.<BR/>Attrition: one family failed to complete follow-up assessment at 1 year. 3 familles withdrew after the third treatment session.<BR/>No significant difference between those that completed study and those that dropped out.<BR/>Groups were comparable with regard to age, parent's marital status and SES of family.<BR/>Equivalence at baseline doubtful.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 21:56:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Powers-2005">
<CHAR_METHODS MODIFIED="2014-06-11 21:56:05 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel RCT.<BR/>Comparing behavioral and nutrition treatment (BEH) with usual standard care (CTL).<BR/>Cross-over from CTL to BEH offered after stage 1 of study finished with 3- and 12-month follow up.<BR/>Hypotheses:<BR/>1. BEH would improve child's energy intake relative to CTL;<BR/>2. improvements would be maintained for 12 months.<BR/>Computer-generated block randomisation code with independent blind allocation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-27 13:17:20 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Population of interest N = 21 with n = 14 meeting criteria. Four withdrew or lost to follow up. Thus, n = 10 participants included aged 18 - 48 months with confirmed diagnosis of CF with pancreatic insufficiency; diagnosis for at least 3 months; and, on unrestricted fat diet. Exclusions for those with developmental delay; receiving supplemental enteral nutrition; an additional diagnosis or medication for condition known to affect growth; baseline diet record of 120% RDA or greater.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:06:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. BEH (N = 4) nutritional counselling - targeted at 1 meal each week. 3 focus areas:<BR/>a. increasing calorie and fat intake;<BR/>b. dosage and timing of pancreatic enzymes;<BR/>c. teaching parent management skills.<BR/>Treatment over 8-week period with baseline at week 1 and 6; intervention sessions during weeks 3 - 6.<BR/>2. CTL (n = 6)<BR/>scheduled clinic visits every 3 months with CF and dietitian consulted whenever diet and growth issues were identified.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-01 14:23:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Change in average energy intake % fat intake measured with 7-day diet diaries 1 week before intervention and 1 week after intervention (8 weeks apart).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-09-27 11:03:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>POI: change in average energy intake per day over a 7-day period from pre- to post-treatment.<BR/>71% recruitment rate.<BR/>No significant difference between the groups at baseline for age, weight, height, sex, nutritional status ethnicity or marital status of caregiver.<BR/>Attrition: 2 families did not attend regularly and 2 declined to participate.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:44:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Quinn-2004">
<CHAR_METHODS MODIFIED="2014-06-11 16:07:26 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>The effectiveness of brief telephone 'Motivational Interviewing' intervention in improving adherence to nebulised antibiotics in adults with CF has been evaluated (compared to treatment as usual).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:44:32 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest, N = 102 (patients prescribed nebulised colistimethate).</P>
<P>Patients who met eligibility, n = 47 (patients invited to the study).</P>
<P>Number of invited patients who declined, n = 8.</P>
<P>Prior to randomisation all participants were given a Prodose nebuliser and used it for a 3-month period to become accustomed to it and to generate baseline data on adherence.</P>
<P>Number of dropouts, n = 4.</P>
<P>Number of patients who received intended treatment, n = 35.</P>
<P>Inclusion criteria:</P>
<P>- participants were diagnosed with CF prior to the study (by 2 positive sweat tests or recognised CF genotypes);</P>
<P>- age &gt; 18 years;</P>
<P>- attending regional CF clinic;<BR/>- prescribed Colistimethate sodium delivered via a Prodose<SUP>TM</SUP> Adaptive Aerosol Delivery system nebuliser.</P>
<P>Exclusion criteria:</P>
<P>- lung function FVC &lt; 30%;</P>
<P>- being involved in other trials;</P>
<P>- being pregnant.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 21:56:13 +0100" MODIFIED_BY="[Empty name]">
<P>1. Treatment as usual plus brief 'Motivational Interviewing' intervention (n = 16).</P>
<P>Delivered via telephone by the principal investigator of the study. Was delivered over a 3-month period with up to 6 MI sessions (fortnightly). Audiotapes of intervention were supervised and checked to ensure treatment fidelity.<BR/>2. Treatment as usual alone (n = 19).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:09:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<P>Difference in adherence (to aerosolised antibiotics) pre- and post-intervention measured electronically monitored using Prodose. (Calculated for the previous 3 months in terms of the number of times the devise was used over the number of times its use was prescribed; 0-100+%). Lung function measured as FEV<SUB>1</SUB> and FVC.<BR/>
<B>Secondary outcomes</B>
</P>
<P>Were measured with questionnaires for anxiety (STAI-Short Form; HADS-A), depression (HADS-D), and quality of life (CFQOL). Physiotherapists who administered questionnaires pre-randomisation and immediately post-intervention were blind to study allocation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:09:19 +0100" MODIFIED_BY="[Empty name]">
<P>Tratement fidelity: the authors reported that audiotapes of the consultations were used in supervision, and were checked by GL to ensure treatment fidelity.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:44:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stark-1996">
<CHAR_METHODS MODIFIED="2008-05-01 15:05:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Parallel RCT with half participants receiving intervention first then other half 3 months later - not reported.<BR/>4 families changed group after randomisation - due to conflicting vacation scheduling. Thus not truly randomised.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-05-01 15:05:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>N = 10.<BR/>1 withdrew from control group after randomisation.<BR/>Total sample n = 9.<BR/>Age range: 5.3 years to 10.1 years.<BR/>Mean age: 7.3 years (SD = 1.7).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:09:44 +0100" MODIFIED_BY="[Empty name]">
<P>1. Group behavioural intervention (n = 5).<BR/>7 weekly sessions - baseline assessment plus snack, breakfast, relaxation skills training, lunch, dinner and maintenance strategies targeted over following 7 sessions.<BR/>2. Wait list control (n = 4).<BR/>Parent meeting and 7-day food diaries at times corresponding to baseline and last week of intervention.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:17:22 +0100" MODIFIED_BY="[Empty name]">
<P>1. Calorie intake.<BR/>2. Anthropometric measures - weight, height and skinfold.<BR/>3. PFT.<BR/>4. REE.<BR/>5. Physical activity - Caltrac electronic accelerator.<BR/>Assessments at baseline, then 3 months and 6 months post-treatment.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 22:44:13 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear what population the sample was drawn from.<BR/>POI: Daily calorie intake.<BR/>ITT - unclear.<BR/>Blinding - unclear.<BR/>No significant difference on z scores for weight or age before treatment.<BR/>Control group average SES group II - technical workers.<BR/>Intervention group average SES III - skilled labour.<BR/>Equaivalence at baseline doubtful.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 16:10:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stark-2003">
<CHAR_METHODS>
<P>Parallel RCT.<BR/>Comparing calorie intake and weight gain in 2 group interventions.<BR/>Hypothesised that those receiving a behavioral intervention would eat more calories and gain more weight.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:10:15 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest, N = 10.<BR/>3 dropped out.<BR/>Total sample, n = 7.<BR/>Children aged 4 to 12 years with CF and their parents.<BR/>Children had chronic pulmonary disease, pancreatic insufficiency and weight below the 40<SUP>th</SUP> percentile.<BR/>Mild disease, chronic phase.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:10:29 +0100" MODIFIED_BY="[Empty name]">
<P>Group educational &amp; behavioural interventions:<BR/>1. nutritional education (n = 4);<BR/>2. behavioural intervention (n = 3).<BR/>7 sessions: baseline, 5 sessions (90 min each) plus 1 follow up session.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-05-01 14:34:50 +0100" MODIFIED_BY="Nikki Jahnke">
<P>1. Calorie intake.<BR/>2. Weight.<BR/>3. Quality of parent/child interaction at mealtime.<BR/>4. CF coping skills.<BR/>5. Adherence to CF regimen.<BR/>Assessments at baseline, post-treatment and 6, 12 &amp; 24 months follow up.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:10:43 +0100" MODIFIED_BY="[Empty name]">
<P>POI: daily calorie intake.<BR/>Unclear what the population of interest was and how sample was selected.<BR/>Attrition - 3 dropped out. One spoke only Spanish. 1 had 3 children with CF, 1 of whom was hospitalised. 1 had conflicting time commitments.<BR/>Equivalence at baseline unclear but unlikely.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:19:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stark-2009">
<CHAR_METHODS MODIFIED="2014-06-11 22:18:14 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>Compared behavioral intervention plus nutrition education to nutrition education alone to improve caloric intake and weight in children with CF.</P>
<P>Hypothesis: Children receiving the behavioral plus nutrition education intervention would have a significantly greater increase from pre-treatment to post-treatment and through 24-month follow up on primary and secondary outcomes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:18:56 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest, N = 177 (met eligibility).</P>
<P>Number randomised, n = 79.</P>
<P>Number of participants received the intervention = 67.</P>
<P>group 'nutrition education', n = 34.</P>
<P>group 'behavioral intervention plus nutrition education', n = 33.</P>
<P>There were 6 drop outs in both arms prior to treatment, leaving 67 participants for analysis.</P>
<P>Recruited from 5 CF centres located in the Eastern, Midwestern, and Southern USA.</P>
<P>Children from 4-12 years with a diagnosis of CF by sweat test, pancreatic insufficiency; and weight for age and height &#8804; 40<SUP>th</SUP> percentile.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:19:50 +0100" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention and nutrition education in group setting.</P>
<P>1. Nutrition education (n = 34),</P>
<P>2. Behavioral intervention for change around nutrition an energy (Be-In-CHARGE!; n = 33) (available online at <A HREF="http://www.oup.com/us/pediatricpsych">www.oup.com/us/pediatricpsych</A>).</P>
<P>7 sessions (each 90 minutes): pre-treatment (session 1), 2 weeks later 5 weekly groups sessions (sessions 2 to 6), 2 weeks later post-treatment (session 7; follow up).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:12:54 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary Outcomes</B>
</P>
<P>Change in caloric intake and weight pre- to post-treatment.</P>
<P>
<B>Secondary outcomes</B>
</P>
<P>%EER (percentage of the estimated energy requirements; calculated by subtracting EER for an active child of same age and gender from individual subject's calorie intake X 100), BMIZ (BMI z scores), weight, %EER, BMIZ (assessed at baseline and post-treatment) and additionally height, HAZ, and FEV<SUB>1</SUB> were examined at 24 months following treatment.</P>
<P>Caloric intake was assessed at baseline, post-treatment, 3, 6, 12, 18 and 24, months follow up.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:13:07 +0100" MODIFIED_BY="[Empty name]">
<P>In one report effects of the intervention on 'Family Interactions at Mealtime' were reported, but data was not sufficient. For detailed information on this specific outcome the leading author has been contacted and we are waiting information.</P>
<P>Treatment fidelity: the authors reported that 'treatment fidelity was assessed by raters coding 4 videotapes from each of the 7 sessions for each intervention.' (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>, p.917).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 16:17:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taylor-2003">
<CHAR_METHODS MODIFIED="2014-06-11 16:13:52 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>Compared written self-disclosure intervention to standard care (wait-list control condition).</P>
<P>Hypothesis: patients who completed the written self-disclosure procedure would evidence improvement in health care utilization, disease severity and subjective health status 3 month following the intervention.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:15:03 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest: N = 81 (met eligibility).</P>
<P>Number randomised: 70.</P>
<P>Number of participants received the intervention: 70.</P>
<P>Dropouts: 14.</P>
<P>Excluded from data analysis because of unusual health care utilization patterns: 17.</P>
<P>Final sample size: 39, intervention group (WSD) n = 18, control group (SMC) n = 21.</P>
<P>Recruited from 2 CF centres located at 2 children&#8217;s hospitals in the southeastern part of the USA.</P>
<P>Initial eligibility criteria included: (1) a diagnosis of CF; (2) age at least 15 years; (3) enrolled in the CF clinic for at least 9 months; (4) physical and mental, ability to complete the research protocol as judged by, the project staff and CF physician or nurse; (5) willingness, to write for 20 min on 3 separate occasions, over a 5-day period and completion of self-report, measures on two occasions over the next 3 months; and (6) access to a telephone on the days that the participants were to write at home.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>Written self-disclosure intervention:</P>
<P>3-sessions written self-disclosure intervention, adapted from Pennebaker's laboratory-based protocol</P>
<P>First session in a private room within the CF clinic, two home-writing sessions prompted by a telephone call (each 20 minutes).</P>
<P>Instructions were in accord with those of Pennebaker (1989, 1993, 1997) and required that participants write about their "deepest thoughts and feelings about the most distressing experience of their entire life for a period of 20 minutes" (Pennebaker 1997).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:17:25 +0100" MODIFIED_BY="[Empty name]">
<P>Health care utilization: number of (1) outpatient visits; and (2) inpatient hospitalizations days.</P>
<P>Physiological disease severity: (1) FEV<SUB>1;</SUB> (2) BMI.</P>
<P>Subjective health status: (1) 'The Patient Health Questionnaire' (PHQ; Spitzer Taylor, Wallander, Anderson, Beasley, and Brown et al 1994; Spitzer, Kronke, Williams et al 1999): symptoms of (a) depression; (b) anxiety; (c) somatic complaints; and (d) psychological distress. (2) 'The Stressful Life Events Scale': 10 psychosocial complaints common among health care seeking populations (e.g., difficulties with family support, problems with significant others, and financial concerns); (3) SF-12: severity and frequency of 12 physical and mental health problems, as well as of their impact on the patients' overall perceived health status.</P>
<P>Feasibility and acceptability: modified version of the 'Visit Specific Satisfaction Questionnaire' (VSQ; Ware &amp; Hays 1988).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:43:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vandemheen-2009">
<CHAR_METHODS MODIFIED="2014-06-11 16:17:40 +0100" MODIFIED_BY="[Empty name]">
<P>Single blind RCT with 1-year follow up.</P>
<P>Compared an evidence-based decision aid for patients with advanced CF considering referral for lung transplantation to usual care.</P>
<P>Primary objectives: to assess whether the decision aid increased knowledge about patient options, improved realistic expectations, and decreased decisional conflict.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:21:58 +0100" MODIFIED_BY="[Empty name]">
<P>Population of interest: N = 155 (assessed for eligibility).</P>
<P>Number randomised: 149.</P>
<P>Number of participants received the intervention: 148 (intervention group n = 70; control group n = 79).</P>
<P>Final sample size after 1-year follow up: N = 125 (intervention group n = 60; control group n = 65).</P>
<P>Recruited from nine Canadian and five Australian outpatient CF centres.</P>
<P>Eligibility criteria:</P>
<P>1.  &gt; 18 years of age;</P>
<P>2. FEV<SUB>1</SUB> &#8806; 40% predicted;</P>
<P>3. Able to read English or French.</P>
<P>Exclusion criteria:</P>
<P>1. patients who previously received a lung transplant;</P>
<P>2. patients on lung transplantation waiting list.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:43:24 +0100" MODIFIED_BY="[Empty name]">
<P>All study patients received an educational session on the process of referral and the risks and benefits of lung transplantation from their CF physician and/or CF team. All patients received a copy of a pamphlet entitled 'Cystic Fibrosis and Lung Transplantation' and were provided addresses to access two generic websites on lung transplantation.</P>
<P>After randomisation:</P>
<P>Intervention group: Received a sealed package containing a paper version of the decision aid and a website address with a user name and password, where they could access the decision aid online (<A HREF="http://decisionaid.ohri.ca/decaids.html">http://decisionaid.ohri.ca/decaids.html</A>).</P>
<P>Control group: received a package contained blank pages and a letter explaining why blank pages were included.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:19:55 +0100" MODIFIED_BY="[Empty name]">
<P>The following primary outcomes were assessed at baseline and 3 weeks after randomisation:</P>
<P>participants&#8217; knowledge and realistic expectations with designed questionnaire (structured format as per the International Patient Decision Aids Standards Guidelines); decisional conflict scores (Decisional Conflict Scale, a validated 16-item scale).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-22 09:07:20 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-11 22:23:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilkinson-2008">
<CHAR_METHODS MODIFIED="2014-06-11 16:20:09 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>Prospective pilot study to investigate the feasibility of a video link to support patients on the transplantation waiting list and their families.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:20:21 +0100" MODIFIED_BY="[Empty name]">
<P>Patients on the transplantation list, at least 16 years of age, with a confirmed diagnosis of CF and willing to have an ISDN line installed in their home.</P>
<P>Number randomised: 16, median age 27 years (range 21 &#8211; 41).</P>
<P>Number of participants completed the intervention: 7 (4 on telemedicine and 3 in the control arm).</P>
<P>Of those who did not complete the study four patients died, three patients received a transplant, one withdrew following randomisation and one was too unwell to continue.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:21:06 +0100" MODIFIED_BY="[Empty name]">
<P>Telemedicine additional to standard care: the participants were provided with an ISDN line to their home and a videoconferencing unit was connected to their home television set. Participants were also given a micro-spirometer, pulse-oximeter and a supply of single use clinical thermometers. Contact was made, on a weekly basis, at a time agreed by the patient and assessor (senior physiotherapist or nurse consultant). The topics which were discussed included: non-invasive ventilation; haemoptysis; physiotherapy and amount of sputum; mobility; difficulties with any clinical procedures; appetite and weight; and any other problems as appropriate.</P>
<P>Control group: standard medical care.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:23:00 +0100" MODIFIED_BY="[Empty name]">
<P>1. 'Cystic Fibrosis Quality of Life Questionnaire'.</P>
<P>2. 'Beck Anxiety Inventory'.</P>
<P>3. 'Beck Depression Inventory'.</P>
<P>4. Seven-point questionnaire which included the number of visits to the cystic fibrosis clinic, general practitioner (GP), courses of intravenous antibiotics, length of hospital inpatient stay and how many visits were made either to a hospital or to the GP.</P>
<P>5. 'Borg Anxiety Scale', which was completed before and after each clinic attendance and after telemedicine link-up.</P>
<P>6. Coping of carers: COPE questionnaire (Carver 1997).</P>
<P>Patients and their caregivers were asked to complete a telemedicine satisfaction questionnaire on completion of the study.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-22 16:07:40 +0100" MODIFIED_BY="[Empty name]">
<P>Authors were contacted for detailed quantitative data on outcome measures, but we did not receive a response within the time updating the review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ACT: airway clearance techniques<BR/>BEH: nutritional and behavioural intervention<BR/>BMI: body mass index<BR/>CCT: controlled clinical trial<BR/>CF: cystic fibrosis<BR/>CFK: CF knowledge<BR/>CPT: chest physiotherapy<BR/>CTL: control condition<BR/>FEV<SUB>1</SUB>: forced expiratory volume at one second<BR/>FVC: forced vital capacity<BR/>HLOC: health locus of control<BR/>KG: kilogram<BR/>ITT: intention-to-treat<BR/>LOC: locus of control<BR/>Mean FEF<SUB>25-75%</SUB>: forced expiratory flow during the middle of the maneuver<BR/>NIH: National Institute of Health<BR/>PEFR: peak expiratory flow rate<BR/>PFT: pulmonary functioning<BR/>POI: primary outcome indicator<BR/>POMS: profile of mood states<BR/>QOL: quality of life<BR/>RCT: randomised controlled trial<BR/>RDA: recommended daily allowance<BR/>REE: resting energy expenditure<BR/>RISCS: role play inventory of situations and coping skills<BR/>SD: standard deviation<BR/>SES: socioeconomic status<BR/>STAI: state trait anxiety inventory<BR/>STAIC: state trait anxiety inventory (children)<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-06-16 08:53:29 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Barbero-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a lecture with a broad remit and does not describe an intervention study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bartholomew-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This was pre-post design - participants were not randomised to the treatment and comparison groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-13 15:10:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bingham-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-13 15:10:22 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study on breath biofeedback - the study had no comparision group (no RCT design).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brady-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention is neither psychological nor does it have a psychosocial focus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brandt-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a cross-sectional survey.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brown-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a case-control study without a psychosocial focus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-25 15:48:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Castellani-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-25 15:48:23 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study on an interactive computer-based program for education in cystic fibrosis carrier tests. The participants were not a population of interest (participants did not have CF or were family members of patients with CF).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-07 15:57:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheuvront-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-07 15:57:10 +0100" MODIFIED_BY="[Empty name]">
<P>This is a parallel RCT to evaulate two approaches to CF gene pre-test education and carrier testing. Genetic clinic education and testing versus Home-based education and testing. The approaches were both educational which are by defintion not eligible for this update of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Clayton-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This a study of population screening. The participants do not have CF nor related to anyone with CF - they were also not CF carriers and had no higher than the average risk of being a carrier.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-07 15:59:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Davis-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-07 15:59:05 +0100" MODIFIED_BY="[Empty name]">
<P>This is a parallel RCT comparing an educational intervention using a CD-ROM with a wait list control. The approach was educational which is by defintion not eligible for this update of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dodd-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a study validating a psychological measure on a CF population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-13 14:52:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dodd-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-13 14:52:49 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study on motivational interviewing for exercise performance in patients with cystic fibrosis. Data has not been published in a journal article and is not available via the author anymore.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Donaldson-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This study is a survey of attitudes and a comparison of 2 approaches to population screening. The participants do not have CF nor are they related to anyone with CF - there is no higher risk of their being a carrier than average.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-07 15:59:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Downs-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-07 15:59:10 +0100" MODIFIED_BY="[Empty name]">
<P>This is a multi-centre parallel RCT investigating the effectiveness of a self-management education programme called &#8217;Airways&#8217;. The approach was educational which is by defintion not eligible for this update of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eng-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This was a study of attitudes towards screening for CF in a population of Askenazi Jews referred for TSD testing. There was no comparison group and no higher risk of being a CF carrier than average.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Falkman-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a descriptive study of a random sample of children with CF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gee-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a report of a part of the development of a psychological measure for CF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-13 14:53:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Georgiopoulos-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-13 14:53:01 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study on ADHD treatment. It is a chart review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Goa-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study it is a review of the literature. The intervention reviewed is not psychological although the reported outcomes are psychosocial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Goldbeck-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This study has a pre-post design - there is no comparison group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-13 14:53:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldbeck-2011a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-13 14:53:26 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study on an inpatient rehabilitation program (including psychological intervention), but there was no control group for comparing outcomes of the program.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gonciartz-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>This study is not concerned with CF although some of the participants may have had CF. The intervention is not psychological nor does it have a psychosocial focus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Green-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a report of a survey of obstetricians views and not an intervention study. The participants do not have CF nor are they related to anyone with CF although they may have a professional relationship with someone with CF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gremse-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a descriptive case-control study and not an intervention study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Grody-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a study of population screening - the participants have no history of CF and no higher than the average risk of being a carrier for CF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-05-01 14:41:06 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Gulmans-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-05-01 14:41:06 +0100" MODIFIED_BY="Nikki Jahnke">
<P>There was no comparison group in this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Haddow-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>This was not an intervention study - it was a summary of the views of professionals who were attending a conference regarding screening for CF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hains--2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This intervention study has no comparison group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hains-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This intervention study has no comparison group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hodson-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a descriptive case-control study - it is not an intervention study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jelalian-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a review of the literature and meta-analysis of interventions for CF. Only 1 of the studies described is a RCT and that is reported separately here (Stark 1996).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Johnson-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This intervention study has no comparison group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kollberg-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a descriptive account - it is not an intervention study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Krauth-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention in this study was not psychological nor did it have a psychosocial focus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Le-Heuzey-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a descriptive single group assessment psychological adjustment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-05-01 12:52:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Leonard-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-05-01 12:52:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>This is not an RCT it used a quasi experimental design to compare two approaches to education information about carrier testing for CF. The participants do not have CF nor do they have any higher risk of being a carrier than average.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-05-01 12:52:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lindstr_x00f6_m-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-05-01 12:52:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>This is not an intervention study - it is a descriptive single group study and it is not wholly concerned with CF although some of the participants had CF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-05-01 12:52:56 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Loader-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-05-01 12:52:56 +0100" MODIFIED_BY="Nikki Jahnke">
<P>This was a study of attitudes and responses to population screening - the participants did not have CF nor were they and higher risk of being a carrier. Of the group identified as carriers there was no comparison group and no psychological intervention was offered.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Magnussen-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>This study was not wholly concerned with CF - it was one of several lung diseases investigated. The intervention was not psychological nor did it have a psychosocial focus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Phillipson-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>This study had no comparison group and the intervention was not psychological nor did it have a psychosocial focus - no psychosocial outcomes were included.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pollitt-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study it is a systematic review of the literature with respect to the cost-effectiveness of population screening. There is no review of psychological interventions nor is there a psychosocial focus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-13 14:54:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pop-Jordanova-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-13 14:54:11 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study on 'Biofeedback', but there was no control group which did not receive the intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-15 09:46:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ralston-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-15 09:46:53 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study on of smoking cessation counselling for parents, but CF parents were not a major subgroup of the study sample. No information about the number of participating CF parents is provided.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ramstr_x00f6_m-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Although this study did not have a psychological intervention there was a psychosocial focus. It was however considered to be more concerned with service delivery.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-06-16 08:53:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rault-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-06-16 08:53:29 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study investigating a CF quality improvement program. It is a pilot study testing the applicability and effectiveness of Clinical Microsystems Approach to improve CF care in France. No control condition.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-31 16:37:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rodrigue-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-31 16:37:56 +0100" MODIFIED_BY="[Empty name]">
<P>This study is a study on quality-of-life therapy for patients awaiting lung transplantation. The study included mostly patients with COPD (only 2 patients with CF).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-06-16 08:53:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rozenfeld-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-06-16 08:53:01 +0100" MODIFIED_BY="[Empty name]">
<P>This is a study investigating Snoezeln in infants ages 0-3 years with CF in a single centre without a comparator.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-07 16:00:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stapleton-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-07 16:00:38 +0100" MODIFIED_BY="[Empty name]">
<P>This is a parallel RCT comparing the effectiveness of an educational programme with standard care for knowledge about nutrition. The approach was educational which is by defintion not eligible for this update of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-13 14:55:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stark-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-13 14:55:15 +0100" MODIFIED_BY="[Empty name]">
<P>Altough the article describes outcomes of a RCT study, only data for intervention group was collected and is provided for the outcome 'Calcium intake'.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Thompson-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a cross-sectional, controlled, descriptive study of psychological adjustment in children with CF.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Thornton-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a study comparing three methods for conveying information about population screening. The participants do not have CF nor do they have any higher risk of being a carrier than average.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-07 16:01:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trapp-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-07 16:01:46 +0100" MODIFIED_BY="[Empty name]">
<P>This ia parallel CCT of 2 interventions with a convenience control group sample to investigate whether self-administration of drugs leads to greater knowledge about medications. The approach was educational which is by defintion not eligible for this update of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tullis-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is an argument for a CF specific psychological measure.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Villari-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study and it is not concerned with CF although some of the participants may have had CF. There is no psychosocial focus to this cross-sectional case-control study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ward-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a descriptive study comparing three groups with respect to energy expenditure.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-07 16:20:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Watson-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-07 16:20:10 +0100" MODIFIED_BY="[Empty name]">
<P>The previous ongoing study is now published as a randomized controlled trial of a new behavioral home-based nutrition education program, "Eat Well with CF," in adults with cystic fibrosis. The approach was educational which is by defintion not eligible for this update of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-07 16:20:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Watson-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-07 16:20:16 +0100" MODIFIED_BY="[Empty name]">
<P>The previous ongoing study is now published as a randomized controlled trial of a new behavioral home-based nutrition education program, "Eat Well with CF," in adults with cystic fibrosis. The approach was educational which is by defintion not eligible for this update of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Welkenhuysen-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an intervention study - it is a survey of attitudes towards population screening in adolescents. The participants do not have CF nor are they related to anyone with CF. They have no higher risk of being a carrier for CF then average.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Williams-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This intervention study does not have a comparison group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wolter-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not a psychological intervention albeit with a psychosocial focus. It was considered to be more concerned with service delivery.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CF: cystic fibrosis<BR/>TSD: Tay Sachs Disease</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-06-11 22:42:07 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2014-06-11 22:42:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bryon-2000">
<CHAR_METHODS MODIFIED="2014-06-11 22:03:52 +0100" MODIFIED_BY="[Empty name]">
<P>Assessed a new developed home visit program to improve health status and psychosocial functioning, randomised allocation to intervention group vs waiting list control group.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:23:27 +0100" MODIFIED_BY="[Empty name]">
<P>Children with CF, are from families with significant psychosocial stresses (consequences: sub-optimal treatment, irregular clinic attendance, erratic health status).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:42:07 +0100" MODIFIED_BY="[Empty name]">
<P>Program included at least four home visits from both nurse and psychologist (in addition to routine nurse specialist input) over a six-month period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:23:52 +0100" MODIFIED_BY="[Empty name]">
<P>'General Health Questionnaire', 'Parenting Stress Index', 'Harter self-esteem' (for children aged over 8 years), pulmonary function (FVC, FEV<SUB>1</SUB>), Take-up of clinic appointments, drug prescription and planned admissions.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:23:56 +0100" MODIFIED_BY="[Empty name]">
<P>Published as an abstract.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:41:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cannon-1999">
<CHAR_METHODS MODIFIED="2014-06-11 16:24:01 +0100" MODIFIED_BY="[Empty name]">
<P>Explored the feasibility and benefit of in-home videoconferencing using inexpensive equipment interfacing to a patient&#8217;s standard telephone and television set, 2 groups (study vs control).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:24:05 +0100" MODIFIED_BY="[Empty name]">
<P>10 patients aged 6 - 13 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:24:14 +0100" MODIFIED_BY="[Empty name]">
<P>Study group received reinforcement of the education message from each clinic visit with weekly in-home videoconferencing contacts by nurse, TR dietitian, or social worker, plus routine clinic education; control group received only routine clinic education.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:41:49 +0100" MODIFIED_BY="[Empty name]">
<P>PFT, weight triceps skin fold thickness, mid-arm muscle circumference, prealbumin, a simple test of basic CF knowledge, the Hopelessness Scale for Children, the Family Empowerment Scale, Client Satisfaction Survey.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 22:23:49 +0100" MODIFIED_BY="[Empty name]">
<P>Published as abstract.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:41:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cummings-2011">
<CHAR_METHODS MODIFIED="2014-06-11 22:41:41 +0100" MODIFIED_BY="[Empty name]">
<P>Pilot study that aimed to assess a mentor-based behavioural modification intervention to enhance self-efficacy for self-management skills and QoL, single-blind RCT, 3 groups (mentor vs mentor plus mobile phone vs control).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:23:55 +0100" MODIFIED_BY="[Empty name]">
<P>17 adolescents and adults aged 14 - 48 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:24:17 +0100" MODIFIED_BY="[Empty name]">
<P>Mentor-based behavioural modification intervention with mentorship and self-monitoring via a modified mobile phone with immediate visual feedback on clinical status. Duration: 6 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:41:14 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
<BR/>Self-efficacy.</P>
<P>
<B>Secondary outcomes</B>
<BR/>CF-related and generic QoL, participant feedback on their experience via semi-structured interviews, lung function and acute healthcare utilization.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 22:24:30 +0100" MODIFIED_BY="[Empty name]">
<P>Published as abstract.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:40:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Davis-1990">
<CHAR_METHODS MODIFIED="2014-06-11 22:40:28 +0100" MODIFIED_BY="[Empty name]">
<P>Examined the psychosocial effects, safety and efficacy of HIVAT comparing to conventional hospital therapy over short term (one exacerbation).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:24:44 +0100" MODIFIED_BY="[Empty name]">
<P>78 CF patients with acute exacerbation (1 dropout).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:40:37 +0100" MODIFIED_BY="[Empty name]">
<P>Home IV antibiotic therapy as part of a multicentre randomised study, all patient were treated with IV tobramycin and ceftazidime every 8 hours (one exception: tobramycin and piperacillin).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:40:46 +0100" MODIFIED_BY="[Empty name]">
<P>Self-concept (&lt; 18: PH; Adults: TSC), Anxiety (8<SUP>th</SUP> grade and under: STAIC, all other: STAI), CHIP</P>
<P>Weight, resting respiratory rate, NIH score, FEV<SUB>1</SUB>, FVC.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 22:40:48 +0100" MODIFIED_BY="[Empty name]">
<P>Published as abstract.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:40:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldbeck-2013">
<CHAR_METHODS MODIFIED="2014-06-10 11:20:32 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:40:18 +0100" MODIFIED_BY="[Empty name]">
<P>151 CF patients aged 6 years or older recruited in 3 CF outpatient clinics.</P>
<P>300 patients from other CF centres receiving usual care and matched for age, sex and lung function were recruited as controls.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:40:12 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up period: 2 years.</P>
<P>Patients in intervention group: program based on 'Individual Treatment Agreements' (ITA) between patient or caregiver and CF physician.</P>
<P>ITA's may focus on medical, nutritional and psychotherapeutic measures.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:39:40 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<P>Quality of care as assessed by the frequency of BMI and lung function measurements per year.</P>
<P>
<B>Secondary outcomes</B>
<BR/>Range of medical (mortality, lung function, BMI) and psychosocial (QoL, adherence, caregiver distress).<BR/>
<BR/>Use of economic resources also assessed</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-10 11:27:50 +0100" MODIFIED_BY="[Empty name]">
<P>Commenced clinically in May 2012. Co-funded by the German Ministry of Health and the German CF-association Mukoviszidose e.V.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:38:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hass-2012">
<CHAR_METHODS MODIFIED="2014-06-11 22:38:24 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, open-label, parallel study on the effects of massage therapy on QoL in youth/young adults with CF.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-10 11:19:04 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis of CF.</P>
<P>Ages: 8 - 21 years.</P>
<P>Estimated enrolment: 24.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:38:15 +0100" MODIFIED_BY="[Empty name]">
<P>Active Comparator: massage therapy. Treatment group receives pre-determined massage therapy protocol x 5 over 10 - 12 weeks. massage therapy protocol includes a blend of Swedish strokes and myofascial trigger point therapy. Initially, dosing will be more frequent. Treatments will be spaced out to determine the ability of the body to maintain a more efficient musculoskeletal system, especially related to respiratory and postural efforts. Each session will end with resting hands and relaxation strokes to signal the end of the session. This protocol invites increased mobility in the musculoskeletal system. The ultimate goal is to return connective tissue (including muscles and fascia) to a more relaxed and neutral state, thus allowing expansion and ease of movement of the areas of the musculoskeletal system being worked.</P>
<P>Control group: no intervention.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:38:06 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome measures</B>
</P>
<P>QoL<BR/>
<BR/>
<B>Secondary outcome measures</B>
<BR/>Pulmonary function<BR/>
<BR/>
<B>Other outcome measures</B>
</P>
<P>Pain</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-07 13:48:43 +0100" MODIFIED_BY="[Empty name]">
<P>Study start date: July 2013; estimated completion date: December 2014.</P>
<P>Country: USA.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:36:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hatziagorou-2011">
<CHAR_METHODS MODIFIED="2014-05-07 13:43:27 +0100" MODIFIED_BY="[Empty name]">
<P>Compares behavioral and nutritional intervention (BEH) with a usual care control condition (CTL) for CF children with pancreatic insufficiency.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-12 14:28:50 +0100" MODIFIED_BY="[Empty name]">
<P>Twenty-four children with CF (aged 8 months to 18 years) were assigned to the BEH group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-12 14:29:58 +0100" MODIFIED_BY="[Empty name]">
<P>BEH included nutrition counselling to increase energy intake and child behavioral management training.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:36:58 +0100" MODIFIED_BY="[Empty name]">
<P>Energy intake (calories per day), weight gain, BMI z scores.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-12 14:31:38 +0100" MODIFIED_BY="[Empty name]">
<P>Published as abstract. Contact to leading author. Detailed data is not published.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:36:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-2010">
<CHAR_METHODS MODIFIED="2014-06-11 21:56:48 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised open-label, parallel study investigating the use of texting to promote chronic disease management.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:36:50 +0100" MODIFIED_BY="[Empty name]">
<P>Enrolment: 81.</P>
<P>Ages: 14 to 22 years.</P>
<P>Have CF, type 1 diabetes, or inflammatory bowel disease for at least 6 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-07 13:39:29 +0100" MODIFIED_BY="[Empty name]">
<P>Experimental: SMS and Internet. The SMS and Internet group will receive information, tips, strategies, and questions related to the self management of chronic disease (cystic fibrosis, inflammatory bowel disease, or type 1 diabetes) on a web-based program and via SMS messages.</P>
<P>No intervention: control. The control group will receive monthly tip sheets on various health topics for adolescents and young adults.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:36:41 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome measures</B>
</P>
<P>1. Health related self-efficacy<BR/>
<BR/>
<B>Secondary outcome measures</B>
</P>
<P>1. Health knowledge</P>
<P>2. Disease health knowledge<BR/>3. Health literacy<BR/>4. QoL</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-05-07 13:46:40 +0100" MODIFIED_BY="[Empty name]">
<P>Start date: October 2009; study completion: March 2012.</P>
<P>Country: USA.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:36:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Irons-2012">
<CHAR_METHODS MODIFIED="2014-06-11 22:36:25 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-10 11:34:09 +0100" MODIFIED_BY="[Empty name]">
<P>51 hospitalized children (mean age¼ 11.6 years, 35% male).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-10 11:33:13 +0100" MODIFIED_BY="[Empty name]">
<P>Participants undertook 8 singing or 8 recreational sessions.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-10 11:35:46 +0100" MODIFIED_BY="[Empty name]">
<P>Respiratory muscle strength using maximal inspiratory and expiratory pressure (MIP and MEP, respectively), spirometry, and QoL were assessed at baseline, postintervention, and follow up.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-10 11:34:25 +0100" MODIFIED_BY="[Empty name]">
<P>Brisbane, Australia.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:36:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jessup-2010">
<CHAR_METHODS MODIFIED="2014-06-11 22:36:19 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>Pilot study that aimed to assist patients to achieve increased levels of self-efficacy through interactions with volunteer mentors coupled with technology supported self-monitoring.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:36:15 +0100" MODIFIED_BY="[Empty name]">
<P>Adolescents and adults with CF.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:36:13 +0100" MODIFIED_BY="[Empty name]">
<P>Volunteer mentors coupled with technology supported self-monitoring.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:36:10 +0100" MODIFIED_BY="[Empty name]">
<P>QoL.</P>
<P>Clinical outcomes measures.</P>
<P>Feedback on all aspects of the intervention: the process, including the mentor relationship with the help of semi-structured interviews</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-12 14:29:03 +0100" MODIFIED_BY="[Empty name]">
<P>Published as abstract. Contact to the leading author MJ - data is not published, yet.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2013-09-27 13:31:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kalnins-1996">
<CHAR_METHODS MODIFIED="2012-08-07 16:10:05 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_PARTICIPANTS MODIFIED="2012-08-07 16:10:05 +0100" MODIFIED_BY="[Empty name]">
<P>N = 13.<BR/>Over ten years of age, less than 90% ideal weight for height or 5% reduction in weight over a three month period.<BR/>Exclusion criteria: routine use of supplements, liver disease, insulin dependent diabetes and oxygen dependence.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-07 16:10:05 +0100" MODIFIED_BY="[Empty name]">
<P>1. Dietary counselling.<BR/>2. Nutritional supplement - Boost Plus over a three month period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-27 13:31:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Pulmonary function FEV<SUB>1</SUB>.<BR/>2. Nutritional status:<BR/>a. weight;<BR/>b. height;<BR/>c. weight for height;<BR/>d. calorie intake;<BR/>e. calorie intake; as per cent of predicted energy needs.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-07 16:10:05 +0100" MODIFIED_BY="[Empty name]"/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:35:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Klig-1989">
<CHAR_METHODS MODIFIED="2014-06-11 22:35:31 +0100" MODIFIED_BY="[Empty name]">
<P>Effectiveness and psychosocial advantage of a self-administered method of pulmonary therapy. FET was compared to CPT in a 2-year prospective study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-03 12:11:40 +0100" MODIFIED_BY="[Empty name]">
<P>50 patients with mild to percussion lung disease, age from 8 - 22 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-04-03 12:11:40 +0100" MODIFIED_BY="[Empty name]">
<P>FET included postural drainage, diaphragmatic breathing and forced expiration. CPT entailed postural drainage, percussion and vibration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:33:51 +0100" MODIFIED_BY="[Empty name]">
<P>FET/CPT compliant, noncompliant PET`s, clincal scores, weight, x-ray scores.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-03 12:11:40 +0100" MODIFIED_BY="[Empty name]"/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:33:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mischler-1998">
<CHAR_METHODS MODIFIED="2014-06-11 22:33:47 +0100" MODIFIED_BY="[Empty name]">
<P>Comprehensive RCT to study both benefits and risks of newborn screening and to determine if early diagnosis would improve the prognosis of children with CF. Compares the nutritional status of patients with CF identified by neonatal screening or by standard diagnostic methods.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:33:38 +0100" MODIFIED_BY="[Empty name]">
<P>650 340 infants, 135 families of children diagnosed as having CF, 206 false-positive families.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-05 18:05:19 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:33:33 +0100" MODIFIED_BY="[Empty name]">
<P>Height percentiles, weight percentiles, head-circumference percentile, anthropometric indexes. Assessments of reproductive knowledge, attitudes and behaviours.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-03 12:11:47 +0100" MODIFIED_BY="[Empty name]"/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:33:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Patel-2010">
<CHAR_METHODS MODIFIED="2014-06-11 22:33:12 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel randomised controlled pilot study, single centre study.</P>
<P>Research question: Effect of incorporating the CLCF-Q into the annual review process.</P>
<P>To assess the impact of a PROM on the Self Efficacy (SE) of parents and carers of children with CF.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:33:15 +0100" MODIFIED_BY="[Empty name]">
<P>Parents/carers of children with CF.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:32:49 +0100" MODIFIED_BY="[Empty name]">
<P>Participants in the intervention group complete the CLCF-Q. They receive feedback at their next clinic appointment from the team in the form of colour coded tables illustrating both the positive and negative issues raised in the CLCF-Q. They are invited to talk to members of the CF team and others (consultants, CF nurses, dietitians, physiotherapists, psychologists, pharmacists, family doctors and the school) about the issues raised in the CLCF-Q.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:32:36 +0100" MODIFIED_BY="[Empty name]">
<P>SE-Questionnaire (SE-Q) as an outcome measure.</P>
<P>Participants complete the SE-Q at 2 time points. Between the two time points the intervention group received the intervention.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-15 14:29:04 +0100" MODIFIED_BY="[Empty name]">
<P>Information is retrieved from an abstract. Information from the author: Data is not published, yet.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:32:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petzel-1991">
<CHAR_METHODS MODIFIED="2014-06-11 22:32:29 +0100" MODIFIED_BY="[Empty name]">
<P>The study use several objective adherence indices to evaluate adherence to medical/behavioral interventions across a broad-age range of nonhospitalized CF patients, identify psychosocial attributes of patients and families associated opportunities for adherence-promoting interventions.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-03 12:11:52 +0100" MODIFIED_BY="[Empty name]">
<P>Parents of 45 children with CF</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:32:20 +0100" MODIFIED_BY="[Empty name]">
<P>Health education intervention.</P>
<P>3 interventions:</P>
<P>- problem-solving lesson in computerized form;</P>
<P>- problem-solving lesson in written form.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:32:06 +0100" MODIFIED_BY="[Empty name]">
<P>Sociodemographic data, psychological test results, measures of the child health status (% predicted wt., x-ray scores), compliance.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-03 12:11:52 +0100" MODIFIED_BY="[Empty name]"/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 21:57:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Powers-2003a">
<CHAR_METHODS MODIFIED="2014-06-11 21:57:26 +0100" MODIFIED_BY="[Empty name]">
<P>Clinical study that compares a behavioral intervention to standard of care over a 2-month period</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:45:11 +0100" MODIFIED_BY="[Empty name]">
<P>Children ages 18 months to 4 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:45:14 +0100" MODIFIED_BY="[Empty name]">
<P>Behavioral interventions to standard of care, and separate multiple baseline studies across meals (RDA guidelines).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:45:15 +0100" MODIFIED_BY="[Empty name]">
<P>Change in calorie intake per day.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:45:16 +0100" MODIFIED_BY="[Empty name]">
<P>Information is retrieved from Symposium Session Summary.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:31:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Powers-2013">
<CHAR_METHODS MODIFIED="2014-06-10 11:42:56 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Children from 7 CF centres.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-10 11:43:12 +0100" MODIFIED_BY="[Empty name]">
<P>Children (aged 2 - 6 years) with CF and pancreatic insufficiency.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-10 11:45:32 +0100" MODIFIED_BY="[Empty name]">
<P>Behavioural and nutritional treatment versus an attention control group (CTL). Treatments occurred weekly for 8 weeks and then monthly for 4 months. Participants returned to standard care and a 12-month follow up was conducted.</P>
<P>CTL provided education and served as a behavioural placebo.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:31:43 +0100" MODIFIED_BY="[Empty name]">
<P>Daily energy intake (7-day, weighed diet diaries) and weight for age z score change from baseline to post-treatment (6 months) and height for age z score change from baseline to follow up (18 months).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:44:56 +0100" MODIFIED_BY="[Empty name]">
<P>ClincialTrials.gov: #NCT00241969.</P>
<P>USA.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:31:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ruddy-2011">
<CHAR_METHODS MODIFIED="2014-06-11 21:57:31 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, open-label, parallel study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-07 13:22:03 +0100" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 20. </P>
<P>Ages: 12 - 25 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-07 13:21:34 +0100" MODIFIED_BY="[Empty name]">
<P>Active comparator: yoga (immediate start) group. This arm will start yoga sessions immediately after screening and will continue sessions for 8 weeks. This group will then continue with home yoga for an additional 8 weeks.</P>
<P>Active comparator: Yoga (waitlist) group. This arm will continue regular CF therapies for 8 weeks and will start yoga sessions at week 9.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:31:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome measures</B>
</P>
<P>1. Number of participants with adverse events as a measure of safety</P>
<P>2. Pain scores on the Visual Analog Scale as a measure of tolerability</P>
<P>Participants will be given a tolerance questionnaire after each yoga session which will assess their degree of musculoskeletal and chest pain on a visual analog scale. Vital signs will also be measured before and after each yoga session.<BR/>
<BR/>
<B>Secondary outcome measures</B>
</P>
<P>1. QoL</P>
<P>2. Respiratory symptoms<BR/>3. Treatment adherence</P>
<P>4. Pulmonary function</P>
<P>5. Ease of breathing<BR/>6. BMI</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 22:31:02 +0100" MODIFIED_BY="[Empty name]">
<P>Start date: February 2011, estimated end date: October 2011.</P>
<P>Country: USA.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:30:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stark-1998">
<CHAR_METHODS MODIFIED="2014-06-11 22:30:57 +0100" MODIFIED_BY="[Empty name]">
<P>Multi-site, clinical study examining two innovative approaches to diet education.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 22:30:53 +0100" MODIFIED_BY="[Empty name]">
<P>33 children between ages 4 and 12 years have completed treatment and 26 of these have completed the 6-month follow up.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 22:30:19 +0100" MODIFIED_BY="[Empty name]">
<P>Nutrition Education (NE) addresses the issue of lack of dietary knowledge by providing families an intensive 7-session program on nutritional<BR/>suggestions for meeting the CF RDA for energy on a meal by meal basis.<BR/>Behavioral Education (BE), combines the nutritional education component, as<BR/>described, above plus training on behavioral child management skills such as contingent attention to appropriate eating, ignoring behaviours incompatible with eating, and use of contingent privileges for meeting calorie goals.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:30:29 +0100" MODIFIED_BY="[Empty name]">
<P>At post treatment the children in the BE groups demonstrated a significantly greater increase in caloric intake than the children in the NE group t(30) = 2.24, P = The BE group also showed a significantly greater weight gain compared<BR/>to the NE. At the 6 month follow up both groups demonstrated a similar rate of weight gain from post treatment. Differences on weight gain post treatment to 6 months and pretreatment to 6 months were not significant<BR/>between the two groups.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 22:30:16 +0100" MODIFIED_BY="[Empty name]">
<P>Information is retrieved from Symposium Session Summary.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 16:43:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wainwright-2009">
<CHAR_METHODS MODIFIED="2014-06-11 16:42:46 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>Pilot study of an education and behavioural adaptation program (delivered via a mentorship system, telephone and IT tools) designed to enhance self-management in adolescents.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:42:48 +0100" MODIFIED_BY="[Empty name]">
<P>46 adolescents aged 12-19 with CF.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:43:09 +0100" MODIFIED_BY="[Empty name]">
<P>3 groups: standard care (controls; N = 15); standard care + phone mentoring (N = 16); standard care, phone mentoring + IT-tool (N = 15).</P>
<P>Treatment lasted for 6 months with a further 6 months follow up, outcomes were re-assessed at 3, 6, and 12 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:43:46 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcomes<BR/>
</B>Stanford Self-Efficacy Scale<BR/>QoL (measured with CFQ-R)</P>
<P>
<B>Secondary outcomes</B>
<BR/>Spirometry<BR/>Height and weight z scores</P>
<P>Qualitative data from 10 intervention participants and mentors</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-13 14:26:54 +0100" MODIFIED_BY="[Empty name]">
<P>Contacted the leading author who provided the information that they are going to publish, but the data is not published, yet.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 22:29:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Widman-2013">
<CHAR_METHODS MODIFIED="2014-06-11 21:57:39 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised open-label cross-over study - a pilot study of behavioural intervention for nutrition in CF.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-05-07 13:11:17 +0100" MODIFIED_BY="[Empty name]">
<P>Anticipate 30 into 2 groups. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-05-07 13:15:29 +0100" MODIFIED_BY="[Empty name]">
<P>This is a feasibility study to try out a multi-component behavioural intervention. The intervention is designed to help people with CF use their nutritional support to gain weight. </P>
<P>The first group receive the behavioural intervention immediately. The second group receive the intervention after 3 months. All participants will be followed up for 6 months. Data will be collected every 6 weeks during clinic reviews.</P>
<P>Experimental: Behaviour change intervention. Intensive behaviour change intervention for 3 months, followed by a maintenance phase for 3 months.</P>
<P>Wait-list ControlUsual care for 3 months, followed by intensive behaviour change intervention for 3 months.</P>
<P>Note: Behavioral: Behaviour change intervention: the behaviour change intervention consists of feedback via a web-based food diary 'coaching' with problem-solving and implementation plansThe intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails.The maintenance phase consists of 3 telephone calls and 4 reminder emails.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 22:29:18 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome measures</B>
<BR/>1. Proportion of patients who accepted invitation to participate as a marker of feasibility<BR/>2. Proportion of people with CF who are randomised into the study after accepting the invitation to participate, as a marker of feasibility</P>
<P>
<BR/>
<B>Secondary outcome measures</B>
<BR/>1. Participants' opinion about the behavioural intervention<BR/>2. Participant attrition rate and phases of study whereby the attrition occurs<BR/>3. Participants' opinion about the study processes<BR/>4. Participants' suggestions for further improvement of the intervention and study processes<BR/>5. Proportion of adults who fulfils the BMI criteria for recruitment with IT facilities<BR/>6. Resources needed by the investigators to deliver the intervention<BR/>7. Proportion of days with missing nutritional data, as a marker for feasibility<BR/>
</P>
<P>Participants are requested to fill in their nutritional intake daily on a web-based food diary. The investigators are interested to find out what the proportion of such data will be missing to determine the feasibility of collecting data with the web-based food diary.</P>
<P>
<B>Other outcome measures</B>
</P>
<P>1. BMI<BR/>2. Weight<BR/>3. BMQ score<BR/>4. The mean SRBAI score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 22:26:09 +0100" MODIFIED_BY="[Empty name]">
<P>Start date: Feb 2014. Anticipated end date: March 2015.</P>
<P>Country: UK.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-06-11 16:28:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Williams-1987">
<CHAR_METHODS MODIFIED="2014-06-11 16:28:13 +0100" MODIFIED_BY="[Empty name]">
<P>Explored the effects of intensive dietary counselling in adolescents with CF upon nutritional status. The participants were randomly divided into three groups (control vs counselling and normal food vs counselling and enteric coated pancreatic enzyme supplements). The groups were matched for age sex and Schwachman score.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:27:56 +0100" MODIFIED_BY="[Empty name]">
<P>28 adolescents with CF aged 9 - 18 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:28:01 +0100" MODIFIED_BY="[Empty name]">
<P>The participants in the first group were the controls. Then the second group received a counselling to improve dietary intake to &gt; 130% of RDI calculated form expected weight for height), using normal foods and simple supplements; the final group received counselling and enteric coated pancreatic enzyme supplements instead of conventional supplements. Duration: 1 year.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:25:57 +0100" MODIFIED_BY="[Empty name]">
<P>Change in weight; dietary intake; improvements in MAC.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-11 16:28:09 +0100" MODIFIED_BY="[Empty name]">
<P>Published as an abstract.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>BMQ: Beliefs about Medicines Questionnaire<BR/>CF: cystic fibrosis<BR/>CPT: chest physical therapy<BR/>FET: forced expiration technique<BR/>HIAT: home intravenous antibiotic therapy<BR/>MAC: mid-arm circumference<BR/>PFT: pulmonary function tests<BR/>QoL: quality of life<BR/>RDI: recommended dietary intake<BR/>SRBAI: Self-Report Behavioural Automaticity Index</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-06-11 22:04:41 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-06-11 16:40:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Quittner-2000">
<CHAR_STUDY_NAME/>
<CHAR_METHODS MODIFIED="2014-06-11 16:40:56 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
<P>The aim of the study was to compare the effects of BFST, an empirically supported treatment, to both the Family Learning Program (FLP) and standard care (SC).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:40:36 +0100" MODIFIED_BY="[Empty name]">
<P>117 adolescents with CF ages 10 to 17 years.<BR/>Inclusion criteria</P>
<P>- Age 9.5 to 16.5 years</P>
<P>- Diagnosed with CF for a minimum of one year<BR/>- FEV<SUB>1</SUB> greater than 35% predicted</P>
<P>- no other chronic disease (other than CF-specific diabetes)</P>
<P>- no history of psychiatric treatment within the past years</P>
<P>- No evidence of intellectual impairment<BR/>Stratified by age, sex, illness severity and family conflict</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:40:10 +0100" MODIFIED_BY="[Empty name]">
<P>Standard care versus 2 manualised and structured interventions. 11 family sessions with a registered nurse or licensed clinical psychologist</P>
<P>1. Standard care (n = 36)</P>
<P>Teens received their usual care at the CF centre.<BR/>2. Family Learning Program (n = 40)</P>
<P>10 90-minute psycheducational sessions over 6 months aimed at increasing knowledge about CF and its management.<BR/>3. 'Behavioral Family Systems Therapy' (n = 41)</P>
<P>10 treatment sessions (90 minutes) over 6 months plus 1 booster session 3 months later. Family problem-solving, communication skills training, and cognitive restructuring were included in the intervention.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:39:49 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluation post-treatment and at 6, 12, &amp; 18 months subsequently.<BR/>1. Treatment adherence:<BR/>a. electronic monitors;<BR/>b. self-report;<BR/>c. daily-phone diary.<BR/>2. Family functioning (family conflict;coping skills; communication):<BR/>a. self-report;<BR/>b. audiotaped role-play vignettes;<BR/>c. videotaped family discussions/interactions.<BR/>3. Quality of life:<BR/>a. CF questionnaire.</P>
<P>Additionally: long-term health outcomes and cost-effectiveness.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-06-11 16:39:29 +0100" MODIFIED_BY="[Empty name]">
<P>Prof. Alexandra Quittner, University of Miami, Department of Psychology.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-10-31 13:46:20 +0000" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-06-11 22:04:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Quittner-2011">
<CHAR_STUDY_NAME MODIFIED="2014-06-11 16:42:01 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of a behavioral adherence intervention for adolescents with CF: I change adherence and raise expectations (iCARE)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-06-11 22:04:35 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: clustered-randomised controlled study.</P>
<P>The study is evaluating two adherence promotion interventions for adolescents, implemented by CF care teams. The centres are randomised to one of the types of interventions.</P>
<P>Half of the centres will receive the Comprehensive Adherence Program (CAP) for 2 years. The other half will receive the Adherence Dashboard only in year 1 of the study and CAP in year 2 of the study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:39:07 +0100" MODIFIED_BY="[Empty name]">
<P>Enrolled: 632 adolescents.</P>
<P>Population of interest: adolescents diagnosed with CF who are prescribed chronic use of a pulmonary medication.</P>
<P>Inclusion criteria:</P>
<P>1. male or female patients age 11-120 years old;.</P>
<P>2. patients with a diagnosis of CF;</P>
<P>3. patients attend the accredited care centre for regularly scheduled clinic visits;</P>
<P>4. patient must be prescribed at least one of the following medications for at least 6 months prior to signing the informed consent (azithromycin; hypertonic saline; Pulmozyme<SUP>®</SUP>; TOBI<SUP>®</SUP>; inhaled compounded tobramycin);</P>
<P>5. Patient has consented to provide data to the CF Foundation Registry prior to conversion to PORTCFv.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:38:02 +0100" MODIFIED_BY="[Empty name]">
<P>Comprehensive Adherence Program (CAP) consists of:</P>
<P>1. Adherence Dashboard - a web-based resource offering automated/regularly updated patients adherence estimates (based on pharmacy refill patterns and health information retrieved from registry);</P>
<P>2. Training in the CF My Way program - a validated problem-solving adherence promotion intervention.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:37:54 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<P>Medication adherence will be assessed via MPR derived from pharmacy refill records. (Time frame 24 months.)</P>
<P>
<B>Secondary outcomes </B>(Time frame 24 months.)</P>
<P>CF knowledge <BR/>Skills associated with CF treatments<BR/>Health-related quality of life (CFQ-R)<BR/>Lung function (FEV<SUB>1</SUB>)<BR/>Pulmonary exacerbation<BR/>CF hospitalizations </P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-06-11 16:35:19 +0100" MODIFIED_BY="[Empty name]">
<P>October 2009.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-06-11 16:35:18 +0100" MODIFIED_BY="[Empty name]">
<P>Prof. Alexandra Quittner, University of Miami, Department of Psychology.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-06-11 16:35:15 +0100" MODIFIED_BY="[Empty name]">
<P>This study is ongoing and is currently recruiting participants (31st July 2012). <A HREF="http://www.clinicaltrials.gov/ct2/show/record/NCT01232478?term=icare+adherence&amp;rank=1)">http://www.clinicaltrials.gov/ct2/show/record/NCT01232478?term=icare+adherence&amp;rank=1)</A>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-06-11 16:35:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Quittner-2012">
<CHAR_STUDY_NAME MODIFIED="2014-06-11 16:34:54 +0100" MODIFIED_BY="[Empty name]">
<P>CFfone: A cell phone support program for adolescents with CF.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-06-11 16:35:02 +0100" MODIFIED_BY="[Empty name]">
<P>The investigators propose to evaluate the efficacy of a cell phone support program for adolescents and young adults (CFfone) in improving CF knowledge, treatment adherence, and quality of life compared to a CF-related educational website intervention (control group).</P>
<P>Study type: interventional.</P>
<P>Study design: efficacy study, randomised allocation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:34:46 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria</P>
<P>1. Have a diagnosis of CF.</P>
<P>2. Be within the target age range of 11-20 years old at enrolment.</P>
<P>3. Have regular access to an internet-connected computer that does not prevent access to websites (i.e. firewall).</P>
<P>Exclusion criteria</P>
<P>1. Have a developmental disorder that would affect ability to respond to survey questions.</P>
<P>Estimated enrolment: n = 146.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-31 13:04:18 +0100" MODIFIED_BY="[Empty name]">
<P>Cell phone support program for adolescents and young adults (CFfone):</P>
<P>Is a behavioral intervention which contains a password-protected, secure website, which can be accessed via web capable cell phone. The website provides age appropriate medical and behavioral information, disease management tools and social networking features for adolescents.</P>
<P>CF-related educational website intervention (control group):</P>
<P>The interventions contains a CF-related educational website which has some areas of CF information and services relevant to adolescents.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:33:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<P>The participants' CF-related knowledge will be assessed via the CFK. It will be administered at baseline, month 3, month 6 and month 9.</P>
<P>
<B>Secondary outcomes</B>
</P>
<P>The participants' quality of life will be assessed via the CFQ-R. The adolescent/adult version will be used for participants aged 15-20 years and the CFQ-R Older Child version will be used for participants ages 11-14 years. Quality of life will be administered at baseline, month 3, month 6 and month 9.</P>
<P>To measure treatment adherence a print out of CF related medications and pharmacy refill data will be collected. To obtain participants' prescription information in order to have adherence calculations for three month periods, the attending physician will fill out a prescribed treatment plan at every clinic visit during the study. Pharmacy refill data will be collected at baseline for the 12 months prior to enrolment; and again after the 9 month clinic visit for the 9 months of the study. The prescribed treatment plan will be collected at baseline, month 3, month 6 and month 9.</P>
<P>Exploratory end point: social support.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-06-11 16:32:17 +0100" MODIFIED_BY="[Empty name]">
<P>September 2010.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-06-11 16:32:16 +0100" MODIFIED_BY="[Empty name]">
<P>Prof. Alexandra Quittner, University of Miami, Department of Psychology.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-06-11 16:32:14 +0100" MODIFIED_BY="[Empty name]">
<P>Information provided by the investigator Prof. Quittner: "This study is ongoing, an already completed enrolment with a sample size of 100 adolescents ages 11 to 20. The study is going on at 6 CF Centers.  We anticipate that all measures will be completed in April of 2013."</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-06-11 22:04:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Riekert-2012">
<CHAR_STUDY_NAME MODIFIED="2014-06-11 16:32:04 +0100" MODIFIED_BY="[Empty name]">
<P>Building adherence to live with and navigate my CF experience (BALANCE).</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-06-11 22:04:41 +0100" MODIFIED_BY="[Empty name]">
<P>The investigators propose to evaluate the relative efficacy of a Motivational Interviewing-focused intervention (MI) in improving adherence and reducing CF-related morbidity compared to a CF education intervention (CFE; attention control group). The investigators hypothesize that MI will result in improved regimen adherence and reduced CF morbidity compared to the CFE control group.</P>
<P>Study type: Interventional.</P>
<P>Study design: efficacy study; randomised allocation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-11 16:31:37 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria</P>
<OL>
<LI>Have a doctor confirmed diagnosis of CF</LI>
<LI>Aged 16 years old or older</LI>
<LI>Prescribed an inhaled mucolytic, inhaled antibiotic therapy, chronic macrolide therapy and/or hypertonic saline therapy for the previous 12 months.</LI>
<LI>Scheduled for a regular visit at either the pediatric or the adult CF clinic at Johns Hopkins Hospital.</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>
<I>Burkholderia cepacia</I> complex isolated from the respiratory tract within the past 2 years.</LI>
<LI>Had a lung transplant</LI>
<LI>Participated in NA_00008649 A pilot study of Motivational Interviewing for adults with CF.</LI>
</OL>
<P>Estimated enrolment: n = 153.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-11 16:31:07 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>CF Education</B>
</P>
<P>This intervention is designed to increase knowledge and enhance the skills needed to optimise CF-management. The strategies used to achieve improved adherence include providing didactic education and skills training, and proscriptively using behavioral modification strategies, such as positive reinforcement for desired behaviours, and problem-solving training to overcome barriers.</P>
<P>
<B>Motivational Interviewing</B>
</P>
<P>The overarching goal for the intervention is to motivate and assist the participant to improve his/her adherence to the CF pulmonary medications. The intervention will begin by providing the patient personal feedback on their adherence(using pharmacy refill data) and health outcomes (e.g., trajectory of lung function values, frequency of exacerbations) as well as clinic-level figures showing the association between adherence and health outcomes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-11 16:30:34 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome</B>
</P>
<P>A MPR will be calculated for each prescribed drug that is being monitored for adherence (time frame: 12 months).</P>
<P>
<B>Secondary outcome</B>
</P>
<P>Change in FEV<SUB>1 </SUB>% predicted (time frame: 12 months).</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-06-11 16:29:44 +0100" MODIFIED_BY="[Empty name]">
<P>July 2009.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-06-11 16:29:46 +0100" MODIFIED_BY="[Empty name]">
<P>Kristin A. Riekert, PhD, The Johns Hopkins Adherence Research Center.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-06-11 16:30:10 +0100" MODIFIED_BY="[Empty name]">
<P>This study is ongoing, but not recruiting participants at the moment (20th July 2012). Information from <A HREF="http://www.clinicaltrials.gov/ct2/show/NCT01013896?term=adherence+cystic+fibrosis&amp;rank=1)">http://www.clinicaltrials.gov/ct2/show/NCT01013896?term=adherence+cystic+fibrosis&amp;rank=1)</A>.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>BFST: Behavioral-Family Systems Therapy <BR/>CF: cystic fibrosis<BR/>CFK: Cystic Fibrosis Knowledge Questionnaire<BR/>CFQ-R: Cystic Fibrosis Questionnaire-Revised<BR/>FEV<SUB>1</SUB>: forced expiratory volume litres per second<BR/>MPR: medication possession ratio<BR/>QoL: quality of life<BR/>RCT: randomised controlled trial<BR/>SRBAI: Self-Report Behavioural Automaticity Index<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-06-11 22:17:56 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-06-11 22:14:27 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 15:56:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Belsky-1994">
<DESCRIPTION>
<P>The 2 groups were not randomised. The authors stated that "2 groups were formed on the basis of comparability of age and clinical ratings" (<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>, p. 284).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:06:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chernoff-2002">
<DESCRIPTION>
<P>The authors did not describe the randomisation process in detail. The stated that of the 161 families being eligible and who agreed to participate were 'randomly assigned to the experimental group and [...] to the control group (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; p. 773).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:05:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2006">
<DESCRIPTION>
<P>The authors describe that the children were randomly assigned to the intervention and control group "using a computer-generated randomization plan". (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>, p. 302)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delk-1994">
<DESCRIPTION>
<P>Details of random generation process were not provided by the authors. They just reported that 'subjects were screened medically, matched by age and severity disease, and randomly assigned to either the experimental group receiving the biofeedback-assisted BRT or to the control groups receiving peripheral temperature biofeedback-assisted relaxation training (RLXT)' (<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>, p. 23).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:04:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Goodill-2005">
<DESCRIPTION>
<P>The author only provided the information that "randomization formed groups similar in age, gender, and disease severity" (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>, p. 76).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-03 12:09:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grasso-2000">
<DESCRIPTION>
<P>The authors did not describe details of random generation process. They just stated that 'the participants were randomly allocated into control and treatment groups.' (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>, p. 372)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 22:13:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hernandez_x002d_Reif-1999">
<DESCRIPTION>
<P>The authors did not describe details of random generation process. They just stated that the participants were 'randomly assigned to a massage therapy or a reading control group' (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>, p. 177).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 16:06:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Powers-2003">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 22:14:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Powers-2005">
<DESCRIPTION>
<P>The authors described the randomisation process in detail. 'The computer-generated randomisation code was developed independently by the study biostatistician.' (<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>, p. 1443)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-15 10:15:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Quinn-2004">
<DESCRIPTION>
<P>The authors provided the information that the participants were randomised using a computer generated pseudo-random number generator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-03 12:10:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stark-1996">
<DESCRIPTION>
<P>The authors did not describe details of random generation process. It is just stated that 'the nine subjects were randomly assigned to either a behavioral intervention or a wait list control group' (<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:02:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-2003">
<DESCRIPTION>
<P>The authors described that families were assigned based on family availability to time slots, which were in a second step then randomly assigned to one of the conditions 'via a coin flip' (<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>, p. 244).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 16:13:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-2009">
<DESCRIPTION>
<P>Participants were 'randomised to the treatment arms by coin flip by research assistant and postdoctoral fellow together' (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>, p.916).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-15 10:54:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>The authors provide insufficient information about the sequence generation. After contacting the authors they provided the information that they followed a published random numbers sequence and assigned the patient to one of the two treatments based on the next number in the sequence being odd or even.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 22:03:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vandemheen-2009">
<DESCRIPTION>
<P>The authors reported that randomisation was performed via a "a randomization schedule prepared through a computer-generated random listing of the two treatment allocations blocked in variable blocks of two or four and stratified by site and by infection status with <I>Burkholderia cepacia</I>" (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>, p.762).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 10:59:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilkinson-2008">
<DESCRIPTION>
<P>Participants were randomised by a physiotherapist distributing a pre-prepared sealed envelope, which was made by a third party not involved with recruitment (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, p. 183).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-06-11 22:14:31 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:06:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Belsky-1994">
<DESCRIPTION>
<P>Because groups were not randomised, participants and/or investigators enrolling participants could probably foresee assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:06:03 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Chernoff-2002">
<DESCRIPTION>
<P>The method of concealment is not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:05:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2006">
<DESCRIPTION>
<P>Assignment could not been foreseen by participants and investigators enrolling participants due to a computer-generated randomisation plan.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:04:52 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Delk-1994">
<DESCRIPTION>
<P>The method of concealment is not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-23 09:06:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Goodill-2005">
<DESCRIPTION>
<P>The author did not describe details of allocation concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 22:13:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grasso-2000">
<DESCRIPTION>
<P>The authors did not describe the method of concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:04:06 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Hernandez_x002d_Reif-1999">
<DESCRIPTION>
<P>The authors did not present information about the allocation concealment method.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 16:06:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Powers-2003">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 22:14:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Powers-2005">
<DESCRIPTION>
<P>The method of concealment was described in detail by the authors. They reported that a decentralised blinded research staff member then was given a copy of the list. Once a family was enrolled [...], another research staff member called the decentralised research staff member and obtained the random assignment.' (<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005,</LINK> p. 1443) The authors noted additionally that all relevant study team members were unaware of the specific allocation concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-15 10:30:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Quinn-2004">
<DESCRIPTION>
<P>Participants were randomised using a computer generated pseudo-random number generator. But the authors did not provide information about adequate concealment of allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-03 12:10:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stark-1996">
<DESCRIPTION>
<P>The authors did not provide information about adequate concealment of allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 16:11:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-2003">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-15 10:53:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-2009">
<DESCRIPTION>
<P>Assignment could not been foreseen by participants and investigators enrolling participants because of coin flipping by research assistant and postdoctoral fellow together.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-15 10:54:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>The authors provide insufficient information on the allocation concealment. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-23 10:02:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vandemheen-2009">
<DESCRIPTION>
<P>The authors reported that a central allocation was conducted (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>, p. 762).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-23 09:22:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilkinson-2008">
<DESCRIPTION>
<P>Participants and investigator could not foresee assignments because the authors reported that they used sequentially numbered sealed envelopes (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, p.183).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-06-11 22:17:56 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-08-23 14:24:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belsky-1994">
<DESCRIPTION>
<P>Blinding of participants and personnel providing the intervention was not possible. The authors provided no information on blinding of outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-09-27 11:06:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chernoff-2002">
<DESCRIPTION>
<P>Due to the nature of the intervention blinding of participants is not possible adequately, but the authors provided the information that 'interviews were completed by paid interviewers who had undergone extensive training and were blind to group assignment' (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; p. 534).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-09-27 11:05:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2006">
<DESCRIPTION>
<P>The authors state that "group assignments were unknown to the CF clinics and research assessment team". (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>; p. 302)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-09-27 11:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delk-1994">
<DESCRIPTION>
<P>Due to the nature of the intervention blinding of participants is not possible adequately. Insuffiecent information about blinding of outcome assessment available,</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-08-23 09:05:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodill-2005">
<DESCRIPTION>
<P>Participants and personnel providing the intervention were not able to be blinded due to the nature of the intervention. Research assistants, who conducted pre- and post-testing were blinded to group assignments (<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>, p.76).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-04-03 12:09:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grasso-2000">
<DESCRIPTION>
<P>The authors reported that the participants were not informed about the group assignment, but blinding for control condition (no audiotape and later familiar music tape) is doubtful. All outcomes were assessed via self-reports by the participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-09-27 11:04:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hernandez_x002d_Reif-1999">
<DESCRIPTION>
<P>Due to the nature of the interventions the participants and the interventionists could not be blinded. The authors did not report whether the research assistants, who were calling the participants and checking for compliance, were blinded (as well as outcome assessment). Due to the lack of blinding the performance might have been influenced.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-06-11 16:06:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Powers-2003">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-09-27 11:03:46 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Powers-2005">
<DESCRIPTION>
<P>Participants and personnel providing intervention could not be blinded to intervention as usual for psychological interventions. The primary outcome 'daily calorie intake' was assessed via self-reported daily diet dairies provided by the parents. The measure, which is not objective, might be influenced by the knowledge of allocation to one of the conditions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-08-15 10:38:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Quinn-2004">
<DESCRIPTION>
<P>Participants and personnel providing the MI telephone intervention could not be blinded to intervention as usual for psychological interventions. Physiotherapists who administered questionnaires were blind to study allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-04-03 12:10:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stark-1996">
<DESCRIPTION>
<P>Participants and personnel providing the intervention were not able to be blinded due to the nature of the intervention and the study design (wait-list-control design). The main outcome 'calorie intake' is assessed via self-reported daily diet dairies. Due to that the measure is not objective and might be influenced by the knowledge of allocation to one of the conditions. All other objective measures (e.g. weight) are not likely to be influenced by the lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-06-11 22:17:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stark-2003">
<DESCRIPTION>
<P>Participants and personnel providing the intervention were not able to be blinded due to the nature of the intervention. One primary outcome 'daily calorie intake' is assessed via self-reported daily diet dairies. Due to that the measure is not objective and might be influenced by the knowledge of allocation to one of the conditions. The other objective measure used as primary outcome ('weight') is not likely to be influenced by the lack of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-06-11 21:56:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stark-2009">
<DESCRIPTION>
<P>The authors of the study state that 'families were never explicitly told which treatment they had been assigned' (Stark et al 2009, p.916). But, 'as with any behavioral intervention, it is not possible to keep subjects unaware of the treatment they are receiving or therapists the treatment they are providing' (<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>, p.921).</P>
<P>No details are provided about blinding of outcome assessors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-08-15 10:55:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>The physician and the clinic staff were not informed as to whether individual patients were in the WSD or the SMC condition. Patients and providers of the intervention knew who was in the WSD or the SMC condition (<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-09-27 11:00:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vandemheen-2009">
<DESCRIPTION>
<P>The authors provided the following information regarding blinding: "Neither research staff nor medical staff as aware of the treatment assignment before and after randomization" (<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>, p.762).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-08-23 09:23:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wilkinson-2008">
<DESCRIPTION>
<P>Due to the nature of the intervention the participants and teams providing the intervention could been blinded, but he authors provided no information on blinding of outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2012-08-15 10:09:16 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-08-15 10:09:16 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-06-11 22:14:43 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 15:57:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Belsky-1994">
<DESCRIPTION>
<P>No information on dropouts were provided by the authors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-27 13:16:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chernoff-2002">
<DESCRIPTION>
<P>The authors reported that about 15.5% of the randomised participants were not available for follow-up analysis. 'of the 161 families randomised, 86 were randomised to the experimental group and 75 to the control group. Overall, 25 families, 14 and 11 from the experimental and the control group, respectively, were lost to follow up [...] (<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>; p. 536).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 22:11:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2006">
<DESCRIPTION>
<P>The authors stated that "all children completed the baseline and 3 follow-up assessments" (<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>, p.301). That means that there was no attrition or loss of any participant during the study and follow-up period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-27 11:04:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delk-1994">
<DESCRIPTION>
<P>Outcomes were analysed as intention-to-treat, but it has to be mentioned that for FEV<SUB>1</SUB> results of one participant is missing (n = 25). Reasons were not explained by the authors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-27 13:17:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Goodill-2005">
<DESCRIPTION>
<P>The author reported a high rate of dropouts at follow up. The percentage of dropouts in each group is unclear. A complete data set was only for 14 participants available, although 42 participants have been randomised.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 22:13:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grasso-2000">
<DESCRIPTION>
<P>The authors report that 21 families were assigned to one of the groups and that 'one family was withdrawn when the child was hospitalised for a chest infection, leaving a total of 10 in each group' (<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>, p.373). That means that the attrition during the study was less than 15%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 22:13:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hernandez_x002d_Reif-1999">
<DESCRIPTION>
<P>The authors reported that out of 23 participants, 20 were available for post analyses. Those three families 'were later dropped from the study due to noncompliance' and 'had failed to keep their 30-day appointment' (<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>, p. 177). Two were assigned to the control condition and one family to the massage therapy condition.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 22:14:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Powers-2003">
<DESCRIPTION>
<P>The authors recorded the drop-outs (33%) and presented the reasons. However, reasons for drop-outs are not reported separately for both conditions. They additionally reported that a comparison of children who withdrew from the study and those who completed the study protocol yielded no significant differences on demographic and anthropometric data' (<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK> p. 304).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 22:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Powers-2005">
<DESCRIPTION>
<P>The authors reported that ITT analysis has been conducted for the three-month follow up. Two families failed to complete the dietary record at this time point. Scores for the two participants were imputed 'by calculating the mean change in: (1) energy intake per day; (2) percentage of RDA; and (3) percentage of fat intake from post-treatment to 3-month follow up for the 7 completers. These mean changes then were used to calculate estimated 3-month follow up data for the 2 noncompleters' (<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>, p. 1446). Furthermore, they reported that two other approaches for imputation revealed similar results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-08-15 10:45:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Quinn-2004">
<DESCRIPTION>
<P>The authors provided the information that of the 39 participants randomised 4 dropped out during the study for the following reasons: possible side effects of the medication, preferring the previous nebuliser, receiving a lung transplant. Four participants were repeatedly unavailable, but were included in the intention to treat analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-04-03 12:10:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-1996">
<DESCRIPTION>
<P>The authors reported that there was no attrition.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-27 13:17:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stark-2003">
<DESCRIPTION>
<P>The authors described in detail the attrition and the reasons for families who dropped out, but it is relatively unclear what the population of interest was and how many families were randomly assigned. Out of originally 15 families, who agreed to participate, seven families completed treatment and follow up (<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>, p. 240).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 21:56:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-2009">
<DESCRIPTION>
<P>Of the 79 enrolled children 40 were assigned to the nutrition education group (NE) and 39 to the behaviour plus nutrition education group. There have been 6 drop outs in both arms prior to treatment. Data of 67 children was available for analysis post-treatment (NE n = 33 and behavioural plus nutrition education intervention n = 34). 24 month follow-up data of 28 children in the behaviour plus nutrition education intervention group and of 31 children in the NE group was available for analysis.</P>
<P>The authors provided a flow diagram of participants randomised to both study arms and assessed at each point in time from baseline to 24-month follow up (<I>see</I> <LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>, p.916 Figure 1).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-08-03 13:48:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>Number of drop-outs in each group is not reported, demographic comparison data between those excluded and included in the final sample, using T-tests and chi-square analyses, revealed no significant differences between the two groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-27 13:18:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vandemheen-2009">
<DESCRIPTION>
<P>The number of drop-outs for 3-week follow up and 12-month follow up were reported for each group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-06-11 16:22:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wilkinson-2008">
<DESCRIPTION>
<P>The authors reported a high number of dropouts. The number of dropouts for each group is unclear. Reasons for dropouts were reported: 4 patients died, 3 patients received transplant, 1 withdrew, and 1 was too unwell to continue (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, p. 183).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-06-11 22:10:23 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-23 14:27:22 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Belsky-1994">
<DESCRIPTION>
<P>The number of participants for post-intervention analysis were not mentioned. Outcomes of interest in the review are reported incompletely so that they cannot be entered in a an analysis (N, means and standard deviations for some of the outcomes).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 22:10:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chernoff-2002">
<DESCRIPTION>
<P>The presentation of the results was selective. The subgroup analysis reported on p. 537 and figure 2 e.g. was not pre-specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-20 13:43:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christian-2006">
<DESCRIPTION>
<P>All outcomes mentioned in the published records are reported. It is unclear if additional outcomes were pre-specified in the study protocol but not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delk-1994">
<DESCRIPTION>
<P>Information is insufficient to judge whether 'low' or 'high' risk.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 16:03:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Goodill-2005">
<DESCRIPTION>
<P>Means and SDs for all outcome parameters for intervention and control group were not reported in the published article. Of the reported measure it was not prespecified which is the primary outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-03 12:09:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Grasso-2000">
<DESCRIPTION>
<P>The available information is insufficient to judge whether 'low' or 'high' risk.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:04:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hernandez_x002d_Reif-1999">
<DESCRIPTION>
<P>All outcomes, which have been assessed, were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-03 12:09:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Powers-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:03:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Powers-2005">
<DESCRIPTION>
<P>All of the study&#8217;s pre-specified outcomes have been reported. It is unclear if additional outcomes were pre-specified in the study protocol but not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-08 16:07:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Quinn-2004">
<DESCRIPTION>
<P>The information is insufficient to judge whether 'low' or 'high' risk.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-03 12:10:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stark-1996">
<DESCRIPTION>
<P>The authors reported alls pre-specified outcomes. It is unclear if additional outcomes were pre-specified in the study protocol but not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-27 11:02:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-2003">
<DESCRIPTION>
<P>All prespecified outcome variables (primary and secondary) are reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-19 15:52:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stark-2009">
<DESCRIPTION>
<P>The study protocol is available and all of the study&#8217;s pre-specified outcomes have been reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-03 13:15:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-2003">
<DESCRIPTION>
<P>All of the study&#8217;s pre-specified outcomes have been reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-23 10:18:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vandemheen-2009">
<DESCRIPTION>
<P>The published report includes all expected outcomes, including those that were pre-specified as primary and secondary outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-11 16:22:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wilkinson-2008">
<DESCRIPTION>
<P>Means and SDs for all outcome parameters for intervention and control group were not reported in the published article.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-09-05 13:48:18 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-03-07 11:00:10 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-03-07 09:42:35 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-03-06 13:04:16 +0000" MODIFIED_BY="[Empty name]">Cognitive behavioral interventions to improve adherence</TITLE>
<TABLE COLS="5" ROWS="12">
<TR>
<TD COLSPAN="5">
<P>Nutrional intervention plus behavioural management training (BEH) <B>compared with </B>Nutritional intervention alone (NUT)<B> for </B>children with CF (4-12 years)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>
<B>Patient or population: </B>Children from 4-12 years with a diagnosis of CF by sweat test, pancreatic insufficiency; and weight for age and height <U>&lt;</U> 40<SUP>th</SUP> percentile</P>
<P>
<B>Settings: </B>group setting</P>
<P>
<B>Intervention: </B>Nutrional intervention plus behavioural management training</P>
<P>
<B>Comparison: </B>Nutritional intervention alone</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>
<B>Comments</B>
</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Nutritional intervention alone</P>
</TH>
<TH VALIGN="TOP">
<P>Nutrional intervention plus behavioural management training</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Change in weight</B>
</P>
<P>pre- and post-treatment in (kg)</P>
</TD>
<TD VALIGN="TOP">
<P>The mean change in weight ranged across control groups from<BR/>0.92 to 1.75kg</P>
</TD>
<TD VALIGN="TOP">
<P>The mean change in weight in the intervention groups was<BR/>
<B>0.11kg</B> <B>higher</B>
</P>
<P>(0.84 lower to 1.07 higher)<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>75<BR/>(2)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>BMIz change </B>
</P>
<P>range: -1.00 to 1.00</P>
<P>2-year follow up</P>
</TD>
<TD VALIGN="TOP">
<P>The mean BMIz change<B> </B>in the control group was<BR/>-0.22</P>
</TD>
<TD VALIGN="TOP">
<P>The mean BMIz change in the intervention group was<BR/>
<B>0.35 higher</B>
</P>
<P>(0 to 0.7 higher)<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>67<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Total calories per day</B>
</P>
<P>post-intervention</P>
</TD>
<TD VALIGN="TOP">
<P>The mean total calories per day ranged across control groups from<BR/>1316 to 2315 calories</P>
</TD>
<TD VALIGN="TOP">
<P>The mean total calories per day in the intervention groups was<BR/>
<B>275.8 calories higher</B>
<BR/>(66.65 to 485.05 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>83<BR/>(3)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Change in calorie intake</B>
</P>
<P>pre- and post-treatment</P>
</TD>
<TD VALIGN="TOP">
<P>The mean change in calorie intake ranged across control groups from<BR/>303.9 to 489 calories</P>
</TD>
<TD VALIGN="TOP">
<P>The mean change in calorie intake in the intervention groups was<BR/>
<B>364.06 calories higher</B>
<BR/>(191.99 to 536.13 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>82<BR/>(3)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Estimated energy requirements (%EER)</B>
</P>
<P>post-intervention</P>
</TD>
<TD VALIGN="TOP">
<P>The mean %EER in the control group was<BR/>127%</P>
</TD>
<TD VALIGN="TOP">
<P>The mean %EER in the intervention group was<BR/>
<B>21% higher</B>
<BR/>(7.76 to 34.24 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>67<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Change in estimated energy requirements (%EER)</B>
</P>
<P>pre- and post-treatment</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of change in %EER in the control group was<BR/>27%</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of change in %EER in the intervention groups was<BR/>
<B>21% higher</B>
</P>
<P>(9.22 to 32.78 higher)<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>67<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2014-03-07 09:44:22 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2014-03-06 13:04:48 +0000" MODIFIED_BY="[Empty name]">Cognitive interventions associated with decision making in lung transplantation</TITLE>
<TABLE COLS="5" ROWS="12">
<TR>
<TD COLSPAN="5">
<P>Decision aid for patients considering lung transplantation <B>compared with</B> usual care<B> for </B>patients with advanced CF considering referral for lung transplantation</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>
<B>Patient or population: </B>patients with advanced CF considering referral for lung transplantation</P>
<P>
<B>Settings: </B>individual</P>
<P>
<B>Intervention: </B>decision aid for patients considering lung transplantation</P>
<P>
<B>Comparison: </B>usual care</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>
<B>Comments</B>
</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Usual care</P>
</TH>
<TH VALIGN="TOP">
<P>Decision aid for patients considering lung transplantation</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Participants' knowledge </B>
</P>
<P>4-item knowledge questionnaire (range 0 to 4)</P>
<P>3 week follow-up</P>
</TD>
<TD VALIGN="TOP">
<P>The mean score of participants' knowledge in the control group was<BR/>1.974</P>
</TD>
<TD VALIGN="TOP">
<P>The mean score of participants' knowledge in the intervention group was<BR/>
<B>0.98 higher</B>
<BR/>(0.66 to 1.31 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>149<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Participants' knowledge - change in knowledge </B>
</P>
<P>4-item knowledge questionnaire (range 0 to 4)</P>
<P>week 3 - baseline</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of change in participants' knowledge in the control group was</P>
<P>0.3<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of change in participants' knowledge in the intervention group was<BR/>
<B>0.94 higher</B>
<BR/>(0.53 to 1.35 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>149<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Patient expectations </B>
</P>
<P>2-item questionnaire (range 0 to 2)</P>
<P>3 week follow-up</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of the expectation score in the control group was<BR/>0.58</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of the expectation score in the intervention group was<BR/>
<B>0.73 higher</B>
<BR/>(0.51 to 0.95 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>149<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Patient expectations - change in expectation score </B>
</P>
<P>2-item questionnaire (range 0 to 2)</P>
<P>week 3 - baseline</P>
</TD>
<TD VALIGN="TOP">
<P>The mean change in the expectation score in the control group was<BR/>0.05</P>
</TD>
<TD VALIGN="TOP">
<P>The mean change in the expectation score in the intervention group was<BR/>
<B>0.66 higher</B>
<BR/>(0.37 to 0.95 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>149<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Decisional conflict - Total score </B>
</P>
<P>range 0 to 100 (low decisional conflict to high decisional conflict)</P>
<P>3 week follow-up</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of the total score</P>
<P>in the control group was<BR/>20.4</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of the total score in the intervention group was<BR/>
<B>8.8 lower </B>
<BR/>(13.7 to 3.9 lower)</P>
</TD>
<TD VALIGN="TOP">
<P>149<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Decisional conflict - Change in total score </B>
</P>
<P>range 0 to 100 (low decisional conflict to high decisional conflict)</P>
<P>week 3 - baseline</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of changes in the total score</P>
<P>of the decisional conflict questionnaire<B> </B>in the control group was<BR/>13.1</P>
</TD>
<TD VALIGN="TOP">
<P>The mean of changes in the total score</P>
<P>of the decisional conflict questionnaire</P>
<P>in the intervention group was<BR/>
<B>3.3 higher</B>
<BR/>(2.28 lower to 8.88 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>149<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Secondary outcome</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2014-03-07 09:45:32 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2014-03-06 14:38:57 +0000" MODIFIED_BY="[Empty name]">Other interventions - Biofeedback</TITLE>
<TABLE COLS="5" ROWS="9">
<TR>
<TD COLSPAN="5">
<P>Biofeedback assisted breathing re-training (BRT) <B>compared with </B>biofeedback assisted relaxation training (RLXT)<B> for </B>individuals with CF (10 - 41 years)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>
<B>Patient or population: </B>individuals with CF (10 - 41 years)</P>
<P>
<B>Settings: </B>individual</P>
<P>
<B>Intervention: </B>biofeedback assisted breathing re-training (BRT)</P>
<P>
<B>Comparison: </B>biofeedback assisted relaxation training (RLXT)</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Biofeedback assisted relaxation training (RLXT)</P>
</TH>
<TH VALIGN="TOP">
<P>Biofeedback assisted breathing re-training (BRT)</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Pulmonary function - Forced expiratory volume (FEV<SUB>1</SUB>) in litres per second</B>
</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>The mean FEV<SUB>1</SUB> in the control group was 0.78</P>
</TD>
<TD VALIGN="TOP">
<P>The mean FEV<SUB>1</SUB> in the intervention group was<BR/>
<B>0.54 higher</B>
<BR/>(0.15 to 0.93 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>24<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Pulmonary function - Forced vital capacity (FVC) in litres</B>
</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>The mean FVC in the control group was<BR/>2.31</P>
</TD>
<TD VALIGN="TOP">
<P>The mean FVC in the intervention group was<BR/>
<B>0.87 higher</B>
</P>
<P>(0.09 lower to 1.83 higher)<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>26<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Pulmonary function - FEF<SUB>25-75% </SUB>in litres per second</B>
</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>The mean FEF<SUB>25-75%</SUB> in the control group was<BR/>1.39</P>
</TD>
<TD VALIGN="TOP">
<P>The mean FEF<SUB>25-75%</SUB> in the intervention group was<BR/>
<B>0.67 higher</B>
</P>
<P>(0.1 to 1.24 higher)<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>26<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2014-03-07 11:00:10 +0000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2014-03-06 14:39:02 +0000" MODIFIED_BY="[Empty name]">Other interventions - Massage therapy</TITLE>
<TABLE COLS="5" ROWS="10">
<TR>
<TD COLSPAN="5">
<P>Massage therapy<B> compared with </B>bedtime reading control<B> for </B>children and adolescents with CF (5 - 18 years)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>
<B>Patient or population: </B>children and adolescents with CF (5 - 18 years)</P>
<P>
<B>Settings: </B>individual</P>
<P>
<B>Intervention: </B>massage therapy<B> </B>
</P>
<P>
<B>Comparison: </B>bedtime reading control</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH VALIGN="TOP">
<P>Bedtime reading control</P>
</TH>
<TH VALIGN="TOP">
<P>Massage therapy<B> </B>
</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Pulmonary function - Peak Air Flow (PEFR) </B>
</P>
<P>Follow-up day 30</P>
</TD>
<TD VALIGN="TOP">
<P>The mean Peak Air Flow in the control group was<BR/>244</P>
</TD>
<TD VALIGN="TOP">
<P>The mean Peak Air Flow in the intervention group was<BR/>
<B>53.9 higher</B>
<BR/>(43.27 lower to 151.07 higher)</P>
</TD>
<TD VALIGN="TOP">
<P>20<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Parent Anxiety </B>
</P>
<P>State Trait Anxiety Inventory (STAI; range from 0 to 80 with a higher score reflecting more anxiety)</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>The mean parent anxiety score in the control group was<BR/>40</P>
</TD>
<TD VALIGN="TOP">
<P>The mean parent anxiety score in the intervention group was<BR/>
<B>9.1 lower</B>
<BR/>(17.84 to 0.36 lower)</P>
</TD>
<TD VALIGN="TOP">
<P>20<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Child Anxiety -</B>
</P>
<P>State Trait Anxiety Inventory for Children (STAIC; range from 0 to 80 with a higher score reflecting more anxiety)</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>The mean child anxiety score in the control group was<BR/>32.9</P>
</TD>
<TD VALIGN="TOP">
<P>The mean child anxiety score in the intervention group was<BR/>
<B>8.2 lower</B>
<BR/>(12.36 to 4.04 lower)</P>
</TD>
<TD VALIGN="TOP">
<P>20<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Child Mood </B>
</P>
<P>Profile of Mood States (POMS)- depression subscale modified (19 items 5-point-scale 0 to 4, score range 0 to 76)</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>The mean score of the depression subscale in the control group was<BR/>7.2</P>
</TD>
<TD VALIGN="TOP">
<P>The mean score of the depression subscale in the intervention group was<BR/>
<B>5.5 lower</B>
<BR/>(8.81 to 2.19 lower)</P>
</TD>
<TD VALIGN="TOP">
<P>20<BR/>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>Primary outcome</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2014-06-17 09:55:15 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-09-27 10:57:55 +0100" MODIFIED_BY="Nikki Jahnke" NO="1">
<TITLE>Report characteristics of relevant studies</TITLE>
<TABLE COLS="7" ROWS="50">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Country of Origin</P>
</TH>
<TH>
<P>Language of Report</P>
</TH>
<TH>
<P>Type of Report</P>
</TH>
<TH>
<P>Contact Author</P>
</TH>
<TH>
<P>Reply</P>
</TH>
<TH>
<P>Assessment</P>
</TH>
</TR>
<TR>
<TD>
<P>Belsky 1994</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Bingham 2010</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Bryon 2000</P>
</TD>
<TD>
<P>UK</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Cannon 1999</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Castellani 2011</P>
</TD>
<TD>
<P>Italy</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Chernoff 2002</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Christian 1999</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Christian 2006</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Cummings 2011</P>
</TD>
<TD>
<P>Australia</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Davis 1990</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Delk 1994</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Dodd 2001</P>
</TD>
<TD>
<P>Ireland</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Georgiopoulus 2011</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Goodill 2005</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Goldbeck 2011</P>
</TD>
<TD>
<P>Germany</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Grasso 2000</P>
</TD>
<TD>
<P>Australia</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Hatziagorou 2010</P>
</TD>
<TD>
<P>Greece</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Hernandez-Reif 1999</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Jessup 2010</P>
</TD>
<TD>
<P>Australia</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Jessup 2011</P>
</TD>
<TD>
<P>Australia</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Kalnins 1996</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Klig 1989</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Marciel 2010</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal Article /</P>
<P>Summary of clinical trial registration</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>ongoing</P>
</TD>
</TR>
<TR>
<TD>
<P>Mischler 1998</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Patel 2010</P>
</TD>
<TD>
<P>UK</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Petzel 1991</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Pop Jordanova 2010</P>
</TD>
<TD>
<P>Macedonia</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal Article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Powers 2003</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Powers 2005</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Quinn 2004</P>
</TD>
<TD>
<P>UK</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Quittner 2000</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Book chapter</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Quittner 2002</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Personal correspondence</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Quittner 2011</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>ongoing</P>
</TD>
</TR>
<TR>
<TD>
<P>Ralston 2008</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Ranström 2000</P>
</TD>
<TD>
<P>France</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Riekert 2012</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Summary of clinical trials registration</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>ongoing</P>
</TD>
</TR>
<TR>
<TD>
<P>Rodrigue 2005</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal Article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Stark 1996</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Stark 1998</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Stark 2001</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Unpublished report</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Stark 2002</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal Article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
<TR>
<TD>
<P>Stark 2003</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>NA</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Stark 2009</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Taylor 2003</P>
</TD>
<TD>
<P>USA</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal Article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>include</P>
</TD>
</TR>
<TR>
<TD>
<P>Vandemheen 2009</P>
</TD>
<TD>
<P>Australia / Canada</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Wainwright 2009</P>
</TD>
<TD>
<P>Australia</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Wilkinson 2008</P>
</TD>
<TD>
<P>UK</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Williams 1997</P>
</TD>
<TD>
<P>UK</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Abstract</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>awaiting</P>
</TD>
</TR>
<TR>
<TD>
<P>Wolter 1997</P>
</TD>
<TD>
<P>Australia</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>Journal article</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>exclude</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2014-06-17 09:55:15 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE>Types of outcome measure used in included studies</TITLE>
<TABLE COLS="3" ROWS="17">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Primary Outcomes</P>
</TH>
<TH>
<P>Secondary Outcomes</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>
</P>
</TD>
<TD>
<P>Physiological: pulmonary function - Average PEFR<BR/>Height<BR/>Weight</P>
<P>Well-being: child behavior, anxiety</P>
</TD>
<TD>
<P>Impact on family<BR/>Ratings of the parents' assessment of the child's illness<BR/>Locus of control and health locus of control Self-concept</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>
</P>
</TD>
<TD>
<P>Well being: depression, anxiety</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>
</P>
</TD>
<TD>
<P>Pulmonary function</P>
<P>Height<BR/>Weight</P>
</TD>
<TD>
<P>Perceived Illness Experience Scale<BR/>Children's Loneliness Scale</P>
<P>Social Support Scale for Children</P>
<P>Self-Perception Profile for Children</P>
<P>Functional Health Status</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>
</P>
</TD>
<TD>
<P>Pulmonary function</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>
</P>
</TD>
<TD>
<P>Well-being: mood state</P>
</TD>
<TD>
<P>Body image<BR/>Adherence</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Enjoyment &amp; perception of time</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>
</P>
</TD>
<TD>
<P>Well-being: anxiety/depression</P>
<P>Pulmonary function</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>
</P>
</TD>
<TD>
<P>Weight</P>
</TD>
<TD>
<P>Calorie intake<BR/>Relational</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>
</P>
</TD>
<TD>
<P>Weight<BR/>Height</P>
</TD>
<TD>
<P>Calorie consumption</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>
</P>
</TD>
<TD>
<P>Well-being: anxiety, depression, quality of life<BR/>Pulmonary function</P>
</TD>
<TD>
<P>Adherence behaviour to aerosolised antibiotics</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>
</P>
</TD>
<TD>
<P>Pulmonary function<BR/>Weight and height</P>
</TD>
<TD>
<P>Activity level</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>
</P>
</TD>
<TD>
<P>Weight</P>
</TD>
<TD>
<P>Daily calorie intake</P>
<P>Quality of parent/child interaction at mealtime<BR/>CF coping skills<BR/>Adherence to CF regimen</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>
</P>
</TD>
<TD>
<P>Change in weight</P>
<P>BMI<BR/>Pulmonary function</P>
</TD>
<TD>
<P>Caloric intake, energy (%EER)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>
</P>
</TD>
<TD>
<P>Pulmonary function<BR/>BMI</P>
</TD>
<TD>
<P>Health care utilization</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Participants&#8217; knowledge and realistic expectations<BR/>Decisional conflict</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>
</P>
</TD>
<TD>
<P>Well-being: quality of life, anxiety, depression</P>
</TD>
<TD>
<P>Coping of carers<BR/>Health care utilization</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Some parts are empty for the following reason: We summarized all reported outcomes of the 16 included studies in this table and categorized them according to our determined primary and secondary outcomes.</P>
<P>BMI: body mass index<BR/>EER: estimated energy requirements<BR/>PEFR: peak expiratory flow rate<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2014-04-03 12:14:06 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE>Subgroup membership of included studies</TITLE>
<TABLE COLS="4" ROWS="18">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Socioeconomic Level</P>
</TH>
<TH>
<P>Age</P>
</TH>
<TH>
<P>Stage of Disease</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Belsky-1994" TYPE="STUDY">Belsky 1994</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>7 - 18 years</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chernoff-2002" TYPE="STUDY">Chernoff 2002</LINK>
</P>
</TD>
<TD>
<P>Mothers' educational level</P>
</TD>
<TD>
<P>7 - 11 years</P>
</TD>
<TD>
<P>chronic?</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Christian-2006" TYPE="STUDY">Christian 2006</LINK>
</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>8 &#8211; 12 years</P>
</TD>
<TD>
<P>chronic</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Delk-1994" TYPE="STUDY">Delk 1994</LINK>
</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>10 - 41 years</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Goodill-2005" TYPE="STUDY">Goodill 2005</LINK>
</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>&gt; 17 years</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Grasso-2000" TYPE="STUDY">Grasso 2000</LINK>
</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>&lt; 2 years</P>
</TD>
<TD>
<P>post diagnosis</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hernandez_x002d_Reif-1999" TYPE="STUDY">Hernandez-Reif 1999</LINK>
</P>
</TD>
<TD>
<P>Hollingshead</P>
</TD>
<TD>
<P>5 - 15 years</P>
</TD>
<TD>
<P>chronic?</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Powers-2003" TYPE="STUDY">Powers 2003</LINK>
</P>
</TD>
<TD>
<P>Hollingshead</P>
</TD>
<TD>
<P>&lt; 3 years</P>
</TD>
<TD>
<P>post diagnosis</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Powers-2005" TYPE="STUDY">Powers 2005</LINK>
</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>18 - 48 months</P>
</TD>
<TD>
<P>post diagnosis</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Quittner-2000" TYPE="STUDY">Quittner 2000</LINK>
</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>9.5 to 16.5 years</P>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Quinn-2004" TYPE="STUDY">Quinn 2004</LINK>
</P>
</TD>
<TD>
<P>Employment status</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stark-1996" TYPE="STUDY">Stark 1996</LINK>
</P>
</TD>
<TD>
<P>Holligshead, Control group - II, Intervention group III</P>
</TD>
<TD>
<P>3 -10 years control, 5 - 10 years intervention</P>
</TD>
<TD>
<P>chronic?</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stark-2003" TYPE="STUDY">Stark 2003</LINK>
</P>
</TD>
<TD>
<P>Hollingshead &amp; family income</P>
</TD>
<TD>
<P>4 - 12 years</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Stark-2009" TYPE="STUDY">Stark 2009</LINK>
</P>
</TD>
<TD>
<P>Mother&#8217;s and father&#8217;s education, income before taxes</P>
</TD>
<TD>
<P>4 &#8211; 12 years</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Taylor-2003" TYPE="STUDY">Taylor 2003</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&gt; 15 years</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Vandemheen-2009" TYPE="STUDY">Vandemheen 2009</LINK>
</P>
</TD>
<TD>
<P>highest level of education</P>
</TD>
<TD>
<P>&gt; 18 years</P>
</TD>
<TD>
<P>considering transplantation </P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>21 - 41 years</P>
</TD>
<TD>
<P>on transplantation list</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Not all characteristics were reported for every study. That is the reason why some parts are left empty.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-06-17 09:46:24 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2014-06-10 10:41:14 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Behavioural group treatment versus wait list control</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2014-03-05 13:14:33 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="141.29352974675857" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="9" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pulmonary function</NAME>
<GROUP_LABEL_1>Behavioral treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.01" MODIFIED="2013-09-27 13:33:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>FEV<SUB>1</SUB> (% predicted)</NAME>
<CONT_DATA CI_END="16.953797578890825" CI_START="-40.353797578890834" EFFECT_SIZE="-11.700000000000003" ESTIMABLE="YES" MEAN_1="73.3" MEAN_2="85.0" ORDER="45" SD_1="12.8" SD_2="23.3" SE="14.619553116745168" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>FVC (% predicted)</NAME>
<CONT_DATA CI_END="19.15522976887934" CI_START="-31.15522976887934" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="91.5" MEAN_2="97.5" ORDER="46" SD_1="11.1" SD_2="20.5" SE="12.834536740113892" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.03" MODIFIED="2013-09-27 13:38:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>FEF<SUB>25-75% </SUB>(% predicted)</NAME>
<CONT_DATA CI_END="33.12581188772622" CI_START="-98.92581188772621" EFFECT_SIZE="-32.9" ESTIMABLE="YES" MEAN_1="40.1" MEAN_2="73.0" ORDER="47" SD_1="18.3" SD_2="56.6" SE="33.6872577294937" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2014-03-07 14:08:17 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="10" TOTAL_2="6" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Anthropometric measures</NAME>
<GROUP_LABEL_1>Behavioral treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.01" MODIFIED="2008-05-01 15:10:23 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>Weight (z score)</NAME>
<CONT_DATA CI_END="1.9975355167513862" CI_START="0.04246448324861396" EFFECT_SIZE="1.02" ESTIMABLE="YES" MEAN_1="-0.74" MEAN_2="-1.76" ORDER="49" SD_1="0.86" SD_2="0.55" SE="0.4987517752683526" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.02" MODIFIED="2008-05-01 15:10:28 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>Height (z score)</NAME>
<CONT_DATA CI_END="1.4599824212732004" CI_START="-1.4599824212732004" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-1.86" MEAN_2="-1.86" ORDER="50" SD_1="1.02" SD_2="1.02" SE="0.7449026782070259" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2014-03-07 18:49:51 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="230.8003860236737" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="20" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Adherence</NAME>
<GROUP_LABEL_1>Behavioral treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.01" MODIFIED="2014-03-07 14:10:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>Activity level - Resting energy expenditure (% predicted)</NAME>
<CONT_DATA CI_END="31.323131662920108" CI_START="-11.583131662920099" EFFECT_SIZE="9.870000000000005" ESTIMABLE="YES" MEAN_1="119.2" MEAN_2="109.33" ORDER="52" SD_1="5.35" SD_2="18.5" SE="10.945676467598215" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.02" MODIFIED="2014-03-07 14:10:13 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>Activity level -Resting energy expenditure (Kcal/24 hours)</NAME>
<CONT_DATA CI_END="478.6140599003933" CI_START="-182.61405990039327" EFFECT_SIZE="148.0" ESTIMABLE="YES" MEAN_1="1169.0" MEAN_2="1021.0" ORDER="53" SD_1="182.39" SD_2="255.74" SE="168.68374240967424" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.03" MODIFIED="2014-03-07 14:09:52 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>Activity level -Activity points</NAME>
<CONT_DATA CI_END="7.74943377475323" CI_START="-9.74943377475323" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="10.4" MEAN_2="11.4" ORDER="54" SD_1="5.2" SD_2="6.6" SE="4.464078852350169" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.04" MODIFIED="2014-03-07 14:09:19 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>Change in Kcalorie intake</NAME>
<CONT_DATA CI_END="1.545482785438702" CI_START="0.314517214561298" EFFECT_SIZE="0.93" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="0.15" MODIFIED="2014-03-07 14:09:19 +0000" MODIFIED_BY="[Empty name]" ORDER="48" SD_1="0.43" SD_2="0.43" SE="0.31402759963629523" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2014-06-10 10:41:14 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.54" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="5" TOTAL_2="3" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Nutrition status</NAME>
<GROUP_LABEL_1>Behavioral treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.04.01" MODIFIED="2014-06-10 10:41:14 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>% Body Fat</NAME>
<CONT_DATA CI_END="3.112586376487777" CI_START="-4.412586376487777" EFFECT_SIZE="-0.6500000000000004" ESTIMABLE="YES" MEAN_1="11.85" MEAN_2="12.5" MODIFIED="2014-03-07 14:08:17 +0000" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="2.1" SD_2="2.9" SE="1.919722202125436" STUDY_ID="STD-Stark-1996" TOTAL_1="5" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-06-11 15:03:46 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Nutrional intervention plus behavioural management training (BEH) versus nutritional intervention alone (NUT)</NAME>
<CONT_OUTCOME CHI2="11.248725307766321" CI_END="0.21016101134854046" CI_START="-0.028006065397025187" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09107747297575763" ESTIMABLE="YES" I2="37.77072682922504" I2_Q="16.313133840600035" ID="CMP-002.01" MODIFIED="2014-03-07 18:58:46 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1281317756507372" P_Q="0.30544891963049936" P_Z="0.13386852830111295" Q="7.169583801323957" RANDOM="YES" SCALE="5.36" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.024059824988654" TOTALS="SUB" TOTAL_1="185" TOTAL_2="200" UNITS="" WEIGHT="700.0" Z="1.4990196737066737">
<NAME>Anthropometric change scores</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>NUT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NUT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.6419663605188055" CI_END="1.0676139202963235" CI_START="-0.8419544292271688" DF="1" EFFECT_SIZE="0.11282974553457742" ESTIMABLE="YES" I2="72.54230541938482" ID="CMP-002.01.01" MODIFIED="2012-08-13 18:20:26 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.05634055162366536" P_Z="0.816837136708387" STUDIES="2" TAU2="0.3483481506238859" TOTAL_1="37" TOTAL_2="38" WEIGHT="100.0" Z="0.23161489630656468">
<NAME>Change in weight (kg)</NAME>
<CONT_DATA CI_END="0.4098737261933838" CI_START="-1.2698737261933837" EFFECT_SIZE="-0.42999999999999994" ESTIMABLE="YES" MEAN_1="1.32" MEAN_2="1.75" MODIFIED="2012-08-13 18:20:11 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="0.64" SD_2="0.57" SE="0.42851487722131654" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="44.60920963932883"/>
<CONT_DATA CI_END="1.1046341349677773" CI_START="-0.004634134967777315" EFFECT_SIZE="0.5499999999999999" ESTIMABLE="YES" MEAN_1="1.47" MEAN_2="0.92" MODIFIED="2012-08-13 18:20:26 +0100" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="1.27" SD_2="1.03" SE="0.2829817993303247" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="55.39079036067117"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8113112812197429" CI_START="-4.871311281219743" DF="0" EFFECT_SIZE="-2.0300000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.02" MODIFIED="2012-08-13 18:21:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.16141942372994156" STUDIES="1" TAU2="0.0" TOTAL_1="3" TOTAL_2="4" WEIGHT="100.0" Z="1.4003136210082154">
<NAME>Change in height (cm)</NAME>
<CONT_DATA CI_END="0.8113112812197429" CI_START="-4.871311281219743" EFFECT_SIZE="-2.0300000000000002" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="7.13" MODIFIED="2012-08-13 18:21:02 +0100" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="2.36" SD_2="0.99" SE="1.4496752509901427" STUDY_ID="STD-Powers-2003" TOTAL_1="3" TOTAL_2="4" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.376633017299209" CI_START="-1.3366330172992098" DF="0" EFFECT_SIZE="0.5199999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.03" MODIFIED="2013-09-27 13:20:04 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.583046206168707" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0" Z="0.5489406158700124">
<NAME>Change in weight (kg) 2-year follow up</NAME>
<CONT_DATA CI_END="2.376633017299209" CI_START="-1.3366330172992098" EFFECT_SIZE="0.5199999999999996" ESTIMABLE="YES" MEAN_1="6.97" MEAN_2="6.45" MODIFIED="2012-08-13 18:21:20 +0100" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="3.6" SD_2="3.67" SE="0.9472791499966804" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.0549348047173972" CI_START="-1.4549348047173958" DF="0" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.04" MODIFIED="2013-09-27 13:20:08 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.754766122116336" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0" Z="0.31236108476271307">
<NAME>Change in height (cm) 2-year follow up</NAME>
<CONT_DATA CI_END="1.0549348047173972" CI_START="-1.4549348047173958" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="13.34" MEAN_2="13.54" MODIFIED="2012-08-13 18:22:11 +0100" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="1.93" SD_2="2.93" SE="0.6402846249299283" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.42268831023625514" CI_START="-0.022688310236255116" DF="0" EFFECT_SIZE="0.2" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.05" MODIFIED="2012-08-13 18:22:38 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.07836109070344348" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="100.0" Z="1.7602755909914478">
<NAME>BMIz change post intervention</NAME>
<CONT_DATA CI_END="0.42268831023625514" CI_START="-0.022688310236255116" EFFECT_SIZE="0.2" ESTIMABLE="YES" MEAN_1="0.38" MEAN_2="0.18" MODIFIED="2012-08-13 18:22:38 +0100" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="0.46" SD_2="0.47" SE="0.11361857258234952" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6978406509953046" CI_START="0.0021593490046953323" DF="0" EFFECT_SIZE="0.35" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.06" MODIFIED="2013-09-27 13:20:17 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.04859463302584404" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0" Z="1.9721311831327006">
<NAME>BMIz change 2-year follow up</NAME>
<CONT_DATA CI_END="0.6978406509953046" CI_START="0.0021593490046953323" EFFECT_SIZE="0.35" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="-0.22" MODIFIED="2012-08-13 18:24:19 +0100" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="0.81" SD_2="0.5" SE="0.17747298100323644" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.14823006073534822" CI_START="-0.16823006073534824" DF="0" EFFECT_SIZE="-0.010000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.07" MODIFIED="2013-09-27 13:20:13 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.9014197966948742" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0" Z="0.12386799167183805">
<NAME>HAZ change 2-year follow up</NAME>
<CONT_DATA CI_END="0.14823006073534822" CI_START="-0.16823006073534824" EFFECT_SIZE="-0.010000000000000002" ESTIMABLE="YES" MEAN_1="0.03" MEAN_2="0.04" MODIFIED="2012-08-13 18:24:42 +0100" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="0.3" SD_2="0.32" SE="0.08073110627717997" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2014-03-07 20:14:30 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="119.81174526937767" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="16" TOTAL_2="15" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>% Anthropometric</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>NUT</GROUP_LABEL_2>
<GRAPH_LABEL_1>
Favours control
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>
Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.01" MODIFIED="2014-03-07 20:14:30 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>% ideal body weight - baseline</NAME>
<CONT_DATA CI_END="95.51888602899555" CI_START="5.2811139710044515" EFFECT_SIZE="50.400000000000006" ESTIMABLE="YES" MEAN_1="83.9" MEAN_2="33.5" MODIFIED="2012-08-13 18:10:00 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SD_1="27.8" SD_2="36.7" SE="23.020262813443292" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.02" MODIFIED="2014-03-07 20:14:30 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>%Ideal body weight - follow up</NAME>
<CONT_DATA CI_END="75.58519877421952" CI_START="23.394801225780476" EFFECT_SIZE="49.49" ESTIMABLE="YES" MEAN_1="92.39" MEAN_2="42.9" MODIFIED="2012-08-13 18:10:28 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SD_1="16.5" SD_2="18.1" SE="13.314121575730535" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.03" MODIFIED="2014-03-07 20:14:30 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Weight % for age -baseline</NAME>
<CONT_DATA CI_END="47.89852073190033" CI_START="2.701479268099675" EFFECT_SIZE="25.3" ESTIMABLE="YES" MEAN_1="42.0" MEAN_2="16.7" MODIFIED="2012-08-13 18:10:50 +0100" MODIFIED_BY="[Empty name]" ORDER="134" SD_1="13.9" SD_2="18.4" SE="11.530069384006325" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.04" MODIFIED="2014-03-07 20:14:30 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Weight % for age - follow up</NAME>
<CONT_DATA CI_END="36.63165805305048" CI_START="12.768341946949526" EFFECT_SIZE="24.700000000000003" ESTIMABLE="YES" MEAN_1="46.2" MEAN_2="21.5" MODIFIED="2012-08-13 18:11:07 +0100" MODIFIED_BY="[Empty name]" ORDER="135" SD_1="8.2" SD_2="9.0" SE="6.087692502089769" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2014-03-07 18:59:00 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="12.422429584671304" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="178" TOTAL_2="192" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Antropometric</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>NUT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NUT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.01" MODIFIED="2012-07-13 15:43:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>weight (kg) post intervention</NAME>
<CONT_DATA CI_END="3.2846690078253187" CI_START="-3.844669007825314" EFFECT_SIZE="-0.2799999999999976" ESTIMABLE="YES" MEAN_1="23.26" MEAN_2="23.54" MODIFIED="2012-07-13 15:43:44 +0100" MODIFIED_BY="[Empty name]" ORDER="1166" SD_1="7.1" SD_2="7.78" SE="1.8187420972747308" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.02" MODIFIED="2013-09-27 13:20:30 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>weight (kg) 2-year follow up</NAME>
<CONT_DATA CI_END="4.258965549122004" CI_START="-6.258965549122004" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="28.51" MEAN_2="29.51" MODIFIED="2012-07-13 15:55:22 +0100" MODIFIED_BY="[Empty name]" ORDER="1167" SD_1="9.77" SD_2="10.84" SE="2.6831949926651983" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.03" MODIFIED="2013-09-27 13:20:34 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>height (cm) 2-year follow up</NAME>
<CONT_DATA CI_END="5.283303214773104" CI_START="-10.883303214773127" EFFECT_SIZE="-2.8000000000000114" ESTIMABLE="YES" MEAN_1="131.07" MEAN_2="133.87" MODIFIED="2012-07-13 15:56:45 +0100" MODIFIED_BY="[Empty name]" ORDER="1168" SD_1="14.66" SD_2="17.01" SE="4.124210076579559" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.04" MODIFIED="2013-09-27 13:20:39 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>HAZ 2-year follow up</NAME>
<CONT_DATA CI_END="0.23626467845942467" CI_START="-0.5362646784594247" EFFECT_SIZE="-0.15000000000000002" ESTIMABLE="YES" MEAN_1="-0.87" MEAN_2="-0.72" MODIFIED="2012-07-13 16:13:53 +0100" MODIFIED_BY="[Empty name]" ORDER="1173" SD_1="0.77" SD_2="0.74" SE="0.19707743688467297" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.05" MODIFIED="2012-08-14 12:25:28 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0" Z="0.0">
<NAME>BMIZ post intervention</NAME>
<CONT_DATA CI_END="0.3781560487063116" CI_START="-0.5381560487063116" EFFECT_SIZE="-0.08000000000000002" ESTIMABLE="YES" MEAN_1="-0.39" MEAN_2="-0.31" MODIFIED="2012-07-13 16:16:42 +0100" MODIFIED_BY="[Empty name]" ORDER="1175" SD_1="1.08" SD_2="0.81" SE="0.23375738142138736" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.06" MODIFIED="2013-09-27 13:20:43 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>BMIZ 2-year follow up</NAME>
<CONT_DATA CI_END="0.5563331246852045" CI_START="-0.25633312468520464" EFFECT_SIZE="0.1499999999999999" ESTIMABLE="YES" MEAN_1="-0.56" MEAN_2="-0.71" MODIFIED="2012-07-13 16:16:00 +0100" MODIFIED_BY="[Empty name]" ORDER="1176" SD_1="0.9" SD_2="0.66" SE="0.20731662820863464" STUDY_ID="STD-Stark-2009" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2014-03-07 18:59:04 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="59.93022084577825" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="26" TOTAL_2="30" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pulmonary function</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>NUT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NUT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.01" MODIFIED="2013-09-27 13:33:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>FEV<SUB>1</SUB> 2-year follow up</NAME>
<CONT_DATA CI_END="13.028932431209865" CI_START="-13.028932431209865" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="87.0" MEAN_2="87.0" MODIFIED="2012-08-13 17:56:31 +0100" MODIFIED_BY="[Empty name]" ORDER="129" SD_1="18.0" SD_2="17.0" SE="6.647536655765321" STUDY_ID="STD-Stark-2009" TOTAL_1="13" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.02" MODIFIED="2013-09-27 13:33:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>FEV<SUB>1</SUB> change 2-year follow up</NAME>
<CONT_DATA CI_END="18.809208874848867" CI_START="-8.489208874848867" EFFECT_SIZE="5.16" ESTIMABLE="YES" MEAN_1="0.16" MEAN_2="-5.0" MODIFIED="2012-08-13 18:04:04 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SD_1="22.0" SD_2="13.0" SE="6.964010044323306" STUDY_ID="STD-Stark-2009" TOTAL_1="13" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="30.46102596556195" CI_END="22.50207181196399" CI_START="9.766227385789396" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="MD" EFFECT_SIZE="16.134149598876693" ESTIMABLE="YES" I2="60.605397816978545" I2_Q="70.45684867191216" ID="CMP-002.05" MODIFIED="2014-03-07 18:59:04 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0023788830608660883" P_Q="6.851102974191337E-4" P_Z="6.83894290737913E-7" Q="27.079034024356375" RANDOM="YES" SCALE="909.41" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="253.03622278586118" TOTALS="SUB" TOTAL_1="254" TOTAL_2="256" UNITS="" WEIGHT="900.0" Z="4.965882288886901">
<NAME>Adherence (nutrition)</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>NUT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NUT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="35.99202590286474" CI_START="-18.952025902864747" DF="0" EFFECT_SIZE="8.519999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.01" NO="1" P_CHI2="1.0" P_Z="0.5432864311356995" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.00000000000001" Z="0.6078508082121428">
<NAME>% RDA Kcal/day</NAME>
<CONT_DATA CI_END="35.99202590286474" CI_START="-18.952025902864747" EFFECT_SIZE="8.519999999999996" ESTIMABLE="YES" MEAN_1="109.72" MEAN_2="101.2" ORDER="56" SD_1="21.9" SD_2="17.5" SE="14.016597304624257" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4703717611205012" CI_END="485.0481157670848" CI_START="66.64713163824618" DF="2" EFFECT_SIZE="275.8476237026655" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.02" MODIFIED="2012-07-13 15:22:30 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.47941642593709266" P_Z="0.009755716623589029" STUDIES="3" TAU2="0.0" TOTAL_1="40" TOTAL_2="42" WEIGHT="100.00000000000003" Z="2.584369674960891">
<NAME>Total calories per day</NAME>
<CONT_DATA CI_END="467.0312276065112" CI_START="-246.23122760651148" EFFECT_SIZE="110.39999999999986" ESTIMABLE="YES" MEAN_1="1426.6" MEAN_2="1316.2" ORDER="57" SD_1="284.2" SD_2="227.3" SE="181.9580514844012" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="34.41015796989415"/>
<CONT_DATA CI_END="1910.9959718539899" CI_START="-609.1559718539897" EFFECT_SIZE="650.9200000000001" ESTIMABLE="YES" MEAN_1="2864.67" MEAN_2="2213.75" ORDER="58" SD_1="862.0" SD_2="814.0" SE="642.907717587317" STUDY_ID="STD-Stark-2003" TOTAL_1="3" TOTAL_2="4" WEIGHT="2.7563346399481166"/>
<CONT_DATA CI_END="613.9168082263673" CI_START="86.08319177363268" EFFECT_SIZE="350.0" ESTIMABLE="YES" MEAN_1="2665.0" MEAN_2="2315.0" MODIFIED="2012-07-13 15:22:30 +0100" MODIFIED_BY="[Empty name]" ORDER="1155" SD_1="553.0" SD_2="549.0" SE="134.65390706569582" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="62.83350739015775"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9116201800850732" CI_END="536.1311113286529" CI_START="191.9949479486308" DF="2" EFFECT_SIZE="364.06302963864186" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.03" MODIFIED="2013-09-06 13:08:56 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.3845006120901129" P_Z="3.369960631510112E-5" STUDIES="3" TAU2="0.0" TOTAL_1="40" TOTAL_2="42" WEIGHT="100.0" Z="4.146907544885471">
<NAME>Change in calorie intake</NAME>
<CONT_DATA CI_END="570.6749962357935" CI_START="-366.53499623579336" EFFECT_SIZE="102.07000000000005" ESTIMABLE="YES" MEAN_1="405.97" MEAN_2="303.9" ORDER="59" SD_1="310.62" SD_2="363.55" SE="239.08857506162857" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="13.483008383139486"/>
<CONT_DATA CI_END="1224.08644615694" CI_START="11.913553843059958" EFFECT_SIZE="618.0" ESTIMABLE="YES" MEAN_1="1036.0" MEAN_2="418.0" ORDER="60" SD_1="401.0" SD_2="410.0" SE="309.2334608889105" STUDY_ID="STD-Stark-2003" TOTAL_1="3" TOTAL_2="4" WEIGHT="8.059934080593887"/>
<CONT_DATA CI_END="577.2604135057445" CI_START="188.7395864942555" EFFECT_SIZE="383.0" ESTIMABLE="YES" MEAN_1="872.0" MEAN_2="489.0" MODIFIED="2012-07-13 15:23:37 +0100" MODIFIED_BY="[Empty name]" ORDER="1156" SD_1="478.0" SD_2="314.0" SE="99.11427711837862" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="78.45705753626662"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.186321468042827E-33" CI_END="440.56021202877844" CI_START="-216.56021202877844" DF="0" EFFECT_SIZE="111.99999999999999" ESTIMABLE="YES" I2="100.0" ID="CMP-002.05.04" MODIFIED="2013-09-27 13:19:12 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.5040602692298279" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0" Z="0.6681148788924532">
<NAME>2-year follow up caloric intake</NAME>
<CONT_DATA CI_END="440.56021202877844" CI_START="-216.56021202877844" EFFECT_SIZE="112.0" ESTIMABLE="YES" MEAN_1="2523.0" MEAN_2="2411.0" MODIFIED="2012-07-13 15:25:57 +0100" MODIFIED_BY="[Empty name]" ORDER="1157" SD_1="620.0" SD_2="577.0" SE="167.6358415871003" STUDY_ID="STD-Stark-2009" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="451.569568944683" CI_START="-75.569568944683" DF="0" EFFECT_SIZE="188.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.05" MODIFIED="2013-09-27 13:19:19 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.1621096814461648" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0" Z="1.3980112748557252">
<NAME>2-year follow up change in caloric intake</NAME>
<CONT_DATA CI_END="451.569568944683" CI_START="-75.569568944683" EFFECT_SIZE="188.0" ESTIMABLE="YES" MEAN_1="721.0" MEAN_2="533.0" MODIFIED="2012-07-13 15:28:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1158" SD_1="522.0" SD_2="436.0" SE="134.4767409114076" STUDY_ID="STD-Stark-2009" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="34.24319110324994" CI_START="7.756808896750059" DF="0" EFFECT_SIZE="21.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.06" MODIFIED="2013-09-27 13:19:45 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.001883866699738523" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="100.00000000000001" Z="3.1079551261055554">
<NAME>Estimated energy requirements (%EER)</NAME>
<CONT_DATA CI_END="34.24319110324994" CI_START="7.756808896750059" EFFECT_SIZE="21.0" ESTIMABLE="YES" MEAN_1="148.0" MEAN_2="127.0" MODIFIED="2012-07-13 15:29:18 +0100" MODIFIED_BY="[Empty name]" ORDER="1159" SD_1="30.0" SD_2="25.0" SE="6.7568543135029735" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="32.77651263979746" CI_START="9.223487360202544" DF="0" EFFECT_SIZE="21.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.07" MODIFIED="2012-07-13 15:30:16 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="4.7401168503208134E-4" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="34" WEIGHT="100.0" Z="3.4950281916437564">
<NAME>Change in %EER</NAME>
<CONT_DATA CI_END="32.77651263979746" CI_START="9.223487360202544" EFFECT_SIZE="21.0" ESTIMABLE="YES" MEAN_1="48.0" MEAN_2="27.0" MODIFIED="2012-07-13 15:30:16 +0100" MODIFIED_BY="[Empty name]" ORDER="1160" SD_1="29.0" SD_2="19.0" SE="6.008535224467941" STUDY_ID="STD-Stark-2009" TOTAL_1="33" TOTAL_2="34" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="23.093511300469984" CI_START="-5.093511300469986" DF="0" EFFECT_SIZE="9.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.08" MODIFIED="2013-09-27 13:19:25 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Z="0.21070954531985653" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0" Z="1.2516168245646666">
<NAME>2-year follow up %EER</NAME>
<CONT_DATA CI_END="23.093511300469984" CI_START="-5.093511300469986" EFFECT_SIZE="9.0" ESTIMABLE="YES" MEAN_1="126.0" MEAN_2="117.0" MODIFIED="2012-07-13 15:32:47 +0100" MODIFIED_BY="[Empty name]" ORDER="1161" SD_1="29.0" SD_2="22.0" SE="7.190699120819466" STUDY_ID="STD-Stark-2009" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="22.725131352019652" CI_START="-4.72513135201965" DF="0" EFFECT_SIZE="9.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.09" MODIFIED="2013-09-27 13:19:30 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Z="0.19871891528538385" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0" Z="1.2852099851317498">
<NAME>2-year follow up change in %EER</NAME>
<CONT_DATA CI_END="22.72513135201965" CI_START="-4.725131352019648" EFFECT_SIZE="9.0" ESTIMABLE="YES" MEAN_1="25.0" MEAN_2="16.0" MODIFIED="2012-07-13 15:35:00 +0100" MODIFIED_BY="[Empty name]" ORDER="1162" SD_1="25.0" SD_2="25.0" SE="7.002746713858894" STUDY_ID="STD-Stark-2009" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2014-03-07 18:57:52 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="28.74" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="4" TOTAL_2="4" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Relational</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>NUT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NUT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.06.01" MODIFIED="2008-04-30 16:18:37 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>Nursing Child Assessment Satellite Training Feeding Scale (NCAST) - Caregiver / Infant total score</NAME>
<CONT_DATA CI_END="9.596947301554403" CI_START="-0.39694730155440006" EFFECT_SIZE="4.600000000000001" ESTIMABLE="YES" MEAN_1="59.4" MEAN_2="54.8" ORDER="55" SD_1="2.2" SD_2="4.6" SE="2.5495097567963922" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2014-06-11 15:03:46 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="40.55" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="4" TOTAL_2="3" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Nutritional status</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>NUT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours BEH</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NUT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.07.01" MODIFIED="2014-03-07 19:01:13 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="3" WEIGHT="0.0" Z="0.0">
<NAME>% Body fat</NAME>
<CONT_DATA CI_END="9.83045278241329" CI_START="-9.430452782413285" EFFECT_SIZE="0.20000000000000284" ESTIMABLE="YES" MEAN_1="35.6" MEAN_2="35.4" MODIFIED="2014-03-07 19:01:13 +0000" MODIFIED_BY="[Empty name]" ORDER="131" SD_1="7.4" SD_2="5.6" SE="4.913586605864736" STUDY_ID="STD-Powers-2003" TOTAL_1="4" TOTAL_2="3" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-03-05 13:04:47 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Behavioral and nutritional intervention (BEH) versus standard care control (CTL)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2014-03-05 13:04:47 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="4" TOTAL_2="6" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>total energy intake per day (kcal)</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>CTL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CTL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.01" MODIFIED="2008-05-01 15:56:06 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="6" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment</NAME>
<CONT_DATA CI_END="1692.034485900099" CI_START="266.16551409990075" EFFECT_SIZE="979.0999999999999" ESTIMABLE="YES" MEAN_1="2235.1" MEAN_2="1256.0" ORDER="68" SD_1="706.0" SD_2="215.0" SE="363.7487686118905" STUDY_ID="STD-Powers-2005" TOTAL_1="4" TOTAL_2="6" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2014-03-05 13:04:03 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="64.65116656253296" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="4" TOTAL_2="6" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>% fat intake</NAME>
<GROUP_LABEL_1>BEH</GROUP_LABEL_1>
<GROUP_LABEL_2>CTL</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CTL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BEH</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.02.01" MODIFIED="2008-05-01 15:56:09 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="6" WEIGHT="0.0" Z="0.0">
<NAME>post-treatment</NAME>
<CONT_DATA CI_END="21.312617625552445" CI_START="-0.5126176255524477" EFFECT_SIZE="10.399999999999999" ESTIMABLE="YES" MEAN_1="39.5" MEAN_2="29.1" ORDER="69" SD_1="10.0" SD_2="6.0" SE="5.5677643628300215" STUDY_ID="STD-Powers-2005" TOTAL_1="4" TOTAL_2="6" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2014-03-07 20:25:57 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Educational problem-solving and social skills intervention versus usual care</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2014-03-07 20:24:25 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="32.16" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pulmonary function (FEV<SUB>1</SUB>)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.01" MODIFIED="2012-08-12 15:05:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="8.817238448766373" CI_START="-4.777238448766381" EFFECT_SIZE="2.019999999999996" ESTIMABLE="YES" MEAN_1="84.36" MEAN_2="82.34" MODIFIED="2012-07-03 15:17:15 +0100" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="19.54" SD_2="17.77" SE="3.4680425264862653" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.02" MODIFIED="2012-08-12 15:05:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="9.978077139518895" CI_START="-3.2780771395189054" EFFECT_SIZE="3.3499999999999943" ESTIMABLE="YES" MEAN_1="83.78" MEAN_2="80.43" MODIFIED="2012-07-03 15:18:27 +0100" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="17.73" SD_2="18.68" SE="3.3817341501172096" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.03" MODIFIED="2012-08-12 15:06:10 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="4.159066946959617" CI_START="-9.039066946959611" EFFECT_SIZE="-2.4399999999999977" ESTIMABLE="YES" MEAN_1="81.67" MEAN_2="84.11" MODIFIED="2012-07-03 15:19:34 +0100" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="18.61" SD_2="17.64" SE="3.3669327594854863" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2014-03-07 20:25:18 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="11.25" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Height (cm)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.02.01" MODIFIED="2012-08-12 15:06:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="4.233586246021137" CI_START="-2.2335862460211366" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="132.96" MEAN_2="131.96" MODIFIED="2012-07-03 15:23:03 +0100" MODIFIED_BY="[Empty name]" ORDER="72" SD_1="9.52" SD_2="8.2" SE="1.6498192168464585" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.02.02" MODIFIED="2012-08-12 15:07:00 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="6.693593769732776" CI_START="-3.033593769732751" EFFECT_SIZE="1.8300000000000125" ESTIMABLE="YES" MEAN_1="133.9" MEAN_2="132.07" MODIFIED="2012-07-03 15:23:26 +0100" MODIFIED_BY="[Empty name]" ORDER="73" SD_1="9.88" SD_2="16.11" SE="2.4814709903325625" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.02.03" MODIFIED="2012-08-12 15:07:10 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="2.84413587227432" CI_START="-3.924135872274304" EFFECT_SIZE="-0.539999999999992" ESTIMABLE="YES" MEAN_1="135.4" MEAN_2="135.94" MODIFIED="2012-07-03 15:23:54 +0100" MODIFIED_BY="[Empty name]" ORDER="74" SD_1="10.05" SD_2="8.48" SE="1.7266316620958058" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2014-03-07 20:25:57 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.72" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Weight in (kg)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.03.01" MODIFIED="2012-08-12 15:07:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="2.3235397895976386" CI_START="-1.9835397895976423" EFFECT_SIZE="0.16999999999999815" ESTIMABLE="YES" MEAN_1="29.08" MEAN_2="28.91" MODIFIED="2012-07-03 15:26:00 +0100" MODIFIED_BY="[Empty name]" ORDER="75" SD_1="6.07" SD_2="5.76" SE="1.0987649806754038" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.03.02" MODIFIED="2012-08-12 15:07:41 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="2.6339520922676694" CI_START="-2.09395209226767" EFFECT_SIZE="0.2699999999999996" ESTIMABLE="YES" MEAN_1="30.27" MEAN_2="30.0" MODIFIED="2012-07-03 15:26:19 +0100" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="6.54" SD_2="6.45" SE="1.2061201690001562" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.03.03" MODIFIED="2012-08-12 15:07:50 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="1.9704199790379424" CI_START="-3.0304199790379376" EFFECT_SIZE="-0.5299999999999976" ESTIMABLE="YES" MEAN_1="30.76" MEAN_2="31.29" MODIFIED="2012-07-03 15:26:42 +0100" MODIFIED_BY="[Empty name]" ORDER="77" SD_1="6.6" SD_2="7.13" SE="1.275747921268418" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.04" MODIFIED="2014-03-07 20:25:57 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="24.5773518923273" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Perceived illness experience</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.04.01" MODIFIED="2012-08-12 15:07:59 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="4.0686893222758815" CI_START="-12.688689322275872" EFFECT_SIZE="-4.309999999999995" ESTIMABLE="YES" MEAN_1="63.9" MEAN_2="68.21" MODIFIED="2012-07-03 15:42:49 +0100" MODIFIED_BY="[Empty name]" ORDER="78" SD_1="22.79" SD_2="23.25" SE="4.274920043616061" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.04.02" MODIFIED="2012-08-12 15:08:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="6.849931060371346" CI_START="-9.02993106037134" EFFECT_SIZE="-1.0899999999999963" ESTIMABLE="YES" MEAN_1="62.81" MEAN_2="63.9" MODIFIED="2012-07-03 15:43:11 +0100" MODIFIED_BY="[Empty name]" ORDER="79" SD_1="21.65" SD_2="21.98" SE="4.051059674055495" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.04.03" MODIFIED="2012-08-12 15:08:25 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="0.7842954330466139" CI_START="-13.984295433046602" EFFECT_SIZE="-6.599999999999994" ESTIMABLE="YES" MEAN_1="57.45" MEAN_2="64.05" MODIFIED="2012-07-03 15:43:34 +0100" MODIFIED_BY="[Empty name]" ORDER="80" SD_1="18.91" SD_2="21.58" SE="3.767566899847644" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.05" MODIFIED="2014-03-07 20:25:53 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="14.21415749316967" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Children's loneliness</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.01" MODIFIED="2012-08-12 15:08:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="2.7407674815154666" CI_START="-4.26076748151547" EFFECT_SIZE="-0.7600000000000016" ESTIMABLE="YES" MEAN_1="24.36" MEAN_2="25.12" MODIFIED="2012-07-03 15:47:02 +0100" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="9.35" SD_2="9.88" SE="1.7861386786334215" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.02" MODIFIED="2012-08-12 15:08:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="3.561335633592468" CI_START="-2.781335633592467" EFFECT_SIZE="0.39000000000000057" ESTIMABLE="YES" MEAN_1="24.18" MEAN_2="23.79" MODIFIED="2012-07-03 15:47:23 +0100" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="8.32" SD_2="9.09" SE="1.6180581166835504" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.03" MODIFIED="2012-08-12 15:09:08 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="1.3903332654785236" CI_START="-5.730333265478527" EFFECT_SIZE="-2.1700000000000017" ESTIMABLE="YES" MEAN_1="22.33" MEAN_2="24.5" MODIFIED="2012-07-03 15:47:42 +0100" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="8.23" SD_2="11.12" SE="1.81652994318364" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.06" MODIFIED="2014-03-07 20:25:50 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="13.47" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Social support - peers</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.06.01" MODIFIED="2012-08-12 15:09:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="2.090846359630172" CI_START="-0.5908463596301716" EFFECT_SIZE="0.75" ESTIMABLE="YES" MEAN_1="21.6" MEAN_2="20.85" MODIFIED="2012-07-03 15:51:28 +0100" MODIFIED_BY="[Empty name]" ORDER="84" SD_1="3.15" SD_2="4.15" SE="0.6841178563517476" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.06.02" MODIFIED="2012-08-12 15:09:31 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.0275961175932617" CI_START="-1.127596117593256" EFFECT_SIZE="-0.04999999999999716" ESTIMABLE="YES" MEAN_1="21.69" MEAN_2="21.74" MODIFIED="2012-07-03 15:51:50 +0100" MODIFIED_BY="[Empty name]" ORDER="85" SD_1="2.77" SD_2="3.14" SE="0.5498040403258425" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.06.03" MODIFIED="2012-08-12 15:09:40 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="0.9521260821245541" CI_START="-1.1321260821245538" EFFECT_SIZE="-0.08999999999999986" ESTIMABLE="YES" MEAN_1="21.76" MEAN_2="21.85" MODIFIED="2012-07-03 15:52:17 +0100" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="2.23" SD_2="3.38" SE="0.5317067509121144" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.07" MODIFIED="2014-03-07 20:25:46 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="14.997272575695195" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Social support - classmates</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.07.01" MODIFIED="2012-08-12 15:09:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1.709514673924665" CI_START="-1.5895146739246604" EFFECT_SIZE="0.060000000000002274" ESTIMABLE="YES" MEAN_1="19.71" MEAN_2="19.65" MODIFIED="2012-07-03 15:56:21 +0100" MODIFIED_BY="[Empty name]" ORDER="87" SD_1="4.27" SD_2="4.78" SE="0.8416045840310454" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.07.02" MODIFIED="2012-08-12 15:09:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.8132418846325593" CI_START="-1.1132418846325636" EFFECT_SIZE="0.34999999999999787" ESTIMABLE="YES" MEAN_1="20.7" MEAN_2="20.35" MODIFIED="2012-07-03 15:56:37 +0100" MODIFIED_BY="[Empty name]" ORDER="88" SD_1="3.3" SD_2="4.63" SE="0.7465657002753248" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.07.03" MODIFIED="2012-08-12 15:10:07 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="2.860715905868076" CI_START="-0.2007159058680723" EFFECT_SIZE="1.3300000000000018" ESTIMABLE="YES" MEAN_1="21.05" MEAN_2="19.72" MODIFIED="2012-07-03 15:56:59 +0100" MODIFIED_BY="[Empty name]" ORDER="89" SD_1="3.11" SD_2="5.07" SE="0.7809918539025033" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.08" MODIFIED="2014-03-07 20:25:43 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="19.05729816815738" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self competence - subscale 'global self-worth'</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.08.01" MODIFIED="2012-08-12 15:10:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1.5629426065073184" CI_START="-0.8429426065073125" EFFECT_SIZE="0.360000000000003" ESTIMABLE="YES" MEAN_1="21.17" MEAN_2="20.81" MODIFIED="2012-07-03 16:00:06 +0100" MODIFIED_BY="[Empty name]" ORDER="90" SD_1="3.27" SD_2="3.34" SE="0.6137575057480511" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.08.02" MODIFIED="2012-08-12 15:11:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.4255627836177749" CI_START="-0.8055627836177774" EFFECT_SIZE="0.3099999999999987" ESTIMABLE="YES" MEAN_1="21.72" MEAN_2="21.41" MODIFIED="2012-07-03 16:00:27 +0100" MODIFIED_BY="[Empty name]" ORDER="91" SD_1="3.04" SD_2="3.09" SE="0.5691751442461153" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.08.03" MODIFIED="2012-08-12 15:11:31 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="1.7984977231351182" CI_START="-0.5384977231351202" EFFECT_SIZE="0.629999999999999" ESTIMABLE="YES" MEAN_1="21.9" MEAN_2="21.27" MODIFIED="2012-07-03 16:00:52 +0100" MODIFIED_BY="[Empty name]" ORDER="92" SD_1="2.94" SD_2="3.46" SE="0.5961832627293563" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.09" MODIFIED="2014-03-07 20:25:40 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="12.76" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self-competence - subscale 'scholastic competence'</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.09.01" MODIFIED="2012-08-12 15:11:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1.9415087709226608" CI_START="-1.3815087709226586" EFFECT_SIZE="0.28000000000000114" ESTIMABLE="YES" MEAN_1="18.76" MEAN_2="18.48" MODIFIED="2012-07-03 16:18:26 +0100" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="4.53" SD_2="4.6" SE="0.8477241337230831" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.09.02" MODIFIED="2012-08-12 15:11:55 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="2.0285336047497715" CI_START="-0.9285336047497701" EFFECT_SIZE="0.5500000000000007" ESTIMABLE="YES" MEAN_1="19.5" MEAN_2="18.95" MODIFIED="2012-07-03 16:18:45 +0100" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="3.81" SD_2="4.3" SE="0.7543677416586504" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.09.03" MODIFIED="2012-08-12 15:12:05 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="2.1659264772359292" CI_START="-0.6459264772359261" EFFECT_SIZE="0.7600000000000016" ESTIMABLE="YES" MEAN_1="20.05" MEAN_2="19.29" MODIFIED="2012-07-03 16:19:05 +0100" MODIFIED_BY="[Empty name]" ORDER="95" SD_1="3.42" SD_2="4.26" SE="0.7173226081324434" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.10" MODIFIED="2014-03-07 20:25:37 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="13.469926714150821" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self-competence - subscale 'social acceptance'</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.10.01" MODIFIED="2012-08-12 15:12:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1.086856270232164" CI_START="-1.846856270232162" EFFECT_SIZE="-0.379999999999999" ESTIMABLE="YES" MEAN_1="19.09" MEAN_2="19.47" MODIFIED="2012-07-03 16:22:33 +0100" MODIFIED_BY="[Empty name]" ORDER="96" SD_1="4.08" SD_2="3.98" SE="0.7484098084467562" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.10.02" MODIFIED="2012-08-12 15:12:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.5748039994929022" CI_START="-1.0948039994929053" EFFECT_SIZE="0.23999999999999844" ESTIMABLE="YES" MEAN_1="20.09" MEAN_2="19.85" MODIFIED="2012-07-03 16:22:54 +0100" MODIFIED_BY="[Empty name]" ORDER="97" SD_1="3.53" SD_2="3.8" SE="0.6810349628981284" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.10.03" MODIFIED="2012-08-12 15:12:36 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="1.8802737269627527" CI_START="-0.8402737269627536" EFFECT_SIZE="0.5199999999999996" ESTIMABLE="YES" MEAN_1="20.31" MEAN_2="19.79" MODIFIED="2012-07-03 16:23:19 +0100" MODIFIED_BY="[Empty name]" ORDER="98" SD_1="3.42" SD_2="4.03" SE="0.694029960597449" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.11" MODIFIED="2014-03-07 20:25:33 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="12.422429584671304" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self-competence - subscale 'athletic competence'</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.11.01" MODIFIED="2012-08-12 15:12:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="2.0814678034008285" CI_START="-0.9014678034008288" EFFECT_SIZE="0.5899999999999999" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="18.41" MODIFIED="2012-07-03 16:24:10 +0100" MODIFIED_BY="[Empty name]" ORDER="99" SD_1="3.94" SD_2="4.25" SE="0.7609669438649569" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.11.02" MODIFIED="2012-08-12 15:12:55 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.751790500014654" CI_START="-1.0917905000146575" EFFECT_SIZE="0.3299999999999983" ESTIMABLE="YES" MEAN_1="18.97" MEAN_2="18.64" MODIFIED="2012-07-03 16:24:27 +0100" MODIFIED_BY="[Empty name]" ORDER="100" SD_1="3.38" SD_2="4.37" SE="0.7254166460351097" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.11.03" MODIFIED="2012-08-12 15:13:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="1.6229340978873472" CI_START="-1.3829340978873523" EFFECT_SIZE="0.11999999999999744" ESTIMABLE="YES" MEAN_1="18.9" MEAN_2="18.78" MODIFIED="2012-07-03 16:24:46 +0100" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="3.77" SD_2="4.46" SE="0.7668172016130409" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.12" MODIFIED="2014-03-07 20:25:30 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="6.654322137572321" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self-competence - subscale 'physical appearance'</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.12.01" MODIFIED="2012-08-12 15:13:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1.6957355512224592" CI_START="-0.9357355512224612" EFFECT_SIZE="0.379999999999999" ESTIMABLE="YES" MEAN_1="20.66" MEAN_2="20.28" MODIFIED="2012-07-03 16:25:42 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="3.27" SD_2="3.93" SE="0.6713059839878764" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.12.02" MODIFIED="2012-08-12 15:13:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.7248652822186754" CI_START="-0.8248652822186768" EFFECT_SIZE="0.4499999999999993" ESTIMABLE="YES" MEAN_1="20.98" MEAN_2="20.53" MODIFIED="2012-07-03 16:26:02 +0100" MODIFIED_BY="[Empty name]" ORDER="103" SD_1="3.36" SD_2="3.64" SE="0.6504534227540153" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.12.03" MODIFIED="2012-08-12 15:13:41 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="1.992919662708337" CI_START="-0.492919662708337" EFFECT_SIZE="0.75" ESTIMABLE="YES" MEAN_1="21.1" MEAN_2="20.35" MODIFIED="2012-07-03 16:26:20 +0100" MODIFIED_BY="[Empty name]" ORDER="104" SD_1="3.08" SD_2="3.72" SE="0.6341543377900455" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.13" MODIFIED="2014-03-07 20:25:27 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="8.317167152828691" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self-competence - subscale 'behavioral conduct'</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.13.01" MODIFIED="2012-08-12 15:13:54 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="2.1286082232109473" CI_START="-0.8886082232109451" EFFECT_SIZE="0.620000000000001" ESTIMABLE="YES" MEAN_1="19.78" MEAN_2="19.16" MODIFIED="2012-07-03 16:26:56 +0100" MODIFIED_BY="[Empty name]" ORDER="105" SD_1="4.16" SD_2="4.13" SE="0.7697122167094167" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.13.02" MODIFIED="2012-08-12 15:14:03 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.634803501700356" CI_START="-1.3548035017003548" EFFECT_SIZE="0.14000000000000057" ESTIMABLE="YES" MEAN_1="19.78" MEAN_2="19.64" MODIFIED="2012-07-03 16:27:17 +0100" MODIFIED_BY="[Empty name]" ORDER="106" SD_1="3.78" SD_2="4.41" SE="0.7626688620256161" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.13.03" MODIFIED="2012-08-12 15:14:11 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="1.560699418369581" CI_START="-1.2406994183695879" EFFECT_SIZE="0.1599999999999966" ESTIMABLE="YES" MEAN_1="20.33" MEAN_2="20.17" MODIFIED="2012-07-03 16:27:56 +0100" MODIFIED_BY="[Empty name]" ORDER="107" SD_1="3.68" SD_2="4.01" SE="0.7146556923586977" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.14" MODIFIED="2014-03-07 20:25:23 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="13.837300323007986" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="174" TOTAL_2="174" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Functional health status</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours usual care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.14.01" MODIFIED="2012-08-12 14:54:32 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1.764285939142483" CI_START="-1.8642859391424826" EFFECT_SIZE="-0.04999999999999982" ESTIMABLE="YES" MEAN_1="4.67" MEAN_2="4.72" MODIFIED="2012-07-03 15:12:24 +0100" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="4.52" SD_2="5.41" SE="0.9256731008596784" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.14.02" MODIFIED="2012-08-12 14:54:54 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.773277556587676" CI_START="-1.433277556587676" EFFECT_SIZE="0.16999999999999993" ESTIMABLE="YES" MEAN_1="4.45" MEAN_2="4.28" MODIFIED="2012-07-03 15:12:56 +0100" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="4.37" SD_2="4.44" SE="0.8180137845563106" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.14.03" MODIFIED="2012-08-12 14:55:06 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>9 months</NAME>
<CONT_DATA CI_END="2.2615421145810153" CI_START="-0.8015421145810144" EFFECT_SIZE="0.7300000000000004" ESTIMABLE="YES" MEAN_1="4.83" MEAN_2="4.1" MODIFIED="2012-07-03 15:13:23 +0100" MODIFIED_BY="[Empty name]" ORDER="68" SD_1="4.46" SD_2="3.94" SE="0.781413396706074" STUDY_ID="STD-Christian-2006" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2014-03-07 20:36:57 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Written self-disclosure intervention versus standard care</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2014-03-05 12:53:25 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="9.81" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="72" TOTAL_2="84" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Subjective health status - PHQ</NAME>
<GROUP_LABEL_1>intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>standard care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.01" MODIFIED="2013-09-27 13:35:16 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>PHQ- Depression scale 3-month follow up</NAME>
<CONT_DATA CI_END="1.1104254670749603" CI_START="-4.11042546707496" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="12.4" MEAN_2="13.9" MODIFIED="2012-08-03 15:30:38 +0100" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="4.1" SD_2="4.2" SE="1.3318742016004699" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.02" MODIFIED="2013-09-27 13:35:28 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>PHQ- Anxiety scale 3-month follow up</NAME>
<CONT_DATA CI_END="0.6752006337077134" CI_START="-2.2752006337077146" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="15.3" MEAN_2="16.1" MODIFIED="2012-08-03 15:33:12 +0100" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="1.4" SD_2="3.1" SE="0.752667214981453" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.03" MODIFIED="2013-09-27 13:35:34 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>PHQ- Somatic complaints 3-month follow up</NAME>
<CONT_DATA CI_END="-0.8397941518182859" CI_START="-5.360205848181714" EFFECT_SIZE="-3.1" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="7.0" MODIFIED="2012-08-03 15:33:38 +0100" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="3.4" SD_2="3.8" SE="1.153187439162112" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.04" MODIFIED="2013-09-27 13:35:41 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>PHQ- Stressfull life events 3-month follow up</NAME>
<CONT_DATA CI_END="3.952330127280675" CI_START="-2.952330127280675" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="14.8" MEAN_2="14.3" MODIFIED="2012-08-03 15:34:57 +0100" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="6.9" SD_2="3.1" SE="1.7614252886850035" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2014-03-05 12:53:09 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="15.82123018695889" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="36" TOTAL_2="42" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Subjective health status - SF-12</NAME>
<GROUP_LABEL_1>intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>standard care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours standard care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.01" MODIFIED="2012-08-12 19:29:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Physical health status 3 month follow-up</NAME>
<CONT_DATA CI_END="6.897952212336205" CI_START="-5.897952212336205" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="43.8" MEAN_2="43.3" MODIFIED="2012-08-12 19:29:47 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="10.3" SD_2="10.0" SE="3.2643213154947923" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.02" MODIFIED="2012-08-12 19:30:07 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Mental health status 3 month follow-up</NAME>
<CONT_DATA CI_END="9.410826367375876" CI_START="-1.0108263673758708" EFFECT_SIZE="4.200000000000003" ESTIMABLE="YES" MEAN_1="53.7" MEAN_2="49.5" MODIFIED="2012-08-12 19:30:07 +0100" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="7.5" SD_2="9.1" SE="2.658633734332981" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="11.131543975177827" CI_START="-14.931543975177824" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.8999999999999986" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.03" MODIFIED="2014-03-07 20:36:53 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.7750597389085363" Q="0.0" RANDOM="YES" SCALE="69.73121232387503" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="SUB" TOTAL_1="18" TOTAL_2="21" UNITS="" WEIGHT="0.0" Z="0.28576288256551613">
<NAME>FEV<SUB>1</SUB> 3-month follow up</NAME>
<GROUP_LABEL_1>intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>standard care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours standard care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_DATA CI_END="11.131543975177827" CI_START="-14.931543975177824" EFFECT_SIZE="-1.8999999999999986" ESTIMABLE="YES" MEAN_1="48.5" MEAN_2="50.4" MODIFIED="2012-08-12 19:23:32 +0100" MODIFIED_BY="[Empty name]" ORDER="129" SD_1="21.2" SD_2="20.1" SE="6.648869100641124" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.04" MODIFIED="2014-03-07 20:36:57 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.55" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="18" TOTAL_2="21" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BMI 3-month follow up</NAME>
<GROUP_LABEL_1>intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>standard care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours standard care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9514950083766016" CI_START="-1.3514950083766002" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="19.3" MEAN_2="19.0" MODIFIED="2012-08-12 19:17:16 +0100" MODIFIED_BY="[Empty name]" ORDER="128" SD_1="3.0" SD_2="2.1" SE="0.8426149773176358" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2014-03-07 20:36:57 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="16.688084653665005" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="36" TOTAL_2="42" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health care utilization</NAME>
<GROUP_LABEL_1>intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>standard care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.01" MODIFIED="2013-09-27 13:36:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Outpatient utilization 3-month follow up</NAME>
<CONT_DATA CI_END="0.32564277435636635" CI_START="-1.9256427743563664" EFFECT_SIZE="-0.8" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="2.0" MODIFIED="2012-08-03 15:17:47 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="1.0" SD_2="2.4" SE="0.5743180911666198" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.02" MODIFIED="2013-09-27 13:36:18 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Inpatient utilization 3-month follow up</NAME>
<CONT_DATA CI_END="2.4264539596151664" CI_START="-8.026453959615168" EFFECT_SIZE="-2.8000000000000007" ESTIMABLE="YES" MEAN_1="5.6" MEAN_2="8.4" MODIFIED="2012-08-03 15:22:07 +0100" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="7.0" SD_2="9.6" SE="2.6666071421927997" STUDY_ID="STD-Taylor-2003" TOTAL_1="18" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2014-03-07 20:41:10 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Motivational Interviewing via telephone (3-month period) versus treatment as usual</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2014-03-07 20:41:03 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="59.93022084577825" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="144" TOTAL_2="171" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life</NAME>
<GROUP_LABEL_1>MI via telephone</GROUP_LABEL_1>
<GROUP_LABEL_2>treatment as usual</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MI via telephone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.01" MODIFIED="2012-08-05 19:48:36 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Physical functioning</NAME>
<CONT_DATA CI_END="10.144950567110111" CI_START="-6.6449505671101115" EFFECT_SIZE="1.75" ESTIMABLE="YES" MEAN_1="77.12" MEAN_2="75.37" MODIFIED="2012-08-05 19:48:36 +0100" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="14.35" SD_2="10.2" SE="4.283216749556834" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.02" MODIFIED="2012-08-05 19:49:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Social functioning</NAME>
<CONT_DATA CI_END="17.10859325979176" CI_START="-3.54859325979176" EFFECT_SIZE="6.780000000000001" ESTIMABLE="YES" MEAN_1="91.25" MEAN_2="84.47" MODIFIED="2012-08-05 19:49:04 +0100" MODIFIED_BY="[Empty name]" ORDER="149" SD_1="13.6" SD_2="17.55" SE="5.269787272247035" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.03" MODIFIED="2012-08-05 19:49:46 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Treatment issues</NAME>
<CONT_DATA CI_END="13.921496203669452" CI_START="-20.10149620366946" EFFECT_SIZE="-3.0900000000000034" ESTIMABLE="YES" MEAN_1="73.75" MEAN_2="76.84" MODIFIED="2012-08-05 19:49:46 +0100" MODIFIED_BY="[Empty name]" ORDER="150" SD_1="30.96" SD_2="17.12" SE="8.679494285534819" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.04" MODIFIED="2012-08-05 19:50:15 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Chest symptoms</NAME>
<CONT_DATA CI_END="14.688337098104556" CI_START="-5.908337098104555" EFFECT_SIZE="4.390000000000001" ESTIMABLE="YES" MEAN_1="82.81" MEAN_2="78.42" MODIFIED="2012-08-05 19:50:15 +0100" MODIFIED_BY="[Empty name]" ORDER="151" SD_1="14.49" SD_2="16.59" SE="5.254350171399334" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.05" MODIFIED="2012-08-05 19:50:45 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Emotional functioning</NAME>
<CONT_DATA CI_END="16.2882130319361" CI_START="-0.528213031936108" EFFECT_SIZE="7.8799999999999955" ESTIMABLE="YES" MEAN_1="91.56" MEAN_2="83.68" MODIFIED="2012-08-05 19:50:45 +0100" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="10.32" SD_2="14.94" SE="4.289983437583045" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.06" MODIFIED="2012-08-05 19:51:09 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Concerns for the future</NAME>
<CONT_DATA CI_END="15.459002127961647" CI_START="-18.059002127961655" EFFECT_SIZE="-1.3000000000000043" ESTIMABLE="YES" MEAN_1="49.58" MEAN_2="50.88" MODIFIED="2012-08-05 19:51:09 +0100" MODIFIED_BY="[Empty name]" ORDER="153" SD_1="27.46" SD_2="22.22" SE="8.550668410314945" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.07" MODIFIED="2012-08-05 19:51:37 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Interpersonal relationships</NAME>
<CONT_DATA CI_END="14.604502161072968" CI_START="-10.764502161072965" EFFECT_SIZE="1.9200000000000017" ESTIMABLE="YES" MEAN_1="64.87" MEAN_2="62.95" MODIFIED="2012-08-05 19:51:37 +0100" MODIFIED_BY="[Empty name]" ORDER="154" SD_1="21.05" SD_2="16.42" SE="6.471803696969282" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.08" MODIFIED="2012-08-05 19:52:01 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Body image</NAME>
<CONT_DATA CI_END="28.485936217052902" CI_START="1.8540637829471027" EFFECT_SIZE="15.170000000000002" ESTIMABLE="YES" MEAN_1="78.33" MEAN_2="63.16" MODIFIED="2012-08-05 19:52:01 +0100" MODIFIED_BY="[Empty name]" ORDER="155" SD_1="20.0" SD_2="20.05" SE="6.793969849490758" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.09" MODIFIED="2012-08-05 19:52:28 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Career concerns</NAME>
<CONT_DATA CI_END="22.069731270273575" CI_START="-12.809731270273556" EFFECT_SIZE="4.63000000000001" ESTIMABLE="YES" MEAN_1="69.37" MEAN_2="64.74" MODIFIED="2012-08-05 19:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="28.16" SD_2="23.72" SE="8.897985579243262" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2014-03-07 20:41:07 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="13.71" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="48" TOTAL_2="57" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Psychological distress</NAME>
<GROUP_LABEL_1>MI via telephone</GROUP_LABEL_1>
<GROUP_LABEL_2>treatment as usual</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MI via telephone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment as usua</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.01" MODIFIED="2012-08-05 19:39:14 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>STAI post intervention</NAME>
<CONT_DATA CI_END="1.0497004898206024" CI_START="-12.049700489820594" EFFECT_SIZE="-5.4999999999999964" ESTIMABLE="YES" MEAN_1="31.87" MEAN_2="37.37" MODIFIED="2012-08-05 19:39:14 +0100" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="9.02" SD_2="10.75" SE="3.3417453287324665" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.02" MODIFIED="2012-08-05 19:40:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>HADS anxiety post intervention</NAME>
<CONT_DATA CI_END="1.4647770471408985" CI_START="-2.7647770471408992" EFFECT_SIZE="-0.6500000000000004" ESTIMABLE="YES" MEAN_1="4.25" MEAN_2="4.9" MODIFIED="2012-08-05 19:40:59 +0100" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="3.02" SD_2="3.36" SE="1.0789877078466699" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.03" MODIFIED="2012-08-05 19:41:40 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>HADS depression post intervention</NAME>
<CONT_DATA CI_END="1.7780545183922736" CI_START="-1.638054518392274" EFFECT_SIZE="0.06999999999999984" ESTIMABLE="YES" MEAN_1="2.44" MEAN_2="2.37" MODIFIED="2012-08-05 19:41:40 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SD_1="2.55" SD_2="2.59" SE="0.8714724004446968" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2014-03-07 20:41:10 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="64.65" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="32" TOTAL_2="38" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Lung function</NAME>
<GROUP_LABEL_1>MI via telephone</GROUP_LABEL_1>
<GROUP_LABEL_2>TAU</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MI</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.01" MODIFIED="2013-09-27 13:36:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>FEV<SUB>1</SUB> post intervention</NAME>
<CONT_DATA CI_END="15.201663089836968" CI_START="-11.441663089836963" EFFECT_SIZE="1.8800000000000026" ESTIMABLE="YES" MEAN_1="56.25" MEAN_2="54.37" MODIFIED="2012-08-05 19:34:01 +0100" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="21.11" SD_2="18.67" SE="6.796891777051284" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.02" MODIFIED="2012-08-10 15:54:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>FVC post intervention</NAME>
<CONT_DATA CI_END="10.350019981439294" CI_START="-14.49001998143928" EFFECT_SIZE="-2.069999999999993" ESTIMABLE="YES" MEAN_1="75.25" MEAN_2="77.32" MODIFIED="2012-08-10 15:54:25 +0100" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="20.57" SD_2="16.14" SE="6.336861329803415" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.04" MODIFIED="2014-03-07 20:41:10 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="63.04" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="16" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>% adherence behavior post intervention</NAME>
<GROUP_LABEL_1>MI via telephone</GROUP_LABEL_1>
<GROUP_LABEL_2>treatment as usual</GROUP_LABEL_2>
<GRAPH_LABEL_1>TAU</GRAPH_LABEL_1>
<GRAPH_LABEL_2>MI via telephone</GRAPH_LABEL_2>
<CONT_DATA CI_END="35.414279262728634" CI_START="-26.774279262728633" EFFECT_SIZE="4.32" ESTIMABLE="YES" MEAN_1="48.8" MEAN_2="44.48" MODIFIED="2012-08-05 19:30:10 +0100" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="47.44" SD_2="45.93" SE="15.864719713217355" STUDY_ID="STD-Quinn-2004" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2014-04-03 12:22:20 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Decision aid for patients considering lung transplantation versus usual care</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2014-03-05 12:39:06 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.7574215797236072" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="140" TOTAL_2="158" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Participants' knowledge</NAME>
<GROUP_LABEL_1>decision aid</GROUP_LABEL_1>
<GROUP_LABEL_2>usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours decision aid</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.01" MODIFIED="2012-08-22 09:08:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>3 week follow-up</NAME>
<CONT_DATA CI_END="1.3086783071173793" CI_START="0.6573216928826204" EFFECT_SIZE="0.9829999999999999" ESTIMABLE="YES" MEAN_1="2.957" MEAN_2="1.974" MODIFIED="2012-08-22 09:08:37 +0100" MODIFIED_BY="[Empty name]" ORDER="128" SD_1="1.08" SD_2="0.93" SE="0.1661654549197273" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.02" MODIFIED="2012-08-22 09:09:56 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>change in knowledge (week 3 - baseline)</NAME>
<CONT_DATA CI_END="1.3536107421820627" CI_START="0.5263892578179371" EFFECT_SIZE="0.94" ESTIMABLE="YES" MEAN_1="1.24" MEAN_2="0.3" MODIFIED="2012-08-22 09:09:56 +0100" MODIFIED_BY="[Empty name]" ORDER="129" SD_1="1.38" SD_2="1.17" SE="0.21102976658988204" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.02" MODIFIED="2014-03-05 12:38:17 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.442218569992257" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="140" TOTAL_2="158" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Patient expectations</NAME>
<GROUP_LABEL_1>decision aid</GROUP_LABEL_1>
<GROUP_LABEL_2>usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours decision aid</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.01" MODIFIED="2012-08-22 09:15:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>3 week follow-up</NAME>
<CONT_DATA CI_END="0.9539833680049623" CI_START="0.5060166319950379" EFFECT_SIZE="0.7300000000000001" ESTIMABLE="YES" MEAN_1="1.31" MEAN_2="0.58" MODIFIED="2012-08-22 09:15:47 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SD_1="0.75" SD_2="0.63" SE="0.11427932848343866" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.02" MODIFIED="2012-08-22 09:16:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>change in expectation score (week 3 - baseline)</NAME>
<CONT_DATA CI_END="0.9508751857001438" CI_START="0.36912481429985594" EFFECT_SIZE="0.6599999999999999" ESTIMABLE="YES" MEAN_1="0.71" MEAN_2="0.05" MODIFIED="2012-08-22 09:16:29 +0100" MODIFIED_BY="[Empty name]" ORDER="131" SD_1="0.98" SD_2="0.81" SE="0.1484084340296711" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.03" MODIFIED="2014-03-05 12:37:33 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="21.18" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="490" TOTAL_2="553" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Decisional conflict</NAME>
<GROUP_LABEL_1>decision aid</GROUP_LABEL_1>
<GROUP_LABEL_2>usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours decision aid</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours usual care</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.01" MODIFIED="2012-08-22 09:24:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Total score 3 week follow-up</NAME>
<CONT_DATA CI_END="-3.897110948402794" CI_START="-13.702889051597204" EFFECT_SIZE="-8.799999999999999" ESTIMABLE="YES" MEAN_1="11.6" MEAN_2="20.4" MODIFIED="2012-08-22 09:24:49 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SD_1="13.6" SD_2="16.9" SE="2.5015199719334476" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.02" MODIFIED="2012-08-22 09:25:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Subscale - certainty 3 week follow-up</NAME>
<CONT_DATA CI_END="-1.3748701529469667" CI_START="-18.62512984705303" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="26.4" MEAN_2="36.4" MODIFIED="2012-08-22 09:25:32 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SD_1="25.9" SD_2="27.8" SE="4.40065731568894" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.03" MODIFIED="2012-08-22 09:25:51 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Subscale - informed 3 week follow-up</NAME>
<CONT_DATA CI_END="-7.631222022773158" CI_START="-17.76877797722684" EFFECT_SIZE="-12.7" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="17.2" MODIFIED="2012-08-22 09:25:51 +0100" MODIFIED_BY="[Empty name]" ORDER="134" SD_1="9.6" SD_2="20.6" SE="2.5861587341444614" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.04" MODIFIED="2012-08-22 09:26:58 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Subscale - values 3 week follow-up</NAME>
<CONT_DATA CI_END="-0.6841479866079991" CI_START="-13.115852013392" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="16.8" MODIFIED="2012-08-22 09:26:58 +0100" MODIFIED_BY="[Empty name]" ORDER="135" SD_1="17.7" SD_2="21.0" SE="3.1714113434848032" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.05" MODIFIED="2012-08-22 09:27:27 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Subscale - support 3 week follow-up</NAME>
<CONT_DATA CI_END="-2.7485518936516025" CI_START="-12.451448106348398" EFFECT_SIZE="-7.6" ESTIMABLE="YES" MEAN_1="6.9" MEAN_2="14.5" MODIFIED="2012-08-22 09:27:27 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="12.3" SD_2="17.7" SE="2.4752741094305817" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.06" MODIFIED="2012-08-22 09:27:46 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Subscale - satisfaction with decision 3 week follow-up</NAME>
<CONT_DATA CI_END="-1.5842410543148135" CI_START="-13.415758945685184" EFFECT_SIZE="-7.499999999999998" ESTIMABLE="YES" MEAN_1="10.4" MEAN_2="17.9" MODIFIED="2012-08-22 09:27:46 +0100" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="16.4" SD_2="20.4" SE="3.018299822010984" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.03.07" MODIFIED="2012-08-22 09:28:14 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Change in total score (week 3 - baseline)</NAME>
<CONT_DATA CI_END="8.880750553487474" CI_START="-2.2807505534874757" EFFECT_SIZE="3.299999999999999" ESTIMABLE="YES" MEAN_1="16.4" MEAN_2="13.1" MODIFIED="2012-08-22 09:28:14 +0100" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="17.9" SD_2="16.7" SE="2.84737403212902" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="70" EVENTS_2="78" I2="0.0" I2_Q="0.0" ID="CMP-007.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-04-03 12:22:11 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="48.82" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="210" TOTAL_2="234" WEIGHT="0.0" Z="0.0">
<NAME>Patient's stated choice at 3-week follow-up</NAME>
<GROUP_LABEL_1>decision aid</GROUP_LABEL_1>
<GROUP_LABEL_2>usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>decision aid</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="47" EVENTS_2="55" I2="0.0" ID="CMP-007.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-03-05 15:05:32 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>Referral for transplantation</NAME>
<DICH_DATA CI_END="1.7154530622542432" CI_START="0.42568808785982926" EFFECT_SIZE="0.8545454545454545" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="55" LOG_CI_END="0.23437883951090144" LOG_CI_START="-0.3709085026279543" LOG_EFFECT_SIZE="-0.0682648315585264" MODIFIED="2014-03-05 15:05:32 +0000" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.35554878099302983" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="78" VAR="0.12641493566562947" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="7" I2="0.0" ID="CMP-007.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-03-05 15:05:32 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>Declined referral for transplantation</NAME>
<DICH_DATA CI_END="4.712506975308797" CI_START="0.6064096595591005" EFFECT_SIZE="1.6904761904761905" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.6732520060437438" LOG_CI_START="-0.21723388940139407" LOG_EFFECT_SIZE="0.22800905832117482" MODIFIED="2014-03-05 15:05:32 +0000" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.5230758229607473" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="78" VAR="0.273608316566063" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="16" I2="0.0" ID="CMP-007.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-03-05 15:05:32 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>Unsure</NAME>
<DICH_DATA CI_END="1.997473076911924" CI_START="0.39102045127603435" EFFECT_SIZE="0.8837719298245614" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.30048093435529744" LOG_CI_START="-0.40780052740194855" LOG_EFFECT_SIZE="-0.053659796523325524" MODIFIED="2014-03-05 15:05:32 +0000" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.41604803668598683" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="78" VAR="0.17309596883026424" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="53" EVENTS_2="49" I2="0.0" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-03-05 15:09:19 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="60" TOTAL_2="65" WEIGHT="0.0" Z="0.0">
<NAME>Durability of patient decisions (12-month follow up)</NAME>
<GROUP_LABEL_1>decision aid</GROUP_LABEL_1>
<GROUP_LABEL_2>usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours decision aid</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.517927392270793" CI_START="0.9377648414089804" EFFECT_SIZE="2.4723032069970845" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="49" LOG_CI_END="0.8141095182476016" LOG_CI_START="-0.027906053819714866" LOG_EFFECT_SIZE="0.39310173221394334" MODIFIED="2012-08-22 09:53:01 +0100" MODIFIED_BY="[Empty name]" ORDER="141" O_E="0.0" SE="0.49460411507664476" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="60" TOTAL_2="65" VAR="0.24463323065075085" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.06" MODIFIED="2014-03-05 15:09:19 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="28.00265585111284" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="70" TOTAL_2="79" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Preparation for decision-making (3-week follow up)</NAME>
<GROUP_LABEL_1>decision aid</GROUP_LABEL_1>
<GROUP_LABEL_2>usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours decision aid</GRAPH_LABEL_2>
<CONT_DATA CI_END="19.65083012695804" CI_START="2.949169873041953" EFFECT_SIZE="11.299999999999997" ESTIMABLE="YES" MEAN_1="65.1" MEAN_2="53.8" MODIFIED="2012-08-22 10:09:55 +0100" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="24.9" SD_2="27.1" SE="4.26070590726581" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0"/>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_DATA="YES" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-04-03 12:22:20 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.45" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Values congruence</NAME>
<GROUP_LABEL_1>Referral</GROUP_LABEL_1>
<GROUP_LABEL_2>Decline</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours decline</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours referral</GRAPH_LABEL_2>
<EFFECT_MEASURE>Odds Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-03-05 18:42:23 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Importance of living longer</NAME>
<IV_DATA CI_END="3.176555910053468" CI_START="1.0199998061838131" EFFECT_SIZE="1.800024003336229" ESTIMABLE="YES" ESTIMATE="0.5878" LOG_CI_END="0.5019565036863967" LOG_CI_START="0.008600089239066135" LOG_EFFECT_SIZE="0.2552782964627314" MODIFIED="2014-03-05 18:42:23 +0000" MODIFIED_BY="[Empty name]" ORDER="178" SE="0.2898" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-03-05 18:43:23 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Importance of avoiding hassle, stress, and worry of lung transplantation</NAME>
<IV_DATA CI_END="0.9881738998110507" CI_START="0.5999533269358316" EFFECT_SIZE="0.7699728688614912" ESTIMABLE="YES" ESTIMATE="-0.2614" LOG_CI_END="-0.005166621118258872" LOG_CI_START="-0.22188253402076122" LOG_EFFECT_SIZE="-0.11352457756951002" MODIFIED="2014-03-05 18:43:23 +0000" MODIFIED_BY="[Empty name]" ORDER="177" SE="0.1273" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="153" EVENTS_2="127" I2="0.0" I2_Q="0.0" ID="CMP-007.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-04-03 11:08:01 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="38.19" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="210" TOTAL_2="237" WEIGHT="0.0" Z="0.0">
<NAME>Acceptability</NAME>
<GROUP_LABEL_1>decision aid</GROUP_LABEL_1>
<GROUP_LABEL_2>usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours decision aid</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="52" EVENTS_2="31" I2="0.0" ID="CMP-007.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-08-22 10:26:10 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Received the right amount of information.</NAME>
<DICH_DATA CI_END="9.015711572383523" CI_START="2.2193242299711793" EFFECT_SIZE="4.473118279569892" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="31" LOG_CI_END="0.9550000094570917" LOG_CI_START="0.34622075468852354" LOG_EFFECT_SIZE="0.6506103820728076" MODIFIED="2012-08-22 10:26:10 +0100" MODIFIED_BY="[Empty name]" ORDER="146" O_E="0.0" SE="0.35759994775696924" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" VAR="0.12787772263578714" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="33" EVENTS_2="27" I2="0.0" ID="CMP-007.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-08-22 10:24:07 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Materials were helpful in helping to arrive at a decision.</NAME>
<DICH_DATA CI_END="3.3253944312092143" CI_START="0.8872794547528169" EFFECT_SIZE="1.7177177177177176" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="27" LOG_CI_END="0.5218431651694051" LOG_CI_START="-0.05193957459599638" LOG_EFFECT_SIZE="0.23495179528670432" MODIFIED="2012-08-22 10:24:07 +0100" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.3370428216085659" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" VAR="0.1135978635978636" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="68" EVENTS_2="69" I2="0.0" ID="CMP-007.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-08-22 10:32:24 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="79" WEIGHT="0.0" Z="0.0">
<NAME>Definitely or probably recommend the materials.</NAME>
<DICH_DATA CI_END="23.324925893134054" CI_START="1.040972795702532" EFFECT_SIZE="4.927536231884058" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="69" LOG_CI_END="1.3678202726005706" LOG_CI_START="0.017439380009428913" LOG_EFFECT_SIZE="0.6926298263049998" MODIFIED="2012-08-22 10:32:24 +0100" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.793220420801261" STUDY_ID="STD-Vandemheen-2009" TOTAL_1="70" TOTAL_2="79" VAR="0.6291986359761295" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2014-03-05 12:30:18 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Community-based support program versus contact telephone number</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2014-03-05 12:30:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="50.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="14" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Psychiatric Symptom Index - Anxiety subscale - mothers</NAME>
<GROUP_LABEL_1>Network support</GROUP_LABEL_1>
<GROUP_LABEL_2>Contact number</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours support</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.01.01" MODIFIED="2013-10-29 10:59:14 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="6" WEIGHT="0.0" Z="0.0">
<NAME>Mothers' anxiety - baseline</NAME>
<CONT_DATA CI_END="19.80209548782517" CI_START="-11.602095487825169" EFFECT_SIZE="4.100000000000001" ESTIMABLE="YES" MEAN_1="23.8" MEAN_2="19.7" MODIFIED="2013-10-29 10:59:14 +0000" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="14.4" SD_2="14.4" SE="8.01142041980429" STUDY_ID="STD-Chernoff-2002" TOTAL_1="7" TOTAL_2="6" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="6" WEIGHT="0.0" Z="0.0">
<NAME>Mothers' anxiety - 12 months post-baseline</NAME>
<CONT_DATA CI_END="10.93916253452464" CI_START="-18.139162534524637" EFFECT_SIZE="-3.599999999999998" ESTIMABLE="YES" MEAN_1="18.6" MEAN_2="22.2" ORDER="33" SD_1="9.5" SD_2="15.9" SE="7.4180763775292275" STUDY_ID="STD-Chernoff-2002" TOTAL_1="7" TOTAL_2="6" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2014-03-05 12:29:56 +0000" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Biofeedback assisted breathing re-training (BRT) versus biofeedback assisted relaxation training (RLXT)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.01" MODIFIED="2014-03-05 12:29:56 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.670142727875054" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="38" TOTAL_2="38" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pulmonary function</NAME>
<GROUP_LABEL_1>BRT</GROUP_LABEL_1>
<GROUP_LABEL_2>RLXT Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RLXT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours BRT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.01.01" MODIFIED="2013-09-27 13:37:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Forced expiratory volume (FEV<SUB>1</SUB>) in litres per second</NAME>
<CONT_DATA CI_END="0.9293707420827373" CI_START="0.15062925791726273" EFFECT_SIZE="0.54" ESTIMABLE="YES" MEAN_1="1.32" MEAN_2="0.78" ORDER="34" SD_1="0.56" SD_2="0.4" SE="0.19866219234335122" STUDY_ID="STD-Delk-1994" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>Forced vital capacity (FVC) in litres</NAME>
<CONT_DATA CI_END="1.8327025838841986" CI_START="-0.09270258388419839" EFFECT_SIZE="0.8700000000000001" ESTIMABLE="YES" MEAN_1="3.18" MEAN_2="2.31" ORDER="35" SD_1="1.58" SD_2="0.8" SE="0.4911838133138535" STUDY_ID="STD-Delk-1994" TOTAL_1="13" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.01.03" MODIFIED="2013-09-27 13:37:23 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>FEF<SUB>25-75% </SUB>in litres per second</NAME>
<CONT_DATA CI_END="1.242920484349002" CI_START="0.09707951565099815" EFFECT_SIZE="0.6700000000000002" ESTIMABLE="YES" MEAN_1="2.06" MEAN_2="1.39" ORDER="36" SD_1="0.88" SD_2="0.58" SE="0.2923117408626514" STUDY_ID="STD-Delk-1994" TOTAL_1="13" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2014-03-07 20:48:20 +0000" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Massage therapy versus bedtime reading control</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.01" MODIFIED="2014-03-07 20:48:20 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="25.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Well-being</NAME>
<GROUP_LABEL_1>Massage Therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours massage</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Parent Anxiety - State Trait Anxiety Inventory (STAI)</NAME>
<CONT_DATA CI_END="-0.36001094683164503" CI_START="-17.83998905316836" EFFECT_SIZE="-9.100000000000001" ESTIMABLE="YES" MEAN_1="30.9" MEAN_2="40.0" ORDER="37" SD_1="9.3" SD_2="10.6" SE="4.45926002830066" STUDY_ID="STD-Hernandez_x002d_Reif-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.02" MODIFIED="2008-04-30 15:43:10 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Child Anxiety - State Trait Anxiety Inventory for Children (STAIC)</NAME>
<CONT_DATA CI_END="-4.039979328509647" CI_START="-12.360020671490352" EFFECT_SIZE="-8.2" ESTIMABLE="YES" MEAN_1="24.7" MEAN_2="32.9" ORDER="38" SD_1="3.2" SD_2="5.9" SE="2.1224985276791126" STUDY_ID="STD-Hernandez_x002d_Reif-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Child Mood - Profile of Mood States (POMS)</NAME>
<CONT_DATA CI_END="-2.1941037002236765" CI_START="-8.805896299776323" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="7.2" ORDER="39" SD_1="2.7" SD_2="4.6" SE="1.6867127793432999" STUDY_ID="STD-Hernandez_x002d_Reif-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.02" MODIFIED="2014-03-05 12:29:04 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="250.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pulmonary function</NAME>
<GROUP_LABEL_1>Massage Therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours massage</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Peak Air Flow (PEFR) - Day 1</NAME>
<CONT_DATA CI_END="97.0411184094652" CI_START="-64.0411184094652" EFFECT_SIZE="16.5" ESTIMABLE="YES" MEAN_1="271.5" MEAN_2="255.0" ORDER="40" SD_1="87.8" SD_2="95.8" SE="41.09316244827112" STUDY_ID="STD-Hernandez_x002d_Reif-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Peak Air Flow (PEFR) - Day 30</NAME>
<CONT_DATA CI_END="151.07146832733207" CI_START="-43.2714683273321" EFFECT_SIZE="53.89999999999998" ESTIMABLE="YES" MEAN_1="297.9" MEAN_2="244.0" ORDER="41" SD_1="94.1" SD_2="125.4" SE="49.578190769732615" STUDY_ID="STD-Hernandez_x002d_Reif-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2014-03-07 20:51:13 +0000" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Music therapy versus familiar music and no audiotape control</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.01" MODIFIED="2014-03-07 20:51:13 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Enjoyment</NAME>
<GROUP_LABEL_1>Music Therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours music</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Parent enjoyment</NAME>
<CONT_DATA CI_END="2.179981992270027" CI_START="0.22001800772997282" EFFECT_SIZE="1.2" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="0.1" ORDER="42" SD_1="1.3" SD_2="0.9" SE="0.5" STUDY_ID="STD-Grasso-2000" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Child enjoyment</NAME>
<CONT_DATA CI_END="3.5895389220049863" CI_START="0.5104610779950134" EFFECT_SIZE="2.05" ESTIMABLE="YES" MEAN_1="1.35" MEAN_2="-0.7" ORDER="43" SD_1="1.9" SD_2="1.6" SE="0.7854934754662193" STUDY_ID="STD-Grasso-2000" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.02" MODIFIED="2014-03-05 12:28:20 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="28.74055349336885" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive</NAME>
<GROUP_LABEL_1>Music Therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours music</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-011.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Parent perception of time</NAME>
<CONT_DATA CI_END="7.534477632835274" CI_START="-16.934477632835275" EFFECT_SIZE="-4.7" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="0.2" ORDER="44" SD_1="16.9" SD_2="10.2" SE="6.242195126716242" STUDY_ID="STD-Grasso-2000" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2014-03-07 20:55:04 +0000" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Self-hypnosis versus control</NAME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.01" MODIFIED="2014-03-07 20:53:48 +0000" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Anxiety: State Trait Anxiety Inventory for Children (STAIC)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 11:09:22 +0100" MODIFIED_BY="[Empty name]" ORDER="149" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>No group differences were observed (U=15, p&gt;.05) for State Anxiety. A significant difference between experimental and control group was found for Trait Anxiety (U=1.5, p&lt;.004) with change scores reflecting decreases in Trait Anxiety for the experimental group and increases for the control group.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.02" MODIFIED="2014-03-07 20:55:00 +0000" MODIFIED_BY="[Empty name]" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Impact on Family Scale</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 11:01:55 +0100" MODIFIED_BY="[Empty name]" ORDER="150" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>No group differences were observed at post-intervention.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.03" MODIFIED="2014-03-07 20:55:04 +0000" MODIFIED_BY="[Empty name]" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Child Behavior Checklist</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 11:01:43 +0100" MODIFIED_BY="[Empty name]" ORDER="151" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>No group differences were observed at post-intervention.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.04" MODIFIED="2014-03-07 20:55:04 +0000" MODIFIED_BY="[Empty name]" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Average peak expiratory flow rate (PEFR)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 10:55:25 +0100" MODIFIED_BY="[Empty name]" ORDER="152" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>The mean PEFR score showed an increase of approximately 76 points from pre- to post-test in the experimental group, whereas it dropped approximately 12 points in the control group. This difference proved to be significant (U=0, p&lt;.001). The difference between the two groups was also significant at the 4-month follow up.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.05" MODIFIED="2014-03-07 20:54:53 +0000" MODIFIED_BY="[Empty name]" NO="5" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Height and weight</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 10:59:05 +0100" MODIFIED_BY="[Empty name]" ORDER="153" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>No group differences were observed (U=125, p&gt;.05) at 4 month follow up.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.06" MODIFIED="2014-03-07 20:54:27 +0000" MODIFIED_BY="[Empty name]" NO="6" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Rating of the parents' assessment of the child's illness</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 11:03:34 +0100" MODIFIED_BY="[Empty name]" ORDER="154" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>No group differences were observed (U=15, p&gt;.05) at post-intervention.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.07" MODIFIED="2014-03-07 20:54:23 +0000" MODIFIED_BY="[Empty name]" NO="7" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Locus of Control (LOC): Nowicki Strickland (1973) LOC for Children</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 11:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="155" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>Significant differences were found in change of Locus of Control (U=0, p=.001) between experimental and control group: The scores of the experimental group decreased, which indicates more internality.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.08" MODIFIED="2014-03-07 20:54:21 +0000" MODIFIED_BY="[Empty name]" NO="8" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Health Locus of Control: Children's Health Locus of Control (HLOC)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 11:07:34 +0100" MODIFIED_BY="[Empty name]" ORDER="156" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>Significant differences were found in change of Children&#8217;s Health Locus of Control (U=0, p=.001) between experimental and control group: The scores of the experimental group increased, which means that children&#8217;s internal expectancies related to health improved more in the experimental group.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-012.09" MODIFIED="2014-03-07 20:54:18 +0000" MODIFIED_BY="[Empty name]" NO="9" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Self-concept: Piers Harris Children's Self-Concept Scale</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 11:08:36 +0100" MODIFIED_BY="[Empty name]" ORDER="157" STUDY_ID="STD-Belsky-1994">
<TR>
<TD>
<P>Self-concept scores improved significantly more in the experimental group than in the control group (U=1.5, p=.003) at post-intervention.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" MODIFIED="2014-06-17 09:46:24 +0100" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Home telemedicine for patients awaiting transplantation versus usual care</NAME>
<OTHER_OUTCOME COLS="1" ID="CMP-013.01" MODIFIED="2012-08-23 12:02:56 +0100" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Quality of Life: Cystic Fibrosis Quality of Life Questionnaire (Gee 2000)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 12:02:56 +0100" MODIFIED_BY="[Empty name]" ORDER="158" STUDY_ID="STD-Wilkinson-2008">
<TR>
<TD>
<P>Telemedicine group a significant improvement in the subjects&#8217; perception of body image (P=.002).</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-013.02" MODIFIED="2014-06-17 09:45:50 +0100" MODIFIED_BY="[Empty name]" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Anxiety: Beck Anxiety Inventory (Beck 1988) + Borg anxiety scale (Borg 1982)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-06-17 09:45:50 +0100" MODIFIED_BY="[Empty name]" ORDER="159" STUDY_ID="STD-Wilkinson-2008">
<TR>
<TD>
<P>"There was no significant change in anxiety before and after link-up for the telemedicine group or before and after clinic attendance for either group. There was no difference in the change of anxiety from pre to post link-up for the telemedicine group or for the control group in pre and post clinic attendance." (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, p.184)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-013.03" MODIFIED="2014-06-17 09:46:24 +0100" MODIFIED_BY="[Empty name]" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Depression: Beck Depression Inventory (Beck 1987)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-06-17 09:46:24 +0100" MODIFIED_BY="[Empty name]" ORDER="160" STUDY_ID="STD-Wilkinson-2008">
<TR>
<TD>
<P>"At the end of the study there was a higher reporting of depression, which was associated with a higher reporting of anxiety, in both groups." (<LINK REF="STD-Wilkinson-2008" TYPE="STUDY">Wilkinson 2008</LINK>, p.184)</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-013.04" MODIFIED="2012-08-23 12:14:22 +0100" MODIFIED_BY="[Empty name]" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Coping of carers: COPE questionnaire (Carver 1997)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 12:14:22 +0100" MODIFIED_BY="[Empty name]" ORDER="161" STUDY_ID="STD-Wilkinson-2008">
<TR>
<TD>
<P>No significant differences between the two groups were found.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-013.05" MODIFIED="2012-08-23 12:16:15 +0100" MODIFIED_BY="[Empty name]" NO="5" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Health care utilization: seven-point questionnaire (number of visits, general practitioner, courses of IV antibiotics, length of hospital inpatient stay, visits either to hospital or GP)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 12:16:15 +0100" MODIFIED_BY="[Empty name]" ORDER="162" STUDY_ID="STD-Wilkinson-2008">
<TR>
<TD>
<P>No significant differences between the two groups were observed.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-014" MODIFIED="2013-10-29 10:59:27 +0000" MODIFIED_BY="[Empty name]" NO="14">
<NAME>Dance/movement therapy for adults versus control</NAME>
<OTHER_OUTCOME COLS="1" ID="CMP-014.01" MODIFIED="2012-08-23 12:24:05 +0100" MODIFIED_BY="[Empty name]" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Mood state: &#8217;The Profile of Mood States&#8217; (POMS; Mc Nair 1992)</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 12:23:57 +0100" MODIFIED_BY="[Empty name]" ORDER="163" STUDY_ID="STD-Goodill-2005">
<TR>
<TD>
<P>Scores were analysed performing a repeated measures ANOVA: Found within-subjects interaction of Time, group, and Gender on Levels of Confusion (F (2,20) =5.99, P=.007, eta2=.231). Men in the treatment group showed the strongest effect.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-014.02" MODIFIED="2012-08-23 12:25:30 +0100" MODIFIED_BY="[Empty name]" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Adherence to exercise and nutrition regimen</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 12:25:30 +0100" MODIFIED_BY="[Empty name]" ORDER="164" STUDY_ID="STD-Goodill-2005">
<TR>
<TD>
<P>No significant differences on exercise at post-intervention or follow-up (1 month later) and not for nutrition at post-intervention. But significant differences at follow-up between groups on adherence to nutrition regimes (Chi<SUP>2 </SUP>(1, N=23) = 4.485, P=.03) with lower levels in the control group.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-014.03" MODIFIED="2012-08-23 12:26:38 +0100" MODIFIED_BY="[Empty name]" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Body Image: Human figure drawing task</NAME>
<TR>
<TH>
<P>Narrative reported results</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2012-08-23 12:26:38 +0100" MODIFIED_BY="[Empty name]" ORDER="165" STUDY_ID="STD-Goodill-2005">
<TR>
<TD>
<P>No group differences were observed.</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-06-11 22:17:57 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-05-07 12:53:58 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Number of reports yielded by the new search for the current update (2014)</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAALKCAYAAAAYt9f9AABW0UlEQVR42u2df8RX5//HP8zMzEzM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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-06-11 22:17:57 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASQAAAL6CAIAAAAQR7x5AAAkqUlEQVR42u2dPW4cxxaFBzBgOJiA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-06-11 22:45:28 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-06-11 22:45:28 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-06-11 22:45:28 +0100" MODIFIED_BY="[Empty name]">New Search for the updated review</TITLE>
<APPENDIX_BODY MODIFIED="2012-11-02 14:46:09 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Psychological Therapies for Cystic Fibrosis: Search strategies June 2012</B>
</P>
<P>
<B>1.      Cochrane Central Register of Controlled Trials (CENTRAL)</B>
</P>
<TABLE COLS="2" ROWS="30">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Intervention: Psychotherapy</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#1</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor PSYCHOTHERAPY explode all trees</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#2</P>
</TD>
<TD VALIGN="TOP">
<P>(CBT or coping skills or counsel* or hypno* or mindfulness or psychoanal* or psychoeducat* or psychodynamic or psychotherapy* or rehabilitat*):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#3</P>
</TD>
<TD VALIGN="TOP">
<P>(psychologic* or behavior or behaviour or cognitive):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#4</P>
</TD>
<TD VALIGN="TOP">
<P>(Abreaction or (Acting NEXT Out) or Adlerian or (Adolescent NEXT Psych*) or (Anger NEXT Control) or (Anger NEXT Management) or (Art NEXT Therap*) or (Assertive* NEXT Training) or (Autogenic NEXT Training) or Autosuggestion or (Aversion NEXT Therap*) or (Balint NEXT Group) or Bibliotherap* or Biofeedback or (Caregiver NEXT Support) or (Child NEXT Psych*) or (Client NEXT Cent*) or (Color NEXT Therap*) or (Colour NEXT Therap*)  or (Mind NEXT Training) or (Conjoint NEXT Therap*) or (Contingency NEXT Management) or (Conversion NEXT Therap*) or (Conversational NEXT Therap*) or Countertransference or (Couples NEXT Therap*) or (Covert NEXT Sensitization) or (Crisis NEXT Intervention)):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#5</P>
</TD>
<TD VALIGN="TOP">
<P>((Dance NEXT Therap*) or Dialectic* or (Dream* NEXT Analys*) or Eclectic or (Emotion* NEXT Focus*) or (Emotional NEXT Freedom NEXT Technique) or (Encounter NEXT Group) or (Existential NEXT Therap*) or (Exposure NEXT Therap*) or (Eye NEXT Movement NEXT Desensiti*) or (Family NEXT Therap*) or (Free NEXT Association) or (Gestalt NEXT Therap*) or Griefwork  or (Group NEXT Therap*) or (Guided NEXT Image*) or Imagery or (Implosive NEXT Therap*) or (Insight NEXT Therap*) or Integrative or Interpersonal):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#6</P>
</TD>
<TD VALIGN="TOP">
<P>(Logotherap* or (Marital NEXT Therap*) or Meditation or (Mental NEXT Healing) or Metacognitive or (Milieu NEXT Therap*) or (Morita NEXT Therap*) or (Music NEXT Therap*) or (Narrative NEXT Therap*) or (Nondirective NEXT Therap*) or (Personal NEXT Construct) or (Person NEXT Cent*) or Persuasion or (Pet NEXT Therap*) or (Play NEXT Therap*) or (Primal NEXT Therap*) or (Problem NEXT Solv*) or Psychodrama or Psychotherapeutic):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#7</P>
</TD>
<TD VALIGN="TOP">
<P>((Rational NEXT Emotive) or (Reality NEXT Therap*) or (Reciprocal NEXT Inhibition) or (Relationship NEXT Therap*) or Relaxation or (Stress NEXT Manage*) or Reminiscence or (Role NEXT Play*) or (Self NEXT Analys*) or (Self NEXT Esteem) or (Sensitivity NEXT Training) or (Sex NEXT Therap*) or (Sleep NEXT Phase NEXT Chronotherap*) or (Socioenvironmental NEXT Therap*) or Sociotherap* or (Solution NEXT Focus*) or (Stress Manage*) or (Support NEXT Group*) or (Systematic NEXT Desensiti*) or (Therapeutic NEXT Communit*) or (Transactional NEXT Analysis) or (Validation NEXT Therap*)):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#8</P>
</TD>
<TD VALIGN="TOP">
<P>(Support NEAR/3 Psycho*):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#9</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor ASSOCIATION explode tree 1</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#10</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor HYPNOSIS explode tree 1</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#11</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor CYSTIC FIBROSIS explode all trees with qualifiers: PX,RH,TH</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#12</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor NUTRITION THERAPY explode all trees</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#13</P>
</TD>
<TD VALIGN="TOP">
<P>((nutrition* or diet*) NEAR/7 (behavi* or educat* or intervention or support* or therap*)):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#14</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor DIET explode all trees with qualifiers: PX,TH</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#15</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor SELF CARE explode all trees</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#16</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor SELF EFFICACY, this term only</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#17</P>
</TD>
<TD VALIGN="TOP">
<P>(self NEAR/3 (care* or educat* or efficacy or help or manage*)):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#18</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor HEALTH EDUCATION explode all trees</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#19</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor COUNSELING explode all trees</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#20</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor GENETIC COUNSELING explode all trees</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#21</P>
</TD>
<TD VALIGN="TOP">
<P>(#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Condition: Cystic Fibrosis</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#22</P>
</TD>
<TD VALIGN="TOP">
<P>MeSH descriptor CYSTIC FIBROSIS, this term only</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#23</P>
</TD>
<TD VALIGN="TOP">
<P>(cystic NEXT fibrosis):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#24</P>
</TD>
<TD VALIGN="TOP">
<P>Mucoviscidos*:ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#25</P>
</TD>
<TD VALIGN="TOP">
<P>((cysti* or cisti*) NEAR/10 fibros*):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#26</P>
</TD>
<TD VALIGN="TOP">
<P>(fibrocystic* NEAR pancrea*):ti,ab,kw</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#27</P>
</TD>
<TD VALIGN="TOP">
<P>(#22 or #23 or #24 or #25 or #26)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#28</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>(#21 and #27)</B>
</P>
</TD>
</TR>
</TABLE>
<P>
<B> 2.      OVID MEDLINE</B>
</P>
<TABLE COLS="2" ROWS="42">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Intervention: Psychotherapy</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1</P>
</TD>
<TD VALIGN="TOP">
<P>exp Psychotherapy/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2</P>
</TD>
<TD VALIGN="TOP">
<P>(CBT or coping skills or counsel?ing or hypno$ or mindfulness or psychoanal$ or psychoeducat$ or psychodynamic or psychotherap$ or rehabilitat$).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3</P>
</TD>
<TD VALIGN="TOP">
<P>(psychologic$ or behavio?r or cognitive).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4</P>
</TD>
<TD VALIGN="TOP">
<P>(Abreaction or Acting Out or Adlerian or Adolescent Psych$ or Analytical Psychotherap$ or Anger Control or Anger Management or Art Therap$ or Assertive$ Training or Autogenic Training or Autosuggestion or Aversion Therap$ or Balint Group or Behavio?r Contracting or Behavio?r Modification or Behavio?r Therap$ or Bibliotherap$ or Biofeedback or Body Psychotherap$ or Brief Psychotherap$ or Caregiver Support or Child Psych$ or Client Cent$ or Cognitive Behavio?r* or Cognitive$ Rehabilit$ or Cognitive Therap$ or Colo?r Therap$ or Compassionate Mind Training or Conjoint Therap$ or Contingency Management or Conversion Therap$ or Conversational Therap$ or Countertransference or Couples Therap$ or Covert Sensitization or Crisis Intervention).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5</P>
</TD>
<TD VALIGN="TOP">
<P>(Dance Therap$ or Dialectic$ or (Dream$ adj3 Analys$) or Eclectic or Emotion$ Focus$ or Emotional Freedom Technique or Encounter Group Therap$ or Existential Therap$ or Experiential Psychotherap$ or Exposure Therap$ or Expressive Psychotherap$ or Eye Movement Desensiti#ation or Family Therap$ or Feminist Therap$ or Free Association or Geriatric Psychotherap$ or Gestalt Therap$ or Griefwork or Group Psychotherap$ or Group Therap$ or Guided Image$ or Holistic Psychotherap$ or Humanistic Psychotherap$ or Hypnosis or Hypnotherap$ or Hypnoti#zability or Imagery or Implosive Therap$ or Individual Psychotherap$ or Insight Therap$ or Integrative Psychotherap$ or Integrative Therap$ or Interpersonal).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6</P>
</TD>
<TD VALIGN="TOP">
<P>(Logotherap$ or Marathon Group Therap$ or Marital Therap$ or Meditation or Mental Healing or Metacognitive Therap$ or Milieu Therap$ or Morita Therap$ or Music Therap$ or Narrative Therap$ or Nondirective Therap$ or Personal Construct Therap$ or Person Cent$ Therap$ or Persuasion Therap$ or Pet Therap$ or Play Therap$ or Primal Therap$ or Problem Solving or Psychoanaly$ or Psychodrama or Psychodynamic or Psychotherapeutic Counsel$ or Psychotherapeutic Processes or Psychotherapeutic Training).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>7</P>
</TD>
<TD VALIGN="TOP">
<P>(Rational Emotive or Reality Therap$ or Reciprocal Inhibition or Relationship Therap$ or Relaxation or Stress Management or Reminiscence Therap$ or Role Play$ or Self Analys$ or Self Esteem or Sensitivity Training or Sex Therap$ or Sleep Phase Chronotherap$ or Socioenvironmental Therap$ or Sociotherap$ or Solution Focused or Stress Management or Support Group$ or (Support adj3 Psycho$) or Systematic Desensiti#ation or Therapeutic Communit$ or Transactional Analysis or Validation Therap$).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>8</P>
</TD>
<TD VALIGN="TOP">
<P>ASSOCIATION/ or ASSOCIATION LEARNING/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>9</P>
</TD>
<TD VALIGN="TOP">
<P>exp HYPNOSIS/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>10</P>
</TD>
<TD VALIGN="TOP">
<P>CYSTIC FIBROSIS / px, rh, th [Psychology, Rehabilitation,Therapy]</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>11</P>
</TD>
<TD VALIGN="TOP">
<P>exp NUTRITION THERAPY/<BR/>
<I>(to include diet therapy/ and nutritional support/)</I>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>12</P>
</TD>
<TD VALIGN="TOP">
<P>((nutrition* or diet*) adj7 (behavi* or educat* or intervention or support* or therap*)).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>13</P>
</TD>
<TD VALIGN="TOP">
<P>DIET/px [Psychology]</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>14</P>
</TD>
<TD VALIGN="TOP">
<P>SELF CARE/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>15</P>
</TD>
<TD VALIGN="TOP">
<P>SELF EFFICACY/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>16</P>
</TD>
<TD VALIGN="TOP">
<P>((self) adj3 (care* or educat* or efficacy or help or manage*)).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>17</P>
</TD>
<TD VALIGN="TOP">
<P>exp HEALTH EDUCATION/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>18</P>
</TD>
<TD VALIGN="TOP">
<P>exp COUNSELING/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>19</P>
</TD>
<TD VALIGN="TOP">
<P>exp GENETIC COUNSELING/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>20</P>
</TD>
<TD VALIGN="TOP">
<P>or/1-19</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Condition: Cystic Fibrosis</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>21</P>
</TD>
<TD VALIGN="TOP">
<P>Cystic Fibrosis/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>22</P>
</TD>
<TD VALIGN="TOP">
<P>cystic fibrosis.tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>mucoviscidos$.tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>24</P>
</TD>
<TD VALIGN="TOP">
<P>((cysti$ or cisti$) adj10 fibros$).tw, ot.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>25</P>
</TD>
<TD VALIGN="TOP">
<P>(fibrocystic* and pancreas*).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>26</P>
</TD>
<TD VALIGN="TOP">
<P>or/15-19</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Filter: RCTs</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>27</P>
</TD>
<TD VALIGN="TOP">
<P>randomized controlled trial.pt.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>28</P>
</TD>
<TD VALIGN="TOP">
<P>controlled clinical trial.pt.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>29</P>
</TD>
<TD VALIGN="TOP">
<P>randomi#ed.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>30</P>
</TD>
<TD VALIGN="TOP">
<P>randomly.ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>31</P>
</TD>
<TD VALIGN="TOP">
<P>placebo.ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>32</P>
</TD>
<TD VALIGN="TOP">
<P>trial.ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>33</P>
</TD>
<TD VALIGN="TOP">
<P>groups.ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>34</P>
</TD>
<TD VALIGN="TOP">
<P>(control$ adj3 (trial or study)).ab,ti.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>35</P>
</TD>
<TD VALIGN="TOP">
<P>((singl$ or doubl$ or tripl$ or trebl$) adj3 (blind$ or mask$ or dummy)).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>36</P>
</TD>
<TD VALIGN="TOP">
<P>(animals not (humans and animals)).sh.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>37</P>
</TD>
<TD VALIGN="TOP">
<P>or/27-35</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>38</P>
</TD>
<TD VALIGN="TOP">
<P>37 not 36</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>39</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>(20 and 26 and 38)</B>
</P>
</TD>
</TR>
</TABLE>
<P>
<B> 3.      OVID EMBASE</B>
</P>
<TABLE COLS="2" ROWS="46">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Intervention: Psychotherapy</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1</P>
</TD>
<TD VALIGN="TOP">
<P>exp Psychotherapy/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2</P>
</TD>
<TD VALIGN="TOP">
<P>(CBT or coping skills or counsel?ing or hypno$ or mindfulness or psychoanal$ or psychoeducat$ or psychodynamic or psychotherap$ or rehabilitat$).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3</P>
</TD>
<TD VALIGN="TOP">
<P>(psychologic$ or behavio?r or cognitive).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4</P>
</TD>
<TD VALIGN="TOP">
<P>(Abreaction or Acting Out or Adlerian or Adolescent Psych$ or Analytical Psychotherap$ or Anger Control or Anger Management or Art Therap$ or Assertive$ Training or Autogenic Training or Autosuggestion or Aversion Therap$ or Balint Group or Behavio?r Contracting or Behavio?r Modification or Behavio?r Therap$ or Bibliotherap$ or Biofeedback or Body Psychotherap$ or Brief Psychotherap$ or Caregiver Support or Child Psych$ or Client Cent$ or Cognitive Behavio?r* or Cognitive$ Rehabilit$ or Cognitive Therap$ or Colo?r Therap$ or Compassionate Mind Training or Conjoint Therap$ or Contingency Management or Conversion Therap$ or Conversational Therap$ or Countertransference or Couples Therap$ or Covert Sensitization or Crisis Intervention).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5</P>
</TD>
<TD VALIGN="TOP">
<P>(Dance Therap$ or Dialectic$ or (Dream$ adj3 Analys$) or Eclectic or Emotion$ Focus$ or Emotional Freedom Technique or Encounter Group Therap$ or Existential Therap$ or Experiential Psychotherap$ or Exposure Therap$ or Expressive Psychotherap$ or Eye Movement Desensiti#ation or Family Therap$ or Feminist Therap$ or Free Association or Geriatric Psychotherap$ or Gestalt Therap$ or Griefwork or Group Psychotherap$ or Group Therap$ or Guided Image$ or Holistic Psychotherap$ or Humanistic Psychotherap$ or Hypnosis or Hypnotherap$ or Hypnoti#zability or Imagery or Implosive Therap$ or Individual Psychotherap$ or Insight Therap$ or Integrative Psychotherap$ or Integrative Therap$ or Interpersonal).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6</P>
</TD>
<TD VALIGN="TOP">
<P>(Logotherap$ or Marathon Group Therap$ or Marital Therap$ or Meditation or Mental Healing or Metacognitive Therap$ or Milieu Therap$ or Morita Therap$ or Music Therap$ or Narrative Therap$ or Nondirective Therap$ or Personal Construct Therap$ or Person Cent$ Therap$ or Persuasion Therap$ or Pet Therap$ or Play Therap$ or Primal Therap$ or Problem Solving or Psychoanaly$ or Psychodrama or Psychodynamic or Psychotherapeutic Counsel$ or Psychotherapeutic Processes or Psychotherapeutic Training).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>7</P>
</TD>
<TD VALIGN="TOP">
<P>(Rational Emotive or Reality Therap$ or Reciprocal Inhibition or Relationship Therap$ or Relaxation or Stress Management or Reminiscence Therap$ or Role Play$ or Self Analys$ or Self Esteem or Sensitivity Training or Sex Therap$ or Sleep Phase Chronotherap$ or Socioenvironmental Therap$ or Sociotherap$ or Solution Focused or Stress Management or Support Group$ or (Support adj3 Psycho$) or Systematic Desensiti#ation or Therapeutic Communit$ or Transactional Analysis or Validation Therap$).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>8</P>
</TD>
<TD VALIGN="TOP">
<P>Association/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>9</P>
</TD>
<TD VALIGN="TOP">
<P>Suggestion/ or Transference/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>10</P>
</TD>
<TD VALIGN="TOP">
<P>CYSTIC FIBROSIS / rh, th [Rehabilitation,Therapy]</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>11</P>
</TD>
<TD VALIGN="TOP">
<P>NUTRITION EDUCATION/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>12</P>
</TD>
<TD VALIGN="TOP">
<P>((nutrition* or diet*) adj7 (behavi* or educat* or intervention or support* or therap*)).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>13</P>
</TD>
<TD VALIGN="TOP">
<P>exp DIET THERAPY/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>14</P>
</TD>
<TD VALIGN="TOP">
<P>DIET/th</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>15</P>
</TD>
<TD VALIGN="TOP">
<P>exp SELF CARE/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>16</P>
</TD>
<TD VALIGN="TOP">
<P>exp SELF CONCEPT/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>17</P>
</TD>
<TD VALIGN="TOP">
<P>((self) adj3 (care* or educat* or efficacy or help or manage*)).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>18</P>
</TD>
<TD VALIGN="TOP">
<P>exp HEALTH EDUCATION/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>19</P>
</TD>
<TD VALIGN="TOP">
<P>exp COUNSELING/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>20</P>
</TD>
<TD VALIGN="TOP">
<P>or/1-19</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Condition: Cystic Fibrosis</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>21</P>
</TD>
<TD VALIGN="TOP">
<P>Cystic Fibrosis/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>22</P>
</TD>
<TD VALIGN="TOP">
<P>cystic fibrosis.tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>mucoviscidos$.tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>24</P>
</TD>
<TD VALIGN="TOP">
<P>((cysti$ or cisti$) adj10 fibros$).tw, ot.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>25</P>
</TD>
<TD VALIGN="TOP">
<P>(fibrocystic* and pancreas*).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>26</P>
</TD>
<TD VALIGN="TOP">
<P>or/21-25</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Filter: RCTs</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>27</P>
</TD>
<TD VALIGN="TOP">
<P>randomized controlled trial.de.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>28</P>
</TD>
<TD VALIGN="TOP">
<P>randomization.de.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>29</P>
</TD>
<TD VALIGN="TOP">
<P>placebo.de.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>30</P>
</TD>
<TD VALIGN="TOP">
<P>placebo.ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>31</P>
</TD>
<TD VALIGN="TOP">
<P>randomi#ed.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>32</P>
</TD>
<TD VALIGN="TOP">
<P>randomly.ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>33</P>
</TD>
<TD VALIGN="TOP">
<P>((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$ or dummy)).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>34</P>
</TD>
<TD VALIGN="TOP">
<P>factorial$.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>35</P>
</TD>
<TD VALIGN="TOP">
<P>(allocat$ or assign$).ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>36</P>
</TD>
<TD VALIGN="TOP">
<P>crossover procedure.de.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>37</P>
</TD>
<TD VALIGN="TOP">
<P>(crossover$ or cross over$).ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>38</P>
</TD>
<TD VALIGN="TOP">
<P>(quasi adj (experimental or random$)).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>39</P>
</TD>
<TD VALIGN="TOP">
<P>(control$ adj3 (trial$ or study or studies or group$)).ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>40</P>
</TD>
<TD VALIGN="TOP">
<P>((animal or nonhuman) not (human and (animal or nonhuman))).de.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>41</P>
</TD>
<TD VALIGN="TOP">
<P>or/27-39</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>42</P>
</TD>
<TD VALIGN="TOP">
<P>41 not 40</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>43</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>(20 and 26 and 42)</B>
</P>
</TD>
</TR>
</TABLE>
<P>
<B> 4.      OVID PsycINFO </B>
<I>(Condition + RCT filter only)</I>
</P>
<TABLE COLS="2" ROWS="25">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Condition: Cystic Fibrosis</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1</P>
</TD>
<TD VALIGN="TOP">
<P>Cystic Fibrosis/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2</P>
</TD>
<TD VALIGN="TOP">
<P>cystic fibrosis.tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3</P>
</TD>
<TD VALIGN="TOP">
<P>mucoviscidos$.tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4</P>
</TD>
<TD VALIGN="TOP">
<P>((cysti$ or cisti$) adj10 fibros$).tw, ot.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5</P>
</TD>
<TD VALIGN="TOP">
<P>(fibrocystic* and pancreas*).tw.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6</P>
</TD>
<TD VALIGN="TOP">
<P>or/21-25</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Filter: RCTs</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>7</P>
</TD>
<TD VALIGN="TOP">
<P>treatment effectiveness evaluation.sh.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>8</P>
</TD>
<TD VALIGN="TOP">
<P>clinical trials.sh.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>9</P>
</TD>
<TD VALIGN="TOP">
<P>mental health program evaluation.sh.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>10</P>
</TD>
<TD VALIGN="TOP">
<P>randomly.ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>11</P>
</TD>
<TD VALIGN="TOP">
<P>randomi#ed.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>12</P>
</TD>
<TD VALIGN="TOP">
<P>(placebo or (attention control)).ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>13</P>
</TD>
<TD VALIGN="TOP">
<P>(waitlist$ or (wait$ adj2 list$)).ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>14</P>
</TD>
<TD VALIGN="TOP">
<P>trial.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>15</P>
</TD>
<TD VALIGN="TOP">
<P>((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$ or dummy)).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>16</P>
</TD>
<TD VALIGN="TOP">
<P>(control$ adj3 (trial$ or study or studies or group$)).ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>17</P>
</TD>
<TD VALIGN="TOP">
<P>factorial$.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>18</P>
</TD>
<TD VALIGN="TOP">
<P>(allocat$ or assign$).ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>19</P>
</TD>
<TD VALIGN="TOP">
<P>(crossover$ or cross over$).ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>20</P>
</TD>
<TD VALIGN="TOP">
<P>(quasi adj (experimental or random$)).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>21</P>
</TD>
<TD VALIGN="TOP">
<P>"2000".md.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>22</P>
</TD>
<TD VALIGN="TOP">
<P> or/7-21</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>(6 and 22)</B>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;7 new studies (14 reports) were included + 1 previously ongoing (4 of the studies provided quantitative data for analysis)&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;32 reports assessed for eligibility + 1 ongoing trial was assessed for eligibility via information provided in the trial registry (24 studies)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;1146 records screened after duplicates removed&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;1705 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;1 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;1114 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;9 studies (9 reports) full-text articles excluded, with reasons&lt;/p&gt;&lt;p&gt;5 studies (6 reports) are awaiting information from authors&lt;/p&gt;&lt;p&gt;3 studies (3 reports + 1 clinical trials entry) are still ongoing&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>